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eRF3 (or alternatively through interactions with cap binding proteins). In the 
presence of UPF2 and UPF3, presumably bound to downstream EJCs on the 
mRNA, SMG1 phosphorylates UPF1; this in turn recruits SMG5, 6 and 7. SMG5, 
6 and 7 bind phosphorylated UPF1 through a common 14-3-3-like domain. SMG5 
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Back cover (bottom): Working model for no-go decay in yeast. During translation 
elongation ribosomes can be stalled for diverse reasons. A prolonged elongation 
stall leads to the recruitment of the Dom34/Hbs1 complex to the empty A site of 
the stalled ribosome. This event triggers the release of the nascent peptide, the 
cleavage of the mRNA in the vicinity of the stalled ribosome by an unknown 
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PROGRAM 
 
 
MONDAY, September 13—7:30 PM 
 
 
SESSION 1 RIBOSOME STRUCTURE AND FUNCTION 
 
Chairperson: J. Dinman, University of Maryland, College Park 
 
 
Structural biology of translation—From Escherichia coli to 
humans 
Jamie H.D. Cate. 
Presenter affiliation: University of California-Berkeley, Berkeley, 
California. 
 
 
 
 
1 
  
The 70S scanning mode of initiation 
Hiroshi Yamamoto, Daniela Wittek, Romi Gupta, Markus Pech, Kaori 
Yamamoto, Takuya Ueda, Knud H. Nierhaus. 
Presenter affiliation: Max-Planck-Institut, Berlin, Germany. 
 
 
 
2 
  
Mapping the eukaryotic translation initiation factor eIF2 binding 
site on the 40S ribosome 
Byung-Sik Shin, Joo-Ran Kim, Thomas E. Dever. 
Presenter affiliation: LGRD, NICHD, National Institutes of Health, 
Bethesda, Maryland. 
 
 
 
 
3 
  
The translocase-like factor Efl1 and Rpl10 act in concert to probe 
the P-site during 60S biogenesis 
Cyril Bussiere, Sucheta Arora, Arlen Johnson. 
Presenter affiliation: University of Texas at Austin, Austin, Texas. 
 
 
 
4 
  
Global rRNA pseudouridylation defects affect ribosomal ligand 
binding and translational fidelity from yeast to humans 
Karen Jack, Arturas Meskauskas, Cristian Bellodi, Noam Kopmar, Olga 
Krashykh, Dori M. Landry, Alison M. Dean, Sunnie R. Thompson, 
Davide Ruggero, Jonathan D. Dinman. 
Presenter affiliation: University of Maryland, College Park, Maryland. 
 
 
 
 
 
5 
  
Disruption of rRNA methylation attenuates the activity of certain 
cellular, but not viral IRESs 
Abhijit Basu, Sujan Chaudhuri, Priyanka Das, Francesca Gaccioli, 
Anton A. Komar, Maria Hatzoglou, Barsanjit Mazumder. 
Presenter affiliation: Cleveland State University, Cleveland, Ohio. 
 
 
 
 
6 
  
 vi 
Head swivel on the ribosome facilitates translocation via intra-
subunit tRNA hybrid sites 
Christian M. Spahn. 
Presenter affiliation: Charité - Universitätsmedizin Berlin, Berlin, 
Germany. 
 
 
 
 
7 
  
Towards energy landscapes of the ribosome—Exploring the 
interplay between ribosome dynamics and tRNA dynamics 
Paul C. Whitford, Peter Geggier, Andreas H. Ratje, Scott C. Blanchard, 
Christian M. Spahn, Karissa Y. Sanbonmatsu. 
Presenter affiliation: Los Alamos National Laboratory, Los Alamos, 
New Mexico. 
 
 
 
 
 
8 
  
The structure of a translating eukaryotic ribosome at 5.5 A 
Andreas M. Anger, Jean-Paul Armache, Alexander Jarasch, Thomas 
Becker, Thorsten Mielke, Roland Beckmann. 
Presenter affiliation: Gene Center, Ludwigs-Maximilians-Universität 
München, Munich, Germany. 
 
 
 
 
9 
  
Crystal structure of eukaryotic ribosome. 
Adam Ben-Shem, Lasse B. Jenner, Gulnara Yusupova, Marat 
Yusupov. 
Presenter affiliation: IGBMC, Illkirch, France. 
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TUESDAY, September 14—9:00 AM 
 
 
SESSION 2 FACTORS AND MECHANISMS 
 
Chairperson: J. Lorsch, Stanford University, California 
 
  
The RNA-binding and PABP-binding elements in the N-terminus 
of yeast eIF4G1 provide redundant pathways for assembly of 
activated eIF4F•mRNPs in vivo 
Eun-Hee Park, Sarah E. Walker, Joseph M. Lee, Stefan Rothenburg, 
Jon R. Lorsch, Alan G. Hinnebusch. 
Presenter affiliation: National Institutes of Health, Bethesda, Maryland. 
 
 
 
 
 
11 
  
Synergistic activation of eIF4A by eIF4B and eIF4G 
Klaus H. Nielsen, Manja A. Behrens, Yangzi He, Cristiano Oliveira, 
Lars S. Jensen, Søren V. Hoffman, Jan S. Pedersen, Gregers R. 
Andersen. 
Presenter affiliation: Aarhus University, Aarhus, Denmark. 
 
 
 
 
12 
  
 vii 
Bypassing of stable stems versus linear base-by-base inspection 
of structured mammalian mRNAs during ribosomal scanning 
Irina S. Abaeva, Vera P. Pisareva, Assen Marintchev, Christopher U. 
Hellen, Tatyana V. Pestova. 
Presenter affiliation: SUNY Downstate Medical Center, Brooklyn, New 
York. 
 
 
 
 
 
13 
  
The heterogeneous nuclear ribonucleoprotein Q (hnRNP-Q) binds 
poly(A) in vitro in competition with PABP—Implications for 
translational control 
Yuri V. Svitkin, Akiko Yanagiya, Nahum Sonenberg. 
Presenter affiliation: McGill University, Montreal, Canada. 
 
 
 
 
14 
  
Human eIF4AIII interacts with an eIF4G-like partner, NOM1, 
revealing an evolutionarily conserved role in ribosome biogenesis 
Andrei Alexandrov, David Colognori, Joan A. Steitz. 
Presenter affiliation: Yale University School of Medicine, Howard 
Hughes Medical Institute, New Haven, Connecticut. 
 
 
 
 
15 
  
Structural basis and function of eIF3i/TIF34 binding to the major 
eIF3 scaffolding subunit eIF3b/PRT1 
Dalia Daujotyte, Anna Herrmannová, Ji-Chun Yang, Lucie Cuchalová, 
Fabrice Gorrec, Susan Wagner, István Dányi, Leoš Valášek, Peter J. 
Lukavsky. 
Presenter affiliation: Institute of Microbiology, ASCR, Prague, Czech 
Republic. 
 
 
 
 
 
 
16 
  
Coordinated movement of eIF1, eIF1A and eIF5 mediates the 
response to start codon recognition 
Jagpreet S. Nanda, Adesh Saini, Alan Hinnebusch, Jon Lorsch. 
Presenter affiliation: Johns Hopkins University, Baltimore, Maryland. 
 
 
 
17 
  
Unveiling faces on eIF5 that interact with eIF2β, eIF1 and eIF1A—
Snapshots of key interactions involved in step-wise assembly of 
translation initiation 
Rafael E Luna, Haribabu Arthanari, Jagpreet Nanda, Chingakham 
Singh, Hiroyuki Hiraishi, Michelle Markus, Amr Fahmy, Sven Hyberts, 
Assen Marintchev, Katsura Asano, Jon Lorsch, Gerhard Wagner. 
Presenter affiliation: Harvard Medical School, Boston, Massachusetts. 
 
 
 
 
 
 
18 
  
Rearrangement of eIF5-CTD interactions defines functional 
transition from 43S to 48S ribosomal pre-initiation complex 
Chingakham R. Singh, Ryouske Watanabe, Yuka Ikeda, Marcelo J. 
Murai, Katsura Asano. 
Presenter affiliation: Kansas State University, Manhattan, Kansas. 
 
 
 
 
19 
  
 viii 
Interplay between intra- and intermolecular interactions involving 
human eIF1A and eIF5B 
Nicolae L. Sandor, Elthea Hendrickson, Dana Sandor, Gerhard 
Wagner, Tatyana V. Pestova, Assen Marintchev. 
Presenter affiliation: Boston University School of Medicine, Boston, 
Massachusetts. 
 
 
 
 
 
20 
  
Regulation of IF2 binding kinetics and 30S initiation complex 
structural dynamics during translation initiation 
Jiangning Wang, Margaret M. Elvekrog, Ruben L. Gonzalez Jr. 
Presenter affiliation: Columbia University, New York, New York. 
 
 
 
21 
  
System-level control properties in eukaryotic protein synthesis 
Helena M. Firczuk, Shichina Kannambath, Shirley Tait, Hans 
Westerhoff, Jürgen Pahle, Pedro Mendes, John E G. McCarthy. 
Presenter affiliation: The University of Manchester, Manchester, United 
Kingdom. 
 
 
 
 
22 
 
 
TUESDAY, September 14—2:00 PM 
 
 
SESSION 3 POSTER SESSION I 
 
  
Individual and synergistic activities of Ded1, DDX3, DHX29 and 
eIFs 4A/4B/4G in eukaryotic translation initiation 
Irina S. Abaeva, Christopher U. Hellen, Tatyana V. Pestova. 
Presenter affiliation: SUNY Downstate Medical Center, Brooklyn, New 
York. 
 
 
 
 
23 
  
Regulation of mTOR signalling pathway by translation 
termination factor eRF3a involves the transcriptional regulator 
ATF4 
Hayet Ait Ghezala, Samia Salhi, Béatrice Jollès, Wassila Carpentier, 
Olivier Jean-Jean. 
Presenter affiliation: Université Pierre et Marie Curie, Paris, France. 
 
 
 
 
 
24 
  
Insights into the structure of human translation initiation factors 
eIF4A , eIF4G and their complex by NMR and SAXS 
Sabine R. Akabayov, Gerhard Wagner. 
Presenter affiliation: Harvard Medical School, Boston, Massachusetts. 
 
 
 
25 
  
 ix 
Chemical genetic studies identify Heme regulated inhibitor kinase 
as a novel target for cancer therapy 
Ting Chen, Duygu Ozel, Limo Chen, Michael Chorev, Jose A. Halperin, 
Bertal H. Aktas. 
Presenter affiliation: Harvard Medical School, Cambridge, 
Massachusetts; Brigham and Women Hospital, Boston, 
Massachusetts. 
 
 
 
 
 
 
26 
  
eIF2γ mutants affects the fidelity of AUG codon selection 
independent of Met-tRNAi
Met binding affinity 
Pankaj V. Alone, Cao Cao, Thomas E. Dever. 
Presenter affiliation: National Institute of Science Education & 
Research, Bhubaneswar, India. 
 
 
 
 
27 
  
Direct observation of the second hybrid state in a translocating 
ribosome 
Mediha E. Altuntop, Yuhong Wang. 
Presenter affiliation: University of Houston, Houston, Texas. 
 
 
 
28 
  
Identification of phosphorylated residues on eukaryotic initiation 
factor 2 by using the LTQ Orbitrap XL 
Armann A. Andaya, Weitao Jia, Masaaki Sokabe, John W. Hershey, 
Julie A. Leary. 
Presenter affiliation: University of California, Davis, Davis, California. 
 
 
 
 
29 
  
eIFs involved in 5' scanning and the closed-loop model of mRNA. 
Stuart K. Archer, Meghna Sobti, Thomas Preiss. 
Presenter affiliation: Victor Chang Cardiac Research Institute, 
Darlinghurst, Australia. 
 
 
 
30 
  
Frameshifting and readthrough in viral and Drosophila 
chromosomal gene expression 
John F. Atkins, Pavel V. Baranov, Betty Y. Chung, Andrew E. Firth, 
Norma M. Wills. 
Presenter affiliation: University of Utah, Salt Lake Ctiy, Utah; University 
College Cork, Cork, Republic of Ireland. 
 
 
 
 
 
31 
  
Cytoskeletal control of c-Jun translation is dependent on eIF2α 
phosphorylation and mediated by an internal ribosome entry site 
Andrea Atzmon, Lior Blau, Iris Ben-Dror, Lily Vardimon. 
Presenter affiliation: Tel Aviv University, Tel Aviv, Israel. 
 
 
 
 
32 
  
 x 
Modulation of mammalian eEF1 function decreases tRNA 
occupancy on ribosomes during mitosis 
Ranen Aviner, Gilad Sivan, Dalia Pinchasi, Orna Elroy-Stein. 
Presenter affiliation: Tel Aviv University, Tel Aviv, Israel. 
 
 
 
33 
  
The hnRNP R/Q homolog Racquetball is required for stable 
expression of specific transcripts during Drosophila 
spermatogenesis 
Catherine C. Baker, Lucineh Parsanian, Margaret T. Fuller. 
Presenter affiliation: Stanford University, Stanford, California. 
 
 
 
 
34 
  
Characteristics of the polysome-binding phosphotyrosine domain 
of PMR1 and identification of a corresponding SH2-domain 
partner protein 
Baskar Bakthavachalu, Maria Neil, Daniel R. Schoenberg. 
Presenter affiliation: Ohio State University, Columbus, Ohio. 
 
 
 
 
35 
  
Regulation of the negative sense HIV-1 vpo by an upstream sORF 
region 
Michael S. Barbagallo, Jennifer A. Mosse, Nicholas J. Deacon. 
Presenter affiliation: Monash University, Churchill, Australia. 
 
 
 
 
36 
  
Investigation of translational regulation during cold-shock 
Amandine Bastide, Ruth V. Spriggs, Anne Roobol, Joanne Roobol, 
Martin Bushell, Mark C. Smales, Anne E. Willis. 
Presenter affiliation: MRC, Leicester, United Kingdom; University of 
Nottingham, Nottingham, United Kingdom. 
 
 
 
 
37 
  
rRNA modifications regulate cellular IRES-mediated translation 
through the 48S pre-initiation complex assembly, which is 
required for tumor suppression 
Cristian Bellodi, Olya Krasnykh, Nikisha Haynes, Marily 
Theodoropoulou, Lorenzo Montanaro, Noam Kopmar, Adrian 
Contreras, Davide Ruggero. 
Presenter affiliation: University of California, San Francisco, San 
Francisco, California. 
 
 
 
 
 
 
 
38 
  
Selenoprotein mRNA hierarchy and sensitivity to nonsense 
mediated decay 
Lucia A. Seale, Christy L. Gilman, Ali Seyedali, Kent Duncan, Matthias 
W. Hentze, Marla J. Berry. 
Presenter affiliation: University of Hawaii, Honolulu, Hawaii. 
 
 
 
 
39 
  
 xi 
Species-specific adaptation of cytomegaloviruses to protein 
kinase R 
Craig J. Bierle, Stephanie J. Child, Greg Brennan, Mark R. Schleiss, 
Adam P. Geballe. 
Presenter affiliation: Fred Hutchinson Cancer Research Center, 
Seattle, Washington; University of Washington, Seattle, Washington. 
 
 
 
 
 
40 
  
Utilizing mechanisms of the unfolded protein response to identify 
factors involved in ribosome scanning of structured mRNA 
Cheryl G. Bolinger, Thomas Dever. 
Presenter affiliation: National Institute of Child Health and Human 
Development, Bethesda, Maryland. 
 
 
 
 
41 
  
Retrovirus assembly requires original Argonaute 2 functions 
unrelated to microRNAs and translation repression 
Manuella Bouttier, Anne Saumet, Marion Peter, Valerie Courgnaud, 
Edouard Bertrand, Charles-Henri Lecellier. 
Presenter affiliation: Institut de Génétique Moléculaire de Montpellier, 
Montpellier, France. 
 
 
 
 
 
42 
  
Circadian translational regulation in Drosophila 
Sean J. Bradley, Michael Rosbash. 
Presenter affiliation: HHMI, National Center for Behavioral Genomics, 
Brandeis University, Waltham, Massachusetts. 
 
 
 
43 
  
Cryo-EM studies of programmed ribosomal frameshifting 
Emily Nikolic, John Flanagan IV, Alistair Siebert, Stephen Moran, 
Olivier Namy, Eszter Csibra, Robert Gilbert, Ian Brierley. 
Presenter affiliation: University of Cambridge, Cambridge, United 
Kingdom. 
 
 
 
 
44 
  
ePABP phosphorylation is required for X. laevis oocyte 
maturation 
Matthew Brook, J. Kyle Friend, Micheal D. Sheets, Nicola K. Gray, 
Emre U. Seli. 
Presenter affiliation: MRC Human Reproductive Sciences Unit, 
Edinburgh, United Kingdom; University of Edinburgh, Edinburgh, 
United Kingdom. 
 
 
 
 
 
 
45 
  
Plant eIFiso4F plays a role in plant development and response to 
stress 
Andrew D. Lellis, M. Leah Allen, Alice W. Aertker, Jonathan K. Tran, 
David E. Hillis, Christian Caldwell, Daniel R. Gallie, Karen S. Browning. 
Presenter affiliation: University of Texas at Austin, Austin, Texas. 
 
 
 
 
46 
  
 xii 
Dissecting the role of a shuttling RNA-binding protein required 
for fungal plant pathogenesis 
Emilio Bueno, Marina Franceschetti, Ane Sesma. 
Presenter affiliation: John Innes Centre, Norwich, United Kingdom. 
 
 
 
47 
  
Nuclear relocalisation of cytoplasmic poly(A)-binding proteins 
Hannah M. Burgess, Christine Salaun, Sheila V. Graham, Nicola K. 
Gray. 
Presenter affiliation: MRC HRSU, University of Edinburgh, United 
Kingdom. 
 
 
 
 
48 
  
p38 MAPK/MK2/3-mediated induction of miR-34c following DNA 
damage prevents Myc-dependent DNA replication 
Ian G. Cannell, Yi W. Kong, Androulla Elia, Martin Eilers, Anne E. 
Willis, Martin Bushell. 
Presenter affiliation: University of Leicester, Leicester, United 
Kingdom. 
 
 
 
 
 
49 
  
Quantitative genetic analysis reveals distinct phenotypes for 
individual snoRNA deletion mutants 
Thomas M. Carlile, Hannes Braberg, Nevan Krogan, Wendy V. Gilbert. 
Presenter affiliation: Massachusetts Institute of Technology, 
Cambridge, Massachusetts. 
 
 
 
 
50 
  
Identification of kinases regulating VEGF IRES translation under 
hypoxic conditions by high-throughput siRNA screening 
Claudia M. Casanova, Peter Sehr, Petra Binninger, Kent Duncan, 
Beate Neumann, Christian Thoma. 
Presenter affiliation: University Hospital of Freiburg, Freiburg, 
Germany; European Molecular Biology Laboratory, Heidelberg, 
Germany. 
 
 
 
 
 
 
51 
  
Selected mRNAs that are translated under glucose starved 
conditions in Sacchaomyces cerevisiae, are important for stress 
Lydia M. Castelli, Susan G. Campbell, Jonathan Bone, Leo Zeef, Paul 
F. Sims, Mark P. Ashe. 
Presenter affiliation: University of Manchester, Manchester, United 
Kingdom. 
 
 
 
 
 
52 
  
Analysis of the mRNA-protein interactome of living HeLa cells 
Alfredo Castello, Katrin Schuschke, Claudia Strein, Lars Steinmetz, 
Jeroen Krijgsveld, Matthias W. Hentze. 
Presenter affiliation: European Molecular Biology Laboratory, 
Heidelberg, Germany. 
 
 
 
 
53 
  
 xiii 
Differentiation of Trypanosoma cruzi into infective forms involves 
phosphorylation of eIF2α and inhibition of translation initiation 
Renata R. Tonelli, Beatriz A. Castilho, Sergio Schenkman. 
Presenter affiliation: Universidade Federal de Sao Paulo, Sao Paulo, 
Brazil. 
 
 
 
 
54 
  
Reversing chemoresistance with inhibitors of eIF4E:eIF4G 
interaction 
Regina Cencic, David R. Hall, Francis Robert, Dima Kozakov, Sandor 
Vajda, Jerry Pelletier. 
Presenter affiliation: McGill University, Montreal, Canada. 
 
 
 
 
55 
  
Myeloid HuR promotes tumor growth and angiogenesis 
Sung-Hee Chang, Yuquan Xiong, Mallika Ghosh, Timothy Hla. 
Presenter affiliation: Weill Cornell Medical School, New York, New 
York. 
 
 
 
56 
  
The ribosomal frameshift which controls the synthesis of HIV-1 
enzymes is influenced by the 5’UTR region of HIV-1 full-length 
mRNA 
Johanie Charbonneau, Karine Gendron, Nikolaus Heveker, Gerardo 
Ferbeyre, Léa Brakier-Gingras. 
Presenter affiliation: Université de Montréal, Montréal, Canada. 
 
 
 
 
 
57 
  
Discovering novel cis-regulatory elements in mRNAs using 
bioinformatics 
Xiaowei (Sylvia) Chen, Josh Gagnon, Stewart Stevens, Augustine 
Chen, Chris Brown. 
Presenter affiliation: Otago University, Dunedin, New Zealand. 
 
 
 
 
58 
  
Competitive and non-competitive binding of eIF4B, eIF4A, and the 
poly(A)-binding protein to wheat translation initiation factor 
eIFiso4G 
Shijun Cheng, Daniel R. Gallie. 
Presenter affiliation: University of California-Riverside, Riverside, 
California. 
 
 
 
 
 
59 
  
The C-terminal region of eIF3a promotes mRNA recruitment, 
scanning and, together with eIF3j and the eIF3b RRM, selection of 
AUG start codons 
Wen-Ling Chiu, Susan Wagner, Anna Herrmannová, Laxminarayana 
Burela, Fan Zhang, Adesh K. Saini, Leoš Valášek, Alan G. 
Hinnebusch. 
Presenter affiliation: LGRD/NICHD, National Institutes of Health, 
Bethesda, Maryland. 
 
 
 
 
 
 
 
60 
  
 xiv 
Functional analysis of PKR from Danio rerio 
Eunseok Choi, Bhavesh Joshi, Wolf Pecher, Rosemary Jagus. 
Presenter affiliation: University of Maryland Center for Environmental 
Science, Baltimore, Maryland. 
 
 
 
61 
  
Translation of the Smcp mRNA in haploid spermatogenic cells in 
transgenic mice is regulated by multiple mechanisms involving 
interactions between the 5’UTR and 3’UTR and a segment 
downstream of the first poly(A) signal 
Tamzid A. Chowdhury, Danielle Cullinane, Jana Bagarova, Kenneth C. 
Kleene. 
Presenter affiliation: University of Massachusetts Boston, Boston, 
Massachusetts. 
 
 
 
 
 
 
 
62 
  
Role of translation initiation factor eIF(iso)4E during infection of 
Arabidopsis thaliana with a Mexican isolate of Tobacco Etch virus 
Carlos A. Contreras-Paredes, Cesar Aguirre-Martínez, Maribel 
Calderón-León, Laura Silva-Rosales, Tzvetanka D. Dinkova. 
Presenter affiliation: Facultad de Química, UNAM, México, Mexico. 
 
 
 
 
63 
  
Fragile X related protein 1 sequesters the translational machinery 
at a subset of large dendritic spines 
Denise Cook, Maria del Rayo Sanchez-Carbente, Claude Lachance, 
Danuta Radzioch, Luc DesGroseillers, Keith Murai. 
Presenter affiliation: McGill University, Montreal, Canada. 
 
 
 
 
64 
  
Post-transcriptional control of gene expression following 
exposure to tobacco smoke 
Rebecca E. Cooper, Weng C. Chan, Anne E. Willis. 
Presenter affiliation: MRC Toxicology Unit, Leicester, United Kingdom; 
The University of Nottingham, Nottingham, United Kingdom. 
 
 
 
 
65 
  
The stem cell regulatory protein, Musashi, exerts context-
dependent mRNA translational control 
Chad E. Cragle, Linda Hardy, Melanie C. MacNicol, Angus M. 
MacNicol. 
Presenter affiliation: University of Arkansas for Medical Sciences, Little 
Rock, Arkansas. 
 
 
 
 
 
66 
  
Compound D inhibits translation elongation via the E site 
Yongjun Dang, Tilman Schneider-Poetsch, Daniel E. Eyler, Shridhar 
Bhat, Rachel Green, Jun O. Liu. 
Presenter affiliation: The Johns Hopkins University School of Medicine, 
Baltimore, Maryland. 
 
 
 
 
67 
  
 xv 
RNA vaccination as a therapeutic tool against cancer—Increased 
immunostimulatory capacity by a phosphorothioate cap analog 
Andreas N. Kuhn, Edward Darzynkiewicz, Mustafa Diken, Sebastian 
Kreiter, Joanna Kowalska, Jacek Jemielity, Christoph Huber, Özlem 
Türeci, Ugur Sahin. 
Presenter affiliation: University of Warsaw, Warsaw, Poland. 
 
 
 
 
 
68 
  
Interaction of human decapping scavenger hDcpS with 5’ mRNA 
cap analogs 
Zbigniew M. Darzynkiewicz, Zbigniew Wieczorek, Ryszard Stolarski. 
Presenter affiliation: University of Warsaw, Warsaw, Poland. 
 
 
 
69 
  
Coupled transcriptional and translational control of ATF4 is 
central for differential regulation of the integrated stress 
response 
Souvik Dey, Thomas Baird, Dan F. Spandau, Ronald C. Wek. 
Presenter affiliation: Indiana university School of Medicine, 
Indianapolis, Indiana. 
 
 
 
 
 
70 
  
Translational regulation by phospho-eIF2α requires 
phosphorylation of specifically position 51 
Madhusudan Dey. 
Presenter affiliation: University of Wisconsin-Milwaukee, Milwaukee, 
Wisconsin. 
 
 
 
 
71 
  
Structure-function analysis of DHX29 
Vidya Dhote, Natalia Kim, Christopher U. Hellen, Tatyana Pestova. 
Presenter affiliation: SUNY Downstate Medical Center, Brooklyn, New 
York. 
 
 
 
72 
  
Translational regulation by RNA secondary structures—New 
strategies for drug discovery ? 
Marie-Cecile Didiot, Hanspeter Nick, Juergen Reinhardt, Christian N. 
Parker. 
Presenter affiliation: Novartis Pharma AG, Basel, Switzerland. 
 
 
 
 
73 
  
TISU directs efficient translation initiation without scanning and 
is differentially regulated by EIF1 
Rofa Elfakess, Hadar Sinvani, Ora Haimov, Rivka Dikstein. 
Presenter affiliation: Weizmann Institute of Science, Rehovot, Israel. 
 
 
 
74 
  
A flexible loop in yeast ribosomal protein L11 coordinates P-site 
tRNA binding 
Michael H. Rhodin, Jonathan D. Dinman. 
Presenter affiliation: University of Maryland, College Park, Maryland. 
 
 
 
75 
  
 xvi 
Phosphorylation of eIF4G1 by PKCα controls interactions of 
eIF4G1 with Mnk1 
Mikhail I. Dobrikov, Elena Y. Dobrikova, Mayya V. Shveygert, Matthias 
Gromeier. 
Presenter affiliation: Duke University Medical Center, Durham, North 
Carolina. 
 
 
 
 
 
76 
  
Multiple identity elements in initiator tRNA control the fidelity of 
start codon recognition 
Jinsheng Dong, Sarah E. Kolitz, Wen-ling Chiu, Hafsa Rahman, Jon R. 
Lorsch, Alan G. Hinnebusch. 
Presenter affiliation: LGRD, National Institutes of Health, Bethesda, 
Maryland. 
 
 
 
 
 
77 
  
The decapping activator HPat a novel factor co-purifying with 
GW182 in Drosophila cells 
Elisabeth Jäger, Silke Dorner. 
Presenter affiliation: Max F. Perutz Laboratories, University of Vienna, 
Vienna, Austria. 
 
 
 
 
78 
  
YB-1 - PABP interplay in specific regulation of YB-1 mRNA 
translation 
Lyabin N. Dmitry, Eliseeva A. Irina, Skabkina V. Olga, Ovchinnikov P. 
Lev. 
Presenter affiliation: Institute of Protein Research, Russian Academy of 
Sciences, Pushchino, Russia. 
 
 
 
 
 
79 
  
A mouse model for eIF2B-leukodystrophy reveals abnormal 
development of brain white matter 
Michal Geva, Yuval Cabilly, Yaniv Assaf, Nina Mindroul, Liraz Marom, 
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STRUCTURAL BIOLOGY OF TRANSLATION: FROM ESCHERICHIA 
COLI TO HUMANS 
 
Jamie H.D. Cate  
 
University of California-Berkeley, Departments of Chemistry and 
Molecular and Cell Biology, Berkeley, CA, 94720 
 
The bacterium Escherichia coli has served for decades as a model for 
understanding translation and the ribosome. I will present x-ray crystal 
structures of 70S ribosomes from Escherichia coli in a number of different 
conformational states that we think shed light on the dynamics of the 
ribosome during translation. Although many aspects of translation are 
universally conserved, many key distinctions exist between the different 
domains of life. I will discuss our recent structural findings regarding the 
selectivity of antibiotics that relies on these distinctions. In addition, I will 
describe our efforts to tackle the structural biology of human translation. I 
will highlight our efforts to understand how translation initiation is 
manipulated by the hepatitis C virus (HCV) through specific interactions 
between the HCV Internal Ribosome Entry Site (IRES) and the translational 
machinery. 
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THE 70S SCANNING MODE OF INITIATION 
 
Hiroshi Yamamoto1, Daniela Wittek1, Romi Gupta1, Markus Pech1,2, Kaori 
Yamamoto2, Takuya Ueda3, Knud H Nierhaus1,2  
 
1Max-Planck-Institut , Molekulare Genetik, Berlin, 14195, Germany, 
2CharitéCentrum für Grundlagenmedizin Institut , Medizinische Physik und 
Biophysik, Berlin, 10117, Germany, 3The University of Tokyo, Medical 
Genome Science, Graduate School of Frontier Sciences, Chiba, 277-8562, 
Japan 
 
According to the standard model of bacterial initiation the small 30S 
ribosomal subunit recognizes the initiation site of protein synthesis on an 
mRNA with the help of three initiation factors and the initiation tRNA 
fMet-tRNA, before it associates with the 50S subunit forming the 70S 
initiation complex.  
However, since decades evidence has been reported by various groups that 
in addition to the canonical 30S-binding initiation also the 70S ribosome 
might be able to form an initiation complex without going over ribosomal 
subunits. At least leaderless mRNA is initiated by 70S ribosomes [1], which 
however plays a minor role in the initiation scenario of bacteria.  
Here we demonstrate that a second frequent initiation mode exists, the 70S 
scanning mode, according to which 70S ribosomes do not immediately 
leave the mRNA after translating a cistron, but rather scan intercistronic 
distances until the next Shine-Dalgarno. The functional horizon of the 
initiation factors IF1 and IF3 is wider than anticipated: IF3 can bind to 70S 
ribosomes and is essential for 70S scanning; IF1 prevents premature, 
abortive initiation by ternary complexes aa-tRNA•EF-Tu•GTP during the 
scanning process and is a 70S rather than a 30S initiation factor. Reducing 
the intracellular IF1 concentration causes a collapse of predominantly the 
50S assembly explaining the essential character of IF1. Furthermore, we 
demonstrate that the 70S scanning initiation mode can occur with both 
mono- and polycistronic mRNAs. 
Our data are setting the initiation factors into a new functional context. The 
70S scanning mode of initiation might be even the prevalent initiation mode 
in bacteria. 
 
Reference: 
1. Moll, I., et al., Translation initiation with 70S ribosomes: an alternative 
pathway for leaderless mRNAs. Nucleic Acids Res., 2004. 32(11): p. 3354-
3363. 
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MAPPING THE EUKARYOTIC TRANSLATION INITIATION FACTOR 
eIF2 BINDING SITE ON THE 40S RIBOSOME 
 
Byung-Sik Shin, Joo-Ran Kim, Thomas E Dever  
 
LGRD, NICHD, Bethesda, MD, 20892 
 
The eukaryotic translation initiation factor eIF2 delivers initiator Met-
tRNAi to the 40S ribosomal subunit in the beginning of translation initiation 
process. The eIF2 is composed of three different subunits: eIF2γ (GCD11 in 
yeast), eIF2α (SUI2), and eIF2β (SUI3). The eIF2γ subunit is composed of 
a GTP-binding domains and two β-barrel domains II and III. Overall, eIF2γ 
has a three-dimensional structure similar to the prokaryotic translation 
elongation factor EF-Tu. Consistent with this structural similarity, both 
eIF2γ and EF-Tu bind aminoacyl-tRNA in a GTP-dependent manner and 
deliver the aminoacyl-tRNA to the ribosome during translation. However, 
whereas EF-Tu delivers tRNA to the ribosomal A site, eIF2 delivers Met-
tRNAi to the P site. To gain insight into the mechanism of Met-tRNAi 
delivery to the 40S subunit during translation initiation, we determined the 
binding position of yeast eIF2 on the 40S subunit using directed hydroxyl 
radical cleavage. First, a cysteine-lite version of eIF2 was generated by 
mutating all cysteine residues the three eIF2 subunits except those in the 
zinc-binding motifs of eIF2γ and eIF2β. Next, cysteine residues were 
introduced at various surface-exposed positions in the cysteine-lite eIF2. 
The cysteine-lite and single cysteine mutant forms of eIF2 were functional 
as the sole-source of eIF2 in yeast and the proteins were purified from a 
yeast strain lacking the native eIF2 subunit genes. For hydroxyl radical 
cleavage assays 48S complexes were assembled by mixing Fe(II)-eIF2–
GTP–Met-tRNAi ternary complexes with eIF1, eIF1A, 40S subunits, and a 
model unstructured mRNA. Mapping of the hydroxyl radical cleavages in 
the 48S complex revealed that domain III of eIF2γ binds near the helix44 
region of the 40S subunit, whereas no specific rRNA cleavages were 
detected when Fe(II) was tethered to eIF2α or eIF2β. In yeast, Gcd- 
mutations are a sensitive reporter of Met-tRNAi binding to the 40S subunit. 
Consistent with the hydroxyl radical cleavage data, a Gcd- mutation 
identified in domain III of eIF2γ showed weakened ribosome binding, but 
normal Met-tRNAi binding. In addition, cleavages in Met-tRNAi by eIF2γ 
and eIF2β derivatives indicate that the Met-tRNAi binds in a novel 
conformation to eIF2 that is radically different from the conformation of the 
EF-Tu–GTP–tRNA complex. We propose that, although eIF2γ has 
structural homology with EF-Tu, the eIF2–Met-tRNAi complex adopts a 
novel conformation required for assembly of the eukaryote-specific 48S 
translation initiation complex. 
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THE TRANSLOCASE-LIKE FACTOR EFL1 AND RPL10 ACT IN 
CONCERT TO PROBE THE P-SITE DURING 60S BIOGENESIS. 
 
Cyril Bussiere, Sucheta Arora, Arlen Johnson  
 
UT Austin, Section of Molecular Genetics and Microbiology and Institute 
for Cellular and Molecular Biology, Austin, TX, 78712 
 
We previously showed that the large (60S) ribosomal subunit protein Rpl10 
is required for the release of the nuclear export adaptor Nmd3 during 
maturation of the pre-60S subunit in the cytoplasm. More recently we have 
ordered the events of cytoplasmic maturation and found that the release of 
Nmd3 requires the prior release of the subunit anti-association factor Tif6 
by the GTPase Efl1. This prompted us to ask if Rpl10 was required for any 
steps upstream of Nmd3 release. Rpl10 (L16 in bacteria) is located in a cleft 
between the central protuberance and the GTPase stalk and contains an 
internal unstructured loop that extends towards the P-site. Deletion of the P-
site loop of Rpl10 trapped Tif6 in the cytoplasm, indicating an unexpected 
role for Rpl10 in release of Tif6, prior to its role in Nmd3 release. Random 
mutagenesis of the P-site loop yielded two classes of mutants: one with a 
60S biogenesis defect and a second that affects ribosome function but does 
not display a defect in 60S levels. Surprisingly, the biogenesis mutants 
could be suppressed by expression of a mutant allele of Tif6 that bypasses 
the function of Efl1. We hypothesize that the P-site loop is involved in 
transducing information to Efl1, signaling to release Tif6. If this were the 
case, we should be able to find mutations in Efl1 that signal to release Tif6 
regardless of the state of the P-site loop of Rpl10. Efl1 is homologous to the 
translocase eEF2/EF-G. The structure of eEF2 has been solved in two 
distinct conformations: the apo and sordarin bound states. Sordarin traps 
eEF2 on the ribosome in the post-translocation state. We found that 
mutations in Efl1 that suppressed the biogenesis Rpl10 P-site loop mutants 
mapped to domain interfaces corresponding to the dynamic interfaces of 
eEF2. We suggest that these mutations facilitate a conformation change in 
Efl1, analogous to the post-translocation state of eEF2, which leads to 
release of Tif6. Our results suggest that Rpl10 plays a functional or 
structural role in signal transduction to Efl1 via the P-site and that Efl1 
assesses the status of the P-site during 60S maturation to signal the release 
of the subunit anti-association factor Tif6 to activate the subunit for 
translation. Thus, Efl1-dependent release of Tif6 may represent a quasi-
functional check of the 60S subunit prior to its first round of bona fide 
translation. 
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GLOBAL RRNA PSEUDOURIDYLATION DEFECTS AFFECT 
RIBOSOMAL LIGAND BINDING AND TRANSLATIONAL FIDELITY 
FROM YEAST TO HUMANS. 
 
Karen Jack1, Arturas Meskauskas1, Cristian Bellodi2, Noam Kopmar2, Olga 
Krashykh2, Dori M Landry3, Alison M Dean3, Sunnie R Thompson3, Davide 
Ruggero2, Jonathan D Dinman1  
 
1University of Maryland, Cell Biology and Molecular Genetics, College 
Park, MD, 20742, 2University of California, San Francisco, 2School of 
Medicine and Department of Urology, Helen Diller Family Comprehensive 
Cancer Center, San Francisco, CA, 94158, 3University of Alabama at 
Birmingham, 3Department of Microbiology, Birmingham, AL, 35294 
 
Isomerization of uridine to pseudouridine (Ψ) is the most common 
posttranscriptional modification of rRNA. In yeast, CBF5, encodes the Ψ 
synthase catalytic subunit of box H/ACA snRNPs. The human homologue 
is DKC1, a gene responsible for the pathological features present in X-
linked Dyskeratosis Congenita (XDC) and Hoyeraal-Hreidarsson syndrome 
(HH). Significant effects on cell growth and drug sensitivity were observed 
in the CBF5 D95A mutant, located in the catalytic site. Mutant ribosomes 
have decreased affinities for both aa-tRNA in the ribosomal A-site and for 
Ac-aa-tRNA in the P-site. Consistent with decreased affinity for aa-tRNA, 
D95A promoted hypersensitivity to anisomycin, a competitive inhibitor for 
aa-tRNA binding, and for sparsomycin, a P-site inhibitor. This mutant was 
hyperaccurate in its ability to properly decode a UAA termination codon, 
indicative of increased proofreading of non-specific binding of aa-tRNAs 
due to the A-site defect. The absence of Ψ promoted an ~3.5-fold increase 
in programmed -1 ribosomal frameshifting (-1 PRF) in yeast (combined A- 
and P-site slippage), and a smaller effect on +1 PRF (P-site slippage) was 
observed. D95A mutant ribosomes also had decreased affinities for the 
cricket paralysis virus (CrPV) intergenic region (IGR) internal ribosome 
entry site (IRES), which has extensive interactions with the E- and P-sites. 
Strikingly, the molecular defects of rRNA pseudouridylation were also 
recapitulated in human cells. siRNA knockdown of DKC1 in HeLa cells 
promoted increased -1 PRF promoted by cis-acting elements in HIV-1 and 
in the human CCR5 mRNA. 48S complex assembly on the CrPV IGR IRES 
was also significantly inhibited in cytoplasmic extracts from DKC1 
hypomorphic mouse embryo fibroblasts, indicative of a 40S ribosomal 
subunit binding defect. These findings suggest that altered translation of 
cellular -1 PRF signals and IRES element containing mRNAs may in part 
be responsible for some of the symptoms associated with XDC and HH. 
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DISRUPTION OF RRNA METHYLATION ATTENUATES THE 
ACTIVITY OF CERTAIN CELLULAR, BUT NOT VIRAL IRESS 
 
Abhijit Basu1, Sujan Chaudhuri1, Priyanka Das1, Francesca Gaccioli2, 
Anton A Komar1, Maria Hatzoglou2, Barsanjit Mazumder1  
 
1Cleveland State University, Center for Gene Regulation in Health and 
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Cleveland, OH, 44115, 2Case Western Reserve University School of 
Medicine, Department of Nutrition, Cleveland, OH, 44106 
 
Methylation of 2’-O-ribose is the most common covalent modification of 
ribosomal RNA (rRNA). We have previously shown that inhibition of 
rRNA methylation does not affect ribosome maturation and/or global 
protein synthesis in mammalian cells [1]. However, it remained possible 
that it might affect the translation of specific mRNAs utilizing minor 
initiation pathways, such as internal initiation. To test this hypothesis we 
inhibited rRNA methylation by either knocking down ribosomal protein 
L13a [1] or by using chemical inhibitor of rRNA methylation – 
cycloleucine, and investigated the translation of various IRES-containing 
mRNAs. It was shown that inhibition of rRNA methylation significantly 
reduced cap-independent translation of the cellular mRNAs carrying IRES 
elements (namely, p53, p27Kip1 and SNAT2). However, it did not affect 
the translation driven by the viral IRES elements [such as Hepatitis C virus 
(HCV) and/or Cricket Paralysis virus (CrPV)]. The mechanism of decreased 
cellular IRES-mediated translation was further studied using the SNAT2-
IRES [2]. Although 48S initiation complex formation was unaffected by 
inhibition of rRNA methylation, assembly of the 80S ribosomes was 
significantly impaired in SNAT2-IRES mediated translation. We further 
revealed an increased accumulation of initiation factor eIF5B in the 
SNAT2-IRES ribosomal complexes. Efficient release of eIF5B is known to 
be required for productive 80S complex formation. Interestingly, rRNA 
methylation-deficient ribosomes fail to efficiently release eIF5B and 
support the 80S complex formation in the SNAT2-IRES, but not the viral 
(HCV) IRES. We have further shown that this initiation defect can be 
corrected by supplementing the in vitro translation system generated from 
rRNA methylation-deficient mammalian cells by the 60S ribosomal 
subunits purified from the methylation-competent wt cells but not from the 
methylation-incompetent cells. We conclude that inhibition of rRNA 
methylation affects the ability of 60S, rather than 40S ribosomal subunits to 
function properly in translation of cellular IRESs.  
[1]. Chaudhuri et al. RNA. 2007, 13(12): 2224-2237. 
[2]. Gaccioli F, et al. J. Biol. Chem. 2006, 281: 17929-17940.  
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HEAD SWIVEL ON THE RIBOSOME FACILITATES 
TRANSLOCATION VIA INTRA-SUBUNIT TRNA HYBRID SITES 
 
Christian M Spahn  
 
Charité - Universitätsmedizin Berlin, Institut für medizinische Physik und 
Biophysik, Berlin, 10117, Germany 
 
The elongation cycle of protein synthesis involves the delivery of 
aminoacyl-tRNAs to the A-site of the ribosome, followed by peptide-bond 
formation and translocation of the tRNAs through the ribosome to reopen 
the A-site. The translocation reaction is catalyzed by elongation factor G 
(EF-G) in a GTP-dependent fashion. Despite the availability of structures of 
various EF-G-ribosome complexes, the precise mechanism by which tRNAs 
move through the ribosome still remains unclear. Here we use multiparticle 
cryo-EM analysis to resolve two previously unseen subpopulations within 
EF-G-ribosome complexes at sub-nanometer resolution, one of them with a 
partially translocated tRNA. Comparison of these sub-states reveals that 
translocation of tRNA on the 30S subunit parallels the swiveling of the 30S-
head and is coupled to un-ratcheting of the 30S-body. Since the tRNA 
maintains contact with the P-site on the 30S-head and simultaneously 
establishes interaction with the E-site on the 30S-platform, a novel intra-
subunit pe/E hybrid state is formed. These findings provide direct structural 
and mechanistic insight into the “missing link” in terms of tRNA 
intermediates involved in the universally conserved translocation process. 
The insights gained enable us to provide a structural explanation for the 
process of translocation in a model where tRNA movements are facilitated 
by ratcheting and un-ratcheting motions of the ribosome. Accordingly, the 
ribosome functions during translocation as a Brownian ratchet machine and 
EF-G is acting as a dynamic pawl, decoupling the un-ratcheting motions of 
the ribosome from the transition of hybrid state tRNAs back into classical 
states. Thereby, EF-G provides directionality and accelerates translocation 
of the tRNAs via several intermediate inter- and intra-subunit hybrid states 
into the classical P/P and E/E sites of the POST state. 
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TOWARDS ENERGY LANDSCAPES OF THE RIBOSOME: 
EXPLORING THE INTERPLAY BETWEEN RIBOSOME DYNAMICS 
AND TRNA DYNAMICS 
 
Paul C Whitford1, Peter Geggier2, Andreas H Ratje3, Scott C Blanchard2, 
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Stochastic motion of tRNAs and ribosomal components (30S head swivel, 
50S stalk motion and 30S body ratcheting) may play a key role during 
translation. To explore the interplay between ribosome fluctuations and the 
progression of tRNA through the ribosome, we have developed an all-atom 
computational technique that uses specific x-ray structures to define the 
force field . This approach has the advantage of being able to achieve 
hundreds of milliseconds of sampling and unambiguously determine the 
role of steric interactions during conformational rearrangements. This 
model accurately describes the structural fluctuations measured by single-
molecule FRET and crystallographic B-factors. The fluctuations observed 
in the structure-based model are also in good agreement with those obtained 
through our longest explicit-solvent simulations of the ribosome, to date 
(3.2 million atoms, cumulative 2000 nanoseconds of sampling). We find 
that (1) accommodation of aminoacyl-tRNA is a stochastic process that 
encompasses large-scale reversible fluctuations, (2) there is a preferred 
ordering of conformational events and (3) there are parallel pathways into 
the PTC. We have now applied this technology to hybrid-state formation 
and translocation, simulating the interplay between stochastic hybrid state 
formation, L1 stalk closure, head swiveling and subunit ratcheting. Our 
initial structural model of hybrid conformations was obtained by modifying 
the structure-based forcefield to include an energetic weight for cryo-EM 
density (called MDfit). We have produced atomic models that agree with 
cryo-EM densities of hybrid conformations while maintaining correct 
stereochemistry. These models were used in structure-based simulations of 
transitions between the classical and hybrid-state conformations. The 
simulations suggest that the structure of the hybrid-state corridor imposes 
stringent limitations on the accessible pathways. We have studied the 
translocation of tRNAs in the P/E state to the E/E state, allowing us to 
isolate specific steric barriers. Finally, we construct the first free energy 
landscape diagrams of ribosome dynamics. The identified mechanisms and 
parallel pathways establish an atomistic framework for interpreting 
biochemical data and suggest that conformational changes occur through a 
stochastic trial and error process, rather than in concerted lock-step motions. 
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THE STRUCTURE OF A TRANSLATING EUKARYOTIC RIBOSOME 
AT 5.5 A 
 
Andreas M Anger1, Jean-Paul Armache1, Alexander Jarasch1, Thomas 
Becker1, Thorsten Mielke2, Roland Beckmann1  
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Protein biosynthesis, the translation of the genetic code into polypeptides, 
occurs on ribonucleoprotein particles called ribosomes. Although X-ray 
structures of bacterial ribosomes are available, high-resolution structures of 
eukaryotic 80S ribosomes are lacking. Using cryo-electron microscopy and 
single-particle reconstruction we have determined the structure of a 
translating plant (Triticum aestivum) 80S ribosome at 5.5 Å resolution. This 
map, together with a 6.1 Å map of a Saccharomyces cerevisiae 80S 
ribosome, has enabled us to model 97.5 % of the rRNA and localize 73/80 
(91 %) of the ribosomal proteins, encompassing 11 archaeal/eukaryote-
specific small subunit proteins as well as the complete complement of the 
ribosomal proteins of the eukaryotic large subunit. Near-complete atomic 
models of the 80S ribosome provide insights into the structure, function and 
evolution of the eukaryotic translational apparatus. 
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CRYSTAL STRUCTURE OF EUKARYOTIC RIBOSOME. 
 
Adam Ben-Shem, Lasse B Jenner, Gulnara Yusupova, Marat Yusupov  
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The higher complexity of eukaryotic cells is at least in part reflected in their 
ribosomes. We obtained ordered crystals of the 3.3 MDa S.cerevisiae 
ribosome and solved its structure to 4.15A resolution. The eukaryotic-
specific elements are located mainly at the solvent exposed side and expand 
considerably the network of interactions within the ribosome. In addition to 
forming extra bridges between the two subunits, one of the novel features of 
this expanded network is the direct structural contact between the entry and 
exit sites of the mRNA. 
Our crystals capture the ribosomes in the ratchet conformation that eluded 
crystallization efforts of prokaryotic ribosomes and may thus contribute to 
the understanding of fundamental evolutionary conserved aspects of protein 
synthesis. The structural rearrangements in the big subunit in response to 
ratcheting include important conformational changes to maintain interaction 
with the small subunit as well as considerable movements of virtually all 
central protuberance elements. Our structure also suggests how ratcheting 
may affect the interaction of the body and platform with mRNA/tRNA and 
raises intriguing questions regarding the back-rotation movement of the 
head and the completion of translocation.  
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FOR ASSEMBLY OF ACTIVATED EIF4F•MRNPS IN VIVO 
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eIF4G is the scaffold subunit of the eIF4F complex, whose binding domains 
for eIF4E and poly(A) binding protein (PABP) are thought to enhance 
formation of an eIF4F·mRNA·PABP mRNP that is competent to bind the 
43S preinitiation complex. It was previously concluded that the PABP-
binding segment in the N-terminal domain (NTD) of yeast eIF4G1 is 
essential for cell viability when eIF4E binding to eIF4G1 is compromised 
by the tif4631-459 mutation in the eIF4E-binding motif Y(x)4LΦ. We 
found, however, that the N-terminal RNA binding region (RNA1) of 
eIF4G1 can functionally substitute for the PABP-binding segment, and that 
eliminating both regions is required for a lethal phenotype in combination 
with the tif4631-459 mutation. Fine-structure deletion mapping, combined 
with assays of RNA-tethered PABP-eIF4G1 association in cell extracts, 
indicates that a 28 amino acid sequence (Box3) located in the canonical 
PABP-binding domain is essential for assembly of eIF4F·mRNA·PABP 
mRNPs. This process is also significantly enhanced by RNA1 and two 
additional conserved sequence elements (Box1 and Box2) in the eIF4G1-
NTD. In vitro binding assays indicate that both RNA1 and Box1 augment 
PABP binding by the eIF4G1-NTD, which is completely dependent on 
Box3. Furthermore, Box1 promotes the RNA binding activity of RNA1. 
Taken together, our results indicate that the contribution of the canonical 
PABP-binding domain in the eIF4G-NTD to forming a “closed-loop” 
mRNP is not essential for translation in vivo, even when the eIF4E·eIF4G 
interaction is impaired, and that efficient mRNA activation can proceed in 
the absence of this PABP·eIF4G1 interaction by virtue of the RNA1 
domain. We envision that interaction of the eIF4G-NTD with either PABP 
or mRNA provides redundant pathways that act together with eIF4G’s 
interaction with eIF4E (bound to the cap) to stimulate assembly of activated 
eIF4F·mRNA complexes. Interestingly, two other RNA binding regions, 
located in the middle and C-terminus of eIF4G1, have critical functions at a 
step downstream of eIF4F·mRNA·PABP assembly. 
 
*Authors contributed equally. 
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eIF4A is a key component in translation initiation; however, it has not been 
clear how auxiliary factors like eIF4B and eIF4G stimulate eIF4A and how 
this mechanism is integrated in the scanning process. We demonstrate that a 
stable complex between eIF4A and eIF4G can be formed. Based on results 
from isothermal titration calorimetry and surface plasmon resonance, we 
obtain a two-site model for eIF4A binding to a eIF4G fragment with a high 
and low affinity site, having a KD of ~50 nM and ~1000 nM, respectively. 
Using an in vitro RNA pull down assay, we establish an eIF4A-eIF4B 
complex requiring RNA, nucleotide and an eIF4G fragment containing both 
eIF4A binding sites. eIF4G does not stably associate with the eIF4A-eIF4B 
complex but acts catalytically in its formation. Based on our results, we 
demonstrate a mutually exclusive binding between eIF4A and either eIF4G 
or eIF4B and furthermore that eIF4B and eIF4G act synergistically in 
stimulation of the ATPase activity of eIF4A. Small Angle X-ray Scattering 
analysis shows that eIF4G adopts an elongated, well-defined structure with 
a maximum dimension of 200 Å, able to span the width of the 40S 
ribosomal subunit. 
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eIF4A, eIF4B and eIF4G mediate initial attachment of 43S complexes to 
eukaryotic mRNAs and also assist 43S complexes during subsequent 
scanning. Although eIFs 4A/4B/4G are sufficient for ribosomal scanning on 
5’-UTRs with moderate secondary structures, scanning on highly structured 
5’-UTRs also requires DHX29, a DExH-box protein that acts 
synergistically with eIFs 4A/4G/4B and which binds directly to 40S 
subunits, likely at the entrance of the mRNA-binding channel. Many 
mechanistic aspects of scanning are poorly understood. Thus, it is not clear 
what happens when a scanning 43S complex encounters a stable stem: can 
such an intact stem penetrate into the mRNA-binding cleft or is it stopped at 
its entry, and can changes to the structure of the mRNA-binding channel 
induced by eIF1, eIF1A and presumably DHX29 influence mechanistic 
aspects of the inhibition of ribosomal scanning by stable mRNA structures. 
We now found that in the presence of eIF1A but absence of eIF1, eIFs 
4A/4B/4G mediate efficient bypassing of stable stems by scanning 43S 
complexes and promote formation of 48S complexes on initiation codons 
downstream of the stems. However, the intact stems likely cannot be 
threaded through the entire Exit portion of the mRNA-binding cleft, 
resulting in looping-out of mRNA between the stem and the AUG codon if 
the region of mRNA in front of the stem remains ribosome-bound, or in 
mRNA dropping off if this region dissociates, and incorrect ribosomal 
fixation of mRNA upstream of the P-site renders such 48S complexes 
susceptible to dissociation by eIF1. Importantly, irrespective of the presence 
of eIF1, eIFs 4A/4B/4G also promote efficient formation of 48S complexes 
on AUG codons preceding stable stems (at positions from -3 to -15 relative 
to the stem), in which the intact stem with an adjacent mRNA region 
between the stem and the AUG codon are accommodated in the ribosomal 
A-site. Thus, eIF1 does not prevent intact stems from entering the mRNA-
binding channel and can assess correct positioning of mRNA in this channel 
only upstream of the P-site. We also found that it is DHX29, which ensures 
that mRNAs are unwound before they enter the mRNA-binding cleft of 40S 
subunits, thereby enforcing linear base-by-base inspection of mRNA by 
ribosomal complexes during scanning. 
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The 3’ poly(A) tail of eukaryotic mRNAs cooperate with the 5’ cap 
structure to synergistically enhance translation. The interaction between the 
poly(A) binding protein (PABP) and eIF4G mediates this translational 
enhancement. The PABP-interacting protein 2 (Paip-2) inhibits translation 
by displacing PABP from the poly(A) tail and eIF4G. We now provide 
more evidence for this mechanism and describe a protein that binds to the 
poly(A) tail under conditions unfavorable for efficient PABP-poly(A) 
interaction. An mRNA harboring a 32P-labeled poly(A) tail was incubated 
with rabbit reticulocyte lysates, HeLa or Krebs-2 cell extracts, UV-
irradiated, and digested with a nuclease. The labeled proteins were analyzed 
by SDS-PAGE. In all extracts, an exclusive crosslinking of a ~70 kDa 
polypeptide (p70) to poly(A) occurred. This polypeptide is PABP, as it was 
not detected in PABP depleted extracts. Adding Paip2 prevented 
crosslinking of PABP, in agreement with the dissociation of the PABP-
poly(A) complex. Remarkably, a novel protein (p68) associated with 
poly(A) in the presence of Paip2 or following PABP depletion. Binding of 
p68 was strongly inhibited in the presence of recombinant PABP. Using 
immunoprecipitation, we demonstrated that p68 is identical or closely 
related to the heterogeneous nuclear ribonucleoprotein Q (hnRNP-Q, 
NSAP1 or SYNCRIP). Recombinant mouse hnRNP-Q variant 2 protein 
(hnRNP-Q2) bound with high affinity to poly(A30) RNA (Kd~25 nM). In 
addition, quantitative Western blot analysis revealed that hnRNP-Q2, 
similar to PABP, is highly abundant in Krebs-2 cell extracts. Thus, hnRNP-
Q2 has the potential to compete with PABP for poly(A) binding and thereby 
negatively regulate translation. Krebs-2 translational extract was 
immunodepleted of hnRNP-Q2 using an anti-hnRNP-Q monoclonal 
antibody (18E4). An ~2.5-fold stimulation of translation of capped and 
polyadenylated luciferase mRNA was achieved after depletion. Poliovirus 
IRES-mediated translation was similarly enhanced. In contrast, hepatitis C 
virus (HCV) IRES-mediated translation, which does not require PABP or 
eIF4G, was not affected by hnRNP-Q2 depletion. Conversely, the addition 
of recombinant hnRNP-Q2 inhibited cap- and poly(A)-dependent 
translation in vitro. We also found that translation in hnRNP-Q2 depleted 
Krebs-2 extracts was less susceptible to inhibition by Paip2 than in control 
extracts. These results attest hnRNP-Q2 as a novel effector of PABP and 
eIF4G dependent translation. 
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Despite lack of an exon junction complex (EJC), S. cerevisiae contains 
Fal1p, a DEAD-box helicase highly homologous to eIF4AIII. We show that 
whereas human or D. melanogaster eIF4AIII specifically complements both 
the lethal phenotype and 18S rRNA biogenesis defect of yeast fal1Δ1, 
mutations in the Walker A/B boxes of human eIF4AIII, previously shown 
not to abrogate nonsense mediated decay or EJC assembly2, abolish 
complementation. We identified mutations in an evolutionarily conserved 
patch of the essential eIF4G-like nucleolar yeast protein Sgd1p that are 
dominant extragenic allele-specific suppressors of a fal1 cold-sensitive 
phenotype; the mutated residues overlap key eIF4A-interacting residues of 
eIF4G when superimposed on the structure of the eIF4A/eIF4G complex3. 
Depletion of yeast Sgd1p yields a defect in 18S rRNA biogenesis identical 
to that of fal1Δ. Specific co-immunoprecipitation of yeast Fal1p and Sgd1p, 
and of their human orthologs eIF4AIII and NOM1, confirms evolutionary 
conservation of an essential functional interaction similar to that of eIF4A 
with eIF4G.  
 
1 Kressler, D. et al. (1997) MCB. 17, 7283–94.  
2 Shibuya, T. et al. (2006) RNA 12, 360–74.  
3 Schütz P. et al. (2008) PNAS 105(28):9564-9.  
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eIF3 is a modular protein assembly, whose essential functions rely on 
conserved subunit interactions the molecular details of which are unknown. 
Here we report the 2.1 Å crystal structure of the complex between the yeast 
seven-bladed beta-propeller eIF3i/TI34 and a C-terminal alpha-helix of 
eIF3b/PRT1. In this double-contact interaction, conserved residues D207 
and D224 of eIF3i/TIF34 bind a conserved Y677– R678 module of 
eIF3b/PRT1, and a hydrophobic pocket on eIF3i/TIF34 accommodates the 
critical eIF3b/PRT1 W674 residue. Mutating these residues displays severe 
growth defects, eliminates association of eIF3i/TIF34 and surprisingly also 
eIF3g/TIF35 with eIF3 and 40S subunits in vivo, and destabilizes 40S-
association of the remaining eIF3 subcomplex. Together with observed 
leaky scanning defects we propose that stable association of the 
eIF3i/TIF34–eIF3g/TIF35 mini-module with the rest of eIF3 anchors eIF3 
on the ribosome in an optimal conformation to ensure stringent AUG 
selection. 
 17 
COORDINATED MOVEMENT OF EIF1, EIF1A AND EIF5 MEDIATES 
THE RESPONSE TO START CODON RECOGNITION 
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Recent data have indicated that in addition to acting as a GTPase activating 
protein for eIF2, eIF5 plays direct roles in start codon recognition. 
Previously, we showed that eIF1A and eIF5 interact strongly within the 43S 
pre-initiation complex (PIC) when an AUG is encountered. This interaction 
is dramatically perturbed by mutations in both eIF1A and eIF5 that affect 
the fidelity of start codon recognition in vivo. Recently, we showed that 
eIF5 also antagonizes binding of eIF1 to the PIC, enhancing the rate of its 
release when the start codon is encountered. Dissociation of eIF1 is the key 
switch in the pathway, triggering both Pi release from eIF2 and conversion 
of the PIC to its closed, scanning arrested state. Based on these and other 
data, a model is developing in which start codon recognition and subsequent 
eIF1 release allow movement of a domain of eIF5 – for example its N-
terminal domain (NTD), which is structurally similar to eIF1 – into the 
binding site previously occupied by eIF1. When the start codon is 
encountered, the C-terminal tail (CTT) of eIF1A also moves out of the P 
site and is then able to interact, directly or indirectly, with eIF5. The 
movements of segments eIF5 and eIF1A trigger Pi release by eIF2 and 
stabilize the closed form of the PIC. Consistent with a role in triggering Pi 
release, we found that mutations in the CTT of eIF1A slow Pi release 
dramatically but have only a small effect on eIF1 release, thus decoupling 
these two steps and indicating that the CTT acts as an intermediary between 
them. To further probe these events and test the model, we have made a 
variety of fluorescently-labeled derivatives of eIF5 and used them to look 
for fluorescence resonance energy transfer (FRET) with CTT-labeled eIF1A 
within the PIC. We observed the strongest FRET between the NTD of eIF5 
and the CTT of eIF1A. This FRET increases when the PIC recognizes a 
start codon, indicating that the distance between the eIF5 NTD and the 
eIF1A CTT decreases upon start codon recognition. Strikingly, the kinetics 
of the increase in FRET between eIF5 and eIF1A are the same as those for 
the start-codon induced decrease in FRET between the CTT of eIF1A and 
eIF1 that we observed previously. Taken together, our data provide strong 
support for a model in which release of eIF1 triggers rearrangements in the 
PIC that move the CTT of eIF1A closer to the NTD of eIF5, structural 
changes that play key roles in triggering downstream events that commit the 
PIC to continuing initiation from that point on the mRNA. 
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Translation initiation in eukaryotes requires a coterie of initiation factors 
that assemble into various time-dependent mega-complexes that orchestrate 
the onset of translation. Start-codon recognition is paramount in the 
initiation process of protein synthesis. Initiation factors eIF5, eIF2, eIF1 and 
eIF1A govern the fidelity of proper AUG selection of the coded mRNA and 
promote 43S-preinitiation complex (PIC) assembly. In order to identify 
critical contacts formed by eIF5 upon start-codon recognition, this work 
utilizes the carboxyl terminal domain of eIF5 (eIF5-CTD) as a biophysical 
probe to identify key interactions with eIF2β, eIF1 and eIF1A. We employ 
nuclear magnetic resonance (NMR) spectroscopy to map the surface of 
eIF5-CTD that binds to eIF2β. Next, we derive a model for the complex 
between eIF5-CTD and eIF1, which is based on NMR-chemical shift 
mapping and paramagnetic relaxation enhancement experiments. We 
validate our eIF5-CTD/eIF1 model by mutating four eIF5-CTD surface 
residues (eIF5-CTD-DDKK) at the interaction interface, which disrupts its 
interaction with eIF1. In addition, we present evidence for a novel 
interaction between eIF5-CTD and eIF1A. Interestingly, the eIF5-CTD-
DDKK mutant also reduces binding with eIF1A. Further in vitro and in vivo 
yeast studies characterizing the function of these eIF5 faces will provide 
useful insights into eIF5‘s role in translation preinitiation complex 
assembly. The data suggest an overall model for mutual interactions of 
eIF5, eIF2, eIF1 and eIF1A on the 40S subunit during start codon 
recognition. 
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In eukaryotic translation, initiation factors (eIFs) promote dissociation of 
the 80S ribosome and assist binding of Met-tRNAiMet and 5’-capped mRNA 
to the 40S subunit to form 43S and 48S preinitiation complexes (PICs), 
respectively. The 43S complex formation is greatly facilitated by the 
preassembly of a subset of initiation factors in the multifactor complex 
(MFC) containing eIF1, eIF5, eIF3 and the eIF2/GTP/Met-tRNAiMet ternary 
complex (TC). The C-terminal domain (CTD) of eIF5 is the assembly core 
of the MFC, touching all the MFC partners as well as eIF4G. Its negatively 
charged surface (Area I) conserved with eIF2Bε-CTD interacts with eIF2β 
and eIF4G; the positively charged surface (Area II) specific to eIF5 
interacts with eIF3c and a part of eIF1. In this study, we identify an Arg-
rich 74 amino acid-long segment of yeast eIF4G2 between eIF4E- and 
eIF4A-binding sites as a minimal binding segment for eIF5-CTD, eIF1 and 
RNA. The substitution of 7 Arg residues (tif4632-7R) in this segment 
strongly reduced its binding to all these partners in vitro. 32P-labeled mRNA 
recruitment to the 40S subunit is compromised in cell extracts prepared 
from the tif4632-7R mutant, which is complemented by adding back 
purified eIF5, but not by eIF1. In agreement with this, the mutant grows 
slowly in the presence of 3-aminotriazole (a drug to induce histidine 
starvation), and the growth defect is complemented by overexpression of 
eIF5. These results indicate that the interaction between eIF5 and the Arg-
rich eIF4G segment mediates mRNA recruitment to the 40S. We previously 
showed that the interaction of eIF5-CTD with the Lys-rich segment of 
eIF2β mediates MFC formation and that this interaction is exclusive with 
the aforementioned eIF5-CTD interaction with eIF4G. The Lys-rich eIF2β 
segment also binds RNA in vitro and this interaction is diminished by the 
addition of eIF5-CTD, while RNA binding to the Arg-rich eIF4G segment 
is increased by the same treatment. Thus, we propose that one of the 
biological effects of the rearrangement is to increase the affinity of the PIC 
to mRNA. Recent studies by the groups of Hinnebusch and Lorsch indicate 
that N-terminal and C-terminal tails of eIF1A play distinct roles in 
regulating the scanning-competency of the 40S subunit in response to start 
codon recognition. We also discuss the possibility that the rearrangement of 
the eIF5-CTD interactions contributes to the regulation of the PIC scanning 
mediated by the terminal tails of eIF1A. 
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Translation initiation requires a number of eukaryotic translation initiation 
factors (eIFs) and consists of several steps: initiation complex assembly; 
binding to mRNA; scanning; start codon recognition; and joining of the 
large ribosomal subunit to form a ribosome with bound initiator Met-
tRNAiMet ready to translate the mRNA. Start codon recognition and 
ribosomal subunit joining are controlled by G-proteins: eIF2 and eIF5B, 
respectively. Another initiation factor, eIF1A is involved in virtually all 
steps of translation initiation, including start codon recognition and 
ribosomal subunit joining. The C-termini of eIF1A and eIF5B interact with 
each other. We have found that human eIF5 (the GTPase activating protein 
of eIF2) competes with eIF1A for binding to eIF5B. The main binding 
interface between eIF5B and eIF5 involves the same eIF5B surface 
responsible for eIF1A binding. Both the eIF1A:eIF5B and the eIF5:eIF5B 
interactions are important for efficient translation initiation and conserved 
in most eukaryotes (eIF1A:eIF5B) and Metazoa (eIF5:eIF5B), respectively.  
Using combination of deletion analysis and NMR chemical shift mapping, 
we found that the folded eIF1A OB (oligonucleotide/oligosaccharide 
binding) domain and the natively unfolded N- and C-terminal tails (NTT 
and CTT) transiently contact each other. Analysis of these intramolecular 
interactions in the context of the recently determined position of eIF1A on 
the ribosome shows that the contact interface between the eIF1A NTT and 
OB domain in solution is the same as that found on the ribosome, between 
two ribosome-binding surfaces of the OB domain. Therefore, ribosome 
binding appears to solidify NTT:OB domain contacts occurring at least 
transiently in solution.  
The intramolecular contact surfaces between the eIF1A CTT and the OB 
domain include the eIF5B binding site in eIF1A CTT and part of the 
ribosome binding surface of the eIF1A OB domain. Our results indicate that 
eIF1A binding to the ribosome disrupts the intramolecular contacts between 
eIF1A-CTT and OB domain making the CTT more accessible for eIF5B 
binding. This explains why deletion of the CTT of yeast eIF1A was 
reported to increase its affinity for the ribosome. Taken together, the 
observed overlaps in intra- and intermolecular contact surfaces offer a 
mechanism for coordination of the interactions of eIF1A and eIF5B with 
eIF5, the ribosome and with each other.  
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During translation initiation in prokaryotes, the small, 30S, and large, 50S, 
ribosomal subunits, along with the initiator formylmethionyl-transfer RNA 
(fMet-tRNAfMet), assemble at an AUG messenger RNA (mRNA) start 
codon. The fidelity of this process is regulated by three protein translation 
initiation factors (IFs) which kinetically control essential steps along the 
reaction pathway. One such step is the recruitment of the 50S subunit to a 
correctly assembled 30S initiation complex (30SIC) containing the 30S 
subunit, mRNA, fMet-tRNAfMet, and IFs 1, 2, and 3 [1-4]. The guanosine 
triphosphatase IF2 is principally responsible for selectively accelerating the 
rate of 50S subunit joining to a correctly assembled 30SIC [1-3], however, 
the molecular mechanism underlying this catalytic activity remains 
unknown. To elucidate this mechanism, we have developed several single-
molecule fluorescence resonance energy transfer signals that report on the 
assembly dynamics and conformational dynamics of partially or incorrectly 
assembled 30S preinitiation complexes (30SPICs) as well as correctly 
assembled 30SICs. Our data reveal that the rate of dissociation of IF2 from 
30S(P)ICs (koff,IF2), a parameter that directly controls IF2's ability to recruit 
the 50S subunit to the 30S(P)IC, can vary by over two orders of magnitude 
and is highly regulated by the composition of the 30S(P)IC. Specifically, we 
find that only in the presence of IF1, IF3, GTP, and a correct AUG 
codon/fMet-tRNAfMet anticodon interaction is binding of IF2 to the 30SPIC 
significantly stabilized. Perhaps most interestingly, we have discovered that 
IF2-bound 30S(P)ICs exist in a dynamic conformational equilibrium 
between at least two conformational states, (P)IC1 and (P)IC2, whose rates 
of exchange (k(P)IC1→(P)IC2 and k(P)IC2→(P)IC1) may directly regulate the 50S 
subunit joining event. These results provide direct evidence for, and allow 
characterization of, the 30S(P)IC conformational heterogeneity that has 
been inferred from the observation of kinetic heterogeneity in ensemble 
studies of 50S subunit joining to 30S(P)ICs [4]. Collectively, our studies 
strongly suggest that precise control of koff,IF2, k(P)IC1→(P)IC2, and k(P)IC2→(P)IC1 
is used to regulate 50S subunit joining to 30S(P)ICs, thus ensuring the 
fidelity of this critical step during translation initiation. 
 
1. Antoun, A. et al. Mol. Cell 23, 183-193 (2006) 
2. Antoun, A. et al. EMBO J. 22, 5593-601 (2003) 
3. Grigoriadou, C. J. et al. Mol. Biol. 273, 562-572 (2007) 
4. Milon, P. et al. Mol. Cell 30, 712-720 (2008) 
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This study provides a comprehensive, system-level definition of control 
across the entire eukaryotic translation pathway, thus quantitating the 
contributions of all of the known yeast translation factors to the 
functionality of the translation machinery. Using the tet07 operator, the 
steady-state intracellular abundance of each translation factor was titrated 
down progressively to determine the effects on yeast growth rate and in vivo 
protein synthesis. The dependence of the protein synthesis rate on 
intracellular concentration provides an estimate of each factor’s degree of 
control over the translation machinery at near-physiological concentrations 
(expressed as RJ; the so-called response coefficient in each case). This 
quantitative approach provides insight at multiple levels that cannot be 
obtained by other means. 
Initiation, elongation and termination manifest distinct control profiles. The 
value of RJ shows no simple correlation with a factor’s intracellular 
concentration. Factors showing strong control (high RJ) near to 
physiological intracellular level include eIF1A, eIF2, eIF4A, eIF4G and 
eEF1A. In contrast, eIF1, eIF2B, eIF4B, eIF5, eIF5B, eEF1B, Ded1 and 
Pab1 are low RJ factors – i.e. in the near-physiological concentration range 
the translation machinery as a system is more tolerant to modulation of (or 
fluctuations in) their activities. Unexpectedly, control is distributed over 
multiple components of the translation machinery and is shared between all 
three phases of the protein synthesis pathway. 
Overproduction of factors generally does not drive super-physiological 
translation rates – although eRF3 is an exception. This is relevant to the 
enhanced levels of factors seen in transformed mammalian cells. Indeed, 
there is a surprisingly sharp transition to zero in the sensitivity of protein 
synthesis to factor activity in the region leading up to 100% of the 
physiological level. 
A scanning competence assay reveals that eIF1, eIF1A, eIF2, eIF2B and 
Ded1 (but not eIF4A) impose control via their influence on ribosomal 
scanning complex stability. 
A newly defined ‘specificity ratio’ (RSp) provides an indication of the 
degree of dedication of system components to translation machinery 
functionality. eRF3, Dbp5, Ded1, Hyp2 (eIF5A), Pab1 and Uri1 are multi-
functional proteins that contribute to control in the translation pathway in 
unexpectedly distinct ways. 
These and other data are best appreciated in the form of a novel type of 3D 
control graph, and reflect the effects of collective molecular evolution. 
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Recent studies suggest that eukaryotic initiation is not limited to 
participation of a single DEAD-box protein, eIF4A, but also involves other 
members of this family. Thus, mammalian DExH-box protein DHX29 
interacts directly with 40S subunits and is required for efficient scanning 
through highly structured 5’-UTRs. DHX29 acts synergistically with eIFs 
4A/4B/4B and it was suggested that it might increase scanning processivity 
by influencing the conformation of the mRNA-binding channel. Yeast 
DEAD-box helicase Ded1 has also been implicated in initiation. Ded1 is 
likely a more potent helicase than eIF4A and their functions are not 
redundant, and it has been proposed that eIF4A promotes ribosomal 
attachment, whereas Ded1 assists during scanning. The involvement in 
initiation of DDX3, a mammalian Ded1 homologue, is more controversial, 
although some data indicate that DDX3 depletion specifically affects 
translation of mRNAs with long structured 5’-UTRs. We investigated the 
individual activities of eIFs 4A/4B/4G, Ded1, DDX3 and DHX29, as well 
as their potential synergy in promoting ribosomal scanning on structured 5’-
UTRs by 43S complexes, by determining their ability to mediate 48S 
complex formation on mRNAs with 5’-UTRs containing defined internal 
stems of various stabilities and AUG codons at different positions relative 
to the stems, using a mammalian in vitro reconstituted translation system. 
Consistent with the reported function of Ded1 in translation initiation and in 
particular, with its suggested role in assisting ribosomal complexes during 
scanning, we found that individually, Ded1 could promote scanning on a 5’-
UTR containing a moderately stable GC-rich stem (ΔG=-13.1 kcal/mol). 
Like DHX29, it was also able to act cooperatively with eIFs 4A/4B/4G. 
However, the activity of eIFs 4A/4B/4G in promoting scanning through 
more stable stems (ΔG=-18.9 kcal/mol) was higher when they were 
combined with DHX29 than with Ded1. Interestingly, the individual 
activity of Ded1 in promoting scanning and its ability to act cooperatively 
with eIFs 4A/4B/4G both required the simultaneous presence of eIF1 and 
eIF1A, in marked contrast to eIFs 4A/4B/4G and DHX29, which were able 
to promote efficient scanning when only one of eIF1 and eIF1A were 
present. Moreover, unlike DHX29, Ded1 did not bind stably to mammalian 
or yeast 40S subunits, which might indicate a difference in the mechanisms 
of coupling of the helicase activities of Ded1 and DHX29 with ribosomal 
complexes. No translational activity of DDX3 was observed in any 
circumstances 
 24 
REGULATION OF MTOR SIGNALLING PATHWAY BY 
TRANSLATION TERMINATION FACTOR ERF3A INVOLVES THE 
TRANSCRIPTIONAL REGULATOR ATF4 
 
Hayet Ait Ghezala1, Samia Salhi1, Béatrice Jollès1, Wassila Carpentier2, 
Olivier Jean-Jean1  
 
1Université Pierre et Marie Curie, FRE3207-CNRS, Paris, 75005, France, 
2Université Pierre et Marie Curie, Plate-forme Post-Génomique P3S, Paris, 
75005, France 
 
In eukaryotes, two interacting polypeptides, eRF1 and eRF3 are involved in 
translation termination. eRF1 recognizes stop codons and triggers the 
release of the nascent polypeptide. eRF3, which belongs to the small 
GTPase family, stimulates eRF1 release activity in a GTP-dependant 
manner. We have recently shown that, in human cell culture, the depletion 
of translation termination factor eRF3a led to (i) the hypophosphorylation 
of S6K and 4E-BP, two direct substrates of the protein kinase mTOR, (ii) 
decrease in the global rate of protein synthesis and (iii) cell cycle arrest in 
G1 phase. These results suggested that eRF3a depletion inhibited translation 
initiation and cell cycle progression via mTOR inhibition (1).  
To further characterize the translation defect caused by eRF3a depletion, we 
performed genome-wide analyses of polysome-bound and total mRNAs 
from eRF3a-depleted and control cells. We found that a few number of 
mRNAs had an increased level in eRF3a depleted cells. Among the ~150 
mRNA species that were increased more than 2 fold in the polysome 
fraction, one-third of them were also increased in the total mRNA pool, 
suggesting that their increased translation was accompanied by an increase 
in transcription or stability. A number of these mRNAs are known to be 
expressed from promoters controlled by the activating transcription factor 4 
(ATF4). These are notably genes involved in amino acid biosynthesis 
(ASNS, aminoacyl tRNA synthetases genes, ...) and genes encoding 
proteins involved in stress responses such as DDIT4 (REDD1) and TRIB3 
which are both described as mTOR inhibitors. In addition, we observed an 
increased level of ATF4 mRNA. These results were confirmed by real time 
qPCR analysis. The results of microarray analyses suggest that eRF3a 
modulates mTOR activity through the ATF4 response. 
ATF4 which is induced by stress signals, regulates the expression of genes 
involved in oxidative stress, ER stress and amino acid synthesis. The human 
ATF4 mRNA includes in its 5' UTR short open reading frames (uORFs) 
that precede ATF4 ORF. The organization of the 5’ UTR uORFs in ATF4 is 
essential for the ATF4 response to stress. We are now investigating the 
mechanisms of ATF4 expression regulation during eRF3a depletion using 
reporter plasmids containing ATF4 5’ UTR. These experiments should 
enable us to determine the exact function of eRF3a in the control of ATF4 
expression.  
 
1. Chauvin C, Salhi S, Jean-Jean O (2007) Mol Cell Biol 27: 5619-29 
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Cap dependent translation requires the recognition of the 5’ cap of the 
mRNA by the cap binding protein complex eIF4F, a heterotrimeric 
initiation factor complex containing the eIF4A, the cap-binding protein 
eIF4E, and the scaffolding protein eIF4G. EIF4A is an ATP dependent 
RNA helicase which unwinds RNA duplexes in the 5’-untranslated region 
(5’-UTR), thus enabling scanning for the start codon by the preinitiation 
complex. EIF4A exhibits low helicase and ATPase activities which are 
enhanced by the auxiliary protein eIF4G. 
The full length structures of eIF4A and eIf4G are unknown; however, a 
structure of the N-terminal domain, a structure of full length eIF4A in 
complex with PDCD4, of the C-terminal domain of eIF4G-I, and of the 
middle domain of eIF4G-II are available. Additionally, interactions between 
individual components have been studied by NMR and models for part of 
the complex and the whole complex have been proposed. However, the 
structures of the heterotrimeric initiation factor complex and of its 
heterodimeric sub-complexes are still unknown.  
Since NMR studies of the whole complex and sub-complexes become 
increasingly difficult with the increasing size of the complexes, we used 
Small Angle X-Ray Scattering (SAXS) to complement the NMR data. 
Nuclear Overhauser effect and residual dipolar couplings data obtained by 
NMR combined with SAXS data allowed us to obtain a solution structure of 
the first HEAT domain of EIF4G-I (middle domain of eIF4G-I, 4GH1). 
Determination of the binding sites of RNA and eIF4A on 4GH1 by NMR 
shows that RNA and eIF4A bind on opposite faces of 4GH1. Based on 
SAXS and NMR data of the 4GH1/eIF4A complex in the presence and 
absence of ATP we derived a structure of the complex. Additionally, we 
obtained SAXS structures of the complex between 4GH1, eIF4A and RNA 
as well as the second HEAT domain of eIF4G (4GH2) with eIF4A.  
The interaction between eIF4A and eIF4G presents an important human 
drug target since inhibition of this interaction would primarily decrease 
translation of growth-regulatory genes, e.g. oncogenes, as well as viral 
RNA utilizing the human translation machinery. Knowledge of the 
structural arrangement of the eIF4A/eIF4G complex will enable better 
understanding of the molecular mechanism of translation initiation and thus 
enabling the design of inhibitors of translation initiation. 
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The eIF2•GTP•Met-tRNAi translation initiation complex plays a critical 
role in the regulation of cell proliferation, differentiation, and 
tumorogenesis. Incresing abundance of the ternary complex either by 
expressing non-phosphorylatable mutant of eIF2α or Met-tRNAi causes 
cellular transformation. The chemical modulators of the eIF2•GTP•Met-
tRNAi ternary complex are therefore invaluable tools for studying its 
normal- and patho-physiology and for treatment of human disorders.  
Using a cell based high throughput screening assay, we identified N,N’-
diarlyureas as inhibitors of ternary complex formation. Through direct 
functional genetic and molecular and cellular studies we determined that the 
N,N’-diarylureas reduce the abundance of the ternary complex by activating 
heme regulated inhibitor kinase (HRI) in intact cells or cell free-extracts 
with no effect on the activity of the other eIF2α kinases. N,N’-diarlyureas 
cause the phosphorylation of eIF2α and activate the downstream effectors 
of the ternary complex depletion such as activating the expression of CHOP 
gene, inhibit preferentially expression of growth promoting proteins, all 
dependent on activation of HRI and phosphorylation of eIF2α. Consistently 
N,N’-diarlyureas display potent anti-proliferative activity against a wide 
range of human cancer cells. These effects are specifically mediated by HRI 
dependent eIF2α phosphorylation as either replacement of wild type eIF2α 
with non-phosphorylatable IF2α-S51A mutant abrogates or activities of 
N,N'-diarylureas. Interestingly, N,N’-diarlyureas also inhibit proliferation of 
malaria parasites at sub-micromolar doses presumably by activating the 
parasite HRI homolog.  
Importantly N,N’-diarlyureas display significant dose dependent anti-cancer 
activity against xenografted human breast and melanoma tumors without 
any apparent macro-or micro-toxicity. We propose that N,N’-diarlyureas are 
important molecular tools for studying the role of HRI and the 
eIF2•GTP•Met-tRNAi complex in normal and patho-biology. Furthermore, 
being highly accessible for derivation and parallel synthesis, our N,N’-
diarylurea lead compounds may be developed into potent and specific 
agents for treatment of cancer and/or other human disorders in which 
reducing translation initiation would be beneficial. 
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In eukaryotes the translation initiation factor eIF2 plays a key role in the 
selection of the start codon. eIF2 is a heterotrimeric complex consisting of 
the GTPase core γ subunit to which binds the α and β subunits. The eIF2γ 
subunit is a structural paralog of EF-Tu. Like EF-Tu, eIF2γ consists of a G-
domain with conserved GTP-binding Switch-I and Switch-II elements, and 
β-barrel domains II and III that help form the Met-tRNAiMet binding pocket. 
The GTP-bound eIF2 binds Met-tRNAiMet forming a ternary complex (TC) 
and then delivers the Met-tRNAiMet to the 40S ribosomal subunit. The AUG 
codon selection is governed by codon-anticodon interaction between the 
mRNA and Met-tRNAiMet and by GTP hydrolysis and Pi release by eIF2. 
Previous studies identified Sui- mutations in eIF2 that enhanced initiation 
from a non-canonical UUG codon by weakening Met-tRNAiMet. 
Consistently, an eIF2γ-N135D mutation in the Switch I element impaired 
Met-tRNAiMet binding both in vitro and in vivo without affecting eIF2α and 
eIF2β binding and caused both a slow-growth and a Sui- phenotype in 
yeast. Intragenic A208V (switch II) and A382V (domain II) suppressor 
mutations were identified that restored yeast cell growth. These suppressor 
mutations restored Met-tRNAiMet binding both in vitro and in vivo, 
however, only the switch II A208V mutation suppressed the Sui- phenotype 
associated with the eIF2γ-N135D mutation. An eIF2γ-A219T mutation 
located at the base of the GTP-binding pocket in the G-domain impaired 
Met-tRNAiMet binding but unexpectedly enhanced the fidelity of initiation, 
suppressing the Sui- phenotype associated with the eIF2γ-N135D,A382V 
mutation.  
Overexpression of eIF1, which is thought to monitor codon-anticodon 
interactions during translation initiation, likewise suppressed the Sui- 
phenotype of the eIF2γ mutants. We propose that these new mutations in 
eIF2γ reveal an alternate mechanism for Sui- phenotypes. Accordingly, the 
mutations introduce structural alterations in eIF2γ that alter the 
conformation of Met-tRNAiMet on the 40S subunit and thereby affect the 
fidelity of start codon recognition independent of Met-tRNAiMet binding 
affinity.  
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Ribosome is the protein synthesis machinery in all kind of cells. There are 
three binding sites for transfer RNA (tRNA) inside the ribosome, occupying 
both the large and small subunits. They are namely A-site for aminoacyl 
tRNA, P-site for peptidyl tRNA and E-site for the tRNA which is going to 
exit ribosome. In the classic form, tRNA stays in both subunits at the same 
binding site forming P/P-A/A tRNAs. They also head in between the two 
binding sites prior to translocation forming the hybrid states by the P/E-A/P 
intermediate and the controversial P/E-A/A hybrid state. There are proposed 
and defined hybrid states of tRNA, but some of the hybrid states are not still 
confirmed. Here, we are using a single molecule FRET (smFRET) system 
for the translating ribosome to directly observe the two distinctive hybrid 
states. The ribosomal protein L27 which is known to protrude into peptidyl 
transferase center in bacterial 50S ribosome is labeled with cy5 fluorescent 
dye and one of the A-site or P-site tRNAs is labeled with cy3 fluorescent 
dye, and the A-site and P-site states of single ribosomes are observed by 
using a TIRF microscope. In certain Rb complexes, we observed 100% of 
the A-site tRNA at A/A state, while 60% of the P-site tRNA was at P/E 
state in a buffer having a concentration of 10 mM Mg2+. Therefore, 40% of 
the active ribosomes were observed in P/P-A/A classic state, when 60% of 
them were in P/E-A/A hybrid state under the indicated condition. When the 
Mg2+ concentration was lowered to 3.5 mM, 40% of the A-site tRNA was at 
A/P state, at the same time 100% of P-site tRNA was at P/E state. As a 
result, in lower Mg2+ concentrations, 60% of the active ribosomes were still 
in P/E-A/A hybrid state, whereas 40% of the ribosomes migrated to P/E-
A/P hybrid state. Hence, the formation of the second hybrid state during 
translocation step is directly observed. 
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Eukaryotic initiation factor 2 (eIF2) is a heterotrimeric protein consisting of 
α, β, and γ subunits. It plays a central role in protein synthesis by delivering 
Met-tRNAi to the 40S subunit during translation initiation. The conversion 
of inactive GDP bound eIF2 to its active form, GTP bound eIF2, is 
catalyzed by eIF2B. A well-characterized mechanism involving 
phosphorylation in translational control, phosphorylation of serine 51 on 
eIF2α inhibits catalysis via eIF2B thereby halting translation. Numerous 
studies have focused on various biological conditions that activate certain 
kinases which phosphorylate serine 51. However, few reports exist as to 
other potential sites of phosphorylation on the heterotrimeric complex 
which may also have a profound impact on protein translation. Herein, we 
analyzed for phosphorylation on eIF2 by first biochemically purifying the 
protein from HeLa cell lysate. After enrichment of eIF2, the protein was 
reduced, alkylated, and digested with trypsin prior to enrichment of the 
phosphopeptides using titanium dioxide. All peptides were then eluted off 
an online C18 column into the LTQ-Orbitrap XL. The MicroChem 
ADVANCE nanospray source was used to inject eluting peptides into the 
mass spectrometer. Parameters on the LTQ-Orbitrap XL were set to trigger 
MS2 of the top 5 most abundant ions per scan with dynamic exclusion set at 
30 seconds. MS3 was triggered once a neutral loss of phosphate was 
detected. All data were analyzed via SEQUEST and manually validated. 
After attaining roughly 87% sequence coverage of the herterotrimeric 
protein (with 10 residues of the 13% not identified as either being a 
threonine or serine), we have preliminarily identified the following residues 
as phosphorylated: For eIF2α, Ser91, Ser105, Thr245, and Thr284 were 
observed phosphorylated. For eIF2β, phosphorylations were identified on 
Ser2, Ser67, Ser158, Thr217, Ser218, Thr222, Thr283, Thr295, Thr304, 
Ser310, Ser313, and Thr316. For eIF2γ, phosphorylations were identified 
on Ser55, Thr56, Thr66, Ser108, Ser305, Ser412, Thr413, Ser418, and 
Thr435. Previous reports have identified phosphorylations on human eIF2α 
and eIF2β, but little to no phosophorylations have been previously 
identified on human eIF2γ. With these findings, we are further investigating 
the possible kinases responsible for phosphorylating the residues of eIF2γ. 
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The classic ‘scanning model’ of cap-dependent translation initiation in 
eukaryotes involves the association of the scanning small ribosomal subunit 
with a number of eIFs. Many of the same eIFs are also implicated in 
forming a bridge between the 3' and 5' ends of the mRNA in the ‘closed-
loop model’, whereby the close proximity of the 5' and 3' ends potentiate 
the involvement of the 3' UTR and poly(A) tail in translation initiation. 
Thus, the 3'-5' bridge may not be static with respect to the mRNA, or may 
stay associated with the 5' cap while the rest of the 5' UTR loops out of the 
scanning initiation complex (the 'cap-tethered' model). The application of 
next-generation sequencing will assist in differentiating between these 
possibilities as it allows quantitative analysis of lateral positioning of eIF 
and PABP association along mRNAs. Translational regulation may also 
occur via intervention in the closed-loop state and this may be observed 
either globally or in certain subsets of mRNAs in eukaryotic cells in 
response to various cues. 
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The stop codon readthrough utilized in the expression of Sindbis and 
several other alphaviruses was thought to be dependent only on the identity 
of the nucleotide 3’ adjacent to the stop codon. However, we have identified 
a 3’ RNA structure that mediates high level readthrough. Programmed 
frameshifting is also found to be involved in alphavirus expression and 
leads to the synthesis of a protein, termed TF, some of whose properties 
were previously attributed to the viral 6K protein. The 3’ recoding signals 
used for alphaviral frameshifting are diverse; that for Semliki Forest virus 
apparently does not involving intra-mRNA pairing. Several insect and 
mammalian flaviviruses are also found to use programmed frameshifting in 
their expression. An investigation of the programmed frameshifting in 
expression of the Drosophila APC gene will also be presented. 
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The cytoskeleton is a dynamic network that undergoes restructuring during 
various cellular events, influencing cell proliferation, differentiation and 
apoptosis. In a recent study we demonstrated that accumulation of c-Jun, a 
member of the AP1 family of transcription factors that plays a key role in 
normal and aberrant cell growth, dramatically increases upon 
depolymerization of the cytoskeleton and that this increase is controlled 
translationally. Consistent with this finding, analysis of c-Jun expression in 
glioblastoma cells, cells that undergo constant remodeling of the 
cytoskeleton, revealed that there too the increase in c-Jun accumulation is 
translationally controlled. The increase in c-Jun translation is mediated by 
the untranslated regions (UTRs) of the c-Jun transcript, in particular by the 
5’UTR, which is exceptionally long (974 bases), conserved across species 
and has the potential of forming stable secondary structures. Deletion 
analysis revealed that the first 277 bases of the 5’UTR are sufficient to 
mediate the cytoskeletal control of c-Jun translation.  
Using bi-cistronic constructs, RNA transfection and in vitro translation 
assays we showed that this region forms an Internal Ribosome Entry Site 
(IRES) and facilitates cap-independent translation. The cytoskeletal-
dependent increase in c-Jun translation was accompanied by a ~40% 
decrease in global protein synthesis and by phosphorylation of the 
translation initiation factor eIF2α. Restructuring of the actin or microtubule 
network (by latranculin A, cytochalasin B, nocodazole or vinblastin) caused 
a dose- and time-dependent increase in eIF2α phosphorylation. The increase 
in eIF2α phosphorylation appears to be mediated by the double-stranded 
RNA-dependent protein kinase (PKR) and is ultimately required for the 
increase in c-Jun translation: (i) Expression of a dominant-negative mutant 
of PKR impeded eIF2α phosphorylation and suppressed the increase in c-
Jun accumulation. (ii) Inhibition of eIF2α phosphorylation, by the vaccinia 
virus protein K3L or by overexpression of a non-phosphorylatable mutant 
form of eIF2α (S51A), inhibited the accumulation of c-Jun. (iii) Expression 
of c-Jun could not be elevated in cells carrying a homozygous mutation at 
the eIF2α phosphorylation site (S51A). This novel mechanism of c-Jun 
regulation appears to be relevant to physiological conditions in which c-Jun 
plays a pivotal role  
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Translation elongation in eukaryotes is mediated by the concerted actions of 
elongation factor 1A (eEF1A), which in its GTP-bound form binds and 
delivers aminoacylated-tRNA (aa-tRNA) to the ribosome; elongation factor 
1B (eEF1B) complex that catalyzes the exchange of GDP to GTP on 
eEF1A; and eEF2 that facilitates ribosomal translocation. Little is known of 
the mechanisms regulating translational elongation in mammalian systems. 
Here we present evidence for a novel mode of regulation conveyed by 
hindrance of aa-tRNA delivery, leading to ribosome stalling during mitosis 
in HeLa cells.  
 
We previously found that mitotic polysomes do not exhibit the ribosomal 
runoff characteristic of initiation block and provided multiple evidences for 
mitotic translational arrest at a post-initiation step (Sivan et al., MCB 2007). 
In the current study, we show by co-immunoprecipitation and confocal 
microscopy that during mitosis, phosphorylation of the catalytic delta (δ)  
subunit of eEF1B on a conserved CDK1 target site leads to a reduction of 
its interaction with eEF1A. Consequently, less eEF1A-GTP is available for 
binding and delivering aa-tRNA to elongating ribosomes. The decreased 
level of eEF1A-tRNA complex in mitotic cells was evident from northern 
blot analysis of flag-tagged eEF1A co-immunoprecipitates. Western and 
northern blot analyses of polysomal sucrose gradient fractions confirmed 
decreased occupancy of eEF1A and tRNA on heavy polysomes. The 
mitosis-dependent decrease in eEF1A-eEF1Bδ interaction was not observed 
in a cell line stably expressing a phosphorylation-null mutant of eEF1Bδ.  
 
Although first discovered during mitosis, this regulatory mode may also be 
applicable to other physiological conditions that involve translational arrest 
at the elongation level. 
 34 
THE HNRNP R/Q HOMOLOG RACQUETBALL IS REQUIRED FOR 
STABLE EXPRESSION OF SPECIFIC TRANSCRIPTS DURING 
DROSOPHILA SPERMATOGENESIS 
 
Catherine C Baker, Lucineh Parsanian, Margaret T Fuller  
 
Stanford University, Developmental Biology, Stanford, CA, 94305 
 
Early in the 3.5-day meiotic G2 prophase of Drosophila spermatogenesis, 
components of the core cell cycle machinery (such as cycB and 
cdc25/twine) and several hundred spermatid differentiation genes are 
transcribed. Several of these transcripts have been shown previously to be 
subject to translational repression; for example, the dj RNA is expressed in 
meiotic prophase but is not translated until several days later in elongating 
spermatids. The mechanism by which these translationally repressed RNAs 
are protected from degradation until their protein products are required is 
not yet known.  
 
We have found that the Drosophila hnRNP R/Q homolog, encoded by 
CG17838 (renamed racquetball, or rq) is required in male germ cells for 
meiotic division and post-meiotic spermatid differentiation. In particular, 
we discovered that Rq is necessary for stable expression of specific 
transcripts during the extended meiotic G2 prophase. Rq-dependence of a 
given RNA did not correlate with a requirement for either of the two major 
transcription complexes known to be active in meiotic prophase. As the 
human hnRNP Q (NSAP1) has been implicated in distinct complexes 
regulating the stability of the c-fos and c-myc RNAs, we are presently 
testing whether Rq – like its vertebrate homolog – acts at the level of RNA 
stability, and if so, by what mechanism.  
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The PMR1 mRNA endonuclease was originally identified by its function in 
catalyzing the destabilization of serum protein mRNAs in Xenopus. An 
important role for polysome binding in the decay process was recognized 
early on as this was the only fraction from which enzymatic activity was 
recovered. PMR1 participates in the RNP complex containing its substrate 
mRNA, and the targeting of PMR1 to this complex together with translation 
of its substrate mRNA are critical aspects of the decay process. The C-
terminal polysome targeting domain contains a tyrosine that must be 
phosphorylated for PMR1 to sediment with polysomes and catalyze mRNA 
decay, and recent work identified c-Src as the responsible kinase and 
demonstrated a common link between these and the Ena/VASP proteins. 
Given the critical role of tyrosine phosphorylation we performed alanine 
scanning mutagenesis across this region, characterizing the impact of each 
mutation on mRNA decay and selective mutations on tyrosine 
phosphorylation and polysome binding. While most substitutions had 
minimal impact on the decay process changing the residue immediately 
upstream of the pTyr site completely inactivated PMR1 decay without 
affecting tyrosine phosphorylation. Because a sequence downstream of the 
pTyr site resembled a consensus CK1 site we also examined the impact of 
adding a CK1 inhibitor or changing the threonine there to serine, cysteine or 
glutamic acid. Neither the CK1 inhibitor nor glutamic acid substitution 
affected PMR1 mRNA decay; however, activity was enhanced by the serine 
and cysteine substitutions, identifying an important role for this region of 
the enzyme in the decay process. Finally, the results of alanine scanning 
mutagenesis informed a bioinformatics search for likely SH2-containing 
partners that identified Nck1/2 closely related adapter proteins shown 
previously to sediment on polysomes and play a role in controlling 
translation.  
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Background  
The positive sense strand of the HIV-1 genome encompasses nine open reading 
frames (ORFs). A tenth negative sense ORF (herein designated vpo) is 
positioned opposite the gp120/gp41 junction of env. Negative sense 
transcription of vpo has been observed in the early stages of infection in vitro 
and in vivo and it has been suggested that LTR sequences regulate vpo 
expression. In this study we propose that an upstream sequence containing a 
series of six sORFs may also regulate expression of the negative sense gene, 
vpo.  
 
Results  
The potential upstream vpo control region from HIV-1NL4-3, was cloned 
upstream of the reporter gene EGFP; the introduction of this sORF region 
inhibited EGFP expression. RT-PCR analysis of message isolated from 
transfected HEK293 cells indicated that the sORF region undergoes alternative 
splicing to remove sORFs I to V (predominant spliced product) or sORFs III to 
V (minor spliced product). Sequence analysis revealed the use of typical splice 
donor and acceptor site motifs which are highly conserved across 29 HIV-1 B 
clade strains. Mutation of the splice acceptor site produced a further reduction 
in EGFP expression, indicating that splicing may partially alleviate inhibition of 
downstream expression.  
 
A series of constructs, in which the AUG codons of individual sORFs were 
mutated in conjunction with the splice acceptor, were produced to investigate 
the relative effect of each sORF on downstream expression. Northern analysis 
indicated a constant amount of transcript for all constructs, implying that 
inhibition of EGFP expression occurs post-transcription. A significant increase 
in expression occurs when the initiation codon of all sORFs (I to VI) are 
mutated in conjunction with the splice acceptor. Mutation of only sORF VI, 
immediately preceding vpo, significantly alters EGFP expression. Together 
these data imply the entire sORF series inhibits downstream gene expression 
potentially via ribosomal stalling. This hypothesis is currently being 
investigated in our laboratory by primer extension analysis.  
 
Conclusions  
Alternative splicing of the sORF region may play a role in the stringent control 
of vpo gene expression. Our studies suggest that the sORF series inhibits 
expression; selective splicing may reduce the number of sORFs upstream of 
vpo, thereby contributing to the control of negative sense gene expression in 
HIV-1.  
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Many industrial fermentations for biotherapeutics production operate a 
biphasic temperature strategy: cells are initially cultured at 37°C to 
accumulate biomass and then the temperature is shifted to sub-physiological 
temperatures (typically 32°C) to enhance protein production and prolong 
culture viability in the stationary growth/production phase. As cells 
approach maximum concentrations and as a direct consequence of cold 
stress there is suppression of global translation initiation by the normal cap-
dependent mechanism due to an increase in phosphorylation of eIF2α. 
However this is associated with an increased translation of specific mRNAs 
such as cold-shock proteins. To identify those mRNA preferentially up-
regulated at the translational level during cold-shock, we have performed 
polysomal mRNA profiling. This technique couples sucrose density 
gradient separation of polysomally associated mRNAs with cDNA 
microarray. This technique was used following culture of human embryonic 
kidney (HEK) cells for 24h at 32°C, compared to cells cultured at 37°C. 
mRNAs translationally up-/down-regulated during cold-shock were 
identified. Data obtained from this screen are under analysis to identify 
putative sequence elements in the 5’ UTR (e.g. IRESs, uORFs) and 3’ UTR 
(e.g. stabilizing elements, miRNAs) of the mRNAs translationally up-
regulated following cold-shock. The role of these elements in translational 
regulation will be investigated. In the longer term these data will be used to 
design vectors with UTRs that facilitate selective translation of 
biotherapeutic genes during cold-shock, against a background of global 
shutdown of mRNA translation. 
 38 
RRNA MODIFICATIONS REGULATE CELLULAR IRES-MEDIATED 
TRANSLATION THROUGH THE 48S PRE-INITIATION COMPLEX 
ASSEMBLY, WHICH IS REQUIRED FOR TUMOR SUPPRESSION 
 
Cristian Bellodi1, Olya Krasnykh1, Nikisha Haynes1, Marily 
Theodoropoulou2, Lorenzo Montanaro3, Noam Kopmar1, Adrian Contreras1, 
Davide Ruggero1  
 
1University of California, San Francisco, Department of Urology, San 
Francisco, CA, 94158, 2University of Rochester, Department of 
Endocrinology, Rochester, NY, 14627, 3University of Bologna, Department 
of Pathology, Bologna, 40126, Italy 
 
Pseudouridylation of rRNA is important for the function of the ribosome. 
However, its specific role in modulating translational control is not 
completely understood. Importantly, defects in ribosome function are 
present in the syndrome X-linked Dyskeratosis Congenita (X-DC), where 
the DKC1 gene, encoding for the pseudouridine synthase that modifies 
rRNA, is found mutated. We have previously shown that impairments in 
DKC1 activity affect accurate translation of messengers containing IRES 
elements. However, the molecular basis of how impaired rRNA 
modifications, resulting from DKC1 mutations, modulate translational 
control remains poorly understood. In the present study, we have focused on 
one important IRES-containing mRNA, p27, which is a critical regulator of 
the cell cycle and acts as a tumor suppressor. We have generated the first 
bioluminescent mouse model to monitor p27 translation directly in vivo, and 
show that p27-IRES mediated translation is greatly impaired in a tissue 
specific manner in DKC1 mutant animals (DKC1m), with the most 
pronounced effect in the pituitary gland. At the molecular level, we 
demonstrate that the assembly of the 48S translational pre-initiation 
complex mediated by the p27 IRES-element is critically impaired in 
DKC1m. To further understand the molecular basis underlying this 
impairment, we are currently undertaking a RNA-based purification method 
to isolate and compare the organization of p27 IRES-containing 48S pre-
initiation complexes in cytoplasmic extracts prepared from primary WT and 
DKC1m cells. We further show that reductions in DKC1 markedly 
exacerbate pituitary tumor formation in p27 heterozygous mice. In addition, 
we investigate the importance of these findings for the pathogenesis of 
human cancers. Strikingly, we identified a novel somatic mutation of DKC1 
(DKC1S485G) that correlates with reductions in rRNA modifications and p27 
protein levels in a human pituitary adenoma. We extend these finding by 
demonstrating that the levels of rRNA pseudouridylation are greatly 
impaired in a large cohort of X-DC patient cells. Altogether, these findings 
provide novel insights into the mechanisms by which reductions in rRNA 
modifications due to defects in DKC1 perturb p27 IRES-mediated 
translation and contribute to cancer susceptibility in X-DC. 
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Selenoprotein expression is regulated at the levels of protein synthesis and 
RNA turnover via complicated mechanisms that are not well understood. 
Selenoprotein mRNAs utilize UGA codons to direct incorporation of 
selenocysteine. The efficiency of incorporation at these codons is decreased 
either by limiting selenium availability or decreases in the abundance or 
activity of factors involved in selenoprotein synthesis. Thus, when the 
corresponding selenoprotein pre-mRNAs contain one or more introns 
sufficiently downstream of the UGA codon, and selenocysteine 
incorporation is impaired, the mRNAs are subject to nonsense-mediated 
decay (NMD). Strikingly, the mRNAs for some selenoproteins predicted to 
be sensitive to NMD based on the intron rule such as glutathione peroxidase 
4 (GPX4) are in fact resistant, while others such as the structurally related 
GPX1 are sensitive. In addition, susceptibility of these mRNAs to NMD 
exhibits differential tissue-specificity, whereby brain and endocrine organs 
preserve selenoprotein mRNAs better than e.g. liver. This has been termed 
the “hierarchy of selenoprotein synthesis”. Previous studies from our 
laboratory and others have implicated a number of factors in contributing to 
this hierarchy. These include expression levels of the SECIS-binding 
proteins, SBP2, and nucleolin, the selenocysteyl-tRNA binding protein, 
SECp43, and the exon junction complex protein, eIF4A3. We have 
uncovered a new factor involved in this regulation, and our studies reveal 
that this factor affects the mRNA levels for a large number of selenoprotein 
mRNAs, with differential tissue-specific effects. In addition, we have used 
GRNA to identify novel selenoprotein mRNPs and are investigating their 
potential roles in selenoprotein translation and NMD. The implications for 
differential expression of different selenoproteins under varying conditions 
will be discussed. 
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Protein kinase R (PKR) is a host anti-viral factor that is poised to bind dsRNA 
and phosphorylate eIF2α, shutting down of cellular protein synthesis and viral 
replication. In response, many viruses have evolved mechanisms to subvert the 
PKR pathway, which in turn has driven rapid evolution of PKR. Several 
characterized cytomegalovirus (CMV) PKR antagonists interact with both 
dsRNA and PKR to inhibit PKR function. These CMV genes have no 
recognizable homology to genes outside the β-herpesvirus lineage. During 
human CMV (HCMV) infection either of two related dsRNA-binding proteins, 
hTRS1 or hIRS1, is necessary to inhibit human PKR (hPKR). The related 
murine CMV (MCMV) proteins, m142 and m143, antagonize PKR as a 
multimeric complex. To better understand the conserved features and evolution 
of the CMV PKR antagonists, we identified functional homologues from guinea 
pig CMV (GPCMV) and rhesus CMV (RhCMV). 
 
The GPCMV homolog of hTRS1 is gp145, one of several dsRNA-binding 
proteins produced during GPCMV infection that were identified by mass 
spectrometry. Subsequent experiments confirmed that gp145 binds dsRNA 
specifically, and that it can rescue the replication of vaccinia virus lacking its 
own PKR antagonist E3L (VVΔE3L) in human cells. Similar to HCMV hTRS1 
and hIRS1 but unlike MCMV m142 and m143, gp145 alone is sufficient to 
block PKR function. 
 
RhCMV encoded rhTRS1 has considerable homology to hTRS1, binds dsRNA, 
and rescues VVΔE3L in BSC40 cells, an African green monkey cell line. 
However, rhTRS1 appears unable to block PKR activation in human cells. 
Conversely, hTRS1 rescues VVΔE3L in human cells but not BSC40 cells, 
suggesting that in primates the TRS1-PKR interaction is species-specific. 
Despite the failure of rhTRS1 to block hPKR, RhCMV can replicate in human 
cells. Moreover, infection of human cells with RhCMV rescues VVΔE3L, 
indicating that RhCMV infection has the ability to block activation of hPKR. 
These results suggest that RhCMV may encode an additional antagonist of the 
human PKR pathway. The mechanisms responsible for the apparent species-
specificity of PKR and its TRS1 antagonists within primates and the broader 
susceptibility of hPKR to inhibition by the rodent CMV PKR antagonists 
remain unclear, but may reflect the evolutionary pressures to which β-
herpesviruses and PKR have been subjected. 
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Control of eukaryotic gene expression at the level of translation allows for a 
rapid response to intracellular and environmental stimuli. A classic example 
is the unfolded protein response (UPR). When the folding capacity of the 
ER is exceeded, the transmembrane kinase/endonuclease IRE1 triggers a 
signaling cascade to turn on expression of genes encoding protein-folding 
catalysts to restore cellular homeostasis. Central to UPR activation in yeast 
is the transcription factor HAC1p, whose mRNA is an IRE1 substrate. 
During normal growth conditions, HAC1 mRNA is constitutively expressed 
but protein levels are undetectable. It has been proposed that HAC1p 
expression is tightly regulated by a basepairing interaction between 21 
complementary nucleotides present in the mRNA 5’ UTR and intron. The 
implicit mechanism is that secondary structure created by the UTR/intron 
interaction blocks scanning ribosomes, and that this translational block is 
alleviated by IRE1-mediated removal of the HAC1 intron through a non-
conventional splicing reaction.  
 
The primary goal of the current study is to define the mechanism of HAC1 
translational control. A series of HAC1 expression plasmids was created 
with mutations that disrupt 5’ UTR/intron basepairing. We have identified 
that within the 21 basepairs reported to block HAC1 mRNA translation, 
disruption of at least 3 consecutive C/G basepairs is sufficient to allow 
HAC1p synthesis. Compensatory mutations restoring complementarity 
restored the translational block, further implicating long-range basepairing 
as important for impeding ribosome scanning. Disruption of only 2 C/G 
basepairs was insufficient to allow HAC1 mRNA translation, suggesting 
that there is a threshold of secondary structure for efficient ribosome 
scanning. Screening experiments are underway to identify factors that 
increase this threshold, and therefore promote efficient ribosome scanning. 
It is expected that study of HAC1 mRNA translation will provide new 
insights on the factors involved in scanning of mRNAs with complex 5’ 
secondary structures. 
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The anti-viral function of RNA silencing was first discovered in plants as a 
natural manifestation of the artificial ‘co-suppression’, which refers to the 
extinction of endogenous gene induced by homologous transgene. Because 
silencing components are conserved among most, if not all, eukaryotes, the 
question rapidly arose as to determine whether this process fulfils 
equivalent functions in animals. It appears that, whereas the anti-viral 
process seems to be similarly conserved from plants to insects, even in 
worms, RNA silencing does influence the replication of mammalian viruses 
through micro(mi)RNAs, endogenous small RNAs naturally implicated in 
translational control. Notably, cellular micro(mi)RNAs recognize foreign 
RNAs and thereby associated proteins (e.g. Argonaute(AGO)2) can 
modulate viral infections. We reveal here that, in contrast to host mRNAs, 
the recognition of unspliced retroviral RNAs by AGO2 is not triggered by 
miRNAs. The GAG proteins of Primate Foamy Virus 1 (PFV-1) and 
Human Immunodeficiency Virus 1 (HIV-1) interact with AGO2, 
independently of RNA, miRNAs and Processing-bodies. AGO2 then 
recognizes viral RNAs through the binding of GAG to encapsidation RNA 
sequences without eliciting RNA silencing and is further encapsidated. We 
also bring evidences that AGO2 might have original features unrelated to 
translation regulation but yet hijacked by retroviruses. 
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Circadian behavioral rhythms are driven by an intracellular transcription-
translation feedback loop. The transcriptional aspects of this loop are well 
explored, and many core clock genes as well as important output genes have 
been shown to manifest cycling expression at the RNA level and even at the 
transcriptional level. However, translational oscillations are much less well-
studied. To this end, we have examined poly-A tail lengths and polysome 
locations of key clock mRNAs in fly heads. Although different clock genes 
show very different tail lengths, they do not appear to change as a function 
of circadian time. Moreover, the different tail lengths of different clock 
genes do not seem to correlate with polysome location, as preliminary data 
indicate that at least three key clock mRNAs with different tail lengths 
show very limited polysome association, i.e., they all appear to be very 
inefficiently translated. Inefficient translation of clock mRNAs may be 
relevant to circadian timekeeping, as regulatory proteins affecting 
translational initiation are enriched in clock neurons and/or affect the 
circadian program. 
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The expression of many viral and some cellular genes requires a 
programmed –1 ribosomal frameshifting event. This is a specific subversion 
of frame maintenance where the ribosome is forced to shift one nucleotide 
backwards into an overlapping reading frame and to translate an entirely 
new sequence of amino acids. Frameshifting is promoted by an mRNA 
signal composed of two essential elements; a heptanucleotide ‘slippery’ 
sequence, and an adjacent mRNA secondary structure, most often an 
mRNA pseudoknot. How these components operate together to manipulate 
the ribosome is unsure. Previously, we employed cryo-electron microscopic 
imaging to investigate the structure of mammalian 80S ribosomes paused at 
a coronavirus frameshift-promoting pseudoknot. Here we describe further 
characterisation of these complexes and present new cryo-EM 
reconstructions of ribosomes stalled at the stimulatory RNAs of the HIV 
and BWYV frameshifting signals. A comparison of the various complexes 
has allowed us to identify features likely to be of general importance in the 
frameshifting process. The reconstructions also provide snapshots of 
eukaryotic ribosomes stalled during the process of translational elongation. 
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The hormone-induced completion of Meiosis I and arrest in metaphase of 
Meiosis II is termed maturation and is critical for production of fertilisation-
competent Xenopus oocytes. Control of maturation involves complex 
cascades of intracellular signalling and gene expression and is highly 
conserved between vertebrates. Crucially, the gene expression events are 
regulated almost entirely at the level of mRNA translation and embryonic 
Poly(A)-binding protein (ePABP) is a putative mediator of this translational 
regulation. 
 
Using a combination of oocyte micro-injection, protein fractionation, mass 
spectrometry and in vivo assays, we here demonstrate that ePABP is 
dynamically phosphorylated during oocyte maturation and that 
phosphorylation of ePABP at specific sites is required for normal oocyte 
maturation. Phospho-mutant forms of ePABP are able to activate translation 
when tethered to a reporter mRNA but are unable to efficiently rescue the 
block in maturation induced by exogenous PAIP2 expression. 
Unphosphorylated endogenous ePABP does not bind to poly(A) and we 
propose that ectopically-expressed phospho-mutant cannot protect the 
nascent poly(A) tails of mRNAs undergoing cytoplasmic polyadenylation. 
Taken together, these findings identify the regulated phosphorylation of 
ePABP as a novel and critical event in the control of oocyte meiotic 
progression and maturation. 
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Higher plants have a second form of initiation factor 4F (eIF4F) that has 
distinct large and cap-binding protein subunits from eIF4F. The eIFiso4G 
subunit is considerably smaller than eIF4G from plants and other 
eukaryotes, but has cap-binding subunit, HEAT-1 (MIF4G) and HEAT-2 
(MA3) domains, but like plant eIF4G lacks the HEAT-3 (W3) domain. 
Arabidopsis thaliana T-DNA insertion mutants in the two genes for 
eIFiso4G were obtained and the phenotype of the single and double 
knockouts of the eIFiso4G genes was observed. Mutants in either 
eIFiso4G1 or eIFiso4G2 do not appear significantly different from wild 
type plants. However, when the two single mutants were crossed, a 
significant phenotype was observed. The plants were slower to grow and 
develop, were pale green compared to parents or wild type due to less 
chlorophyll and have altered chloroplasts. In addition, the double mutants 
have reduced fertility and reduced long term seed viability. The double 
mutant also shows altered responses to several environmental stresses. 
These phenotypes suggest that eIFiso4G plays a role in the expression of 
mRNA(s) for a subset of genes that when absent result in the observed 
phenotypes. To identify this subset of mRNAs, polysomes from double 
mutant and wild type plants were obtained, and the RNA used to probe 
DNA arrays. A number of mRNAs were identified that were reduced on the 
double mutant polysomes. 
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The Magnaporthe oryzae T-DNA mutant M35 was identified as being 
defective in plant colonization. M35 has undergone insertional inactivation 
of a gene encoding a novel RNA-binding protein (RBP35) with two protein 
modules, a RRM domain and six RGG boxes. The RBP35 orthologues are 
found only in filamentous fungi. The RBP35 gene is constitutively 
expressed in vitro and in planta. A His-tagged version of the RBP35 protein 
binds specifically poly(G) RNA homopolymers and not ssDNA or dsDNA. 
Amino and carboxy RBP35-cherry protein fusion constructs show a steady-
state nuclear localisation. An RBP35 variant lacking the arginine aminoacid 
within the six RGG boxes accumulates in cytoplasmic granules located near 
the fungal cell wall. Western blots performed with a specific antibody 
raised against RBP35 revealed the presence of two protein isoforms, the 
expected full length protein (44 kDa, RBP35a), and a smaller protein (31 
kDa, RBP35b) derived from the proteolytic cleaveage of the carboxy end of 
RBP35a. RGG1 and RGG6-containing aminoacid sequences are substrates 
for thrombin-like enzymes. Generation of RBP35 variants in the RGG 
boxes is underway to help to clarify the nature of the proteolytic cleavage. 
Additional analysis of RBP35 protein domains is being carried out by 
generating truncated variants of RBP35. A transcriptomics and proteomics 
comparison between the ∆rbp35 mutant and the wild-type strain showed 
that several enzymes required for flavonoid and melanin synthesis were up- 
and down-regulated in ∆rbp35. RBP35 protein variants containing the HA-
FLAG tag fused to amino and carboxy ends have been generated and 
currently we are optimizing tandem affinity purification experiments in 
order to identify proteins and mRNAs interacting with RBP35. 
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In mammals, four cytoplasmic poly(A)-binding proteins (PABPs) with a 
common domain structure have been described (PABP1, tPABP, PABP4 
and ePABP) which display different tissue and cellular patterns of 
expression. The vast majority of research on PABP mechanism, function 
and sub-cellular localisation is however limited to PABP1. PABP1 
predominantly localises to the cytoplasm where it is an important regulator 
of mRNA translation and stability. PABP1 has also been shown to localise 
to the nucleus during rotavirus and herpesvirus infection and following 
treatment with transcriptional inhibitors such as actinomycin D. 
 
Here we show that PABP4 also relocalises to the nucleus following 
actinomycin D treatment and that both PABP1 and PABP4 relocalise to the 
nucleus following UV-C irradiation. While UV-C also induces 
transcriptional inhibition, we find that nuclear relocalisation of PABP1 and 
PABP4 requires prolonged actinomycin D treatment (6 hours), beyond 
transcriptional inhibition which is effected within minutes. This suggests 
that a transcriptional block per se is not sufficient to induce nuclear PABP 
accumulation. We hypothesize that nuclear export of PABPs may also be 
influenced by mRNA export, which we find to be inhibited following UV 
irradiation. This hypothesis is supported by our finding that PABP1 and 
PABP4 accumulate in the nucleus following inhibition of the TAP/NXF1 
mRNA export pathway, implying that nuclear export of cytoplasmic PABPs 
may be at least partially mRNA dependent. 
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The DNA damage response activates several pathways that stall the cell 
cycle and allow DNA repair. These consist of the ATR/CHK1and ATM 
/CHK2 pathways and the ATM/ATR/p38MAPK/MK2 checkpoint. Crucial 
to maintaining the integrity of the genome is the S-phase checkpoint that 
functions to prevent DNA replication until damaged DNA isrepaired. 
Inappropriate expression of c-Mycis known to cause DNA damage. One 
mechanism by which c-Mycinduces DNA damage is through binding 
directly to components of the prereplicativecomplex thereby promoting 
DNA synthesis, resulting in replication-associated DNA damage and 
checkpoint activation. We showed that following etoposide-induced DNA 
damage, translation of c-Mycis repressed by miR-34c via a highly 
conserved target-site within the 3' UTR. While miR-34c is induced by p53 
following DNA damage, we show that in cells lacking p53, an alternative 
pathway which involves p38 MAPK signalling to MK2/3/5 is used. 
Inhibition of miR-34c activity prevents S-phase arrest in response to DNA 
damage leading to increased DNA synthesis, DNA damage, and checkpoint 
activation in addition to that induced by etoposidealone, which are reversed 
by c-Mycdepletion. These data demonstrate that miR-34c is a critical 
regulator of c-Mycexpression following DNA damage acting downstream 
of p38 MAPK/MK2/3 and suggest that miR-34c serves to remove c-Mycto 
prevent inappropriate replication. There is dispute in literature as to whether 
p38 MAPK directly activates MK5 and we are currently determining if 
MK2/3 and MK5 act in a serial or parallel in response to p38 MAPK 
activation. 
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Small nucleolar RNAs (snoRNAs) are an evolutionarily conserved class of 
noncoding RNAs, the majority of which are involved in either the 2'-O-
methylation (Box C/D snoRNAs) or the pseudouridylation (Box H/ACA 
snoRNAs) of specific rRNA bases. Each class of snoRNA associates with a 
specific set of proteins to form functional snoRNPs. Base-pairing between 
individual snoRNAs and their RNA targets positions the target base for 
modification, which is then catalyzed by a catalytic protein specific for each 
class of snoRNP. While the biochemical functions of individual snoRNAs 
are well understood, much less is known about the biological function of 
individual snoRNAs and their corresponding rRNA modifications. In order 
to elucidate the biological roles of individual snoRNAs and their 
modification we have performed epistatic miniarray profiling (E-MAP) on a 
collection of of 49 snoRNA deletion strains. E-MAPs allow high-
throughput analysis of double mutants through quantitative determination of 
their growth rates, and subsequent generation of genetic-interaction maps 
through hierarchical clustering. E-MAPs thus allow the elucidation gene 
function and of functional relationships between genes. These snoRNA 
deletions were crossed to an array of 1,536 single mutants covering a broad 
spectrum of yeast biology, creating a collection of ~75,000 double mutants. 
This analysis has revealed that individual snoRNAs show distinctive 
phenotypic profiles, suggesting that individual snoRNAs have biologically 
distinct functions. Additionally, a subset of snoRNAs show strong negative 
genetic interactions with genes of the secretory pathway, and the unfolded 
protein response (UPR). This suggests a possible role for these 
modifications in translation and/or translocation of secretory system 
substrates. 
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Cancer development and progression requires stimulation of angiogenesis 
by hypoxia, which inhibits the canonical cap-dependent translation pathway 
and selectively stimulates cap-independent translation of mRNAs 
containing internal ribosome entry sites (IRESes)1. One such IRES-
containing mRNA is that encoding VEGF, a major regulator of 
angiogenesis, and a key oncology drug target. Thus, specific positive-acting 
regulators of VEGF IRES activation are potential new oncology drug 
targets. However, upstream regulators of VEGF IRES translation and the 
molecular mechanisms controlling cap-independent translation via the 
VEGF IRES are still largely unclear. To identify key regulatory molecules 
affecting selective IRES translation under hypoxic conditions in cancer cells 
we performed a high-throughput RNAi screen using an in vivo assay based 
on transfection of a VEGF IRES reporter mRNA lacking a canonical 7mG-
cap structure. By screening a library of 1000 siRNAs targeting all 700 
known human kinases and 300 phosphatases, we identified four kinases that 
positively regulate VEGF IRES function. These genes are likely to be bona 
fide novel regulators of VEGF IRES translational activity under hypoxia, 
since they 1) were identified with at least two independent siRNA 
sequences, 2) do not affect cap-dependent translation, and 3) do not cause 
indirect effects on translation by altering cell viability. Strikingly, none of 
the four identified genes has previously been directly implicated in 
translational control. We are currently testing whether the identified factors 
regulate VEGF IRES translation exclusively under hypoxic but not under 
normoxic conditions, or are more general regulators of IRES activity. In 
either case, our results have identified novel kinase regulators of VEGF 
IRES activity that may ultimately prove to be useful therapeutic targets. 
More generally, they demonstrate the power of high-throughput functional-
genomic screening for identifying novel regulators of translation in human 
cells.  
 
Reference 
1Braunstein et al., Molecular Cell 28:501-12 (2007) 
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A variety of cellular stresses have been shown to induce a global inhibition 
of protein synthesis at the level of translation initiation. Of the stresses 
studied in the yeast S. cerevisiae, glucose depletion causes the most 
dramatic inhibitory effect, both in terms of the rapidity and scale of the 
reduction in protein production. The novel mechanism involved in the 
translational inhibition following glucose starvation is currently unknown. 
We have further characterised the stage of protein synthesis that is inhibited 
following glucose starvation and provide evidence for altered protein-
protein interactions within the 48S complex.  
Specific mRNAs that are important for the adaptation to this stress must 
somehow continue to be translated. We have taken a polysomal microarray 
approach to determine which mRNAs remain translated early after glucose 
starvation. These experiments enable us to provide a physiological context 
for this translational regulation by ascribing defined functions that are 
required for the early adaptation to glucose depletion. Analysis of the 
mRNA’s with altered profiles shows an up-regulation of genes involved in 
the utilization of alternative carbon sources and cellular transport. 
Comparison of array data generated under different stress conditions 
indicates that key mRNAs in the pentose phosphate pathway are 
translationally activated following both glucose and amino acid starvation. 
These data support the hypothesis that activation of the pentose phosphate 
pathway is important for stress survival and it is possible this relates to a 
requirement for NADPH under increasingly oxidative metabolic conditions. 
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Cellular mRNAs assemble into dynamic mRNPs. The protein composition 
of these complexes critically affects mRNA biological fates, e.g. 
determining whether they will be efficiently translated or degraded. 
Numerous past efforts have contributed to the identification of mRNA-
binding proteins by in vitro approaches. However it is still unknown 
whether some of those proteins bind RNA in the intracellular environment. 
Making use of UV cross-linking in living cells, we have established two 
efficient, reliable and complementary protocols to preserve physiological 
mRNA-protein interactions throughout stringent purification procedures 
employing oligo d(T) beads. By mass spectrometric analysis of the co-
isolated proteins we have studied the HeLa cell mRNA-protein interactome 
identifying more than six hundred proteins. As expected, gene ontology 
analysis revealed significant p values for functional groups such as 
initiation and elongation factors, ribosomal proteins, translational 
regulators, RNA nucleases, RNA helicases, and factors involved in 
miRNA-mediated repression. Interestingly, four of the subunits (a, c, d and 
g) of eIF3 were detected with high confidence in the pool of proteins 
associated with polyadenylated mRNAs, suggesting that these eIF3 subunits 
directly contact the mRNA. Surprisingly, a significant enrichment of 
Rossmann fold-containing metabolic enzymes was also observed. The in 
vivo association of metabolic enzymes with mRNAs may foreshadow a 
novel posttranscriptional regulatory network that links cellular metabolism 
to gene regulation. It will be important to determine its biological scope and 
dynamic changes as a function of alterations in cellular metabolism. Our 
comprehensive list of the mRNA binding proteins in a (HeLa) cell furthers 
our understanding of mRNA biology and posttranscriptional regulation. 
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Trypanosoma cruzi is the protozoan parasite that causes Chagas’ disease in 
humans. Unlike other eukaryotes, regulation of gene expression in 
trypanosomatids is essentially post-transcriptional. Nevertheless, 
mechanisms that regulate translation initiation have not been described in 
these parasites, although they express typical initiation factors and also 
three eIF2α kinases. The transformation of T. cruzi epimastigote form, the 
insect proliferative stage of the parasite, into the non-proliferative, but 
infective metacyclic-trypomastigote stage is named metacyclogenesis. It 
occurs naturally in the last portion of the digestive tract of triatomine insect 
vector, when nutrients are scarce, just before feces and urine excretion. 
Metacyclogenesis can be reproduced in vitro by submitting epimastigotes to 
a nutrient poor medium that mimics the composition of triatomine urine 
(TAU) followed by incubation in TAU supplemented with amino acids and 
glucose (TAU3AAG). Here we investigated whether the phosphorylation of 
eIF2α, which causes translational arrest in response to amino acid starvation 
in other eukaryotes, is involved in this differentiation process. 
Trypanosomatids’ eIF2α diverge from other eukaryotes in having an 
extended N-terminus, and a Threonine residue (T169) in place of the typical 
Serine51 that is phosphorylated in other eukaryotes. We generated 
antibodies that recognize the phosphorylated form of T. cruzi eIF2α 
specifically at Thr169. The specificity of this antibody was determined by 
showing that: a) recognition was abolished after treatment with active λ-
phosphatase; and b) the antibodies did not react with the eIF2α protein of 
trypanosomes containing a Thr169Ala mutation. When exponentially 
growing epimastigotes were incubated in TAU medium, an increase in Tc-
eIF2α phosphorylation was observed along with a simultaneous decrease in 
polysomes and in total protein synthesis. Upon transfer to TAU3AAG 
medium, required for efficient metacyclogenesis, there was a decrease in 
eIF2α phosphorylation concomitant with partial recovery of translation. 
Incubation of parasites directly in TAU3AAG did not elicit eIF2α 
phosphorylation and differentiation was not efficient. These results indicate 
that nutritional stress in trypanosomatids leads to phosphorylation of Tc-
eIF2α, and suggest that this event inhibits translation. Furthermore, our 
analysis also indicated that translational inhibition mediated by eF2α 
phosphorylation is involved in the generation of infective forms of T. cruzi. 
 
Supported by FAPESP and CNPq 
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The PI3K/Akt/mTOR signalling pathway is frequently activated in many 
human cancers. mTOR is a regulator of eukaryotic translation initiation and 
its stimulation leads to increases in protein synthesis. The recruitment of the 
40S ribosomal subunit and its associated factors to the mRNA is highly 
regulated by eukaryotic initiation factor (eIF) 4F, a heterotrimeric protein 
complex. The translation initiation factor eIF4E is the least abundant 
component of the eIF4F complex and has been shown to be over-expressed 
in many human cancers. Small molecule inhibitors that target eIF4F 
function would be highly valuable in assessing the potential of targeting 
cap-dependent translation as a chemotherapeutic strategy.  
Screening of 269,000 compounds using a TR (time resolved) -FRET 
(fluorescence resonance energy transfer) based HTS (high throughput 
screening) assay that monitors eIF4E:eIF4G interaction led to the 
identification of several small molecule inhibitors. These compounds 
inhibited cap-dependent in vitro translation and showed inhibition of eIF4F 
complex formation in vivo. Two of the compounds were tested for their 
ability to reverse chemoresistance in a pre-clinical murine lymphoma 
model. Data will be presented to support the idea of using inhibitors of 
eIF4E:eIF4G interaction to reverse chemoresistance in vivo. 
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ANGIOGENESIS 
 
Sung-Hee Chang, Yuquan Xiong, Mallika Ghosh, Timothy Hla  
 
Weill Cornell Medical School, Pathology, New York, NY, 10065 
 
HuR, an RNA binding protein that regulates the mRNA stability and 
translation is essential for proliferating progenitor cell survival in mice (JCI, 
2009;119(12):3530–3543). It binds to numerous mRNAs with AU-rich 
elements and regulates their expression. In various human tumor cells, 
correlation between the expression of cytosolic HuR and poor disease 
outcome has implicated a role of HuR in cancer development. Here we 
show that the deletion of Hur (Elavl1) in myeloid lineage (Hurflox/floxLysM-
Cre) resulted in an attenuated LLC (Lewis Ling Carcinoma cell) tumor 
growth. FACS analysis and immunohistochemistry demonstrated a 
significant infiltration by cells of myeloid lineage (F4/80+ cells) into LLC 
tumors both in Hurflox/flox and Hurflox/floxLysM-Cre mice. Interestingly, the 
vasculature in tumors of Hurflox/floxLysM-Cre mice was less tortuous with 
reduced vessel branching and length. These findings suggest that regulation 
of post-transcriptional gene expression by HuR in myeloid cells regulate 
angiogenesis and tumor growth. 
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The human immunodeficiency virus type 1 (HIV-1) uses a programmed -1 
ribosomal frameshift (FS) to control the synthesis of its viral enzymes when 
its full-length mRNA is translated by the ribosomes of infected cells. This 
FS occurs at a slippery sequence and its efficiency is controlled by a stem-
loop, the frameshift stimulatory signal (FSS). The FS efficiency is critical 
for the production of infectious viral particles and it is therefore important 
to fully understand how it is controlled. To study HIV-1 FS, we and others 
usually use a dual-luciferase reporter that contains the sequence coding for 
the Renilla luciferase (Rluc) and the firefly luciferase (Fluc) separated by 
the HIV-1 FS region. With such a reporter, Rluc is synthesized following 
the conventional rules of translation whereas Fluc synthesis requires a -1 
FS. The reporter mRNA corresponding to this dual-luciferase reporter 
contains a short and unstructured 5’UTR. However, HIV-1 full-length 
mRNA has a long and structured 5’UTR. In this study, we investigated 
whether the 5’UTR of HIV-1 full-length mRNA affects the FS efficiency. 
Derivatives of the dual-luciferase reporter were constructed where the 
5’UTR contains either the complete 5’UTR of HIV-1 full-length mRNA (nt 
1-336), a shorter 5’UTR (nt 104-336) or the TAR-Poly(A) stem-loops (nt 1-
104). These reporters were used to transfect HEK 293T and Jurkat cells. 
Our results show that, in the presence of the complete 5’UTR or the TAR-
Poly(A) region, the FS efficiency is increased about two-fold compared to 
that obtained with the conventional reporter. No change was seen when the 
shorter 5’UTR is present although this region is highly structured. Also, 
when either the complete 5’UTR region or only the TAR-Poly(A) region 
was present, the initiation rate decreased about two-fold. It is known from 
the literature that this decrease can be ascribed to the presence of TAR. We 
propose that the decreased initiation rate could increase the probability that 
each ribosome encounters the folded FSS. Since the viral protein Tat, by 
binding to TAR, can counteract the effect of TAR on the initiation rate, we 
investigated whether the presence of Tat or mutants of Tat influenced the 
FS efficiency. Surprisingly, the presence of Tat further increased HIV-1 FS 
efficiency, independently of its effect on the rate of initiation. A model is 
presented that accounts for the influence of the 5’UTR and Tat on HIV-1 FS 
efficiency (supported by the Canadian Institutes of Health Research). 
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The mRNAs of eukaryotes contain a large number of regulatory RNA 
motifs, which are often located in 3’ untranslated regions (3’-UTRs). These 
cis-regulatory RNA elements are involved in a variety of post-
transcriptional regulations, such as mRNA localization and stability, control 
of translation efficiency and polyadenylation. The cis-regulatory RNAs are 
often characterized by conserved sequence motifs and/or structures which 
serve as recognition signals for RNA-binding proteins. Given the large 
spectrum of RNA-interacting proteins, many potential classes of cis-
regulatory elements are yet to be discovered.  
Based on currently available comparative genomic data, it is possible to 
predict new cis-regulatory elements through multi-species sequence motif 
and RNA structural comparisons. In our study, we have applied a number of 
bioinformatics approaches to search for novel elements in 3’-UTRs of the 
human genome. Our strategies include structural predictions on sets of pre-
aligned sequences and motif discovery on sets of un-aligned but 
functionally related sequences. The resulting predictions are analyzed by 
comparing the structural properties with the known cis-regulatory RNAs 
and non-coding RNAs for evaluation of possible candidates, using 
databases of such elements including Transterm and Rfam. We then use 
Gene Ontology (GO) to refine our searches in functionally related genes. 
The best predictions will then be used for experimental testing and 
verification. Our results will continue to build up the classes of elements in 
current databases of cis-regulatory RNA elements. 
 59 
COMPETITIVE AND NON-COMPETITIVE BINDING OF eIF4B, eIF4A, 
AND THE POLY(A)-BINDING PROTEIN TO WHEAT TRANSLATION 
INITIATION FACTOR eIFiso4G 
 
Shijun Cheng, Daniel R Gallie  
 
University of California-Riverside, Biochemistry, Riverside, CA, 92521 
 
The eukaryotic translation initiation factor (eIF) 4G functions to organize 
the assembly of initiation factors required for the recruitment of a 40S 
ribosomal subunit to an mRNA and for interacting with the poly(A) binding 
protein (PABP). Many eukaryotes express two highly similar eIF4G 
isoforms. eIFiso4G, one of two isoforms in plants, is highly divergent and 
unusually small in size. Unlike animal and yeast eIF4G, the domain 
organization of plant eIF4G proteins is largely unknown. Consequently, 
little is known about the conservation of plant eIF4G with those in other 
eukaryotes. We show that eIFiso4G is similar to other eIF4G proteins in 
that there are interaction domains for eIF4A and PABP and we identify, for 
the first time, the interaction domain for eIF4B. In contrast to previous 
reports, two eIF4A binding domains were identified, similar in number and 
organization to animal eIF4G. The eIFiso4G domain organization does 
differ, however, in that it contains two PABP interaction domains. The N-
terminal eIF4A interaction domain partially overlaps with the interaction 
domains for PABP and eIF4B. PABP and eIF4B compete with eIF4A for 
binding eIFiso4G when only the N-terminal eIF4A binding domain is 
present but not in the presence of both eIF4A binding domains, suggesting 
that the C-terminal eIF4A interaction domain functions to alleviate the 
competition with eIF4B and PABP. Competitive binding to eIFiso4G was 
also observed between eIF4B and PABP. Thus, despite its substantial 
divergence in size and domain organization, eIFiso4G maintains its 
interaction with multiple initiation factors during translation initiation. 
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eIF3 is the most complex initiation factor, and has been implicated in 
multiple steps of the translation initiation pathway. The C-terminal domain 
(CTD) of the largest subunit of yeast eIF3, a/Tif32, interacts with the j/Hcr1 
and b/Prt1 subunits of eIF3 and the helix 16-helix 18 segment of 18S rRNA, 
which is close to the mRNA entry channel pore on the solvent side of the 
40S subunit. To illuminate the in vivo functions of the a/Tif32-CTD, we 
characterized three a/Tif32-CTD mutations identified by their temperature-
sensitive or slow-growth phenotypes. Our results indicate that substitutions 
in the conserved Lys-Glu-Arg-Arg (KERR) motif, or in residues of the 
nearby box6 element, of the a/Tif32-CTD all impair mRNA recruitment by 
43S preinitiation complexes in vivo, and confer phenotypes indicating 
defects in scanning and start codon recognition. Previous studies 
demonstrated that a/Tif32 and j/Hcr1 interact simultaneously with the RNA 
recognition motif (RRM) in b/Prt1, and with one another, to form a trimeric 
module in eIF3. The a/Tif32-CTD mutations abolish its binding to the 
RRM, and weaken j/Hcr1 association with eIF3 in a manner rescued by 
j/Hcr1 overexpression, which also suppresses the growth defects of the 
a/Tif32-CTD KERR mutations. Substitutions in the j/Hcr1-CTD weaken its 
binding to a/Tif32 and also impair j/Hcr1 association with eIF3. Although 
removing the j/Hcr1 CTD normally does not affect cell growth, the j/Hcr1-
CTD mutations exacerbate the growth defects of the a/Tif32-CTD 
mutations. Thus, association of j/Hcr1 with b/Prt1 and a/Tif32 in eIF3 
mitigates the deleterious effects of the a/Tif32-CTD mutations on 
translation initiation. Interestingly, mutations in the j/Hcr1 N-terminal 
domain and the a/Tif32-CTD mutations, which disrupt their interactions 
with the RRM, increase leaky scanning of the AUG codon of uORF1 in 
GCN4 mRNA, indicating that integrity of the b/Prt1-RRM·j/Hcr1·a/Tif32-
CTD module promotes efficient AUG recognition. j/Hcr1 binds to 40S 
protein Rps2, and we found that the extreme CTD of a/Tif32 also binds 
Rps2 and Rps3, which are situated near the mRNA entry channel pore. 
Hence, we propose that the b/Prt1-RRM·j/Hcr1·a/Tif32-CTD module binds 
near the mRNA entry channel, enabling the a/Tif32-CTD to stabilize 43S-
mRNA interaction and regulating the transition between scanning-
conducive and initiation-competent conformations of the preinitiation 
complex. 
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Although tetrapod PKRs contain two dsRNA binding domains (dsRBDs) in 
the regulatory region, PKR from a range of fish species contain three 
dsRBDs. As in tetrapods, the PKRs from fish are upregulated by interferon 
and an accumulation of data has demonstrated indirectly that fish PKRs do 
function as eIF2α-kinases. An investigation of recombinant zebrafish PKR, 
drPKR, in in vitro reactions demonstrates that it is able to phosphorylate 
recombinant wild-type zebrafish and human eIF2α, but not the S51A 
variant, confirming its function as an eIF2α-kinase. The relative roles and 
requirement of the three dsRBDs have been investigated in vitro using a 
constitutively active kinase domain variant, DrPKRΔ1-329. The kinase 
domain is constitutively active in vitro and can be inhibited in trans by the 
entire regulatory region containing the three dsRBDs. Recombinant 
regulatory domain variants containing only dsRBD1 and dsRBD2 are 
sufficient to inhibit eIF2α-kinase activity of DrPKRΔ1-329, although 
dsRBDs 1 and 3 are the most closely related to dsRBD in the conserved 
domain database. dsRBD1 has the highest ability to bind dsRNA. 
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The cessation of mRNA transcription midway through the two week long 
haploid phase of spermatogenesis in mice necessitates developmental 
regulation of translation of many mRNAs to complete the differentiation of 
spermatozoa. Previous studies in transgenic mice using the GFP reporter 
demonstrate that translation of the sperm mitochondria cysteine-rich protein 
(Smcp) mRNA is repressed in early spermatids by uORFs for one day by 
the 5’UTR and by four days by the 3’UTR. Analysis of a transgene 
containing both Smcp UTRs demonstrates that interactions between the 
Smcp 5’ UTR and 3’UTR are required for the six day delay in translational 
activation exhibited by the natural Smcp mRNA, to neutralize repression by 
uORFs in the 5’ UTR in late spermatids and to block the formation of 
pseudopolysomes in early spermatids. Mutation of the segments slightly 
upstream and downstream of the first polyadenylation signal result in partial 
and total loss of translational repression by the 3’ UTR, indicating that these 
segments, respectively, contain weak and strong negative translational 
control elements. RNA-EMSA using UV-crosslinking and SDS-PAGE 
demonstrate that the segment downstream of the first poly(A) signal binds a 
protein that resembles a Y-box protein in size and abundance even though 
this segment lacks a Y-box recognition sequence. Studies of the Prm1 and 
Smcp mRNAs in transgenic mice demonstrate that translation of both 
mRNAs is regulated by negative and positive mechanisms, and that the 
duration of initial repression is determined primarily by the distal end of the 
3’UTR. However, the sequences that repress translation and positive 
regulatory mechanisms in each mRNA differ, and interactions between the 
5’ and 3’ UTR are not required for normal Prm1 mRNA translation. 
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Three members from the family of translation initiation factors eIF4E have been 
reported in plants: eIF4E, eIF(iso)4E and nCBP. These proteins recognize the 
5’Cap mRNA during translation initiation. Absence of eIF(iso)4E in A. thaliana 
is not associated with apparent phenotypic changes, but confers resistance to 
Potyvirus infection: Turnip Mosaic Virus, Lettuce Mosaic Virus and Tobacco 
Etch Virus (TEV). Potyvirus contain ssRNA positive polarity, ~10 Kb long, 
with one open reading frame for a polyprotein. The RNA genome carries a VPg 
(viral protein genome-linked) bound to the 5’ end and a poly(A) tail at the 3’ 
end. Arabidopsis eIF(iso)4E interacts with VPg from TEV. Such interaction has 
been proposed to have a role in viral translation, stability, cell to cell and long 
distance movements. However, the mechanisms underlying eIF(iso)4E 
relevance in viral infection are unclear.  
 
We studied the role of eIF(iso)4E during infection of A. thaliana Col-0 ecotype 
with a Mexican TEV isolate (TEV-Nay). Two different lines were used: 
AteIF(iso)4E-1, reported as a true knock out line (Duprat, 2002; Plant J. 
32:927-934) and AteIF(iso)4E-2, over-expressing eIF(iso)4E fused to the green 
fluorescent protein (GFP). Wild type (WT) and mutant plants were inoculated 
with TEV-Nay. The stability and replication of viral RNA were analyzed at 4 
days post-inoculation (dpi) by RT-PCR. The viral movement was tested by RT-
PCR on systemic leaves at 4 and 15 dpi. Further, translation efficiency of TEV-
Nay was analyzed by distribution of the RNA measured through real time RT-
PCR on sucrose density gradients (polyribosomal profiles).  
 
Results indicated that TEV-Nay infects A. thaliana Col-0 host locally and 
systemically. The viral RNA is stable, replicated and translated equally well in 
WT and AteIF(iso)4E-1 knockout plants at local leaves. However, TEV-Nay 
only could spread systemically in WT plants. Interestingly, TEV-Nay is able to 
overcome Restriction To Movement (RTM) reported for Col-0 ecotype, though 
only when eIF(iso)4E is present. TEV-Nay was sequenced and compared with 
other isolates, revealing changes in proteins involved in systemic viral 
movement. Plants AteIF(iso)4E-2 showed a physical interaction of the viral 
RNA with the fusion protein. The overall data indicate that, in the context of A. 
thaliana Col-0 infection with TEV-Nay, eIF(iso)4E plays a role in TEV 
systemic movement.  
 
This work was supported by grants from CONACyT (81708) and PAPIIT 
(IN204309) 
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Objectives: RNA-binding proteins control how mRNAs get transported, 
translated and localized in the cell. This regulation ensures that mRNAs get 
translated when and where they are needed. In neurons, this control is 
exerted locally in the dendrite and at dendritic spines and allows for local 
changes in protein content at synapses in response to activity. Which RNA-
binding proteins participate in this local mRNA translation in dendrites and 
at spines remains to be fully understood. Fragile X Related Protein 1 
(Fxr1p) is an RNA-binding protein that is known to regulate mRNA 
translation in non-neuronal cells. However, its role in modifying mRNA 
translation in neurons and at spines is unknown. As a first step to addressing 
this question we wanted to determine if Fxr1p localizes with the 
translational machinery in dendrites and at spines.  
 
Methods: To test this, we co-expressed Fxr1p tagged with green 
fluorescent protein and membrane-targeted red fluorescent protein in 
dissociated hippocampal neurons and monitored the localization of Fxr1p 
with respect to the dendrite and spines. Using immunofluorescence and 
fluorescence in situ hybridization we also tested whether Fxr1p colocalized 
with ribosomes and mRNAs. We quantified the localization of Fxr1p in the 
dendrite and at spines as well as the degree of colocalization of Fxr1p with 
ribosomes and mRNAs.  
 
Results: We found that Fxr1p clustered with ribosomes and mRNAs in the 
dendrite and at a subset of spines in hippocampal neurons. Interestingly, this 
subset of spines was on average larger than those that lacked Fxr1p.  
 
Discussion: This suggests that Fxr1p sequesters the mRNA translation 
machinery at large spines where it may regulate local protein synthesis.  
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Exposure of human cells to cigarette smoke condensate (CSC) induces 
chemical shock and the effect that this elicits on the post-transcriptional 
control of gene expression has been investigated. Our data show that 
following exposure of liver-derived cell lines, Huh-7 and Hep G2, to CSC 
there is a transient and dose-dependent induction of global protein synthesis 
which is mediated, in part, by dephosphorylation of eEF2K. In agreement 
with these data, sucrose density gradient centrifugation to separate actively 
translating ribosomes (polysomes) following CSC exposure showed that 
there was a significant increase in polysomally associated mRNAs after 
treatment. Polysome profiling using cDNA microarray has been used to 
identify those mRNAs that are translationally up- or down-regulated 
following CSC exposure. Differentially translated mRNAs are currently 
being analysed for regulatory elements present in the 5’ and 3’ untranslated 
regions (UTRs). Analytical chemistry techniques will then be used to 
determine which components of CSC are responsible for the increase in 
translation of these specific mRNAs. 
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Musashi exerts translational repression of target mRNAs to promote cell 
cycle progression in mammalian neural stem cells. Conversely, Musashi has 
been shown to exert translational activation of target mRNAs to promote 
cell cycle progression in Xenopus oocytes. The molecular mechanisms 
underlying this context-dependent behavior of Musashi have not been 
elucidated. We have previously demonstrated that knockdown of 
endogenous Musashi function in Xenopus oocytes by antisense injection 
abolished Musashi target mRNA translational activation and cell cycle 
progression. Expression of wild-type Xenopus Musashi, but not an RNA 
binding mutant form, fully rescued cell cycle progression in the antisense-
treated oocytes. Exploiting this assay system, we show that mammalian 
Musashi1 and Musashi2 isoforms can separately function to rescue both 
target mRNA translational activation and cell cycle progression in Musashi 
antisense-treated oocytes. In mammalian NIH3T3 cells, expression of the 
Xenopus Musashi1 protein functions to repress reporter mRNA translation. 
Thus, the differential action of Musashi on target mRNA translation in 
mammalian stem cells and Xenopus oocytes is not due to species-specific 
differences in the Musashi protein but reflects context-dependent control of 
Musashi function. We will describe our structure/function analyses to 
identify critical regulatory domains of the Musashi protein that exert 
context dependent translational regulation. 
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Compound D is a candidate anti-cancer drug, which was originally isolated 
from a marine sponge. While its inhibitory effect on protein synthesis had 
been previously noted, its mechanism remained incompletely understood. 
We first confirmed the inhibition of translation elongation by in vitro HCV 
IRES dual luciferase assays, ribosome assembly and in vivo [35S] methinine 
labeling experiments. The IC50 for inhibiting protein synthesis is about 12 
nM in vivo, which is close to its IC50 ( about 1 nM) for inhibiting cell 
proliferation, suggesting that the interference of translation is the primary 
effect of this compound in vivo. In comparison with cycloheximide, both 
compound D and cycloheximide inhibit translation elongation, without 
affecting the eEF1A mediatedloading of tRNA to the ribosome nor AUG 
recognition or inhibition of tripeptide synthesis. In addition, we found that 
both compounds inhibited eEF2 mediated translocation. Using chemical 
footprinting, we identified their binding site on the large ribosomal subunit. 
Its binding pocket near C3993 had been previously identified biochemically 
and structurally as the interaction site between the CCA tail of the E-site 
tRNA and ribosome. While both molecules inhibited translation elongation, 
their mechanisms did differ in several aspects. First, compound D arrested 
the ribosome on mRNA one codon ahead of cycloheximide. Second, 
compound D specifically blocked tRNA binding to E site, while 
cycloheximide had no effect even at 100 μM concentration. Moreover, they 
display different polysome profiles in vivo. In conclusion, compound D 
inhibits translation elongation by directly occupying the E site of the large 
ribosomal subunit and blocking tRNA translocation from P to E site. 
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Vaccination with in vitro transcribed RNA coding for tumor antigens is 
considered a promising approach for cancer immunotherapy and has already 
entered human clinical testing. One of the basic objectives for development 
of RNA as a vaccine is the optimization of immunobioavailability of the 
encoded antigen in vivo. In previous work, we have developed plasmid 
templates for in vitro transcription of RNA-encoded antigens with modified 
3' structures (3' UTR and poly(A)-tail) stabilizing the RNA and optimizing 
its translational performance in dendritic cells (DCs), the major antigen-
presenting cells (1). Moreover, we achieved significant leverage of MHC 
class I and II presentation of the antigen in DCs by introducing routing 
signals (2). By combining these measures we were able to profoundly 
improve properties of RNA-encoded vaccines. Yet another important 
structural element of in vitro transcribed RNA is the 5' cap structure. 
Capping of in vitro synthesized RNA is achieved by transcribing the DNA 
template in the presence of the cap dinucleotide m7GpppG as structural 
homolog of the endogenous cap structure. Recently, several synthetic cap 
analogs have been described with modifications that influence stability and 
translational characteristics of the respective RNA species. Up to now, such 
modified cap analogs have been primarily employed to study RNA 
metabolism. Their impact, however, on bioavailability of the encoded 
protein in antigen presenting cells such as DCs and eventually on induction 
of potent T-cell responses in vivo has never been investigated. Therefore we 
have preclinically evaluated novel cap analogs for immunopharmacological 
improvement of vaccines based on antigen-encoding RNA. We demonstrate 
that RNAs capped with the D1 diastereoisomer of m27,2'-OGppSpG (beta-S-
ARCA) have increased stability and translational efficiency in immature but 
not mature DCs. Accordingly, in vivo delivery of the antigen as β-S-
ARCA(D1)-capped RNA species led to increased protein expression and 
enhanced priming and expansion of naïve antigen-specific T-cells in mice. 
We expect that our findings pave the way for inauguration of modified cap 
analogs into RNA vaccine development and will likely contribute to a better 
clinical outcome.  
(1) Holtkamp et al. (2006) Blood 108: 4009-17  
(2) Kreiter et al. (2008) J. Immunol. 180: 309-18  
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The human decapping scavenger (hDcpS) is a protein involved in the 3’→ 
5’ mRNA degradation pathway. The enzyme catalyzes the cleavage of free 
dinucleotide caps, m7GpppN and/or capped oligoribonucleotides, produced 
by exosom-mediated digestion. The hydrolysis of the cap releases m7GMP, 
and a suitable nucleoside diphosphate or an RNA oligomer terminated with 
the diphosphate, respectively. The crystallographic structure showed that 
apo-hDcpS is a symmetric homodimer, and it forms an asymmetric dimer 
when bound either to the substrate or to the product molecule. To gain a 
deeper insight into the formation and stability of the hDcpS-cap complexes, 
we applied the fluorescence time-synchronized titration (TST) method. The 
equilibrium association constants and the corresponding Gibbs free energies 
were determined for several nonhydrolysable dinucleotide, as well as 
mononucleotide, cap analogs, to characterize the molecular basis of the cap 
affinity for hDcpS. The synthetic analogs were modified in both 
triphosphate bridge and the ribose ring, including the ARCAs (anti-reverse 
cap analogs). A relatively high affinity of both natural and synthetic caps 
for hDcpS confirmed a highly specific mechanism of the hydrolysis of the 
5’mRNA terminus. Moreover, the affinity parameters obtained for hDcpS 
were significantly higher than those for the other cap-proteins, i. e. eIF4E 
and CBC. Our results allowed to make a further selection of those analogs 
that may be useful for biological in vivo experiments. Advanced biophysical 
methods were also applied to investigate a molecular mechanism of the 
binding and cleavage of cap substrates by hDcpS. The stoichiometric rate 
and a presumptive cooperative mechanism were verified by means of 
isothermal titration calorimetry (ITC) and fluorescence lifetime 
measurements, the latter being a precise and efficient method for 
determination of the protein-ligand association. 
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In response to different environmental and physiological stresses, 
phosphorylation of eIF2 (eIF2-P) represses global translation coincident 
with preferential translation of ATF4. ATF4 is a transcriptional activator of 
the Integrated Stress Response, a program of gene expression involved in 
metabolism and nutrient uptake, anti-oxidation, and the activation of 
additional transcription factors, such as CHOP, that can induce apoptosis. 
While eIF2-P induces translational control in response to many different 
stress arrangements, there are selected stresses, such as exposure to UV 
irradiation, that do no increase ATF4 expression despite robust eIF2-P. We 
addressed the underlying mechanism for the differential induction of ATF4 
by eIF2-P. We show that following UV irradiation there is a 3-fold 
reduction in ATF4 mRNA, while in other stress conditions that induce 
eIF2-P and ATF4, such as endoplasmic reticulum (ER) stress, ATF4 mRNA 
levels are increased 3-fold. These findings were similar between several 
different cultured mouse and human cell types. ATF4 mRNA is short-lived, 
with a half-life of about 2 hours, independent of the stress arrangement. 
Fusion of the ATF4 promoter to a luciferase reporter indicated that ATF4 
transcription was reduced by UV irradiation and enhanced during ER stress 
to levels comparable to the changes measured for ATF4 mRNA levels. We 
conclude that transcriptional regulation of ATF4 accounts for the different 
levels of ATF4 mRNA in response to UV and ER stress. Expression of a 
reporter plasmid expressing the 5’-leader of the ATF4 mRNA, central for 
preferential translation, from the constitutively-active TK promoter, showed 
preferential translation in response to UV irradiation. These results indicate 
that if ATF4 mRNA is available following UV irradiation, there can be 
elevated ATF4 translational expression. eIF2-P enhances cell survival in 
response to UV irradiation. However, forced expression of ATF4 by 
pretreatment with salubrinal, a drug that enhances eIF2-P/ATF4, leads to 
increased sensitivity to UV irradiation. Deletion of either ATF4, or its target 
CHOP, rescues the UV sensitivity accompanying the salubrinal 
pretreatment. Our study suggests that coupled transcriptional and translation 
regulation of ATF4 can determine differential expression of ATF4 during 
select stress conditions, and this regulatory scheme is essential for 
maintaining the balance between stress remediation and apoptosis. 
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Phosphorylation of eIF2α on Ser51 by kinases (PKR, GCN2, HRI and 
PERK) is a conserved mechanism to down-regulate cellular protein 
synthesis. The consensus residues of Ser51 phosphorylation site include 
L46L47SEL50S51R52R. We observed that PKR can phosphorylate eIF2α-
R52S and eIF2α-S51A,R52S, but not eIF2α-L50S,S51A. These data 
suggest that eIF2α protein could be phosphorylated at both positions 51 and 
52. Recently, we demonstrated that conformational change of 
phosphorylation site residues of eIF2α is required for Ser51 
phosphorylation by its cognate kinase PKR. To further analyze the 
conformational change of residues flanking Ser51, an alanine was inserted 
in between residues L46 and L47 to make an engineered eIF2α-
L46ALSEL51S52R. This insertion of a single residue brings changes in 
positions of downstream amino acids, i.e. moving Ser51 to position 52. We 
further mutated L51 to serine to make eIF2α-L46ALSES51S52R. Both 
residues S51 and S52 of the engineered protein were phosphorylated in 
vitro by PKR and GCN2, confirming stoichiometric phosphorylation of 
both positions 51 and 52. 
 
We tested the physiological significance of these position-51 and -52 
phosphorylation events in yeast. Insertion of the Ala residue between L46 
and L47, moving Ser51 to position 52, significantly impaired translational 
regulation. However, translational regulation was restored by a second 
mutation that restored phospho-acceptor amino acid at position 51. These 
data suggest that phosphorylation of position 51 is more critical than the 
flanking residues in regulating translation. 
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Translation initiation on mRNAs containing stable secondary structures in 
their 5’-UTRs requires DHX29, a DExH-box protein that acts 
synergistically with eIFs 4A/4G/4B to ensure efficient ribosomal scanning 
through stable RNA secondary structures, and which binds directly to 40S 
subunits, likely at the entrance of the mRNA-binding channel. Silencing of 
DHX29 in vivo impairs translation, resulting in polysome disassembly and 
accumulation of mRNA-free 80S ribosomes. Analysis of its protein 
sequence revealed that along with the central helicase core comprised of 
two RecA-like domains, DHX29 additionally possesses a ~500-a.a. long N-
terminal region containing a double-stranded RNA-binding domain 
(dsRBD), and a ~300-a.a. long C-terminal region within which a winged 
helix domain (WHD), a ratchet domain, and an 
oligonucleotide/oligosaccharide-binding (OB) domain can be identified. In 
order to understand the distinct functions of these domains, we expressed 
and purified recombinant DHX29 that was fully active in 48S complex 
formation, and initiated an extensive mutagenesis study of this protein. We 
found that both the N-terminal region and the central helicase domain were 
able to bind stably to 40S ribosomal subunits. Consistently, N-terminally 
truncated DHX29 comprising the helicase domain and the entire C-terminal 
region, as well as a C-terminally truncated protein comprising the entire N-
terminal region and the helicase domain were both able to associate with 
40S subunits. The N-terminally truncated DHX29 retained some activity in 
48S complex formation, albeit substantially lower than that of the full-
length protein. In contrast, deletion of the C-terminal region resulted in 
complete loss of DHX29’s translational activity. The WHD, ratchet, and 
OB domains in the C-terminal region are conserved in other DExH 
helicases, such as Prp43p, and are proposed to assist in translocation of 
helicases along nucleic acids to facilitate unwinding. The loss of activity of 
the C-terminally truncated DHX29 could indicate the loss of an analogous 
translocation activity. Further studies of variants of DHX29 containing 
point mutations within conserved motifs are underway. 
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Post-transcriptional regulation of gene expression is a complex process 
involving many different mechanisms allowing cells to rapidly modulate 
protein production. mRNA metabolism (maturation, localization, 
translation, degradation) involves trans-acting factors (proteins and other 
RNAs), and cis-acting elements present in the coding region and the 5’ and 
3’UTR of mRNAs. Long 5’ and 3’UTR can form secondary structures, such 
as Internal Ribosome Entry Sites (IRES), hairpin loops or guanines 
quadraduplexes (G-quartets) that can serve as sites for the control of 
translation in particular during initiation.  
It is believed that IRES elements are used to favor cap-independent 
translation initiation for protein synthesis under stress conditions (e.g. 
starvation or hypoxia). Hairpin loops and G-quartets could regulate 
translation in specific cell states such differentiation. These structural RNA 
motifs (SRM) were identified in a number of disease relevant mRNAs 
implicated in the control of cell growth or death which are deregulated in 
some cancers (e.g. c-myc, FGF2 or VEGF).  
This project is based on the hypothesis that gene expression may be 
modulated by SRM through environmental factors or low molecular weight 
compounds. Such regulators may act either directly by binding the SRM or 
indirectly by modulating the activity of factors interacting with the SRM.  
To explore this hypothesis, a cell line expressing a Firefly luciferase 
reporter gene directed by the EMCV IRES element was used. After the 
assay conditions optimization, a screen was conducted to identify 
compounds that apparently modulate positively or negatively the reporter 
gene expression. Experiments are currently ongoing to investigate the 
mechanism of action of these compounds.  
Moreover, the SRM from c-myc and VEGF mRNAs are used to generate a 
series of mono- or bi-cistronic reporter gene constructs to run similar 
screening experiments.  
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 The translation initiator of short 5’UTR (TISU), is a recently 
identified element present in genes with fundamental cellular functions and 
bearing short 5’UTR. TISU is located downstream and close to the 
transcription start site and has the unique ability to control the initiation 
stages of both transcription and translation. Our previous characterization of 
TISU revealed that it can direct accurate translation initiation from short 
5’UTR mRNAs. Here we compared translation initiation of mRNAs 
bearing different AUG contexts and 5’UTR lengths. We found that reducing 
the distance between the cap and the AUG to the minimal possible 
selectively retained the high level of translation initiation capacity of TISU 
as well as efficient 48S ribosome binding, suggesting a non-scanning 
mechanism of initiation. Using three independent assays we established that 
recruitment of the initiation machinery to TISU is cap-dependent. While 
EIF1 inhibited Kozak AUG selection when placed close to the 5'-end of 
mRNA, TISU was unaffected by EIF1. Our data suggest that TISU directs a 
unique mode of cap-dependent and scanning independent translation 
initiation and is differentially regulated by certain initiation factors. 
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High resolution structures reveal that yeast ribosomal protein L11 and its 
bacterial/archael homologs called L5 contain a highly conserved, basically 
charged internal loop that interacts with the peptidyl-tRNA T-loop. We call 
this the L11 “P-site loop”. Chemical protection of wild-type ribosome 
shows that that the P-site loop is inherently flexible, i.e. it is extended into 
the ribosomal P-site when this is unoccupied by tRNA, while it is retracted 
into the terminal loop of 25S rRNA Helix 84 when the P-site is occupied. 
To further analyze the function of this structure, short segments of amino 
acids within the P-site loop were mutated to poly-alanine. A mutant that 
favors interaction of the P-site loop with the terminal loop of Helix 84 
promoted increased affinity for peptidyl-tRNA, while another that favors its 
extension into the ribosomal P-site had the opposite effect. The two mutants 
also had opposing effects on binding of aa-tRNA to the ribosomal A-site, 
and downstream functional effects were observed on translational fidelity, 
drug resistance/hypersensitivity, virus maintenance, and overall cell growth. 
These analyses suggest that the L11 P-site loop normally helps to optimize 
ribosome function by monitoring the occupancy status of the ribosomal P-
site. 
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Eukaryotic initiation factor 4G-1 (eIF4G1) plays a critical role in the 
recruitment of mRNA to the 43S pre-initiation complex. eIF4G1 is 
downstream of major mitogenic signal transduction pathways, but 
regulation of eIF4G function via phosphorylation by protein kinases is not 
understood. The MAPK signal integrating kinases (Mnk) 1 and 2 bind to the 
C-terminal part of eIF4G1 and catalyze phosphorylation of eIF4E. Growth 
factors or phorbol esters activate Mnk1 through the PKC/Raf/Erk signaling 
pathway. We previously demonstrated that phosphorylation of Mnk1 by Erk 
or p38 MAPKs is essential for Mnk1 binding to eIF4G. Here we 
investigated TPA-dependent phosphorylation of eIF4G1 by PKCα.  
 
Mapping of PKCα phosphorylation sites in eIF4G1 with p-PKC substrate-
specific antibodies revealed Ser1186 as a critical target site for eIF4G1 
phosphorylation. Mutational analysis suggested that phosphorylation of 
S1186 strongly stimulates binding of Mnk1 to eIF4G1. The proposed 
structure of the C-terminal region of eIF4G1 indicates that an 
arginine/lysine-rich unstructured region of eIF4G1 surrounding Ser1186 
may compete with Mnk1 docking site on eIF4G1. Phosphorylation of 
Ser1186 by PKCα may increase electrostatic repulsion from negatively 
charged amino acids in the Mnk1 binding site, thus stimulating the binding 
of Mnk1 to eIF4G1.  
 
Our data suggest surprisingly intricate regulation of Mnk1-eIF4G1 binding 
through Mnk1 itself, via MAPK-mediated phosphorylation, and through 
eIF4GI, through PKCα-catalyzed phosphorylation of Ser1186. This may 
reflect tight control over eIF4E phosphorylation, which categorically 
depends on Mnk1 binding to eIF4G.  
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Initiator tRNAMet (tRNAi) plays a key role in accurate selection of initiation 
sites, as perfect complementarity with the tRNAi anticodon is required for 
efficient recognition of AUG start codons. Apart from the anticodon, we 
investigated the role of other structural elements in stringent AUG selection 
by testing tRNAi substitutions for altered frequencies of initiation at near-
cognate UUG start codons. Eukaryotic tRNAi contains several identity 
elements not present in elongator tRNAs, including 3 consecutive G-C pairs 
in the anticodon stem loop (ASL), of which the third (G31:C39) is 
characteristic of tRNAi. Replacing G31:C39 with all other possible base-
pairs increases the ratio of UUG:AUG initiation (Sui- phenotype), whereas 
all substitutions of G31 that abolish base-pairing reduce the UUG:AUG 
ratio. In fact, replacing G31:C39 with unpaired U residues, as found in 
elongator tRNAMet (tRNAe), confers an Ssu- phenotype, suppressing the 
elevated UUG:AUG ratio in cells harboring Sui- alleles of eIF5 (SUI5) or 
eIF2β (SUI3-2). Other tRNAi identity elements include A54 and A60 in the 
T-loop, and replacing them with the cognate residues found in tRNAe (U 
and C, respectively) confers a Sui- phenotype that, interestingly, is 
suppressed by the G31U,C39U Ssu- substitutions in the ASL to yield a 
nearly WT UUG:AUG ratio in the quadruple mutant. Remarkably, the 
mutual suppression by these T-loop and ASL substitutions is mirrored by in 
vitro measurements. First, we showed previously that the ASL substitutions 
abolish thermodynamic coupling between TC and the AUG in 40S binding, 
and this coupling is restored by the T-loop substitutions (Kapp et al. 2006). 
Here we found that the ASL substitutions destabilize TC binding to 48S 
complexes more so at UUG than at AUG start codons, consistent with their 
Ssu- phenotype, and that the T-loop substitutions restore the WT differential 
between TC binding at AUG versus UUG in the quadruple mutant. The 
C3:G70 base-pair in the acceptor stem of tRNAi is highly conserved in all 
three kingdoms of life and, interestingly, G70 substitutions increase the 
UUG:AUG initiation ratio in vivo, in a manner suppressed by a 
compensatory substitution that restores base-pairing. Together, our results 
show that identity elements in different portions of tRNAi function in 
stringent AUG recognition. Perfect codon-anticodon pairing might induce a 
conformational change in the body of tRNAi that signals AUG recognition 
to initiation factors or the ribosome. 
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microRNAs (miRNAs) are small non-coding RNAs post-transcriptionally 
regulating gene expression in many eukaryotes. In general animal miRNAs 
bind the 3’ UTR of mRNAs and thereby mediate mRNA degradation and/or 
translational repression. Known protein factors required for miRNA-
mediated mRNA degradation are the components of the miRNA effector 
complex (AGO1 and GW182) and the general mRNA degradation 
machinery (deadenylation and decapping enzymes). However, it is unclear 
how miRNAs recruit the mRNA decay machinery to their targets.  
We started to address this question by searching for interaction partners of 
GW182 in Drosophila S2 cells. In particular we did co-
immunoprecipitation experiments to test for interactions of GW182 with 
various factors involved in mRNA degradation or translation. We have 
identified the decapping activator HPat as a novel factor consistently co-
purifying with GW182. Furthermore, this interaction is not sensitive to 
RNase treatment, thus it is either a direct or a protein-mediated interaction. 
We have further demonstrated that the C-terminal domain of GW182, 
known to be essential for miRNA function, is sufficient to mediate co-
purification of HPat.  
We currently investigate the significance of the interaction of HPat and 
GW182 in the miRNA pathway. The results of these functional studies will 
be presented. 
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The Y-box binding protein 1 (YB-1) is a member of the protein family with 
the cold shock domain. It is involved in virtually all DNA- and mRNA-
dependent events. The amount of YB-1 in the cell strongly influences the 
transcriptome and proteome profiles of the cell, affects its phenotype, 
prevents or promotes cell oncotransformation, and contributes to tumor 
aggressiveness. Therefore, knowledge of the regulatory mechanisms of YB-
1 synthesis may be useful for development of novel approaches to cancer 
therapy. Previously, we found that YB-1 mRNA contains a regulatory 
element in its 3’ untranslated region (3’ UTR). This element specifically 
binds two major mRNP proteins, YB-1 and poly(A) binding protein 
(PABP). Their binding sites on YB-1 mRNA overlap, and the two proteins 
compete for binding to the regulatory element. In doing so, YB-1 
selectively inhibits (autoregulates) YB-1 mRNA translation, while PABP, in 
contrast, stimulates it in rabbit reticulocyte lysates in a poly(A) tail-
independent manner. In studying the mechanism of YB-1 - PABP interplay 
in regulation of YB-1 mRNA translation, a question arises as to whether 
these proteins act independently or the role of one of them is reduced solely 
to displacement of the other from the regulatory element. The specific task 
of our study was to answer this question. We have shown that the deletion 
of the entire regulatory element from YB-1 mRNA results in elimination of 
both the negative effect of YB-1 and positive effect of PABP on YB-1 
mRNA translation. Mutations in the YB-1 binding site strongly decrease the 
inhibitory effect of YB-1 and eliminates the stimulating effect of PABP. 
With partially deleted PABP binding site, YB-1 mRNA translation keeps 
being inhibited by YB-1, but PABP becomes incapable of preventing this 
inhibition. 
Thus, we have shown that regulation of YB-1 mRNA translation is a result 
of specific interaction of YB-1 and PABP with the regulatory element in 
YB-1 mRNA 3’ UTR. Our results allowed concluding that only one of the 
two proteins, YB-1, can have a direct negative effect on YB-1 mRNA 
translation initiation, while the positive effect of PABP is presumably 
explained by YB-1 displacement from the regulatory element. 
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Eukaryotic translation initiation factor 2B (eIF2B) is a major house-keeping 
complex that governs the rate of global protein synthesis under normal and 
stress conditions. Mutations in any of its five subunits lead to 
leukoencephalopathy with vanishing white matter, an inherited chronic-
progressive fatal brain disease, the etiology of which is unknown and is 
among the most prevalent childhood white matter disorders. We generated 
the first animal model for the disease by introducing a point mutation into 
the mouse Eif2b5 gene locus, leading to R132H replacement corresponding 
to the clinically-significant human R136H mutation in the catalytic subunit. 
In contrast to human patients, mice homozygous for the mutant Eif2b5 
allele (Eif2b5R132H/R132H mice) enable multiple analyses under a 
defined genetic background during the pre-symptomatic stages and during 
recovery from a defined brain insult. Time-course magnetic resonance 
imaging revealed for the first time the delayed development of the brain 
white matter due to the mutation. Electron microscopy demonstrated higher 
proportion of small-caliber nerve fibers. Immuno-histochemistry detected 
abnormal abundance of oligodendrocytes and astrocytes in the brain of 
younger animals, as well as abnormal level of major myelin proteins. Most 
importantly, mutant mice failed to recover from cuprizone-induced 
demyelination, reflecting an increased sensitivity to brain insults. The 
anomalous development of white matter in Eif2b5R132H/R132H mice 
underscores the importance of tight translational control to normal myelin 
formation and maintenance.  
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During protein synthesis, mRNA and tRNA undergo coupled translocation 
through the ribosome in a process that is catalyzed by elongation factor EF-
G. Based on cryo-EM reconstructions, counterclockwise and clockwise 
rotational movements between the large and small ribosomal subunits have 
been implicated in a proposed ratcheting mechanism to drive the 
unidirectional movement of translocation. We have used a combination of 
two fluorescence-based approaches to study the timing of these events: 
Intersubunit FRET measurements to observe relative rotational movement 
of the subunits and a fluorescence quenching assay to monitor translocation 
of mRNA. Under conditions where translocation is slowed, two rotational 
events are resolved. Binding of EF-G•GTP first induces rapid 
counterclockwise intersubunit rotation, followed by a slower, clockwise 
reversal of the rotational movement. Comparison of the rates of these 
movements reveals that mRNA translocation occurs during the second, 
clockwise rotation event, corresponding to the transition from the hybrid 
state to the classical state.  
 
 82 
INVESTIGATION OF TRANSLATIONAL ERROR FREQUENCY IN A 
PURIFIED S. CEREVISIAE TRANSLATION SYSTEM. 
 
Daniel E Eyler1, Rachel Green1,2  
 
1Johns Hopkins School of Medicine, Molecular Biology and Genetics, 
Baltimore, MD, 21205, 2Investigator, Howard Hughes Medical Institute, 
Baltimore, MD, 21205 
 
Translation is a remarkably accurate process, with in vivo error rates 
estimated to be between 10-4 and 10-5 per codon translated. Recent work in 
our laboratory (Zaher Nature 2009) revealed a previously unknown, 
retrospective translational quality control mechanism in E. coli. This 
mechanism appears to monitor the fidelity of the previous round of tRNA 
selection and, when an error has been made, alter critical parameters of both 
tRNA selection and peptide release. The first parameter, the rate at which 
near-cognate aminoacyl-tRNAs or release factors are allowed to enter the A 
site and proceed to react, is increased. The second parameter is the affinity 
of release factor for the ribosomal A site, and this affinity is increased after 
a miscoding event. Sequential miscoding events increase these parameters 
even further. Consequently, ribosomes which have made an initial 
misreading error are prone to making a second mistake, and thereafter 
become good substrates for peptide release factor. Thus this quality control 
mechanism can be described as sequential miscoding followed by 
premature peptide release. We have extended our investigation of this 
quality control mechanism to the yeast S. cerevisiae in order to determine if 
a similar system exists in eukaryotes. 
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MicroRNAs (miRNAs) generally inhibit protein synthesis by base-pairing 
to the 3’UTR of target mRNAs where they repress translation and/or initiate 
deadenylation and subsequent mRNA degradation. miRNAs function in the 
form of ribonucleoprotein complexes, miRISCs (microRNA-induced 
silencing complexes). miRISCs are comprised, at least in part, of Argonaute 
and GW182 proteins with GW182 being a core component of the protein 
complex. We established a mouse Krebs-2 ascites extract that faithfully 
recapitulates the miRNA response (Mathonnet et al., 2007). Using this 
system, we demonstrated that the let-7 miRNA inhibits translation of 
reporter mRNA at the initiation step and also mediates poly(A) binding 
protein (PABP)-dependent deadenylation (Fabian et al., 2009). PABP 
functions to enhance deadenylation by making direct contact with GW182 
(Fabian et al., 2009). Here, we report progress towards elucidating how 
mammalian GW182 proteins facilitate translational repression and 
deadenylation. 
 
 
Mathonnet G, Fabian MR, Svitkin YV, Parsyan A, Huck L, Murata T, Biffo 
S, Merrick WC, Darzynkiewicz E, Pillai RS, Filipowicz W, Duchaine TF, 
Sonenberg N. (2007). MicroRNA inhibition of translation initiation in vitro 
by targeting the cap-binding complex eIF4F. Science 317: 1764-1767. 
 
Fabian MR, Mathonnet G, Sundermeir T, Mathys H, Zipprich JT, Svitkin 
YV, Rivas F, Jinek M, Wohlschlegel J, Doudna JA, Chen C-Y, Shyu A-B, 
Yates III J-R, Hannon GJ, Filipowicz W, Duchaine TF and Sonenberg N. 
(2009). Mammalian miRNA RISC recruits CAF1 and PABP to affect 
PABP-dependent deadenylation. Molecular Cell 35:868-80. 
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The process of protein synthesis consumes a majority of cellular energy and 
thus the accuracy of the process is vital to cell survival. We have developed 
a method to determine the in vivo frequency of all possible translational 
misreading errors by a variety of tRNAs. The method involves mutating 
codons encoding active site residues in Photinus pyralis (firefly) luciferase 
and Escherichia coli β-galactosidase and measuring the residual activity 
resulting from infrequent misreading of the mutant codon to insert the wild 
type amino acid. We have demonstrated (Kramer & Farabaugh, 2007) that 
errors by a single tRNA--tRNALys (anticodon UUU)--vary among codons 
over two orders of magnitude from a low of approximately 10-4 per codon 
to a high of nearly 10-2 per codon. A principle cause of high frequency 
errors is poor recognition of the mutant codon by its correct (cognate) 
tRNA, which allows misreading by the near-cognate tRNA responsible for 
inserting the normal, wild type amino acid. 
 
We have extended this analysis in two ways. We have measured the 
frequency in E. coli of misreading errors by several other tRNAs (those 
decoding Glu, Asp, Gln and Tyr) and find that the pattern of misreading 
varies significantly among them. The lower limit of frequency of 
misreading errors can be as low as approximately 10-5 per codon and the 
upper limit of error frequency can vary from about 10-4 to almost 10-2 per 
codon. Some tRNAs have frequent errors only at a small number of codons 
although wobble errors are frequent in general. 
 
We have also measured the frequency of errors in the yeast Saccharomyces 
cerevisiae and find that the distribution of errors is significantly different 
than in E. coli. Also, the absolute level of errors is different, both basal error 
rates at most codons and the more frequent errors at several codons. These 
data are consistent with our general conclusion that competition by cognate 
tRNAs for decoding of the mutant codons limits errors but suggests that 
yeast and bacteria may be significantly different in how they limit 
translational misreading errors. 
 
 
Kramer EB, Farabaugh PJ. 2007. The frequency of translational misreading 
errors in E. coli is largely determined by tRNA competition. RNA. 2007 
13:87-96. 
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Efficient mRNA recruitment to the human ribosome requires a region of 
single stranded RNA close to the cap structure. The eukaryotic initiation 
factor 4A (eIF4A) is a DEAD box helicase that is essential for unwinding 
any stable secondary structure that would inhibit this step. Although studied 
for many years, RNA unwinding assays involving eIF4A and its associated 
proteins have failed to rigorously analyze the kinetic events that occur 
during mRNA unwinding. To provide this kinetic understanding we have 
developed a continuous fluorescence-based assay to measure RNA duplex 
unwinding events. This assay utilizes an RNA oligonucleotide modified 
with cyanine 3 (Cy3) annealed to a complimentary strand modified with 
black hole quencher (BHQ). Separation of the RNA duplex region 
significantly enhances the Cy3 fluorescence, enabling the measurement of 
RNA unwinding activity in real time by fluorescence spectroscopy. 
Importantly, the presence of a large excess of competitor DNA ensures that 
unwinding events are measured separately to reannealing events. 
 
We will present data to show how we are using this assay to determine the 
kinetic role of accessory factors eIF4B, eIF4H and domains of eIF4G on the 
unwinding activity of eIF4A. Preliminary data using this kinetic assay 
indicates that efficient duplex unwinding by eIF4A and its accessory 
proteins requires a single stranded binding region. Moreover, the 
stimulation of eIF4A unwinding activity by eIF4G requires the RNA 
binding domain located close to the central HEAT repeat in eIF4G. We will 
also present data employing RNA duplexes of different length and/or 
stability in order to fully characterize the unwinding properties of eIF4A. 
This study will enable us to understand how the activity of eIF4A is 
influenced by other initiation components and provide the foundation to 
begin understanding the kinetic framework of mRNA unwinding and 
recruitment to the human ribosome. 
 
This work is supported by NIH grant R01 GM092927. 
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MicroRNAs (miRNAs) are small regulatory RNAs that play a pivotal role 
in post-transcriptional gene regulation. Most commonly in animals, 
miRNAs target mRNAs by imperfectly binding to complementary sites in 
3’ untranslated regions (3’UTRs), thereby directing translation inhibition, 
deadenylation and/or destabilization. The contribution of each aspect of the 
mechanism, and their importance in different biological context is 
unknown. We screened for targets of the highly abundant and 
embryonically-expressed miR-35-42 and miR-58/Bantam families of 
miRNAs. Potential targets obtained from the mirWIP and TargetScan 
algorithms were cloned and regulation by miRNAs was assessed by 
examining translation efficiency, integrity of the poly(A) tail, and target 
mRNA stability. This survey revealed a broad impact of miRNAs on the 
poly(A) tail of embryonic mRNAs, and an intricate network of cooperation 
between miRNA families and multiple sites within 3’UTRs to drive 
deadenylation. The screen also identified several bona fide miRNA targets, 
including the BH3-only encoding protein egl-1, the homeobox gene ceh-18 
and toh-1. Interestingly, the functional survey of the 3’UTRs revealed novel 
isoforms of some of the targets encode 3’UTR in which miRNA recognition 
sites were no longer present, suggesting differential regulation by miRNA 
during development. These results further support a role for the 3’UTR 
shortening observed in embryogenesis and cancer, to differentially regulate 
targets in a miRNA-dependant manner. 
 87 
COTRANSCRIPTIONAL RECRUITMENT OF THE TRANSLATIONAL 
REPRESSORS LOC1P AND PUF6P ON NASCENT ASH1 MRNA 
 
Zhifa Shen1, Amélie Forget1, Anik St-Denis1, Thomas Vergnaud2, Pascal 
Chartrand1  
 
1Université de Montréal, Département de Biochimie, Montréal, H3T 1J4, 
Canada, 2Université de La Rochelle, IUT Génie Biologique, la Rochelle , 
17000, France 
 
mRNA localization is a fundamental mechanism of regulation that restricts 
protein expression to specific regions of the cell. This regulation is 
important for the establishment of cellular polarity and cell fate 
determination in several organisms. One of the most well studied models of 
active mRNA localization is the ASH1 mRNA in the yeast Saccharomyces 
cerevisiae. ASH1 mRNA localization leads to asymmetric cell division of 
the budding yeast and prevents mating-type switching in the daughter cell. 
ASH1 mRNA localization to the bud tip depends on the RNA-binding 
protein She2, which binds to four localization elements in this transcript, 
and recruits the motor protein Myo4 via the bridging protein She3. During 
its transport, translation of the ASH1 mRNA is repressed by the presence of 
the translational repressors Khd1p, Puf6p and Loc1p, which bind to specific 
elements in this mRNA, and inhibit translation initiation via interactions 
with eIF4G and eIF5B. At destination, translation is activated by 
phosphorylation of Khd1p and Puf6p, which allows local expression of 
Ash1p. Recently, we discovered that She2p is actively recruited 
cotranscriptionally to the ASH1 mRNA via interactions with the RNA 
polymerase II machinery. Furthermore, She2p is necessary for the 
recruitment of Puf6p and Loc1p on the ASH1 transcript. Therefore, we 
hypothesized that the mechanism of recruitment of Puf6p and Loc1p on the 
ASH1 mRNA is also cotranscriptional. We found by chromatin 
immunoprecipitation that Loc1p and Puf6p are recruited cotranscriptionally 
to the ASH1 gene in a She2p-dependent manner. Moreover, the association 
of Puf6p with the ASH1 gene depends on Loc1p. We also observed that 
Loc1p and Puf6p interact with the large subunit of the RNA polymerase II, 
Rpb1p. Determination of the mechanism leading to the recruitment of these 
factors on the nascent mRNA is currently under way. This work reveals that 
factors involved in cytoplasmic mRNA localization or translational control 
can be recruited in a cotranscriptional manner on their target mRNAs and 
that the transcription machinery directly participates in this process. 
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Argonaute proteins are the key components of the RNA induced silencing 
pathway and are involved in processes such as translational repression, 
deadenylation and decay of messenger RNAs. To accomplish these various 
functions the Argonaute proteins associate with small RNAs and other 
proteins to form distinct ribonucleoprotein complexes. 
We are investigating Argonaute2 (Ago2) containing protein complexes in 
mouse embryonic fibroblasts (MEF) applying a modified quantitative 
immunoprecipitation combined with a knock-down (QUICK) approach. For 
this purpose we generated and characterized a new specific monoclonal 
anti-Ago2 antibody termed mAgo2 (6F4). The mAgo2 (6F4) antibody 
precipitates mouse Ago2 and its associated RNAs in a highly specific 
manner and the bound protein can be efficiently eluted from the antibody 
with a competing peptide after immunoprecipitation. Using an Ago2 knock-
out cell line as control to minimize false positives due to antibody cross-
reactivity, we immunoprecipitated Ago2 containing complexes from SILAC 
labeled MEFs and analyzed the protein composition by quantitative 
proteomics. Our data reveals Ago2 in association with cytoskeletal proteins 
including actin and myosin and we identified multiple actin-binding 
proteins as potential new cellular interaction partners for Ago2. Among 
these potential interactors we find several LIM domain proteins. Members 
of the LIM domain protein family have recently been shown to function as 
molecular linkers that couple Argonaute proteins to various cellular 
processes. We are currently in the process of validating the new potential 
interactions and are investigating the role of the identified LIM domain 
proteins in connecting Ago2 to the cytoskeleton in order to elucidate the 
function of this novel protein complex.  
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Eukaryotic ribosomes are heterogeneous particles. Thus, it has been proposed 
that specific interactions between mRNA, rRNA, ribosomal proteins and 
associated non-ribosomal proteins may regulate the translation of discrete 
mRNAs. For example, it has been shown that methylation of the fragile X 
mental retardation protein (FMRP) changes the RNA binding properties of 
FMRP, resulting in decreased translation of target mRNAs (1). Additionally, 
ribosomal proteins have been shown to become modified by addition of O-
linked N-acetylglucosamine (O-GlcNAc) during stress (2). However, the 
prevalence of modulators of ribosome function and their mechanism is still 
unknown. 
 
In an effort to identify non-ribosomal proteins that modulate ribosome activity, 
non-translating and translating populations of ribosomes were purified from 
cultured HeLa cells. Following a high salt wash, the protein composition of the 
ribosomes was analyzed by mass spectrometry. This analysis revealed that the 
non-ribosomal protein glycogen synthase (GYS1) is associated with translating 
ribosomes. We find that puromycin treatment releases a phosphorylated form of 
GYS1, which is known to be less active in glycogen synthesis, from polysomes. 
Sucrose gradient analysis of extracts from GYS1 siRNA-depleted HeLa cells 
revealed a loss of polysomes, indicating that GYS1 may control the translation 
of all or a subset of mRNAs. To distinguish between these possibilities, the 
polysomal distribution of mRNAs in untreated and GYS1 siRNA-treated cells 
was examined by microarray analysis. Results from these experiments revealed 
that the polysomal abundance of subsets of mRNAs was affected by GYS1. 
 
Next, immunofluorescence analysis was performed to examine the subcellular 
localizations of GYS1 and phospho-GYS1. Surprisingly, in addition to some 
cytoplasmic staining, phospho-GYS1 strongly concentrated in nuclear speckles 
that co-localize with the splicing factor SC-35; in contrast, GYS1 was widely 
distributed in the cytoplasm. These findings suggest that GYS1 may also play a 
role in the regulation of splicing. 
Although GYS1 is well known to function in energy storage, its ribosomal 
association and the localization of phospho-GYS1 to nuclear speckles suggest 
that it may have a more extensive role, possibly coupling and fine-tuning 
splicing, translation and energy metabolism. 
 
(1) Dolzhanskaya et al. J Cell Sci. (2006) 
(2) Ohn et al. Nat Cell Biol. (2008) 
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Hu proteins are RNA-binding proteins that bind to adenosine-uridine (AU)-
rich elements (AREs). Hu proteins affect almost every posttranscriptional 
aspect of RNA metabolism. HuD is one member of the neuronal Hu family 
of proteins and promotes neuronal differentiation. We have previously 
shown that HuD enhances cap-dependent translation in a eIF4A- and 
poly(A)-dependent manner1. We have also shown that the stimulatory effect 
of HuD on neurite outgrowth in PC12 cells depends on the interaction of 
HuD with eIF4A- and poly(A) 1. Here we further explored the underlying 
molecular interactions and found that HuD but not the ubiquitously 
expressed HuR directly and specifically interacts with Akt1. This 
interaction is physiologically significant, since it is required for HuD-
induced neurite outgrowth in PC12 cells. Strikingly, we also find that HuD 
recruits Akt1 into the cap-binding complex suggesting that HuD might 
recruit Akt1 to regulate translation. To identify potential targets of Akt1 in 
the cap-binding complex we are currently performing the GRNA 
chromatography approach2. The status of these experiments will be 
discussed. 
 
References 
1Fukao et al., Mol Cell 36, 1007-1017 (2009) 
2Duncan et al., Mol Cell 36, 571-582 (2009) 
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The tumor suppressor p53 acts in response to a variety of cellular stresses 
resulting in DNA repair, apoptosis, or cell cycle arrest in G1 or G2 phases. 
The mechanisms, that determine which functional arm of p53 will 
dominate, are not fully understood yet. p53 mRNA can be translated from 
an alternative initiation codon to produce N-terminal truncated isoform ΔN-
p53, also referred to as p53/47, which lacks the Mdm2 binding site and the 
first trans-activation domain. It has been reported that the full-length p53 
and the p53/47 isoforms are distinct in their biological outcome, leading 
under certain cellular settings to G1 or G2 arrest, respectively. Two internal 
ribosome entry sites (IRESs) regulate the translation of p53. While the one 
residing in the 5’UTR drives the translation of the full-length p53, a second 
residing in the coding region is responsible for the translation of the p53/47 
isoform. Notably, the p53/47 IRES is selectively activated under ER stress 
conditions. Here we studied whether DAP5 regulates IRES driven 
translation of the p53 isoforms. DAP5 is a member of the eIF4G family that 
regulates IRES driven translation of various mRNAs such as Bcl-2, CDK1, 
c-Myc, Apaf-1, XIAP, c-IAP1 and DAP5 itself. We found that DAP5 knock 
down by RNA-interference in H1299 cells results in a significant reduction 
in the activity of the p53/47 IRES. The dependence of this IRES on DAP5 
was also prominent in ER stressed cells exposed to thapsigargin, i.e., under 
conditions in which we measured strong reduction in cap-dependent 
translation and a selective increase in the p53/47 IRES activity. In contrast, 
the full-length p53 IRES which was not activated by thapsigargin was less 
affected by the knock down of DAP5. Further studies in these directions 
may reveal new mechanisms that confer selectivity in the utilization of the 
p53 IRESs thus controlling the ratio between the full-length p53 and p53/47 
isoforms. 
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Translation of the full-length messenger RNA (mRNA) of the human 
immunodeficiency virus of type 1 (HIV-1) generates the precursor of the 
viral structural proteins and that of the viral enzymes. Initiation of 
translation of this mRNA can be cap-dependent, but the presence of an 
internal ribosome entry site (IRES) in its 5’untranslated region (5’UTR) has 
been demonstrated. Recent studies showed that cap-dependent translation 
was predominant for this mRNA. An interesting hypothesis is that HIV-1 
IRES becomes activated under specific conditions triggered by viral 
infection. Our aim was to perform a mutational analysis of the 5’UTR IRES 
in order to identify regions that are important for its activity. A dual-
luciferase reporter construct where the Renilla luciferase (Rluc) translation 
is cap-dependent while the firefly luciferase (Fluc) translation depends on 
the HIV-1 5’UTR IRES was used. The Fluc/Rluc ratio was measured in 
lysates of Jurkat T cells transfected with the dual-luciferase plasmid bearing 
the wild-type or mutated 5’UTR IRES. We found that deleting or mutating 
a stem-loop preceding the primer binding site increases the IRES activity 
about two-fold. We also observed such an increase with the wild-type IRES 
when its activity was monitored in cells treated with agents that induce an 
oxidative stress. However, oxidative stress had no effect on the activity of 
the IRES when the stem-loop was mutated. We propose that this stem-loop, 
which we name IRENE (for IRES negative element), is involved in a switch 
that regulates the IRES activity in cells infected with HIV-1. HIV-1 
infection is known to cause oxidative stress and our results support the 
suggestion that HIV-1 IRES activity is upregulated in the course of HIV-1 
replication cycle (supported by the Canadian Institutes of Health Research). 
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Ribosomal protein (rp) S5 belongs to the family of ribosomal proteins that 
contains rpS7 from prokaryotes and rpS5 from eukaryotes. RpS5 forms part 
of the exit (E) site on the 40S ribosomal subunit and is essential for cell 
viability of yeast. To investigate the function of the rpS5 and in particular 
the role of the N-terminal extension of the yeast protein (absent in bacteria), 
we obtained and characterized yeast strains in which the wt yeast rpS5 was 
replaced by its truncated variants, lacking 13, 24, 30 and 46 N-terminal 
amino acids, respectively. Biochemical analysis of the mutant yeast strains 
previously showed that the N-terminal part of the yeast S5 plays important 
roles in ensuring the efficiency and accuracy of elongation and initiation 
processes. In particular, we have found that cap-dependent initiation in 
YS5-46 strain (lacking 46 N-terminal amino acids) was reduced by about 
50% as compared to the wild type strain. Here we further show that this 
strain fails to support re-initiation as evident by the use of GCN4-lacZ 
reporter constructs. Comparison of lacZ expression from various GCN4-
lacZ reporter constructs (containing all four uORFs and/or two uORFs 
(uORFs 1&4) as well as one uORF4) allowed us to suggest that YS5-46 
yeast strain possesses an initiation defect downstream of the 48S complex 
assembly. An increased association of initiation factors eIF2alpha, eIF1 and 
eIF5B with mutant 40S ribosomal subunits was also observed. We thus 
hypothesized, that rpS5 N-terminal truncation likely results in a slow 
dissociation of eIF2 from 48S complexes, thus also causing accumulation of 
eIF5B and in turn leading to compromised subunit joining. Therefore, 
truncation of rpS5 causes mutant ribosomes leaky-scan through the uORF1 
AUG, making it further impossible for the scanning subunits to bypass 
uORFs 2, 3 or 4 and re-initiate at AUG codon 5 to translate the GCN4 ORF. 
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An iron switch targets the family of animal mRNAs, which encodes 
proteins for iron homeostasis, when the conserved 5’UTR regulatory 
structure (iron resonsive element or IRE) is complexed to repressor 
proteins, (IRP1, 2); the protein/RNA complex inhibits ribosome binding. 
IRE-RNA contains absolutely conserved protein binding sites (terminal tri-
loop/GC closing bp and C bulge), with phylogenetically conserved base 
pairs that are specific to each IRE-mRNA and influence RNA/protein 
stability. We have recently shown that Fe2+ destabilizes the protein/RNA 
complex. To further explore the differences in protein/RNA stability for 
ferritin (FTH) and mt-aconitase (ACO2), using 5’UTR- IRE-RNAs and 
IRP1 as before (Khan et al., JBC, 2009), we compared the kon and koff rates, 
by fluorescence anisotropy, for 5’ fluorescein labeled RNA. FTH IRE-RNA 
binds IRP almost 10 times faster than ACO2 RNA, while the koff rates are 
comparable. Since the two RNAs share the same protein binding sites in the 
terminal loop and helix bulge, the differences in IRP binding must reflect 
the differences in the helix base pairs of each IRE-RNA. A bimolecular 
association reaction is suggested by pseudo-first order dependence of 
binding on IRP1 concentration. The larger effect of ionic strength on kon, 
compared to koff, indicates induced structural changes. The effect of ionic 
strength is much larger for the FTH IRE-RNA than ACO2 IRE-RNA and 
may relate to FTH IRE-RNA folding in the absence of protein. Metal Ion 
selectivity in weakening IRE-RNA/IRP: Fe2+ > Mg2+ > K+ and are 
approximately equivalent for 200 mM K+ , 2.0 mM Mg2+, and 0.005 mM 
Fe2+. Interestingly, differences in IRE-RNA/IRP binding kinetics and 
biological iron regulation coincide. The greater RNA/protein sensitivity to 
Fe2+ , among mono and divalent cations, suggests that excess Fe2+ itself is 
the biological iron signal that releases 5’UTR IRE-RNAs from IRP1 for 
translation. Part support: NIH-DK20251 
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Control of translation is a critical step in the regulation of gene expression 
during cell cycle, embryonic development, or malignant transformation. As 
a crucial cap-dependent translation repressor, eIF4E Binding Protein (4E-
BP) is now recognized as a tumor suppressor. This small protein of 12.8 
kDa sequesters specifically the eukaryotic Initiation Factor 4E (eIF4E), 
which is a master switch that binds to the cap structure of the mRNA and 
participates in recruiting mRNA to the ribosome for translation initiation. 
Binding of 4E-BP to eIF4E was classically described as resulting from the 
interaction between the 4E-BP central consensus motif and eIF4E, which is 
dependent upon the phosphorylation status of 4E-BP. Hypophosphorylated 
4E-BP binds to eIF4E whereas the hyperphosphorylated does not. However, 
the relationships between the multiple states of 4E-BP phosphorylation and 
its dissociation from eIF4E are far from being fully understood. The 
understanding of the interactions between these different actors, with 
functional and structural approaches, is a very important step for cellular 
biology. Using an original structural technique that consists in measurement 
of small angles X-ray scattering (SAXS), we report here the analysis of 4E-
BP structure in solution, which reveals that while 4E-BP is intrinsically 
disordered in the free state, it adopts a partially folded conformation upon 
the binding to eIF4E. We observed that the 4E-BP interacting surface is 
much larger than the one previously reported, challenging current visions of 
eIF4E/4E-BP complex regulation. 
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Members of the subfamily Pneumovirinae of the family Paramyxoviridae, given 
the collective name pneumoviruses, are responsible for acute respiratory 
infections in their hosts. The subfamily is divided into two genera on the basis 
of differences in genome organisation. The genus pneumovirus contains two 
members, the respiratory syncytial viruses (RSV) and pneumonia virus of mice 
(PVM). The genus metapneumovirus contains two members, avian 
metapneumovirus (AMPV) and human metapneumovirus (hMPV).  
Sequence analysis has shown that the M2 mRNAs of all pneumoviruses contain 
two open reading frames, conserved in location though not in sequence. The 
first major ORF of the M2 gene utilises 60-75% of the potential coding capacity 
of the mRNA and encodes the M2-1 protein. The second major ORF is located 
towards the 3’ end of the mRNA, overlaps ORF-1 and utilises the remainder of 
the unassigned available nucleotide sequence. ORF-2 encodes the M2-2 protein.  
We have shown that ribosomes access the RSV M2 gene second ORF using a 
mechanism in which expression of the RSV M2-2 protein is initiated at AUGs 
located upstream of the ORF-1 termination codon, and that expression from 
these initiation codons requires the prior termination of M2 ORF-1 translation 
in vivo. A similar, but not identical process has been shown by others for 
caliciviruses and influenza B.  
Our studies with the human RSV M2 gene have shown that not only the overlap 
region (containing the final 32nts of ORF1) but unknown sequence segments 
present within ORF-1 were also essential for this process. Utilising deletion 
mutants we have identified regions of ORF-1 upstream of ORF-2 that are either 
essential for coupling or promote its efficiency to varying levels. These regions 
are located throughout the final half of the M2-1 coding sequence (~250nts) 
indicating long range sequence interactions with the terminating ribosome at the 
ORF1 stop codon. Increasing the distance between these essential regions and 
the overlap by an additional 255nts had no effect on coupling, indicating these 
elements can promote coupling over substantial distances. Unlike the other 
virus coupled translation processes these sequences do not appear to recruit 18S 
rRNA. The data show ribosomal coupling in human RSV requires sequence 
elements not only in the overlap region but present in regions situated -253 to -
86nt from the stop codon of ORF1.  
All viruses are dependent on host cellular translation machinery. We have 
investigated if coupled translation is utilised by human mRNAs which contain 
overlapping ORFs. Using a bioinformatics approach we have identified putative 
overlapping ORFs within the human genome, verified expression of ORF2 
within these mRNAs and tested for translational coupling. Progress on these 
studies will be presented.  
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The eukaryotic translation factor eIF5A is highly conserved from archaea to 
mammals, essential for cell viability and it is the only cellular protein 
known to contain the essential amino acid hypusine. eIF5A was originally 
identified as a translation initiation factor due to its ability to stimulate the 
first peptide bond. However, recent studies have shown that depletion of 
eIF5A causes a significant increase of the ribosome transit time and 
decrease of polysome run-off, suggesting that eIF5A is involved in the 
elongation step of protein synthesis. We have previously shown that the 
depletion mutant tif51A-3 of eIF5A has a synthetic sick genetic interaction 
with the dominant negative mutant eft2H699K of eEF2. Here we use two 
different mutants of eIF5A, eIF5AK56A and eIF5AQ22H/L93F, to further 
analyze the functional interaction with eEF2. These eIF5A mutants are 
temperature-sensitive and show defects in protein synthesis as observed 
during eIF5A depletion; however eIF5AK56A and eIF5AQ22H/L93F proteins are 
stable at the restrictive temperature. The K56A substitution is located within 
the hypusine loop in the N-terminus of eIF5A and induces decreased levels 
of hypusine modification, probably being the cause of its partial loss of 
function. On the other hand, the eIF5AQ22H/L93F mutant contains 
substitutions in both N- and C- terminal domains that result in increased 
stability of eIF5A when compared to the wild type protein with no defect in 
hypusine formation. Interestingly, while the overproduction of eEF2 
improves the cell growth of the eIF5AK56A mutant strain, it has a deleterious 
effect upon growth of the eIF5AQ22H/L93F mutant strain. In agreement with 
the cell growth data, the polysome profile defect of the eIF5AK56A mutant is 
partially complemented by overproduction of eEF2, whereas polysome 
profile of the eIF5AQ22H/L93F mutant is aggravated. These data further 
support the functional link between eIF5A and eEF2, and future 
experiments will aim to dissect the mechanism of eIF5A in translation 
elongation together with eEF2.  
 
Supported by FAPESP, CNPq and PADC-FCF.  
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Eukaryotic Initiation Factor 4F (eIF4F) is composed of the cap-binding 
protein eIF4E, the scaffold protein eIF4G and the ATP-dependent helicase 
eIF4A, which, assisted by eIF4B/H, unwinds secondary structures in the 5’ 
UTR of the mRNA. The activity of eIF4F complex increases translation of 
most capped, polyadenylated mRNAs and translation of 5'UTR structured 
mRNAs. Many mRNAs involved in cell cycle progression and 
tumorigenesis have a structured 5'UTR and consequently, indirect inhibition 
of eIF4F is crucial in cancer therapy. eIF4F is controlled by the mTORc1 
pathway that is activated by growth factors and optimal nutrient conditions. 
Rapamycin blocks the formation of the eIF4F complex by inhibiting 
mTOR. However, in several cancer cells, mTOR inhibition only marginally 
blocks the translation rate, suggesting that other pathways are important.  
We investigated mTOR independent translation in malignant mesothelioma 
(MM), a fatal type of tumor arising from pleura and peritoneum, associated 
with exposure to asbestos. MM cell line (REN) was grown in presence or 
absence of growth factors, in order to study regulation of translation. We 
found growth factor independent translation in REN cells. Next we 
dissected the pathway regulating protein synthesis. Pharmacological 
inhibition of mTOR and MAP kinase pathways, resulted in 
dephosphorylation of molecular targets, but global level of protein synthesis 
was not affected. The level of initiation factors is analyzed in REN cells and 
in other MM cell lines. We found different expression of eIF4F initiation 
factors between cell lines derived from mesothelioma patients, both 
rapamycin sensitive and insensitive. 4EBP1 overexpression recapitulates 
rapamycin sensitivity in REN cells. Cap complex formation and TOP 
messengers translation were both impaired by blocking mTORc1, 
suggesting that different classes of mRNAs are translated in REN cells 
when mTOR signaling is impaired. We will further address whether 
different classes of mRNAs are translated in REN cells and in other models 
of mTOR independent translation.  
In conclusion we found that the initiation factor eIF4E (but not its 
phosphorylation level) is a candidate to be analyzed in order to predict 
resistance to rapamycin treatment also in an mTOR independent model of 
regulation of translation. 
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Exposure of monocytes and macrophages to endotoxin/lipopolysaccharide 
(LPS) from gram-negative bacteria activates the NF-kB signaling pathway. 
At early times, this leads to their production of pro-inflammatory cytokines, 
but subsequently, they produce anti-inflammatory IL-10 to quell the 
immune response. LPS-mediated induction of IL10 gene expression 
requires the p40 isoform of RNA-binding protein AUF1. As LPS exerts 
modest effects upon IL10 mRNA stability, we hypothesized that AUF1 
controls expression of signaling proteins. Indeed, knockdown of AUF1 
impairs LPS-mediated p38 MAPK and NF-kB signaling, and expression of 
an RNAi-refractory p40AUF1 cDNA restores both signaling pathways. To 
define the molecular mechanisms by which p40AUF1 controls IL10 
expression, we focused on the NF-kB pathway in search of AUF1-regulated 
targets. Here, we show that p40AUF1 serves to maintain proper levels of the 
kinase TAK1 which phosphorylates IKK-beta within the IkB kinase 
complex to activate NF-kB–regulated genes. However, p40AUF1 does not 
control levels of TAK1 mRNA or TAK1 protein stability, suggesting that it 
promotes translation of TAK1 mRNA. Thus, p40AUF1 regulates a critical 
node within the NF-kB signaling pathway to permit IL10 induction for the 
anti-inflammatory arm of an innate immune response. 
 
*Authors contributed equally 
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eEF1A is an abundant G- protein whose primary function is to transport 
aminoacyl-tRNA to elongating ribosomes during eukaryotic translation. 
Additionally, eEF1A has also been identified as an actin binding protein. 
This second property of eEF1A allows it to bind and subsequently bundle 
filamentous actin into two specific structures: patches and cables. These 
structures collectively referred to as the cytoskeleton provides the network 
by which intracellular transport and endocytosis occur in yeast. We have 
shown that a strain expressing an S405P eEF1A-Ura3p fusion mutant 
protein exhibits a disorganized actin cytoskeleton and reduced total 
translation. Polyribosome analysis of this eEF1A mutant strain also shows 
an increase in 80S ribosomal subunits. Interestingly, we now show altered 
translation is accompanied by an increase in eIF2α phosphorylation. 
Ongoing work is looking at the relationship of this finding to the Gcn2p 
kinase in yeast. Using genome wide analysis we plan to analyze alternations 
in translational genes in the eEF1A S405P mutant strain. Together, these 
studies address the interface of the cytoskeleton and gene expression. 
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Initiation on the 450nt-long Type 2 Foot-and-mouth disease virus (FMDV) and 
encephalomyocarditis virus (EMCV) IRESs begins with binding of eIF4G to 
the IRES’ J-K domain, which is enhanced by eIF4A. Together, they restructure 
the IRES downstream of this domain and promote recruitment of the 43S 
complex. Directed hydroxyl radical cleavage experiments indicated that 
eIF4G’s central functional domain (eIF4G-M) bound with its C-terminus 
oriented towards the apex of IRES Domain J and its N-terminus towards the 
base. Probing experiments revealed that residues 33 and 42 in the eIF4A-NTD 
were also close to Domain J’s apex, whereas residue 351, near eIF4A’s mRNA-
binding cleft, bound upstream of the initiation codon, on the 40S subunit’s E-
site side. Analysis of eIF4G-M-directed cleavage of 18S rRNA in 48S 
complexes formed on the EMCV IRES indicated that the apex of Domain J 
bound to eIF4G-M and the eIF4A-NTD was located on the 40S subunit’s 
solvent side, below the platform. 
 
Despite their structural similarity, type 2 IRESs have differing IRES trans-
acting factor (ITAF) requirements. Initiation on the EMCV IRES is moderately 
enhanced by PTB (pyrimidine tract-binding protein) whereas the FMDV IRES 
requires PTB and ITAF45. To test the hypothesis that ITAFs act as chaperones 
that stabilize the active conformation of the IRES, we assayed their influence on 
eIF4G-M-mediated cleavage of EMCV and FMDV IRESs. In the absence of 
ITAFs, cleavage of IRESs extended beyond the J-K domain into domains I and 
L in a manner that suggests they adopt a side-by-side orientation. Inclusion of 
PTB enhanced eIF4G-mediated cleavage at the base of Domain I, consistent 
with it promoting adoption by the IRES of this configuration. Analysis of 
cleavage by eIF4G-M of the EMCV IRES in 48S complexes indicated that it 
folded into a compact conformation like that induced by PTB. ITAF45 reduced 
cleavage at Domain J’s apex, with PTB synergistically enhanced cleavage at 
Domain I’s base, and promoted cleavage at its apex. The implication that 
ITAF45 induces this region of Domain I to move closer to the eIF4G-bound J-K 
domain is consistent with data from probing experiments done to map the 
interaction of ITAF45 with the FMDV IRES, which indicate that residues on one 
surface of ITAF45 bind in proximity to both regions.  
 
Together these data show how the activities of ITAFs and eIFs are coordinated 
to induce conformational changes in IRESs that promote productive ribosomal 
binding. 
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PKR-like ER kinase (PERK) plays a fundamental role in pancreatic β-cell 
development and differentiation. PERK is activated in β-cells in response to 
both patho-physiologically high and physiologically low glucose 
concentrations. We investigated, in dispersed rat islets of Langerhans and 
mouse insulinoma-6 (MIN6) cells, the relationship between extracellular 
glucose concentration, the free endoplasmic reticulum (ER) calcium 
concentration ([Ca2+]ER) measured directly using an ER targeted FRET 
based calcium sensor, and the activation of PERK. We found that a 
decrease in glucose concentration leads to a concentration-dependent 
reduction in [Ca2+]ER that parallels the activation of PERK and the 
phosphorylation of its substrate eIF2α. We provide evidence that this 
decrease in [Ca2+]ER is caused by a decrease in SERCA pump activity 
mediated by a reduction in the energy status of the cell. Importantly, PERK-
dependent eIF2α phosphorylation was found to play an important role in: 1. 
the regulation of both proinsulin and global protein synthesis; 2. cell 
viability and 3; conferring pre-emptive cytoprotection against ER stress. 
Taken together, these results provide evidence that a decrease in the 
ATP/energy status of the cell in response to a decrease in glucose 
concentration results in SERCA pump inhibition, the efflux of Ca2+ from 
the ER and the activation of PERK, which plays an important role in both 
pancreatic β-cell function and survival. 
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In eukaryotic translation, initiation factors (eIFs) promote dissociation of 
the 80S ribosome and assist binding of Met-tRNAiMet and 5’-capped mRNA 
to the 40S subunit to form 43S and 48S preinitiation complexes (PICs), 
respectively. The 43S complex formation is greatly facilitated by the 
preassembly of a subset of initiation factors in the multifactor complex 
(MFC) containing eIF1, eIF5, eIF3 and the eIF2/GTP/Met-tRNAiMet ternary 
complex (TC). The C-terminal domain (CTD) of eIF5 is the assembly core 
of the MFC, touching all the MFC partners as well as eIF4G. Its negatively 
charged surface (Area I) conserved with eIF2Bε-CTD interacts with eIF2β; 
the positively charged surface (Area II) specific to eIF5 interacts with eIF3c 
and a part of eIF1. Upon MFC binding to the 40S subunit, eIFs 1, 2, 3 and 
Met-tRNAiMet are proposed to interact with defined areas of the 40S 
subunit, while the interactions linking MFC constituents are rearranged 
prior to or concomitant with mRNA binding to the PIC. It is crucial to 
understand the biological significance of these events of rearrangement. 
Recent studies by the groups of Hinnebusch and Lorsch indicate that N-
terminal and C-terminal tails (NTT; CTT) of eIF1A play distinct roles in 
regulating the scanning-competency of the 40S subunit in response to start 
codon recognition. In this study, we extend our characterization of eIF5-
CTD interaction with eIF1 and evaluate the significance of its newly 
discovered interaction with eIF1A in humans using yeast as a model 
system. We identify a second negatively charged surface (Area III) of eIF5-
CTD as the second binding site of eIF1. We also show that yeast eIF1A 
interacts with eIF5-CTD depending on the eIF1A-NTT in vitro. Previous 
studies indicated that mutations in eIF1A-NTT are lethal, in a manner 
suppressible by eIF1 overexpression, and impair the scanning-inhibitor 
function of eIF1A. We examine whether eIF5-CTD interaction with eIF1A-
NTT regulates the scanning inhibition by the latter and whether eIF5-CTD 
mediates some of the observed genetic interactions between eIF1 and 
eIF1A. 
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Stress granules (SGs) are small cytoplasmic foci that form after cells are 
exposed to various stress conditions such as oxidative stress, UV 
irradiation, nutrient starvation, or heat shock. As a response to these 
different types of stress, mRNA translation is attenuated and SGs occur. 
Recent data suggest that SGs are dynamic structures that function as sites of 
triage where mRNAs are sorted either for degradation or storage. The 
formation of SGs is thought to happen in two steps: First, the block of 
mRNA translation causes disassembly of polysomes and an accumulation of 
stalled mRNAs. Second, these stalled mRNAs and their associated proteins 
aggregate into cytoplasmic foci. For many types of stress, translation 
inhibition depends on activation of specific kinases that phosphorylate 
eIF2α and thereby cause depletion of the ternary complex.  
We identified cold shock as a new trigger for SG assembly in mammalian 
cell lines and yeast. Several bona fide SG markers could be localized to 
cold shock SGs, such as eIF4G, G3BP, and HuR. Further, we found that 
cold shock SGs form very slowly with a maximum response after 10 hours. 
In stark contrast, the disassembly of SGs during recovery from cold shock 
takes place within minutes. Additionally, we detected an increase in 
phospho-eIF2α levels upon continued cold shock. Experiments with 
phospho-deficient eIF2α mouse embryonic fibroblasts (AA-MEFs), 
however, revealed that cold shock SGs form independently of eIF2α 
phosphorylation. Likewise, translational repression upon cold shock still 
happens in AA-MEFs. This observation is consistent with our finding that 
deletion of Gcn2, the only eIF2α kinase in S. cerevisiae, does not prevent 
translation repression and SG formation after cold shock in yeast. Currently, 
we are investigating the mechanism by which translation is attenuated 
during cold shock. 
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Scanning mechanism is the generally accepted hypothesis for explaining 
how eukaryotic 40S ribosomal subunits locate initiation codons that are far 
removed from the ribosome recruiting site (eg. the 5’ cap structure). 
Recently, we showed that cap-dependent translation can occur by ‘RNA 
looping’ without scanning through the intervening mRNA segment between 
the cap structure and the initiation codon. We tested whether IRES-
dependent translation occurs through “RNA looping” by using two viral 
IRESs [encephalomyocarditis viral (EMCV) and polioviral IRESs]. EMCV 
mRNA contains a short intervening segment between the IRES element and 
the initiation codon, which may suggest that the initiation codon is directly 
recognized by the 40S ribosome loaded on the IRES element. When 
heterologous RNAs of variable length were inserted between the IRES 
element and the initiation codon, translation efficiency of the artificial 
mRNAs were dramatically reduced suggesting that the recognition of the 
EMCV’s initiation codon occurs mostly by direct touching of ribosome on 
the IRES element. On the other hand, polioviral mRNAs contain a long 
variable region between the IRES element and the initiation codon. When 
heterologous RNAs of variable length were inserted between the IRES 
element and the initiation codon, translation of the artificial mRNAs 
reached the maximum when the length of the intervening segment was 
about 200 nucleotides. After the optimal length, translation efficiency was 
gradually decreased. This effect of the intervening segment on translation 
was correlated well with the theoretical probability of collision of two 
elements on a string. This suggests that translation of polioviral mRNA 
occurs through the looping of the variable region of the mRNA.  
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It is now well established that altered regulation at the level of translation 
makes a significant contribution to both cancer development and 
progression, however, in contrast to changes that occur at the level of 
transcription this process has not been much studied. We have carried out 
an extensive study to examine changes at the level of translation in Non-
Hodgkin lymphoma (NHL which is comprised of over thirty distinct 
subtypes).  
Compairing 6 cell lines derived from patients with diffuse large B-cell 
lymphoma (DLBCL; which makes up approximately 55% of all new cases 
each year) containing the t(14:18)(q32:q11) translocation with cell lines 
(GM03201 and GM1953) derived from disease-free individuals, we have 
identified changes in individual groups of mRNAs. An increase in 
polysome association was found for mRNAs that have not been shown 
previously to be aberrantly regulated in NHL but which are relevant to 
disease progression.  
Thus we show that pro-apoptotic proteins including TRADD and the FAS 
receptor are downregulated at the level of translation while proto-oncogenes 
involved in this process (e.g. c-Myc) are up-regulated. The up-regulation of 
DNA repair protein led us to discover a constitutive activation of ATM 
pathway in response to endogenous DNA damage in NHL. Interestingly, 
there was a reduced expression in proteins involved in glutathione 
metabolism, suggesting NHL might be particularly sensitive to oxidative 
stress. These new oncogenic pathways could open novel therapeutic 
strategies.  
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Tob is a member of the anti-proliferative protein family, which functions in 
transcription and mRNA decay. We have previously demonstrated that Tob 
is involved in the general mechanism of mRNA decay by mediating mRNA 
deadenylation through interaction with Caf1 and a general RNA-binding 
protein, PABPC1. Here, we focus on the role of Tob in the regulation of 
specific mRNA. We show that Tob binds directly to a sequence-specific 
RNA-binding protein, CPEB3. CPEB3 negatively regulates the expression 
of a target by accelerating deadenylation and decay of its mRNA, which it 
achieves by tethering to the mRNA. The carboxyl-terminal RNA-binding 
domain of CPEB3 binds to the carboxyl-terminal unstructured region of 
Tob. Tob then binds Caf1 deadenylase and recruits it to CPEB3 to form a 
ternary complex. The CPEB3-accelerated deadenylation was abrogated by a 
dominant negative mutant of either Caf1 or Tob. Together, these results 
indicate that Tob mediates the recruitment of Caf1 to the target of CPEB3 
and elicits deadenylation and decay of the mRNA. Our results provide an 
explanation of how Tob regulates specific biological processes. 
 
*These authors contributed equally to this work. 
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Pokeweed antiviral protein (PAP) is an N-glycosidase isolated from the 
leaves of Phytolacca americana. This enzyme has been shown to inhibit the 
proliferation of several human and plant viruses; however, its mechanism of 
action has not been clearly defined. We have shown recently that PAP 
removes purine bases from the Gag open reading frame of Human T cell 
leukemia virus genomic RNA and reduces the synthesis of viral proteins. 
Decreased amounts of the viral transactivator protein, Tax, resulted in 
inhibition of transcription from the viral promoter. Therefore, the antiviral 
protein suppressed viral gene expression at both translation and 
transcriptional levels. In the current study, we expressed PAP in 293T cells 
with an HIV-1 proviral clone, to test for the effect of the enzyme on virus 
propagation. We show that PAP significantly reduced the level of viral 
particles released from cells, as measured by p24 ELISA. This decrease was 
not observed from cells expressing the enzymatically inactive form of PAP. 
Immunoblot analysis indicated a reduction in the level of viral proteins in 
cells, including Rev. Rev binds to Rev response elements on full-length 
genomic and singly spliced viral RNAs, to escort them from the nucleus to 
the cytoplasm. We observed an increase in the level of fully spliced viral 
RNAs, relative to full-length genomic RNA, in cells expressing PAP, 
suggesting that decrease in Rev may have altered the ratio of spliced to 
unspliced viral RNAs. We are currently testing whether enhanced levels of 
Rev rescue the splicing ratio to normal. The lower abundance of full-length 
gag/pol mRNA, relative to fully spliced mRNAs, likely contributed to 
decreased Gag protein levels. In addition, the translational efficiency of 
gag/pol mRNA, measured as amount of p24 in cells relative to gag/pol 
mRNA, was reduced in PAP-expressing cells. We will verify that reduction 
in fitness for translation is due to depurination of this mRNA by PAP. Our 
preliminary results suggest that PAP inhibits HIV-1 particle production by 
altering the splicing ratios of viral RNAs and by reducing their translation. 
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A genome is only as good as its annotation and high quality gene annotation 
is important for both experimental design and interpretation of data. As part 
of the GENCODE consortium we are currently building a comprehensive 
geneset of all protein-coding, non-coding and pseudogene loci across the 
human genome; providing an unparalleled coverage of alternative splicing 
and untranslated regions. 
 
Our annotation of splice variation has historically been reliant upon mRNAs 
and ESTs to provide the evidence for our gene models, generating an 
average of ~8 splice variants per multi-exon locus. However, new 
sequencing technologies are producing an unprecedented volume of data 
that has tremendous potential to enhance our annotation via the addition of 
novel splice variants with coding potential. 
 
This increase in the numbers of splice variants can, however, complicate the 
interpretation of the CDSs they may encode. This may be due to the 
presence of upORFs, skipping of canonical ATGs, translational initiation at 
internal ATG start sites, and the presence of multiple plausible competing 
ORFs. For example, the introduction of a novel 5’ UTR exon may result in 
the incorporation into a transcript of an upORF that overlaps the initiating 
ATG of the canonical variant at the locus: how should this be interpreted? 
This is a nascent area of research, and there is little data to inform such 
decisions at most coding loci. We will describe how we annotate alternative 
splice variants, assess their coding potential and tag them with descriptive 
functional information.  
 
Much gene annotation is predictive and as such experimental data is 
required for validation. Whilst proteomics continues to lag behind 
transcriptomics in terms of sheer data volume, technical advances in mass 
spectroscopy are beginning to yield vastly more data than was previously 
possible with a commensurate improvement in quality. We have performed 
an analysis of high confidence, unambiguously mapping peptides identified 
using Mascot and MascotPercuolator in mouse, and have been able to detect 
the translation of significant numbers of stable proteins from alternative 
splice variants across the genome. As these data become integrated into our 
annotation pipeline the HAVANA manually annotated geneset will become 
even more of a valuable resource. 
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Aminoacyl tRNA synthetases appeared early in evolution, possibly as the 
transition was made from the RNA world to the theatre of proteins. The 
emergence of polypeptides with unique, defined sequences—true chemical 
entities—required extraordinary specificity of the aminoacylation reaction. 
This high specificity was achieved by editing activities that clear errors of 
aminoacylation and thereby prevent mistranslation. These activities are 
conserved back to the base of the Tree of Life. Recent x-ray 
crystallographic, biochemical, and genetic studies have demonstrated the 
structural basis of powerful selective pressures on the editing site of a 
specific tRNA synthetase--AlaRS. These analyses also provide a rationale 
for the appearance of a separate, trans-acting, genome encoded fragment 
(AlaXp) encoding just the editing domain of AlaRS. This genome encoded 
fragment provides redundancy for clearance of serine that has been 
mischarged to alanine-specific tRNA. Work in bacteria, mammalian cells, 
and the mouse demonstrated the high sensitivity of cell survival and disease 
states to even small amounts of misacylation with serine, and the need for 
re-iterative editing using the mistranslation-preventing activity of AlaRS 
and, separately, that of AlaXp. In other work, mistranslation caused by 
editing defects was shown to result in heritable genetic mutations. 
Collectively, these studies highlight the fundamental role throughout 
evolution of mistranslation control by tRNA synthetases, for cell viability 
and survival. 
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Here we have identified a novel mechanism for translational control that 
operates during the earliest events of tumor suppression and leads to 
irreversible cell cycle arrest. We show that during oncogene-induced 
senescence (OIS), a translational switch between cap- to IRES-dependent 
translation occurs and is required to maintain cellular quiescence. During 
this switch, an IRES element positioned in the 5’untranslated region of the 
p53 tumor suppressor messenger is engaged and promotes p53 translation. 
We further discovered a key role of DKC1, the gene that encodes the 
enzyme required for rRNA pseudouridylation, in control of p53 mRNA 
translation during this translational switch. Specifically, in DKC1 mutant 
cells (DKC1m), p53 IRES-dependent translation is impaired during OIS and 
upon DNA damage and is associated with a significant decrease of p53 
protein expression and activity. This defect in p53 translation perturbs the 
cellular response against oncogenic insult, leading to uncontrolled 
proliferation of cells carrying potential oncogenic alterations. As DKC1 is 
found mutated in a cancer susceptibility syndrome known as X-linked 
dyskeratosis congenita (X-DC), we further extended these findings to X-DC 
human patient cells in which we characterized similar impairments in rRNA 
modifications and p53 IRES-dependent translation. Importantly, re-
introduction of wild-type DKC1 in these human cells restores p53 protein 
levels. These findings identify a novel translational switch between cap- and 
IRES-mediated translation that operates during the earliest events following 
an oncogenic insult, which lead to maintenance of p53 expression at the 
level of translational control. Defects in DKC1 and rRNA modifications 
impair this exquisite translational modality, which is essential for tumor 
suppression. These results provide insight into the basis for cancer 
susceptibility in human syndromes associated with ribosome dysfunction. 
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Mulibrey Nanism is an autosomal recessive genetic disease characterized by 
dwarfism, craniofacial dismorphism, muscular hypotonia, enlarged liver, 
increased tumor risk, and early-onset of metabolic syndrome. It is caused by 
mutations in the TRIM37 gene, however the biological function of TRIM37 
and the pathogenic mechanisms induced by TRIM37 mutations are 
unknown. By using in vivo crosslinking-coupled affinity purification we 
found that TRIM37 interacts with specific sequences of the C/EBPα-
3’UTR. The mRNA of the C/EBPα transcription factor is translated into 
three functionally different protein isoforms, extended, p42 and p30, 
through differential translation initiation. Translation into p30 is achieved 
through translation re-initiation at a downstream AUG-codon by ribosomes 
that have first translated a small upstream open reading frame (uORF) in the 
5’UTR. Our results indicate that a complex of TRIM37, Nucleolin and 
DDX3x associates with the C/EBPα -3’UTR and recruits the translation 
initiation factor eIF3 to stimulate translation re-initiation at the p30-AUG. 
Disease-associated mutations in TRIM37 result in loss of TRIM37-RNA 
interaction and consequently in reduced levels of p30. Knock-in mice that 
carry mono-allelic ablation of the C/EBPα-uORF phenocopy the reduction 
of p30 levels in Mulibrey Nanism, which results in striking similar 
metabolic disturbances as found in the human disease. Taken together, our 
results reveal that a genetic disease (Mulibrey Nanism) is caused by non-
functional mutation of an RNA binding protein (TRIM37), and that the 
resulting mistranslation of one of its target mRNAs (C/EBPα) results in 
disease associated clinical features. 
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Mice, whose rpS6 cannot be phosphorylated due to Ser->Ala replacement 
of all phosphorylatable residues (rpS6P-/-), exhibit a small-size phenotype of 
their β-cells and impaired glucose tolerance. Contrarily, transgenic mice, 
whose β-cells overexpress myr-Akt1 (Akttg), display a significant increase 
in both the number and size of their β-cells, as well as improved glucose 
tolerance. A cross between Akttg and rpS6P-/- mice has established the 
dominance of the growth stimulating effect of Akt1 over the growth defect 
resulting from rpS6 phosphorylation deficiency. Interestingly, however, in 
addition to their large size, Akttg β-cells tend to undergo transformation with 
the development of insulinoma, concomitantly with a selective rpS6 
phosphorylation in the tumor cells. The causal relationship between these 
two variables has become evident by the fact that insulinoma was detected 
in none of 12 Akttg/rpS6P-/- mice. Intrigued by the possibility that rpS6 
phosphorylation might exert a pro-oncogenic activity, we examined the 
involvement of phospho-rpS6 in pancreatic ductal adenocarcinoma (PDA). 
To this end, pellets of 7,12-dimethylbenzanthracene (DMBA) were 
implanted into pancreas head of mice. Like in the case of the endocrine 
pancreas, rpS6P-/- mice were protected from the development of PDA and its 
precursor lesions. Notably, PDA often involves somatic activation of K-Ras 
oncogene, which has also been implicated in various DMBA-induced 
tumors. In order to examine the role of rpS6 phosphorylation in the context 
of K-Ras-induced tumorigenicity, we crossed rpS6P-/- mice with PDX1-Cre; 
K-RasLSLG12V mice. The latter strain expresses an activated K-ras variant (K-
RasG12V) in all cells of pancreatic lineage, causing the widespread 
development of precursor lesions for PDA. Histopathological analysis has 
demonstrated that K-Ras-induced tumorigenicity is suppressed in rpS6P-/- 
mice. 
In an attempt to study the mechanism underlying the pro-tumorigenic effect 
of rpS6 phosphorylation, we infected immortalized WT and rpS6P-/- MEFs 
with myr-Akt expression vector. Our results indicate that rpS6 
phosphorylation deficiency inhibited colony formation in soft agar, relative 
to the number counted in WT cells, concomitantly with increased cell death. 
Taken together, these results suggest that phosphorylated rpS6 displays a 
cell-autonomous pro-oncogenic activity. 
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The obligate intracellular parasite Toxoplasma gondii infects nucleated cells 
and is the causative agent of toxoplasmosis, which is life-threatening in the 
immunocompromised. The lytic cycle of T. gondii tachyzoites consists of 
host cell adherence and invasion, replication, egress from and movement to 
another host cell. Outside a host cell, tachyzoites are viable for only a 
limited time. A well-characterized stress response conserved among 
eukaryotic cells involves translational control by virtue of eIF2α 
phosphorylation. We identified and characterized an eIF2α orthologue in T. 
gondii (TgIF2α), as well as four TgIF2 kinases (TgIF2K-A through -D). 
While TgIF2K-C and -D are most closely related to GCN2, TgIF2K-A is 
localized to the parasite ER and likely mediates the activation of the 
unfolded protein response analogous to PERK/PEK. TgIF2K-B is a novel 
eIF2 kinase that likely responds to cytoplasmic stresses. To address the role 
of TgIF2α phosphorylation in acute infection, we generated a transgenic 
parasite harboring a single point mutation in TgIF2α that blocks 
phosphorylation at its regulatory serine (Ser71). Parasites containing 
mutated TgIF2α (S71A) exhibited a growth defect during the lytic cycle in 
vitro and reduced viability following continuous exposure to the 
extracellular environment. TgIF2α phosphorylation increases over time as 
these obligate intracellular parasites are outside of their host cells. TgIF2α 
phosphorylation is more robust in hypervirulent than in less virulent strains, 
possibly contributing to their ability to remain viable longer outside the host 
cell. Conditional knockout of TgIF2K-D increased sensitivity of the parasite 
to extracellular stress, supporting the idea that this GCN2-like eIF2 kinase 
provides the extracellular parasite resistance to nutrient deprivation. When 
we introduced the S71A TgIF2α mutant parasites into Balb/c mice, it 
showed a 30% slower doubling-time compared to parental parasites, as well 
as a significant delay in disease onset. We conclude that phosphorylation of 
TgIF2α plays a critical role during the progression through the lytic cycle 
by ameliorating the stress of the extracellular environment while the 
parasite searches for a new host cell. Considered with our previous 
observation that phosphorylated TgIF2α accumulates in the latent 
bradyzoite from of the parasites, our new data indicates that TgIF2α 
phosphorylation plays critical roles during both acute and chronic infection. 
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Vaccinia is an orthopox virus whose replication can be suppressed through 
the activation of translational control pathways. This is particularly well 
demonstrated in the ΔE3L mutant vaccinia virus (VV), where lack of the 
E3L protein allows PKR activation, leading to eIF2α phosphorylation, a 
blockade of virus translation (but not transcription) and an inhibition of 
replication. We have used this virus to test the hypothesis that cytoplasmic 
stress granule components are part of a successful antiviral response that is 
triggered by eIF2α phosphorylation. In cells that were infected with ΔE3L 
VV we observed that TIA-1 and G3BP-containing cytoplasmic granules 
formed around virus replication centers in >80% of cells. The granules 
formed cage-like structures around the replication centers of ΔE3L VV. 
This suggested they were important for limiting virus replication. 
Consistent with this hypothesis, the formation of these putative “antiviral 
granules” was dependent on PKR- eIF2α signaling. Granule appearance was 
reduced or eliminated in cells lacking PKR or containing a non-
phosphorylatable eIF2α. Reduced granule formation correlated with 
increased replication of the ΔE3L VV in these cells. Granule components 
appear to be important for inhibiting viral replication downstream of eIF2α 
phosphorylation. Cells lacking the granule nucleating protein TIA-1 showed 
high-levels of eIF2α phosphorylation but did not block virus translation or 
virus replication. These results suggest that the successful restriction of 
virus replication by PKR depends not only on eIF2α phosphorylation but on 
the subsequent formation of a TIA-1 containing cytoplasmic granule that 
coordinates the inhibition of viral mRNAs. 
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By virtue of its very function, the mammalian lung is under continuous 
challenge from airborne pulmonary pathogens. Since complete avoidance of 
the exposure is unlikely, one would expect that lung has evolved innate 
defense mechanisms for damage control. Here, we provide evidence for a 
novel and critical role of L13a-dependent translational silencing in this 
defense. We focused on respiratory syncytial virus (RSV), a clinically 
significant pulmonary virus, for which no reliable therapy or vaccine 
currently exists. We made the unexpected discovery that RSV growth is 
highly enhanced (40-fold) in a stably L13a-knocked-down lung epithelial 
cell line, demonstrating a novel anti-viral role of lung L13a. Our quest for 
its mechanism revealed a more efficient translation of RS viral M protein 
mRNA, as judged by its greater association with the polyribosomal fraction, 
in the L13a-depleted cells. In addition, we found that in normal lung cells, 
L13a is released from 60S ribosomal subunit in response to RSV infection. 
In silico RNA folding analysis revealed two hairpin structures near the 3'-
end of RSV M mRNA, showing high folding homology to the well-studied 
GAIT element responsible for L13a-dependent translational silencing in 
IFN-gamma-activated monocytes/macrophages. Our goal is to study the 
significance of this mechanism in an animal model by creating a lung-
specific L13a KO mouse and subsequent challenging it with RSV. To this 
end, we have already created the L13a flox+/+ mice, which will be crossed 
with CCt-Cre mouse, in order to create a Lung-specific L13a-knockout 
(LLKO) mouse. As proof-of-concept, we have depleted L13a ex vivo from 
the primary lung fibroblasts of L13a flox+/+ mice upon introduction of Cre 
recombinase by an adenoviral vector, and found that these L13a-depleted 
cells support robust growth of RSV compared to the fibroblasts isolated 
from the lungs of wild type mice. Together, these studies support the role of 
L13a-dependent translational silencing as a new paradigm in the pulmonary 
defense mechanism against clinically significant airborne pathogens, such 
as RSV. 
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All viruses require cellular ribosomes to translate their mRNAs. Viruses 
producing m7GTP-capped mRNAs, like Herpes Simplex Virus-1 (HSV-1), 
stimulate 40S ribosome-recruitment by activating mTORC1, which inhibits 
the translational repressor 4E-BP1. Here, we establish that the HSV-1 
kinase Us3 masquerades as Akt to switch on mTORC1. Remarkably, Us3 
displays no sequence homology to the cellular kinase Akt, yet directly 
phosphorylates TSC2 on identical sites triggering mTORC1. TSC restricted 
viral replication in a Us3-dependent manner, establishing that Us3 
antagonized a TSC antiviral checkpoint. Moreover, Us3 stimulated Atk 
substrate phosphorylation in infected cells, including FOXO1 and GSK3. 
Thus, HSV-1 encodes an Akt surrogate with overlapping substrate and 
target site-specificity to activate mTORC1, stimulating translation and virus 
replication. Not only does this establish that other kinases can 
phosphorylate TSC2 residues targeted by Akt, but inactivating TSC 
bypasses S6K-mediated feedback inhibitory circuits, identifying a new 
strategy to constitutively activate mTORC1 and a unique viral kinase with 
drug development potential.  
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Efficient translation of plant virus RNA genomes that lack a 5' cap and have 
a limited 5'UTR requires critical 3’ translation enhancers (3'TE), whose 
function remains elusive. We have discovered a novel 3'TE in Turnip 
crinkle virus (TCV), a member of the carmovirus genus that is also present 
in Pea enation mosaic virus (PEMV), a member of a different genus. This 
element, composed of three hairpins and two pseudoknots, was determined 
by computational prediction and NMR-SAXS to fold into a tRNA-shaped 
structure (TSS). Single molecule optical tweezer analysis of the TSS 
confirms that it is an unusually stable structure that disassembles under 
force in a large single step transition in Mg2+ and three transitions in the 
absence of Mg2+. The TSS binds to the P site of yeast 80S ribosomes and 
60S ribosomal subunits, and binding is unaffected by salt-washing. 
Function of the TSS in translation requires adjacent upstream hairpin H4 
and a 50 nt unstructured region (3’USR).  
Unlike other plant viral 3’TE that can form RNA:RNA bridges with 
sequences in the 5’UTR, no obvious RNA:RNA interactions exist between 
3’ sequences and the 63 nt 5’UTR of TCV, which together are synergistic 
for translation in vivo. Surprisingly, 5’UTR from other Carmoviruses with 
little or no sequence similarity with that of TCV are fully functional at 
replacing the TCV 5’UTR in single luciferase translation assays and one is 
functional in the full-length viral genomic RNA. Preliminary analysis of the 
TCV 5’UTR indicates that a pyrimidine-rich unstructured region (5’USR) 
just upstream of the initiation codon is important for 40S binding and for 
translation in vivo. 80S ribosome binding to the 5’UTR causes structural 
changes in this poly-pyrimidine region, while ribosome binding to a short 3’ 
fragment containing the TSS causes structural changes to the region of the 
TSS that mimics the acceptor stem. When the entire 3’UTR is subjected to 
ribosome binding, reproducible structural changes are present in the 3’USR 
and H4. Ribosome binding to combined 5’ and 3’UTR fragments causes 
additional base flexibility in the 5’ fragment beyond that seen for ribosome 
interaction with the individual fragment. This suggests that ribosomes may 
be mediating contact between the two ends. Ribosomes also have a similar 
effect when added to 5’ and 3’ fragments of PEMV. Unlike TCV, efficient 
PEMV translation requires sequences downstream of the initiation codon, 
which may aid in the interaction between the 5’ and 3’ ends.  
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Translation of the calicivirus minor structure protein VP2 occurs by a 
termination/reinitiation mechanism. Reinitiation depends on an upstream 
region of 40-70 nucleotides, denoted “termination upstream ribosomal 
binding site” (TURBS). Two short sequence motifs within the TURBS are 
essential for reinitiation, as we have shown for FCV (Vesivirus) and RHDV 
(Lagovirus). Motif 1 is complementary to a region within helix 26 of 
mammalian 18S rRNA and thus probably tethers the ribosome to the 
mRNA. Motif 2 interacts with a complementary region upstream of motif 1 
(motif 2*), thus forming a secondary structure that is supposed to position 
post-termination ribosomes in an optimal distance to the VP2 start codon. 
Sequence analyses reveal the presence of these three essential motifs 
upstream of the VP2 start site in the RNA of all caliciviruses.  
The exact arrangement of VP1 stop codon and VP2 start codon varies 
between members of the 5 genera of the Caliciviridae. Two principal 
patterns can be differentiated. In lagoviruses, vesiviruses and most 
sapoviruses the AUG is located upstream of the stop codon requiring a 
backwards movement of the posttermination ribosome. In contrast, the 
genomes of members from the genera Norovirus and Nebovirus display a 
pattern with the AUG codon located downstream of the stop, so that the 
ribosome has to move on for reinitiation. These different arrangements of 
the two signals might be indicative of mechanistic specificities. We 
therefore analyzed translation reinitiation in human norovirus (NV) and 
compared the results with those obtained earlier for FCV and RHDV. The 
data show that the basic mechanism of VP2 expression is conserved also in 
human NV, requiring the presence and integrity of the three essential motifs 
identified by sequence analysis. Furthermore we analyzed the requirements 
for recognition of the reinitiation start site and found interesting differences 
between the three caliciviruses indicating mechanistic diversity. The 
importance of these differences with regard to the mechanism of translation 
reinitiation in the eukaryotic system will be discussed. 
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The Exon Junction Complex (EJC) is a multiprotein complex deposited on 
mRNA as a consequence of splicing. By accompanying mRNAs to the 
cytoplasm, the EJC is involved in mRNA transport, translation and quality 
control. In mammals, the EJC is notably required for efficient elimination of 
mRNAs containing a premature termination codon by the process of 
nonsense-mediated mRNA decay (NMD). So far, the EJC has been detected 
on few spliced mRNAs tested. However, several observations made in 
Drosophila led us to hypothesize that the EJC might be bound to only a 
subset of spliced junctions.  
 
To test this hypothesis we developped a NMD reporter system to identify 
introns with the potential to activate EJC-dependent NMD in Drosophila S2 
cells. We selected different intron-containing 3’UTRs that we fused 
downstream of the firefly luciferase. Hence, we showed that some of those 
confer NMD. RNAi knockdown of EJC core proteins Magoh, Y14 or Btz 
and analysis of intronless reporters showed that the EJC was responsible for 
the splicing-dependent NMD of particular transcripts in fly. Interestingly, 
mRNP co-precipitations revealed that the EJC is deposited on particular 
spliced junctions. Finally, by swapping sequences between reporters that 
trigger or not EJC-dependent NMD we showed that junction-specific EJC-
deposition is modulated by specific RNA elements found in pre-mRNAs. 
 
This study provides the first evidence that EJC deposition is not a 
constitutive mark of splicing but rather is a regulated process. Given the 
multiple functions attributed to this complex, the regulation of its deposition 
may have major impacts on mRNP destiny.  
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In mammalian cells, two different messenger ribonucleoproteins (mRNPs) 
serve as templates for protein synthesis. Newly synthesized CBP80/CBP20-
bound mRNPs initially undergo a pioneer round of translation. One purpose 
of this round of translation is to ensure the quality of gene expression, as 
exemplified by nonsense-mediated mRNA decay (NMD). NMD largely 
functions to eliminate mRNAs that prematurely terminate translation, 
although NMD also contributes to proper gene control, and it targets 
CBP80/CBP20-bound mRNPs (for recent publications, see Sato et al., 
2008; Isken et al., 2008). CBP80/CBP20-bound mRNPs are remodeled to 
eIF4E-bound mRNPs as a consequence of the pioneer round of translation 
as well as independently of translation (Sato and Maquat, 2009). eIF4E-
bound mRNPs support the bulk of cellular protein synthesis and are the 
primary targets of mRNA decay mechanisms that conditionally regulate 
gene expression. We have found that precluding the binding of the NMD 
factor UPF1 to CBP80 inhibits NMD at two steps: the association of SMG1 
and UPF1 with the two eukaryotic release factors (eRFs) during SURF 
complex formation at a PTC, and the subsequent association of SMG1 and 
UPF1 with an exon-junction complex. Furthermore, data indicate that UPF1 
binds PTC-containing mRNA more efficiently than the corresponding PTC-
free mRNA in a way that is promoted by the UPF1-CBP80 interaction. A 
unifying model proposes a choreographed series of protein-protein 
interactions occurring on an NMD target.  
 
Isken, O., Kim, Y.K., Hosoda, N., Mayeur, G.L., Hershey, J.W.B. and 
Maquat, L.E. (2008) Cell 133:314-327.  
 
Sato, H., Hosoda, N. and Maquat, L.E. (2008) Mol. Cell 29:255-262.  
 
Sato, H. and Maquat, L.E. (2009) Genes & Dev. 23:2537-50.  
 
Hwang, J., Sato, H., Tang, Y., Matsuda, D. and Maquat, L.E. (2010) Mol. 
Cell, in press.  
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The nonsense-mediated mRNA decay (NMD) pathway degrades mRNAs 
containing premature stop codons (PTCs or nonsense codons). In 
vertebrates, stop codons are efficiently recognized as being premature when 
located upstream of an Exon Junction Complex (EJC). PTC-recognition 
leads to recruitment of the NMD machinery and degradation of the mRNA 
target. Target degradation requires the endonucleolytic activity of SMG6, a 
conserved NMD factor. The precise role of the EJC in PTC-recognition and 
how this event leads to the recruitment of SMG6 remains to be clarified. 
Here we show that SMG6 interacts with NMD factors and the EJC via an 
N-terminal domain, which is essential for NMD. Remarkably, within the N-
terminal domain, two conserved EJC-binding motifs (EBMs) confer binding 
to the EJC. SMG6 EBMs are related to a motif that in UPF3b mediates 
direct EJC-binding. Accordingly, UPF3 competes with SMG6 for binding 
to the EJC. Unexpectedly, mutations that abolish SMG6 binding to the EJC 
also abrogate NMD, even though these mutations do not affect SMG6 
interaction with NMD factors. Our findings reveal an unexpected role for 
the EJC in the recruitment (or activation) of the SMG6 endonuclease and 
more generally indicate that current NMD models must be revised to 
account for this unprecedented interaction. 
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Cis-acting elements that program ribosomes to shift translation reading 
frames were first discovered in viruses, but have since been shown in all 
kingdoms of life. We previously showed that -1 PRF signals in eukaryotes 
promote mRNA destabilization in yeast via nonsense mediated decay 
(NMD). Using computational methods, we identified a potential -1 PRF 
signal in the human CCR5 mRNA, which encodes the co-receptor for HIV-
1. RNA structural analyses confirmed the presence of the computationally 
predicted mRNA pseudoknot structure. Dual luciferase assays showed 
levels of frameshifting similar to the well characterized HIV-1 frameshift 
signal dependent on the presence of a functional slippery site. Notably, a -1 
PRF event is predicted to shift elongating ribosomes into a premature 
codon, which should result in mRNA destabilization through NMD. To test 
this hypothesis, the CCR5 -1 PRF signal was cloned into a tetracycline 
repressible rabbit β-globin reporter plasmid, and transfected into HeLa cells. 
Analyses of mRNA steady state abundance showed that the CCR5 -1 PRF 
signal promoted significant mRNA destabilization. This was not observed 
using a construct containing an inactivated slippery site, demonstrating that 
mRNA destabilization was dependent on -1 PRF. A control β-globin 
reporter containing an AU rich element (ARE) from TNFα was also 
unstable. Time course experiments revealed that the CCR5 -1 PRF signal 
promoted exponential rates of mRNA decay, consistent with continuous 
NMD, i.e. beyond the pioneer round. hUPF1/2 siRNA knockdowns 
stabilized the CCR5 -1 PRF signal containing mRNA, but not the ARE 
containing reporter. In the reciprocal experiment, AUF1 siRNA knockdown 
stabilized the ARE containing reporter but not the CCR5 -1 PRF signal 
containing mRNA. Taken together, these data demonstrate that – 1 PRF 
signals can function as mRNA destabilizing elements in human cells, that 
they do so through the NMD pathway, and that NMD can function beyond 
the pioneer round of translation. These findings also suggest that -1 PRF 
signals may function as a general class of mRNA destabilizing elements in 
eukaryotes, providing evidence for a new, broad class of post-
transcriptional regulatory elements. 
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Nonsense-mediated mRNA decay (NMD) rids cells of mRNAs that contain 
termination codons recognized as premature. NMD in higher eukaryotes employs 
factors not present in Saccharomyces cerevisiae, such as the exon junction complex 
(EJC), which has a role in mRNA splicing. The genome of the model filamentous 
fungus Neurospora crassa contains core NMD components and EJC components, 
and, unlike S. cerevisiae, many of its mRNAs are spliced. We have established that 
knockouts of N. crassa genes for the NMD components UPF1 and UPF2 lead to the 
increased stability of specific mRNAs that are NMD substrates. 
 
We used a pulse-chase procedure to measure mRNA half-life. The uracil analog 4-
thiouracil (4TU) is rapidly incorporated into N. crassa RNA when added to cultures. 
Incorporation required that the cells contain the gene for uracil phosphoribosyl 
transferase which converts uracil to UMP. The incorporation of 4TU was quickly 
blocked by addition of 50-fold molar excess uracil to cultures. We pulse-labeled 
cells with 4TU, chased with uracil, purified total RNA, and then purified 4TU-
containing RNA by affinity chromatography following its (reversible) biotinylation.  
 
N. crassa strains containing knockouts of NMD factors showed increased levels of 
transcripts for many genes, including arg-2, whose mRNA contains an upstream 
open reading frame (uORF) that stalls ribosomes, and eukaryotic release factor 1 
(eRF1), whose mRNA interestingly contains a long 3’UTR with a spliced intron. 
Each mRNA had a longer half-life in upf1 and upf2 NMD mutants. We reintroduced 
the upf1 gene into the mutant upf1 strain and this reduced overall levels and half-
lives of these transcripts. 
 
Luciferase reporter genes containing wild-type or mutated arg-2 uORFs, or eRF1 
3’UTR sequences, were introduced into wild-type and upf1 strains. Measurements of 
reporter mRNA indicated that the wild-type arg-2 uORF (but not a mutated uORF 
that does not stall ribosomes) increased the level and the half-life of the reporter 
mRNA in the upf1 mutant. The presence of the eRF1 3’UTR in the reporter gene 
also increased the level of reporter mRNA and its half-life in the upf1 mutant strain. 
 
We are additionally investigating the functions of the N. crassa homologs of Y14 
and Magoh (EJC components in other systems) using these strategies. Coupling 
these methods for mRNA analyses with the availability of a knockout strain 
collection comprising nearly all predicted N. crassa protein-coding genes should 
provide the basis for obtaining comprehensive understanding of RNA stability 
control mechanisms in this eukaryote. 
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Decapping is a critical step in several eukaryotic mRNA decay pathways. In 
yeast, mRNA decapping requires the Dcp1p/Dcp2p decapping enzyme and 
the activities of specific decapping activators. Our recent experiments have 
implicated one such decapping activator, Edc3p, in the transcript-specific 
degradation of the intron-containing YRA1 pre-mRNA (Dong et al., 2007, 
Mol. Cell, 25:559-573 and Dong et al., 2010, PLoS Biology, e1000360). 
We find that YRA1 pre-mRNA is exported to the cytoplasm where it is 
degraded by a decapping-dependent 5’ to 3’ mechanism. YRA1 pre-mRNA 
decay is independent of translation and requires five structurally distinct but 
functionally interdependent modular elements in the YRA1 intron. Two of 
these elements target the pre-mRNA as an Edc3p substrate and the other 
three mediate transcript-specific translational repression. Translational 
repression of YRA1 pre-mRNA also requires the heterodimeric 
Mex67p/Mtr2p general mRNA export receptor, but not Edc3p, and serves 
to enhance Edc3p substrate specificity by inhibiting the susceptibilty of this 
pre-mRNA to NMD. Interestingly, the role of Edc3p in YRA1 pre-mRNA 
decay is solely dependent on its Lsm domain, but not its FDF and YjeN 
domains, and is largely independent of direct Edc3p:Dcp2p interaction. Our 
data suggest that the principal role of Edc3p may be to remodel specific 
mRNP substrates to target them for decapping. 
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No-Go decay (NGD) is an mRNA quality control mechanism that leads to 
degradation of mRNAs stalled during translation elongation. The key 
factors in recognition of the stalled mRNA are Dom34 and Hbs1. Dom34 is 
related to eRF1, but has a distinct N-terminal domain. Hbs1 is a GTPase 
that shares homology to eRF3, eEF1 and EF-Tu, but has an additional N-
terminal domain with an as yet unknown function. Ribosomal NGD 
intermediates were generated by stalling translating yeast ribosomes at a 
well-characterized stem-loop structure within the open reading frame of the 
mRNA (Doma and Parker, 2006; Hosada, 2003). These NGD intermediates 
were stably bound by Dom34/Hbs1 in the presence of GDPNP and the 
complex was analyzed by cryo-EM and single particle reconstruction. At ~8 
Å resolution, the cryo-EM map enables assignment of all the domains of 
Dom34 and Hbs1 by docking the available crystal structures of Dom34 and 
homology models of Hbs1 into the observed density. The N-terminal 
domain of Dom34 reaches deep into the decoding site of the 40S subunit, 
whereas the middle and C-terminal domains of Dom34 are packed against 
the G-domain of Hbs1. Interestingly, we observe density at the mRNA entry 
site of the 40S subunit, which we could unambiguously assign to the N-
terminal domain of Hbs1. Collectively, our structure provides the first 
structural insights into how stalled mRNA is recognized on the ribosome. 
We suggest a dual recognition mechanism whereby (i) Dom34 senses for 
mRNA presence in the ribosomal A-site, which leads to rearrangement and 
maybe destabilization of accommodated mRNA, and (ii) Hbs1 provides a 
second checkpoint near the mRNA entry site, ideally positioned for the 
recruitment of further mRNA processing enzymes to the stalled ribosome. 
Based on the close structural relation of Dom34 and Hbs1 to eukaryotic 
release factors, we could build a homology model for the ribosome bound 
eRF1/eRF3 complex. We observe, that the N-terminal and central domain 
of eRF1 bearing the conserved NIKS and GGQ motifs crucial for release 
activity and stop-codon recognition, respectively have to ondergo 
substantial conformational changes compared to their solution structures. 
The model provides first insights in how the eucaryotic release factor 
complex could act in stop codon recognition and peptide release. 
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Cells have surveillance systems that recognize and eliminate aberrant 
mRNAs to prevent the production of potentially harmful protein products. 
In eukaryotes, an aberrant mRNA lacking a termination codon (nonstop 
mRNA) is recognized and degraded by the quality control system referred 
to as nonstop decay (NSD). It has been shown that nonstop mRNA is 
rapidly degraded by a 3’-to-5’ degradation pathway in yeast. We have 
reported that translation of a poly(A) mRNA sequence results in translation 
arrest by the synthesis of polylysine and leads to cotranslational protein 
degradation, thereby repressing expression of the aberrant protein1, 2. 
Translation arrest results in endonucleolytic cleavage of mRNA. 
Dom34/Hbs1 complex is involved in the endonucleolytic cleavage of 
mRNA by translation arrest, which is called no-go decay (NGD). The 
complex is also involved in the quality control system to eliminate 
ribosomes containing nonfunctional 18S rRNA (18S NRD). It has been 
proposed that 18S NRD and NGD are different observable outcomes of the 
same initiating event, a ribosome stalled inappropriately at a sense codon 
during translation elongation. 
We have reported that consecutive basic amino acid residues induce 
translation arrest coupled with Not4p-depedent cotranslational protein 
degradation3. Here we show evidence that the receptor for activated C 
kinase (RACK1), which is the platform for signaling and is a 40S ribosome 
associated factor, participates in nascent peptide-dependent translation 
arrest. The binding of RACK1 to the 40S subunit, among other functions of 
RACK1, is crucial for translation arrest. We also found that translation 
arrest by the nascent peptide results in endonucleolytic cleavage of the 
mRNA, and RACK1 stimulates this cleavage event. Dom34/Hbs1 is not 
required for the cleavage but translation of a truncated product of the 
cleavage, a nonstop mRNA without poly(A) tail. These results lead us to 
propose that translation arrest induced by basic amino acid sequences 
results in Dom34/Hbs1-independent endonucleolytic cleavage of the mRNA 
as well as cotranslational protein degradation. 
1Inada T. et al. (2005) EMBO J. 24:1584-1595. 
2Ito-Harashima S. et al. (2007) Genes Dev. 21:519-524. 
3 Dimitrova L. &Kuroha K. et al. (2009) J. Biol. Chem. 284:10343-10352. 
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Control of mRNA stability and translation is often mediated by elements in 
the 3’UTR. These elements are recognized by regulatory proteins and 
miRNAs that elicit shortening of the poly(A) tail (deadenylation), 
translational repression, and mRNA decay. Multiple regulatory proteins and 
miRNAs recruit the CCR4-CAF1-NOT complex, a major cytoplasmic 
deadenylation complex in both yeast and mammals.  
Maternal mRNAs are deadenylated at specific times and to specific lengths. 
To understand the mechanisms of this process, we focused on the CAF1 and 
CCR4 enzymes in Xenopus oocytes and embryos. By injecting Xenopus 
oocytes, we demonstrate that Xenopus CCR4 and CAF1 enzymes are active 
deadenylases. Strikingly, CAF1 possesses an intrinsic repression activity, 
independent of deadenylation. Tethered CAF1 represses a reporter mRNA 
that lacks poly(A), and functions robustly as a repressor even when it’s 
deadenylase activity is eliminated by mutation of its active site. Both frog 
and human enzymes possess this intrinsic repression activity. CAF1’s 
deadenylation-independent repression requires the mRNA’s 5’ cap 
structure, as it is lost with mRNAs possessing an ApppG cap. Repression 
also appears to require eIF4F and/or eIF3, as it is alleviated by use of the 
classical swine flu virus (CSFV) IRES.  
We conclude CAF1 posseses an intrinsic translational repression activity. 
Mere recruitment of CAF1, even without deadenylation, is sufficient to 
repress a target mRNA.  
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Messenger RNAs bearing AU-rich elements (AREs) are regulated by trans-
acting factors. AUF1 is an ARE-binding protein (AUBP) that recruits 
translation initiation factors and molecular chaperones to the ARE, forming 
the AUBP and Signal Transduction-Regulated Complex (ASTRC) which 
destabilizes many mRNAs. We recently identified chaperone Hsp27 as a 
subunit of ASTRC that binds the TNFα ARE with high affinity and 
accelerates TNFα mRNA degradation in monocytes. Hsp27 is a 
multifunctional protein that also participates in ubiquitination of proteins for 
their degradation by proteasomes. A variety of extracellular stimuli promote 
Hsp27 phosphorylation on three serine residues – Ser15, Ser78 and Ser82 – 
by a number of kinases including p38 mitogen-activated protein (MAP) 
kinase and MAP kinase-activated protein kinase-2 (MK2). Activating either 
kinase stabilizes ARE-mRNAs. Likewise, ectopic expression of 
phosphomimetic mutant forms of Hsp27 stabilizes reporter ARE-mRNAs. 
Here, we continued our examination of the contributions of Hsp27 to 
mRNA degradation. As AUF1 is ubiquitinated and degraded by 
proteasomes, we addressed the hypothesis that Hsp27 phosphorylation may 
control AUF1 levels to, in turn, control ARE-mRNA degradation. Indeed, 
selected phosphomimetic mutants of Hsp27 promote proteolysis of AUF1 in 
a proteasome-dependent fashion and render TNFα ARE-mRNA stable. We 
also identified an F-box protein required for AUF1 ubiquitination and 
degradation. Taken together, our results suggest that the p38 MAP kinase-
MK2-Hsp27 signaling axis may target AUF1 destruction by proteasomes to 
reduce its levels, thereby promoting ARE-mRNA stabilization. 
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The inflammatory cytokine IL-1 induces profound changes in gene 
expression. This is contributed in part by activating translation of a distinct 
set of mRNAs including IκBζ, as indicated by genome-wide analysis of 
changes in ribosomal occupancy in IL-1α-treated HeLa cells. Polysome 
profiling of IκBζ mRNA and reporter mRNAs carrying its 3'UTR indicated 
poor translation in unstimulated cells. 3'UTR-mediated translational 
silencing was confirmed by suppression of luciferase activity. Translational 
silencing was unaffected by replacing the poly(A)-tail with a histone stem-
loop, but lost under conditions of cap-independent internal initiation. IL-1 
treatment of the cells caused profound shifts of endogenous and reporter 
mRNAs to polysome fractions and relieved suppression of luciferase 
activity. IL-1 also inhibited rapid mRNA degradation. Both, translational 
activation and mRNA stabilization involved IRAK1 and -2 but occurred 
independently of the p38 MAP kinase pathway, which is known to target 
distinct other post-transcriptional mechanisms. The translational silencing 
element in the IκBζ 3'UTR overlaps only partially with a destabilization 
element. Evidence for proteins selectively interacting with these elements 
was obtained in gel-shift assays and by affinity purification. Mutations 
destroying a putative secondary structure impaired translational silencing 
while leaving rapid degradation unaffected. Thus degradation of this mRNA 
appears to proceed independently of its translational state. These results 
provide evidence for a novel mode of post-transcriptional control by IL-1 
which impinges on the time course and pattern of IL-1-induced gene 
expression. 
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G3BP is a multifunctional protein whose overexpression nucleates stress 
granules (SGs) by a largely unknown mechanism. We show that 
knockdown of G3BP or its binding partner caprin1 strongly inhibits stress 
granule assembly, whereas overexpression of either protein nucleates SG 
assembly. Knockdown of USP10, another G3BP-interacting protein, also 
impairs SG assembly. All three proteins associate with polysomes in the 
absence of stress. Paradoxically, USP10 overexpression fails to nucleate SG 
assembly and instead blocks SG formation, without inhibiting stress-
induced polysome disassembly or P-body (PB) assembly. Overexpressed 
G3BP, but not caprin1, rescues SG assembly in cells overexpressing 
USP10, suggesting that caprin and USP10 mediate SG dynamics through 
competition for G3BP. Consistent with this model, immunoprecipitation 
studies indicate that G3BP can bind either caprin or USP10, but caprin-
USP10 interactions are not detected, in agreement with previous studies 
showing that both proteins bind overlapping regions on G3BP. Binding of 
G3BP to either caprin or to USP10 is regulated by phosphorylation of 
G3BP S149, previously shown to regulate SG assembly. Taken together, the 
data suggest that SG assembly involves a cyclic process in which G3BP 
exhibits alternate binding to USP10 and caprin1, but does not both at the 
same time. Protein starvation, but not glucose starvation, recapitulates the 
effects of overexpressed USP10, blocking SG assembly but not PB 
assembly, without affecting stress-induced polysome disassembly. USP10-
G3BP complexes are required for starvation induced ribophagy in yeast, 
and both G3BP and USP10 bind and regulate p53 localization and activity. 
Thus, G3BP and USP10 comprise molecular links between SGs and other 
signaling pathways involving TOR and p53 signaling. As many other SG 
proteins (TIA-1/TIAR, FMRP/FXR1) also shuttle between the nucleus and 
the cytoplasm, we suggest that SG assembly integrates stress signals 
initiated by the eIF2-α kinase system with nuclear functions such as 
transcription. 
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Fine regulation of mRNA transport and translation at synapses underlies 
synaptic plasticity and brain development. One of the key molecules 
implicated in this process is the Fragile X Mental Retardation Protein 
(FMRP), the protein lost in the mental retardation form called Fragile X 
Syndrome (FXS). We have recently demonstrated that FMRP represses 
translation initiation via its cytoplasmic interacting protein CYFIP1/Sra1, 
known as a regulator of the actin cytoskeleton. FMRP tethers a specific 
subset of neuronal mRNAs to CYFIP1, which can in turn bind the 
translation initiation factor eIF4E, and thus blocks the access of eIF4G. 
After neuronal stimulation, the CYFIP1-eIF4E complex is released and 
protein synthesis ensues. 
We analysed different subcellular fractions of the neurons by 
immunoprecipitation/mass spectrometry and found new interactors of the 
CYFIP1-FMRP particle assembled in specific molecular complexes 
according to their subcellular location. Some of these factors are 
specifically involved in mRNP transport, others in translational regulation 
and a third class seems to be mainly involved in cytoskeleton remodeling 
and anchoring to membrane receptors. In particular, we were able to (a) 
show the different distribution of the FMRP-CYFIP1 complex in the spines, 
(b) identify new molecular partners of CYFIP1 that link protein synthesis to 
the cytoskeleton, (c) demonstrate that actin-remodeling factors and the 
mTOR pathway have an effect on the CYFIP1-FMRP-eIF4E complex. 
These findings provide novel evidence for the interplay of local 
translational regulation and cytoskeleton remodeling. Neuronal activity 
through receptor activation would control this process, leading to synaptic 
macromolecular changes and enabling synaptic plasticity. 
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Translational control of specific mRNAs in synapto-dendrites is thought to 
underlie synaptic plasticity and possibly learning and memory. One protein 
involved in this process is CPEB, which regulates local translation in 
hippocampal and other neurons by promoting cytoplasmic polyadenylation 
of specific mRNAs. In synapto-dendrites, CPEB is associated with Gld2, a 
poly(A) polymerase; PARN, a deadenylating enzyme; Neuroguidin (Ngd), 
an eIF4E-binding protein; and Symplekin, a scaffold protein upon which 
these factors are thought to assemble. Synaptic stimulation induces CPEB 
phosphorylation, PARN expulsion from the ribonucleoprotein complex, and 
Gld2-dependent dendritic polyadenylation. Stereotactic injection of 
lentiviruses expressing shRNAs against Gld2 and Ngd into the rat 
hippocampal dentate gyrus of living rats elicits reduced and elevated, 
respectively, theta-burst stimulation (TBS)-induced long-term potentiation 
(LTP). Knockdown of these same factors in cultured neurons leads to 
corresponding reduction and elevation of mature synaptic spines. mRNAs 
encoding HuD and NR2A were identified in a screen for transcripts whose 
cytoplasmic polyadenylation is controlled by Gld2. Dendritic NR2A mRNA 
polyadenylation and translation were inhibited following knockdown of 
Gld2. These data demonstrate that the cytoplasmic polyadenylation 
apparatus controls and specific mRNA translation in dendrites and synaptic 
plasticity.  
 
JHK present affiliation: Research Institute, National Cancer Center, 
Goyang, Gyeonggi 410-769, Korea 
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Development of the nervous system requires the precise control of sprouting 
and elongation of axons and dendrites in a timely manner. The control of 
protein synthesis, specially localized to neuronal compartments such as growth 
cones and synapses, is a key determinant of neuronal development and synaptic 
function. One mechanism that regulates translation initiation is the 
phosphorylation of the alpha subunit of eukaryotic Initiation Factor 2 (eIF2α), 
which reduces general translation but increases translation of a specific class of 
mRNAs containing uORFs, such as ATF4 and ATF5. GCN2, one of the four 
mammalian stress activated eIF2α kinases, responds to amino acid deprivation 
and other stresses. Recently, GCN2 was found to act as a negative regulator of 
the passage from short-term to long-term forms of synaptic plasticity and 
memory, processes that depend on new protein synthesis. In yeast, GCN2 
activation requires its interaction with the GCN1 protein. We have shown that 
IMPACT, a GCN2 inhibitor, is a protein preferentially expressed in neurons and 
interacts with GCN1 in the same region to which GCN2 binds, suggesting that 
IMPACT inhibits GCN2 by competing for GCN1 interaction. Here, we 
demonstrate that IMPACT inhibits GCN2 activation in neuronal cells. 
Furthermore, IMPACT is present in granules along neuronal processes, co-
localizing with FMRP, a Neuronal Granule-associated protein. Treatments that 
disassemble polysomes, such as puromycin and arsenite, increased the size of 
IMPACT-containing granules, suggesting that IMPACT may shuttle between 
granules and polysomes. Indeed, a fraction of IMPACT was found associated 
with small polysomes. We show that IMPACT expression increases drastically 
during neuronal differentiation in parallel with the elongation of neuronal 
processes and increased expression of differentiation markers. Depletion of 
IMPACT in neuronal cells inhibits neurite outgrowth, indicating that IMPACT 
is a facilitator of an early event in differentiation. Importantly, we also show 
that both the depletion of GCN2 by siRNA in a neuronal cell line and the lack 
of GCN2 in primary neurons from Gcn2-/- mice result in increased spontaneous 
neuritogenesis. Thus, GCN2 functions as a negative regulator of an early step in 
neuronal differentiation, while IMPACT, a GCN2 inhibitor, positively controls 
this process. Taken together, our results indicate that IMPACT, a new neuronal 
granule protein, may function to inhibit GCN2 in a localized manner in 
neuronal processes to promote neurite outgrowth.  
Supported by FAPESP. 
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The alpha subunit of translation initiation factor eIF2 is a key regulatory 
target in cells undergoing stress. Recently we demonstrated that human 
OGFOD1 modulates eIF2α phosphorylation to impact cell survival. 
OGFOD1 interacts with the eIF2α kinase HRI and eIF2α in an RNA-
independent manner in both unstressed and arsenite-stressed cells. Like 
OGFOD1, a portion of HRI re-localizes to stress granules following 
exposure to arsenite and is localized to both the nucleus and cytoplasm in 
the absence of stress. Knockdown of HRI by RNAi results in deficient 
eIF2α phosphorylation and prevents complete inhibition of translation in 
HeLa cells exposed to arsenite.  
 
During the recovery from arsenite-induced stress, altering levels of 
OGFOD1 impacts the abundance of phosphorylated eIF2α, the number of 
polysomes and the ability of cells to survive stress. Three hours after 
exposure to arsenite, cells overexpressing OGFOD1 exhibit noticeably 
higher levels of phosphorylated eIF2α and lower levels of polysomes. 
Increased apoptotic signaling, as evidenced by the accumulation of cleaved 
PARP and Caspase-9, suggests that this prolonged repression of translation 
is unfavorable to cell survival. Knockdown of OGFOD1 however appears 
beneficial to cells as they appear to recover from arsenite induced stress 
more rapidly - lower levels of phosphorylated eIF2α, higher levels of 
polysomes and lower levels of apoptotic signaling three hours post arsenite 
exposure. We hypothesize that OGFOD1 regulates the phosphorylation of 
eIF2α during stress via its interaction with HRI.  
 
Because OGFOD1 also interacts with HRI and eIF2α in unstressed cells, we 
have investigated the role of these proteins in cycling cells in the absence of 
stress. Knockdown of OGFOD1 results in the loss of polysomes containing 
four or more ribosomes and the appearance of large halfmers associated 
with the disome and trisome peaks on polysome profiles. Knockdown of 
HRI results in a dramatic loss of polysomes containing four or more 
ribosomes with little or no change to the amount of free ribosomal subunits. 
These results argue that HRI also regulates translation in unstressed cells. In 
addition to playing roles in regulating initiation during and after arsenite-
induced stress, the OGOFD1/HRI complex seems to have roles in 
subsequent steps of translation, such as subunit joining or the first round of 
elongation, in unstressed cells.  
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MECP2 was identified as a Methyl-CpG DNA binding protein and is best 
known as a regulator of chromatin structure and transcription. Mutations in 
MeCP2 cause the autism spectrum disorder Rett syndrome (RTT), but the 
biological function of MeCP2 and pathogenic mechanism of RTT remain 
not well understood. Here we report a post-transcriptional role, including 
translation regulation, of MECP2. MECP2 is associated with ~1000 
transcripts in mature mouse brain and directly binds mRNAs in-vitro. 
MECP2 is detected in poly-ribosomes of brain lysates and interact with 
multiple partners involved in mRNA transport and translation. In contrast to 
the subtle impact on steady-state transcript levels in the brain, MECP2 
deficiency results in profound alterations in hundreds of actively translating 
mRNAs that are normally associated with MECP2 and significant changes 
in neuronal signaling proteins encoded by subset of these mRNAs. Our 
results establish a novel biological function of MeCP2 and implicate 
translation regulation in the pathogenesis of RTT. 
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The recruitment of eukaryotic mRNA by eIF4 complex and PABP is one of crucial 
steps in translation initiation; it is a sensitive point in translational regulation by 
various mitogenic and stress conditions. eIF4G is a large scaffolding protein that 
orchestrates the formation of 48S pre-initiation complex. It functions through 
interactions with many other eIFs and proteins, including eIF4E, eIF4A, eIF3, PABP 
and Mnk, and is susceptible to the fine control by signal transduction. Three 
phosphorylation sites of eIF4I are well studied in response to mitogenic stimuli 
through PI3K/mTOR pathway, and many other phosphorylation sites of eIF4GI 
have been reported by high throughput screening and theoretical prediction. 
However, the physiological functions are largely unknown. In this study, we 
identified a novel phosphorylation site of eIF4GI at Thr719. It was phosphorylated 
by Pak2 in vitro and in response to Pak2 activation in vivo, suggesting this site 
might be phosphorylated by stress signaling as Pak2 is a stress activated kinase. The 
phosphorylation of Thr719 was identified by mass spectrometry under both in vitro 
and in vivo conditions. To understand the function of this phosphorylation site, an in 
vivo translational assay was performed through over-expression of eIF4GI T719A 
and T719E mutants under the background of knockdown of endogenous eIF4GI by 
siRNA. The bicistronic luciferase mRNA was used as a reporter. It was found that 
T719E inhibited the cap-dependent and independent translation under normal 
growth condition, but not T719A. The translation was differentially affected by 
T719E under different stress conditions. The inhibitory effect of eIF4G 
phosphorylation at Thr719 was found to be concomitant with the decrease in cell 
growth rate. The underlying mechanism was first investigated at eIF4GI interactome 
level. When eIF4GI was immunoprecipitated through the N-terminal myc tag, it was 
identified the interactions of T719E mutant with eIF3 and eIF4A were decreased, 
whereas T719A was not effective. The interaction of T719E mutant with eIF4E was 
not altered. A custom phosphospecific antibody was made and applied to the 
confirmation of phosphorylation in vivo and functional studies. Analysis with 
phospho-eIF4GI (T719) antibody revealed that eIF4GI was not phosphorylated at 
Thr719 under normal growth condition, but phosphorylated under several stress 
conditions with enhanced response to DNA damage and TNFα. To further examine 
the involvement of this phosphorylation in physiological and pathological conditions 
in vivo, an inflammation induced colon cancer mouse model was investigated. It 
was intriguingly found that the phosphorylation was elevated at colitis stage and 
highest at cancerous lesion stage. These cellular and animal studies imply an 
important role of phosphorylation of eIF4GI at Thr719 in stress signaling and cancer 
development. 
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Regulation of cap-dependent translation is mediated in most systems by 
competition for the rate-limiting cap-binding protein eIF4E. We study 
translation in primary sensory neurons from the marine mollusk, Aplysia 
californica, a leading model for understanding translational regulation of 
synaptic plasticity. In this system the behavioral memory, sensitization, is 
caused by long-term increases in synaptic strength between sensory neurons 
and motor neurons, termed long-term facilitation. Long-term facilitation 
depends on translational control in the sensory neuron and is blocked by 
rapamycin, a TORC1 inhibitor. Recently, we showed that while expression 
of a dominant negative S6 kinase blocks LTF, it does not block a TORC1 
mediated increase in cap-dependent translation monitored using a bi-
cistronic vector.(Weatherill et al, 2010 JBC 285:12255-12267). 
Surprisingly, expression of a dominant negative 4EBP also does not block 
the TORC1 dependent increase in cap-dependent translation. Decreased 
elongation induced by phosphorylation of eEF2 can increase translation of 
poorly initiated constructs due to a release of rate-limiting initiating factors. 
In Aplysia neurons, overexpression of eeF2 kinase leads to an increase in 
eeF2 phosphorylation, a strong decrease in IRES-dependent translation and 
a surprising increase in cap-dependent translation, suggesting that 
decreasing elongation releases a factor specific for cap-dependent 
translation. This factor is not eIF4E since increasing levels of eIF4E do not 
increase cap-dependent translation in this system (Carroll et al, 2006 MCB 
26:8586-8598). Interestingly, activation of TORC1 does not increase cap-
dependent translation in the presence of enhanced eEF2 phosphorylation, 
suggesting that both TORC1 and eeF2 phosphorylation increase cap-
dependent translation through increasing levels of an unknown regulator of 
cap-dependent translation. Identification of this factor will reveal a novel 
regulator of cap-dependent translation. 
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The initial cell-fate decisions in vertebrate embryos occur shortly after 
fertilization and depend on regulatory proteins, called maternal determinants. 
The synthesis of these determinant proteins from maternal mRNAs is highly 
regulated in time and space. However, in vertebrate embryos little is known 
about the mechanisms of this critical spatial control. Here, using Xenopus 
embryos, we show that a conserved RNA-binding protein, Bicaudal-C (Bic-C), 
is sufficient for spatial regulation of an important maternal determinant, the 
Cripto-1 protein.  
The Xenopus Cripto-1 protein is an evolutionarily conserved receptor of the 
Nodal signaling pathway. This pathway must be precisely controlled for 
embryonic development to occur normally. Translation of the Cripto-1 mRNA 
is activated soon after fertilization, but translation is restricted to cells from one 
region of the embryo, the animal hemisphere (1). In cells from other regions of 
the embryo, such as the vegetal hemisphere, translation of Cripto-1 mRNA is 
repressed.  
To identify proteins that provide the spatial specificity for Cripto-1 mRNA 
translation, we focused on potential repressors that are encoded by mRNAs 
localized to vegetal cells. Xenopus Bicaudal-C (Bic-C) mRNA is one such 
mRNA. Bic-C is an evolutionarily conserved protein that possesses three KH 
domains for binding specific mRNAs and a SAM domain of unknown function 
at its C-terminus. Ectopic expression of Bic-C in Xenopus embryonic cells from 
the animal hemisphere repressed translation of a reporter mRNA containing the 
3’UTR of the Cripto-1 mRNA. Repression by ectopic Bic-C was specific, as it 
required a similar region of the Cripto-1 3’UTR as was necessary for vegetal 
repression. A short 32-nt region of the Cripto-1 3’UTR was sufficient to bind 
Bic-C, and binding required a stem-loop structure confirmed by compensatory 
mutations. Full-length Bic-C repressed translation of an mRNA to which it was 
tethered, as did a region derived from its C-terminus. The remainder of the 
protein, including the KH domains, did not possess repression activity, either 
when ectopically expressed in animal cells, or when tethered. Repression 
appears to hinge on the cap, since it is lost with a reporter mRNA containing a 
5’ IRES and Bic-C forms a complex with eIF4F components.  
We propose that Bic-C, present in the vegetal cells of Xenopus embryos 
represses translation of the Cripto-1 mRNA. Binding of the KH domains to the 
Cripto-1 3’UTR tethers the repression domain at the C-terminus of Bic-C to the 
mRNA. Animal cells do not possess Bic-C, and so evade this repression.  
 
(1) Zhang, Sheets et al MCB (2009) 29:3791 
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Maturation and fertilization competence requires immature oocytes, arrested 
in the late G2 phase, to re-enter the cell cycle and progress to metaphase of 
Meiosis II. This cell cycle progression occurs in the absence of active gene 
transcription, so the proteins required are synthesized from pre-existing 
(maternal) mRNAs in a specific temporal pattern. This temporal control is 
due to regulated translation of maternal mRNAs harboring specific 3’ 
untranslated region regulatory elements. We have shown that the Musashi 
protein is critical for mediating translational activation of early class 
Xenopus maternal mRNAs and for the subsequent activation of mRNAs 
under the control of cytoplasmic polyadenylation elements (CPEs). 
Although Musashi is present in immature Xenopus oocytes, Musashi 
activity is only stimulated in response to progesterone. In mammalian 
neural stem cells, Musashi exerts repression of mRNA translation to 
promote self-renewal. However, in response to neuronal differentiation, 
Musashi target mRNAs are de-repressed. The mechanisms that control 
Musashi activity in response to extracellular stimuli have not been 
previously determined. We report that translation of the Xenopus mRNA 
encoding Ringo (an atypical activator of cyclin dependent kinases) is 
necessary for Musashi activation in response to progesterone. Ablation of 
Musashi function blocked early class mRNA translation and attenuated cell 
cycle progression stimulated by ectopic Ringo expression. Further, ablation 
of Musashi function did not prevent progesterone-stimulated synthesis of 
endogenous Ringo protein, indicating that Musashi function is downstream 
of Ringo. We further demonstrate that Musashi protein undergoes 
progesterone-dependent phosphorylation on a site that is conserved in all 
vertebrate Musashi isoforms. Antisera that specifically recognize the 
phosphorylated form of Musashi reveal that Musashi phosphorylation is 
correlated with initiation of translation of the early class mRNAs. This 
regulated phosphorylation is functionally important, since a non-
phosphorylatable mutant form of Musashi is compromised it its ability to 
mediate progesterone-dependent cell cycle progression. Interestingly, the 
phosphorylation of Musashi on this site temporally precedes de-repression 
and translation of target mRNAs in mammalian primary neural 
stem/progenitor cells undergoing differentiation. We propose that regulated 
phosphorylation of Musashi serves as an evolutionarily conserved 
mechanism to modulate target mRNA translation in response to diverse 
extracellular stimuli. 
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Protein kinase TOR (target-of-rapamycin) signalling positively controls 
translation initiation via phosphorylation of downstream targets in response 
to integrating signals from growth factors, hormones, energy sufficiency 
and nutrients. The viral reinitiation factor TAV from Cauliflower mosaic 
virus (CaMV) activates polycistronic translation reinitiation through a 
mechanism involving recruitment of eIF3 and the host factor RISP to 
translating ribosomes that ensures recruitment of the ternary complex and 
60S-complexes by reinitiating 40S. Here we uncover the essential role of 
the TOR signalling pathway in TAV-mediated reinitiation after long ORF 
translation. We demonstrate that the TOR/S6K1 pathway, which promotes 
TAV-mediated reinitiation, is hyperactivated in plants either constitutively 
expressing TAV or infected by CaMV. Activation of TOR depends on its 
direct physical interaction with TAV, with mutations in the TOR binding 
site of TAV abolishing both TOR binding to TAV and TOR activation. 
Only functionally active TOR was able to stimulate TAV-mediated 
reinitiation efficiency, and knockdown of TOR abolishes TAV function in 
plant protoplasts and CaMV infection in plants. TAV binding to TOR is 
critical for both the reinitiation event and viral fitness. Furthermore, we 
identified a novel substrate of TOR signalling within reinitiation supporting 
factors: RISP is a putative substrate of TOR/S6K1 in Arabidopsis. Upon 
activation, TOR binds to polyribosomal complexes concomitantly with 
polysomal accumulation of eIF3 and RISP in a TAV-dependent manner. In 
polysomes, TOR signalling leads to phosphorylation of RISP. Our data 
support a model whereby TOR functions to ensure the phosphorylation state 
of factor(s) recruited to translating ribosomes to enable reinitiation at a 
downstream ORF. 
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The mechanisms that couple translation and protein processing are poorly 
understood in higher eukaryotes. The mammalian target of rapamycin 
(mTOR) in association with raptor and mLST8 (termed mTOR complex 1 
or mTORC1), regulates translation initiation in a rapamycin-sensitive 
manner. mTOR also forms a structurally distinct complex with rictor, SIN1, 
and mLST8 (termed mTORC2). The function of mTORC2 and why this 
complex is insensitive to rapamycin are currently poorly understood. So far 
it is known that mTORC2 is involved in actin cytoskeleton reorganization 
and phosphorylation of Akt/PKB, an AGC kinase family member that 
becomes deregulated in cancer. Recently, we found that mTORC2 controls 
the folding and stability of Akt and conventional PKC by phosphorylation 
at the highly conserved turn motif site. We now find that this 
phosphorylation occurs during translation as the nascent AGC kinase 
polypeptide emerges from the ribosomal tunnel. Furthermore, mTORC2 
interacts with actively translating ribosomes and that an intact mTORC2 
allows mTOR interaction with large ribosomal subunit proteins. Thus, 
mTORC2 can function cotranslationally by phosphorylating residues in 
nascent chains that are critical to attain proper conformation. Our findings 
reveal that mTOR links protein production with quality control. 
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Special and temporal control of protein production is regulated in part by 
transcript localization and local translation. In neurons, up to hundreds of 
mRNAs are packaged into macrocomplexes, called RNA granules, and 
subsequently transported to their final destination in the dendrite where 
their translation is believed to be initiated locally by presynaptic 
stimulation. In addition to mRNAs and their bounded RNA-binding 
proteins, RNA granules contain essential translational machinery including 
40S and 60S ribosomal subunits, translation initiation factors (e.g., eIF4E 
and eIF2α), and the eEF1A, translational elongation factor.  
 
We have identified an N-ethyl-N-nitrosourea (ENU)-induced mouse mutant 
with progressive death of neurons including cerebellar granule cells, 
hippocampal pyramidal cells, dentate granule cells, and retinal ganglion 
cells. Degeneration of these neurons begins between three and four weeks 
after birth, and mice die by two months of age. By positional cloning, we 
identified the genetic defect in this strain as a point mutation in a splicing 
site of a novel gene, GTP-binding protein 2 (Gtpbp2), which leads to early 
protein truncation. GTPBP2 has a similar domain structure and sequence 
homology to eEF1A, suggesting it plays a role in translation. Indeed, 
biochemical studies and polysome fractionation assays revealed that 
GTPBP2 binds extensively to components found in neuronal RNA granules. 
Western blot analysis of proteins encoded by RNAs associated with 
dendritic RNA granules such as calcium/calmodulin-dependent protein 
kinase II (CaMKII) and the NMDA receptor NR1 subunit demonstrated 
decreased protein expression in mutant. Furthermore, Golgi staining 
revealed suppressed development of dendritic spines in mutant neurons. 
Together, our results suggest that GTPBP2 regulates local protein synthesis 
at multiple postsynaptic sites, providing novel molecular means of 
regulating the elongation step of dendritic-targeted mRNAs. 
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Cytoplasmic poly(A) binding protein (PABP1) binds to the 3’ poly(A) tail 
of eukaryotic mRNAs. PABP1 is a multifunctional protein but is widely 
known as a factor that promotes translation through the formation of an 
mRNA closed loop structure when it interacts with eIF4G in a 5’ cap-
binding complex. The importance of PABP1 in translation is highlighted by 
the fact that many viruses hijack the host translational machinery through 
manipulating PABP1. PABP1 consists of four RNA recognition motifs 
(RRMs1-4), a central linker required for homo-oligomerization and a C-
terminal domain (PABC) involved in protein protein interactions. In 
metazoans, PABP1 is directly regulated by binding to a translation enhancer 
PABP1-interacting protein (Paip1), and a translation repressor, Paip2. Paip1 
and Paip2 interact with PABP1 through two PABP interacting motifs 
(PAMs): PAM1 and PAM2. The PAM1 domain of Paip1 interacts with 
RRMs1-2 of PABP1, while that of Paip2 binds to RRMs2-3. The PAM2 
domains of both proteins recognize the PABC domain. PABP1 has been 
well characterized at a biochemical level; however, mechanistic details of 
many PABP1-regulated processes remain unclear due to the lack of 
structural information on full-length PABP1 complexes with its interacting 
protein partners and RNA. This study aims to elucidate how PABP1 
mutimerizes on the poly(A) tail and how its interactions with the two Paip 
proteins fine tune translation by solving crystal structures of PABP1 
complexed with various lengths of poly(A) RNA, Paip1 and Paip2. The 
recombinant proteins were purified by affinity, ion exchange and size 
exclusion chromatography. Complexes for crystallization were prepared 
from these purified components using gel filtration and their properties 
evaluated by light scattering and gel shift assays. The light scattering results 
revealed unexpected stoichiometry of the PABP1:Paip1 complex. 
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Cleavage of tRNA is an evolutionary conserved phenomenon serving 
different functions in different organisms. Currently, the specific role of 
tRNA cleavage in mammalian cells is unknown, although several reports 
suggest that the cleavage is an important and regulated biological process. 
Recently, we discovered the existence of stress-induced tRNA cleavage. We 
identified angiogenin, a secreted protein promoting angiogenesis and cell 
survival, as a ribonuclease responsible for this cleavage. We show that 
angiogenin enters cells and targets the anticodon loop of tRNA to produce 
tRNA-derived stress-induced small RNAs (tiRNAs). We found that selected 
tiRNAs inhibit protein translation and trigger eIF2α-independent assembly 
of Stress Granules. Here, we will report on the identification of tiRNA 
binding partners and discuss the mechanism of tiRNA-mediated inhibition 
of translation. 
 146 
STRESS- INDUCED CELL SURVIVAL AND DEATH: IMPORTANCE 
OF PHOSPHORYLATION OF ERK AND EIF2 ALPHA IN SF9 CELLS 
 
Aarti Iyer, Kamindla Rajesh, Ramaiah Kolluru  
 
University of Hyderabad, Biochemistry, Hyderabad, 500 046, India 
 
Phosphorylation of the alpha-subunit of eIF2 is a stress signal and is known 
to promote cell death under certain conditions. However, typical ER 
stressors such as tunicamycin, thapsigargin and brefeldin promote 
eIF2alpha phosphorylation without leading to cell death in Sf9 cells, a 
natural host of baculovirus. Although, the survival signaling in response to 
ER stress remains elusive, BiP, an ER chaperone, appears to play an 
important role in protecting cells from death. In this study, we evaluated the 
role of extracellular-regulated kinase (ERK), a map kinase pathway that is 
highly conserved in many systems for balancing cell survival and death. 
Irradiation of Sf9 cells with UV-B light promotes phosphorylation of 
eIF2alpha, ERK, JNK and P38 MAPK. In contrast, treatment with ER 
stressors, like thapsigargin and tunicamycin, enhanced phosphorylation of 
eIF2alpha and ERK kinase, but not JNK and P38. Targeting the ERK 
pathway using a specific inhibitor like UO126 significantly reduced 
phosphorylation of ERK which correlated to enhanced phosphorylation of 
eIF2alpha and hastens cell death in thapsigargin and UV-irradiated treated 
cells, suggesting that ERK activation is predominantly a pro-survival signal 
and delays eIF2alpha phosphorylation mediated caspase activation. This is 
consistent with our observations in UV-irradiated cells, where 
phosphorylation of eIF2alpha precedes caspase activation and cell death. 
However, ERK inhibition instantaneously promotes both eIF2a 
phosphorylation and cell death. In contrast, SP60025, a specific JNK 
inhibitor and SB203580, a specific P38 MAPK inhibitor, were able to 
reduce eIF2 phosphorylation but have no effect on BiP expression and 
apoptosis indicating that these pathways may be activated downstream to 
caspase activation and can affect the caspase mediated eIF2alpha kinase 
activation. These results strongly suggest that ERK activation that occurs 
upstream to eIF2alpha phosphorylation and promotes cell survival by 
delaying the eIF2alpha phosphorylation mediated caspase activation and the 
overall cellular fate depends on the balance between the phosphorylation of 
pro-survival ERK and the phosphorylation of pro-apoptotic proteins like 
eIF2alpha, JNK and P38 (Financial support by DST, New-Delhi to KVAR 
and CSIR research fellowships to AI and KR is acknowledged). 
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Aberrant expression of tRNA species has been reported in a variety of 
tumours, though these changes have generally been assumed artefacts rather 
than drivers of oncogenesis. However, a modest overexpression of 
tRNAiMet in mouse embryo fibroblasts was shown to increase protein 
synthesis, proliferation, and colony formation in vitro, and tumour 
development when injected into athymic mice.  
Furthermore, we show, by cycle analysis using bromodeoxyuridine, a clear 
shift from G1 to S phases in MEF clones with high tRNAiMet expression.  
Increased tRNAiMetcauses a marked increase in the expression of cyclin D1, 
without a corresponding increase in its mRNA. Using polysome profiling 
we identified a wide range of messages whose translational efficiency is 
altered in response to increased tRNAiMet levels, including genes associated 
with apoptosis and cell cycle control. 
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The Upf proteins preferentially associate with ribosomes engaged in 
premature translational termination to trigger NMD and to promote 
reutilization of the respective 40S and 60S subunits. To test whether the 
selective association of Upf1 with prematurely terminating (as opposed to 
normally terminating) ribosomes reflected simple competition between 
Pab1 and Upf1 for eRF3, we have investigated the in vitro binding 
properties of the respective recombinant yeast proteins. Although Pab1 
appeared to bind more tightly to eRF3 than Upf1 it did not compete 
effectively for eRF3:Upf1 interaction and its direct interaction with eRF3 
was competed by Upf1. Since our results did not support the simple 
competition model we sought other means to elucidate the selectivity of 
Upf-ribosome association. We find that purified puromycin-released yeast 
40S subunits are enriched for Upf1 and have thus used epitope-tagged 40S 
and 60S subunits to uncover the ribosome-association pathway for Upf1, 2, 
and 3. Using crude extracts and cell-free translation extracts derived from 
numerous strains, including those with mutations in the Upfs and the eRFs, 
we are systematically evaluating which subunits have bound Upfs, when 
binding occurs, and to what extent it is dependent on prior association of 
eRF1 and/or eRF3. Using a functionally active “split” Upf1, i.e., a Upf1 
molecule in which the major N-terminal and C-terminal domains are 
localized to separate polypeptides, we are also defining the role of these 
domains in the Upf:ribosome association pathway. 
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Vascular endothelial growth factor-A (VEGFA) expression by tumor-
associated macrophages (TAMs) has an essential role in tumor progression 
and metastasis. Hypoxia, a common feature of the neoplastic 
microenvironment, induces VEGFA expression by increased transcription 
and mRNA stabilization. Here, we report a new mechanism of VEGFA 
induction by hypoxia that involves reversal of microRNA-mediated 
suppression of VEGFA expression. We have discovered that the CA-rich 
element (CARE) in the human (VEGFA) 3’-UTR is targeted by several 
microRNAs that repress VEGFA expression by monocytic cells. Among 
these microRNAs, endogenous expression of miR-297 and 299 by 
monocytic cells was shown by Northern blot analysis. Transfection with 
anti-miRNAs specifically targeting miR-297 and 299 showed that these 
miRNAs repress VEGFA secretion by about 50%. Unexpectedly, hypoxia 
completely overcomes microRNA-mediated repression of VEGFA 
expression. We have found that heterogeneous nuclear ribonucleoprotein L 
(hnRNP L), which also binds the CARE in human VEGFA 3’-UTR, is 
responsible for neutralization of miRNA activity. Overexpression of hnRNP 
L in normoxic cells has the same effect as hypoxia, namely, it overcomes 
microRNA-mediated repression of VEGFA expression. The mechanism 
involves hypoxia-induced translocation of nuclear hnRNP L to the 
cytoplasm accompanied by a dramatic increase in hnRNP L binding to 
VEGFA mRNA. In summary, our results elucidate a novel regulatory 
mechanism by which an interplay between miRNA and RNA-binding 
proteins influence expression of a critical hypoxia-inducible angiogenic 
protein. 
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Dinoflagellates are unicellular protists with large genomes that exhibit a 
predominance of post-transcriptional. Microarray cDNA expression studies 
have shown little remodeling of the transcriptome in response to diurnal 
changes and environmental challenges, although changes in mRNA 
recruitment are observed. An emerging characteristic of dinoflagellates is 
the widespread trans-splicing of mRNA caps using unique spliced leader 
(SL) RNAs. A novel cap-4 structure has been found on mRNAs from 
Karlodinum veneficum, a toxic dinoflagellate found as a frequent bloomer 
of the Chesapeake. The proposed structure of K. veneficum SL-RNA is 
m7GpppA(U)pm2’Cpm2’CpG, with modifications to A(U) and G still to be 
determined. Five eIF4E family members have been identified in K. 
veneficum, eIF4E-1 and eIF4E-2a, b, c, d. A neighbor-joining tree predicts 
that the atypical dinoflagellate eIF4E-2 is related to eIF4E from the 
kinetoplasts Leishmania and Trypanosoma, known to bind the 
kinetoplastid-specific CAP-4 structure. An alignment of eIF4E-1 suggests a 
Class I-like signature similar to the prototypical mammalian eIF4E; 
however, the eIF4E-2 subtypes contain extended amino acid stretches 
between the structural units of the core, a characteristic shared by eIF4Es 
from a wide range of alveolates and stramenopiles. A preliminary 
investigation looking at binding to m7GTP- and TMG-Sepharose indicates 
differential activities for eIF4E-1 and eIF4E-2a with the latter binding to 
m7GTP-Sepharose. These results are consistent with eIF4E-2a being a 
functional translation factor, although its cap structure of preference 
remains to be determined. eIF4E-1 does not bind to either m7GTP- and 
TMG-Sepharose, indicating a preference for a different cap structure or an 
alternate role in translation. 
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Dicistroviruses have a monopartite positive-strand RNA genome, 
containing two long open reading frames (ORFs) that encode the non-
structural and structural polyproteins. Each ORF is regulated by distinct 
internal ribosome entry site (IRES) mechanisms. The intergenic region 
(IGR) IRES mimics a tRNA to directly assemble 80S ribosomes and initiate 
translation from the ribosomal A-site at a non-AUG codon. Bioinformatic 
analyses have indicated that a subgroup within the Dicistroviridae family, 
including several bee paralysis viruses, contain an additional ORF (ORFx) 
overlapping the 5’ end of the structural polyprotein coding sequence in the 
+1 reading frame. Moreover, a stem-loop structure was identified that is 5’ 
adjacent to the IGR IRES and overlapping the coding region of the 
upstream ORF. In this study, we have characterized the role of these 
elements within the Israeli acute paralysis virus (IAPV) IGR IRES. We 
demonstrate that ORFx is translated and is dependent on IGR IRES activity, 
suggesting that ribosomes are assembled and positioned on the IRES prior 
to translating ORFx. Current results suggest that translating ribosomes 
mediated by the IGR IRES shift to the +1 frame a short distance from the 
IRES. To investigate the role of the conserved stem-loop structure, we 
engineered IGR IRES-containing bicistronic reporter RNAs with or without 
the stem-loop. When translation of the upstream ORF is inhibited by using 
chemicals that inhibit scanning, translation of the downstream ORF is also 
inhibited in reporter RNAs where the stem-loop is fused with the upstream 
ORF. This indicates that translation of the two open reading frames in the 
IAPV RNA is coupled. We are currently determining the significance of the 
stem-loop structure and the translation of ORFx in the IAPV viral life cycle. 
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During translation initiation, the G-protein initiation factor eIF2 functions in 
its GTP bound state to deliver tRNAiMet to the 40S ribosomal subunit. 
During start site recognition, the GTPase accelerating protein (GAP) eIF5 
stimulates hydrolysis of eIF2-bound GTP. Both eIF5 and eIF2 are 
dissociated from the ribosome together and have been shown to exist in a 
large cellular pool lacking tRNAiMet. To investigate the role of eIF5 in this 
eIF2/eIF5 complex we assessed if eIF5 could modulate the affinity of eIF2 
for GDP. We found that eIF5 acts as a GDP dissociation inhibitor (GDI) 
stabilizing eIF2 bound GDP. By assessing the GDI function of mutated 
eIF5 proteins we found that GDI activity is distinct to the GAP function. 
Thus eIF5 functions to both hydrolyze eIF2 bound GTP and prevent the 
release of its product, GDP. We confirm the necessity of the C-terminal 
domain of eIF5 for interaction with eIF2 and show that a conserved 
'DWEAR' motif in between the C-terminal and N-terminal domains is 
necessary for GDI function. Furthermore we demonstrate that this motif 
interacts with the GDP binding γ subunit of eIF2. Taken together we 
propose that the GDI function of eIF5 represents an additional step in 
translation initiation pathway, one that antagonizes recycling of eIF2. 
eIF2•GDP must then be reactivated by the guanine nucleotide exchange 
factor (GEF) eIF2B to facilitate continuous translation. This reactivation of 
eIF2 by eIF2B is a key step in regulating translation initiation and can be 
inhibited by eIF2(αP) phosphorylation at Ser 51. We investigated whether 
the eIF5 GDI function contributes to this regulatory pathway by examining 
the Gcn2p-mediated amino acid starvation response. We used a 
combination of genetic and biochemical approaches which revealed that 
eIF2(αP) enhances eIF2/eIF5 complex formation and that a GDI mutation in 
eIF5 which weakens eIF2 binding is resistant to the inhibition of eIF2B by 
eIF2(αP). Together this study has established that eIF5 is a bi-functional 
protein with additional GDI activity and is a novel additional component of 
the well-characterized eIF2(αP) pathway critical for translational control. 
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Protein folding in vivo starts as a co-translational process, i.e. it begins 
while the polypeptide is synthesized on the ribosome. However, the number 
of cases demonstrating the co-translational folding of proteins is yet limited. 
Fluorescence resonance energy transfer (FRET) between two dyes that are 
incorporated into nascent chain by the use of fluorescent lysine derivatives 
allows the study of protein conformation during protein synthesis on the 
ribosome. This approach has allowed previously to demonstrate the folding 
of a short model nascent polypeptide into a compact conformation (alpha-
helix) near the peptidyltransferase center of the ribosome. So far, this 
method has not been used to address the co-translational folding of a full-
length natural protein. We have used this approach to study the co-
translation folding of an all-beta protein gamma-B crystallin. Gamma-B 
crystallin from calf eye lens is a 174 amino acids long protein, which 
consists of two homologous domains (composed of two Greek keys motifs) 
connected by a six-residue linker peptide. There are only two Lys residues 
in calf gamma-B crystallin (Lys2 and Lys163) located about 39 Å apart in 
the folded protein. Incorporation of the fluorescent labels at these sites 
yields a strong FRET signal in a completely and correctly folded protein. 
We show here that that FRET efficiency of the labeled, isolated and 
correctly folded gamma-B crystallin is similar to that of the ribosome bound 
nascent chains extended by 29 amino acids at the C-terminal end. Thus, the 
co-translational folding of gamma-B crystallin is suggested. We believe this 
model system can be used to investigate the impact of translation kinetics 
on the co-translational folding of proteins.  
 
* This project is supported by the HFSP grant RGP0024  
**contributed equally to this work  
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A proteomic screen of PKCa interactors resulted in the identification of 
Trm61 as a potential partner of PKCa in the C6 glioma cell line. Trm61 is 
an essential gene in the yeast : it is the catalytic subunit of the methyl-
transferase Trm6/61 that methylates the tRNAiMet and controls its stability. 
Control of tRNAiMet level is crucial in mammalian cells since the over-
expression of the tRNAiMet is oncogenic. We therefore decided to 
investigate the role that PKCa could play on the control of the tRNAiMet 
via a potential regulation of Trm61. 
First, we found that transfection of siRNA targeting the Trm61 mRNA 
resulted in a dramatic decrease in cell proliferation and in cell death, 
indicating that, like in the yeast, Trm61 is essential for mammalian cell 
survival. We then looked at the intracellular localization of PKCa, Trm6 
and Trm61. Trm6 was exclusively detected in the nucleus whereas PKCa 
was cytoplasmic and Trm61 was present in both compartiments, thus 
colocalized with PKCa in the cytoplasm. siRNA-mediated inhibition of 
PKCa expression resulted in an increase in the amount of Trm61, while 
PKCa overexpression resulted in a decrease in Trm61, which was not due to 
an increased degradation via the proteasome or via a calpain-induced 
proteolysis. Inhibiting PKCa was associated to an increased cell 
proliferation and in these conditions, Trm61 and the tRNAiMet 
accumulated in a fraction which cosedimented with the 40S ribosomal 
fraction of polysome gradients. Altogether, these results provide for the first 
time a link between translational control at the level of the tRNAiMet and 
intracellular signaling, and suggest that the PKCa-Trm61 interaction could 
be involved in the control of the cytoplasmic amount of Trm61. 
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Interferon-γ mRNA potently activates PKR, mediating local eIF2α 
phosphorylation and strongly inhibiting its own translation. In this manner, 
enough IFN-γ is made to allow for protective immunity but inflammatory 
disease caused by excess IFN-γ is avoided. To achieve this goal, the IFN-γ 
gene evolved an ingenious strategy: the activator element of PKR comprises 
not only the entire 5’-UTR but also the first 26 codons. Thus, during 
translation when ribosomes disrupt its structure, IFN-γ mRNA must 
undergo dynamic refolding to enable its dual function as translation 
template and activator of PKR. In the predominant structure of the activator, 
the AUG initiation codon is paired with the 5’-end and juxtaposed directly 
to the cap, rendering it accessible for translation initiation and concomitant 
denaturation of the PKR activator. Through gain-of-function mutations, we 
show that the PKR activator structure can adopt alternative RNA 
conformations in two domains essential for PKR activation. This flexibility 
promotes facile alternation of the mRNA between two functional states, 
translation template and PKR activator, permitting tight regulation of IFN-γ 
synthesis. Our data support the concept that once the ribosome has moved 
on, the PKR activator is regenerated rapidly. Thus, activation of PKR may 
resume even before translation by a given ribosome has been completed.  
 
We present a 3D model of the IFN-γ RNA activator of PKR that 
accommodates a pseudoknot, a novel kink turn, and several short helices 
into a constrained RNA structure that forms two parallel helical domains, 
each just long enough to bind a PKR monomer to allow for facile kinase 
dimerization and activation. These structural features are supported by 
extensive mutagenesis and are conserved.  
 
Rather than activation of PKR being an esoteric property of IFN-γ mRNA, 
we show that intragenic RNA activators of PKR are abundant in the human 
immune system. We identified a specific activator of PKR in the 5’ mRNA 
domains of IL18 (IFN-γ inducing factor), chemokines CCL5 and CXCL10 
(a major downstream effector induced by IFN-γ), and IL23 (inducer of 
Th17 cell development). As for IFN-γ mRNA, PKR activators in CCL5 and 
CXCL10 mRNA comprise not only the 5’-UTR but enter substantially into 
the ORF. Strong RNA activators of PKR reside entirely within the 5’-UTR 
of IL18 and IL23 mRNA. These locations render the PKR activators 
sensitive to continual disruption by ribosomes. Our results suggest that 
intrinsic RNA activators of PKR are an ancient tool of nature, used broadly 
to control cytokine mRNA translation. 
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Protein synthesis in a cell is separated into three distinct steps and requires a 
large commitment of the cellular resources. At least two proteins, eRF1 and 
eRF3, mediate the final and least characterized step, termination. In this 
report, we demonstrate that the steady-state levels of eRF1 are coupled to 
the efficiency of polypeptide chain release in Saccharomyces cerevisiae. 
We found that steady-state eRF1 protein and mRNA levels were elevated in 
three release factor variants: eRF1-CΔ19, eRF3-H348Q, and eRF1-
Eo1/Sc23-C124S. This increase was not observed in a strain carrying a 
knockout of the TPA1 gene and prion form of eRF3 (tpa1Δ[PSI+]) despite 
having heightened stop codon readthrough levels. This showed that the 
increase in steady-state eRF1 levels is not simply coupled to a mechanism 
that responds to stop codon readthrough in the cell. We utilized two in vitro 
assays to look at the GTPase activity and rate of polypeptide chain release 
of the mutants to find a translation termination defect common to the three 
mutants where eRF1 levels are elevated. From the in vitro results, we show 
that while the eRF1-CΔ19 and eRF3-H348Q mutants exhibit a defect in 
GTP hydrolysis, eRF1-Eo1/Sc23-C124S does not. Utilizing an in vitro 
termination release assay, we show that the mutants eRF1-CΔ19, eRF3-
H348Q, and eRF1-Eo1/Sc23-C124S all have a slow rate of polypeptide 
release. When we combine the results of the readthrough assay, the GTPase 
assay, the polypeptide chain release assay, and the assays to measure eRF1 
steady-state levels for the three mutants, our results indicate that steady-
state levels of eRF1 are most likely coupled to a slow rate of nascent 
polypeptide chain release. We hypothesize that a slow rate of peptide 
release will trigger an unknown regulatory mechanism to increase steady-
state levels eRF1 by increasing the half-life of the SUP45 mRNA. 
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Eukaryotic Release Factor Three (eRF3) is an essential GTPase in all 
eukaryotes which forms a stable complex with the essential release factor 
Eukaryotic Release Factor One (eRF1). In translation termination, eRF1 
recognizes the mRNA stop codon (UAA, UAG, UGA) at the ribosomal A 
site. eRF3’s GTPase activity increases the efficiency of stop codon 
recognition and stimulates nascent chain release from the ribosome. 
Recently, a GFP-tagged human eRF3 construct was shown to be post-
translationally modified by ubiquitin in HEK293 cells [RNA. 2008 
Feb;14(2):240-5]. We have also observed eRF3 mono-ubiquitination in 
Saccharomyces cerevisiae, and eRF3 accumulation upon MG132 treatment. 
However, no change in the efficiency of translation termination was 
observed in the presence of MG132. To explore the significance of this 
finding we carried out a screen of deubiquitinase (DUB) knock out strains 
and found that ubp3Δ, ubp10Δ, and ubp15Δ were sensitive to the 
aminoglycoside antibiotic paromomycin. Translation readthrough of stop 
codons was detected in the ubp3Δ and ubp10Δ strains at all three stop 
codons, whereas elongation fidelity was slightly enhanced in the ubp15Δ 
strain. Polysome profile analysis showed that the ubp3Δ strain exhibited a 
low polysome to monosome ratio and increased 80S peak; ubp10Δ had no 
obvious defect; and ubp15Δ had a high polysome to monosome ratio. 
Ubp3p has recently been proposed to control ribophagy, the preferential 
turnover of ribosomes during starvation conditions. Because the ubp3Δ 
strain exhibited paromomycin sensitivity and increased steady state levels 
of eRF3 we proposed that eRF3 may be regulated by ribophagy in response 
to nitrogen starvation. Surprisingly, eRF3 was downregulated during 
starvation, but in a manner that was independent of Ubp3p. eRF1 protein 
was also downregulated in starvation and both release factors were 
degraded before the ribosomal protein RPL3, indicating a preference for 
release factor degradation during the initial stages of nitrogen starvation. 
The elongation factors eEF1A and eEF2 were degraded similarly to RPL3, 
whereas the initiation factors eIF2α, eIF5A, and eIF5B were not degraded in 
response to nitrogen starvation. Future studies will address why release 
factor autophagy “RF phagy” occurs prior to ribophagy.  
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Polypyrimidine tract binding protein (PTB) is a multifunctional RNA 
binding protein that has both nuclear and cytoplasmic roles and our data, 
and that of others, strongly suggest that cytoplasmic PTB plays a central 
role in alternative types of post-transcriptional regulation. Of particular 
interest is internal ribosome entry in which protein synthesis is initiated via 
a RNA structural element termed an IRES, that in the presence of trans-
acting factors (ITAFs) is able to recruit the ribosome to a site that is a 
considerable distance from the 5’ end of the mRNA.  
 
We have identified a set of ITAFs including hnRNPA2B1, hnRNPA1, 
YBX1, and DAZAP, which bind to PTB-dependent-IRESs that are known 
to remain polysomally associated during TRAIL-induced apoptosis namely 
SET7, cyclin T1, MTG8a and CYP1b1. We have shown that during 
apoptosis there is an increase in the cytoplasmic levels of many of these 
proteins and importantly they additionally show an increase in their 
association with PTB. Our data suggest a model whereby alternative PTB-
containing-complexes exist in the cytoplasm that are influenced by the 
cellular state.  
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Continuous PI3-kinase signaling stimulated by nerve growth factor (NGF) 
binding to the TrkA receptor is essential to maintain HSV-1 latency in 
primary neuron cultures. Moreover, it is well established that the diverse 
consequences of NGF on target neurons require new protein synthesis. 
Here, we demonstrate that global interruption of neuronal protein synthesis 
by pulse-treating with puromycin, a reversible inhibitor of polypeptide 
elongation, or suppression of cap-dependent mRNA translation by hypoxia 
both resulted in efficient reactivation of latent HSV-1 even in the presence 
of NGF. Hypoxia and NGF-deprivation each inhibit mTOR and activate the 
cellular 4E-BP translational repressors, raising the possibility that they 
stimulated reactivation through a common mechanism. Significantly, 
preventing 4E-BP phosphorylation by inhibiting mTOR with rapamycin or 
a newer active-site inhibitor PP242 stimulated HSV-1 reactivation, 
indicating that mTOR plays a critical regulatory role in the NGF-stimulated 
PI3-kinase signaling cascade required to maintain viral latency in primary 
neurons. Furthermore, it suggests that continuous synthesis of one or more 
labile cellular proteins is required to maintain HSV-1 latency in cultured 
sympathetic neurons. 
 
 160 
SIRT3 REGULATES MITOCHONDRIAL TRANSLATION BY 
MODULATING MRPL12 BINDING TO THE RIBOSOME 
 
Min-Joon Han1, Huseyin Cimen1, Hasan Koc1, Yongjie Yang2, Qiang 
Tong2, Emine C Koc1  
 
1Pennsylvania State University, Biochemistry and Molecular Biology, 
University Park, PA, 16802, 2Baylor College of Medicine, Children's 
Nutrition Research Center, Houston, TX, 77030 
 
Reversible acetylation of mitochondrial proteins has been known to regulate 
mitochondrial function in response to caloric intake. In general, acetylation 
of many metabolic enzymes occurs when levels of acetyl-CoA are high. 
While acetylation reduces the activities of many enzymes involved in the 
oxidation of acetyl-CoA to carbon dioxide and water, we discovered the 
stimulation of mitochondrial protein synthesis by acetylation of 
mitochondrial ribosomal protein MRPL10. Reversible acetylation of 
MRPL10 is critical for oxidative phosphorylation; however, the mechanism 
of this regulation is not known. In this study, we established that the SIRT3-
dependent deacetylation of MRPL10 is responsible for a decrease in 
mitochondrial protein synthesis by destabilizing MRPL12 binding to the 
ribosome in mouse cell lines stably expressing SIRT3. SIRT3-dependent 
decrease in mitochondrial translation also resulted in reduced ATP 
production and Complex I and IV activities in the same cell line. These 
observations strongly suggest that the reversible acetylation of MRPL10 
regulates mitochondrial translation, and consequently, oxidative 
phosphorylation by modulating MRPL12 binding to the mitochondrial 
L7/L12 stalk. 
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In Alzheimer's disease, increased translation efficiency of β-site APP 
cleaving enzyme 1 (BACE1) mRNA is hypothesized to lead to elevated 
BACE1 enzyme levels, increased production of neuritic plaques, and 
disease pathology. Earlier studies using recombinant BACE1-reporter 
mRNAs have established that translation is cap-dependent and can occur 
predominantly at either upstream AUG codons or the initiation codon, 
depending on cell type and expression system. In the present study, we 
investigated RNA structural stability in the 5' leader and coding region of 
endogenous BACE1 mRNAs in living cells for evidence of the translation 
initiation mechanism. RNAs were probed using lead(II) acetate, a cell-
permeable chemical that induces cleavage of unpaired nucleotides with 
conformational flexibility. The results revealed that the coding region was 
generally susceptible to cleavage, consistent with destabilization by 
translating ribosomes. By contrast, the 5' leader was largely resistant to 
cleavage and no cleavage was observed within approximately the first 110-
nucleotides from the 5' terminus. Extensive cleavage occurred at two sites: 
the 5' end of the second open reading frame and proximal to the initiation 
codon. Cleavage did not correlate with predicted stabilities in different 
regions of the mRNA and was unaffected by blocking the helicase activity 
of initiation factor eIF4A. This study indicates that the 5' leaders of 
endogenous BACE1 mRNAs are not actively destabilized by the translation 
process, and provides new evidence supporting a shunting mechanism of 
translation initiation in this mRNA. 
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The 9-aminoacridine derivative quinacrine (QC) has a long history of safe 
human use as an anti-protozoal and anti-rheumatic agent. QC intercalates 
into DNA and RNA and can inhibit DNA replication, RNA transcription 
and protein synthesis. The extent of QC intercalation into RNA depends on 
the complexity of its secondary and tertiary structure. Internal ribosome 
entry sites (IRESs) that are required for initiation of translation of some 
viral and cellular mRNAs typically have complex structures. Recent work 
has shown that some intercalating drugs including QC are capable of 
inhibiting Hepatitis C virus IRES-mediated translation in a cell-free system. 
Here, we show that QC suppresses translation directed by the 
Encephalomyocarditis virus (EMCV) and poliovirus IRESs in a cell-free 
system and in virus-infected HeLa cells. In contrast, IRESs present in the 
mammalian p53 transcript that are predicted to have less complex structures 
were not sensitive to QC. Inhibition of IRES-mediated translation by QC 
correlated with the affinity of binding between QC and the particular IRES. 
Expression of viral capsid proteins, replication of viral RNAs, and 
production of virus were all strongly inhibited by QC (and 9AA). These 
results suggest that QC and similar intercalating drugs could potentially be 
used for treatment of viral infections.  
 
*contributed equally to this work  
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INHIBITION OF POLYADENYLATION TARGETS NEWLY 
TRANSCRIBED MRNAS AND BLOCKS THE INFLAMMATORY 
RESPONSE 
 
Alexander V Kondrashov1, Hedda A Meijer2, Adeline Barthet-Barateig1, Sarah 
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3’ Deoxyadenosine, also known as cordycepin, is present in several species of 
the parasitic mushroom genus Cordyceps, which is highly prized in traditional 
medication. Cordycepin has been proposed as a therapy for a variety of 
conditions, including cancer and inflammatory disease. Previously, we have 
shown that cordycepin specifically affects the polyadenylation of particular 
mRNAs and that in proliferating cells it inhibits signalling by the mTOR 
pathway, probably by activating the AMP activated kinase (AMPK) (1). Using 
thiouridine labelling and cellular fractionation, we have now proven that 
cordycepin predominantly acts on nuclear polyadenylation and on freshly 
synthesised transcripts in a dose-dependent fashion. The mRNAs that are 
specifically affected are highly transcribed, unstable mRNAs, because mature 
mRNAs that are sensitive to cordycepin are also sensitive to the transcription 
inhibitor actinomycin D. However, cordycepin is not strongly inhibitory for 
transcription itself, as unspliced transcripts are much more affected by 
actinomycin D than by cordycepin. Therefore cordycepin appears to reduce the 
stability of newly transcribed nuclear mRNAs. 
Because the induction of inflammation involves the rapid transcription of 
unstable mRNAs, we hypothesised that cordycepin would block the 
inflammatory response. Indeed, both in primary human airway smooth muscle 
cells and in lung epithelial carcinoma cells, cordycepin reduced the induction of 
inflammatory genes by tumour necrosis factor α. The activation of the 
inflammatory transcription factor NFκB appeared unimpaired, as IκB 
phosphorylation and NFκB phosphorylation, as well as NFκB translocation and 
promoter-binding were unaffected. Cordycepin did not affect the half lives of 
inflammatory mRNAs and had smaller effects on unspliced than on spliced 
mRNA, once more implicating reduced nuclear mRNA stability. Knockdown of 
poly(A) polymerase α also inhibited the inflammatory response, indicating that 
cordycepin is indeed acting as a polyadenylation inhibitor. These data indicate 
that polyadenylation by poly(A) polymerase α is required for the induction of 
inflammatory mRNAs and that polyadenylation is a potential target for anti-
inflammatory drugs working by a novel mechanism that involves the nuclear 
degradation of mRNA. 
 
1. Wong, Y. Y., Moon, A., Duffin, R., Barthet-Barateig, A., Meijer, H. A., 
Clemens, M. J., and De Moor, C. H. (2010) J. Biol. Chem. 285, 2610-2621 
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HCV AND CRPV BUT NOT EMCV IRESS CAN OVERCOME 
MICRORNA REPRESSION FROM MONOCISTRONIC MRNA BUT 
NOT DICISTRONIC MRNA DUE TO LOCALISATION OF 
MICRORNA-REPRESSED MRNAS TO P-BODIES.  
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MicroRNA (miRNA) inhibition can occur at either initiation or post-
initiation of protein synthesis and this is dictated by the promoter used to 
drive the transcription the miRNA-targeted mRNA. To gain further 
mechanistic insight into inhibition at initiation stage, we have utilised the 
intergenic internal ribosome entry segment (IRES) of the Cricket Paralysis 
virus (CrPV), which engages translation in a factor-independent manner. 
We postulated that CrPV IRES-dependent translation should overcome the 
initiation block mediated by a miRNA-targeted mRNA transcribed by the 
SV40 promoter. Rather surprisingly, a dicistronic miRNA-targeted reporter 
RNA containing the CrPV IRES was unable to overcome this initiation 
block after transfection of the plasmid into cells. These data suggests that 
SV40-derived transcripts may be compartmentalised away from ribosomes, 
possibly in P-bodies. In agreement with this, deletion of LSM family 
members enabled the CrPV IRES to overcome miRNA-mediated 
repression, suggesting that the first cistron of the miRNA-repressed mRNA 
is relocating to P-bodies. To test this we used monocistronic mRNAs with 
CrPV, EMCV and HCV IRESs. Both the CrPV and HCV IRESs were able 
to overcome the miRNA-mediated repression irrespective of target sites. 
These data resolves disparate results within the literature regarding the role 
of IRESs and P-bodies in microRNA-mediated translational repression.  
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STRUCTURAL INSIGHTS INTO THE MECHANISM OF 
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Termination of protein synthesis on the 70S ribosome depends of release factors 
RF1 and RF2. Peptidyl-tRNA hydrolysis is promoted by RF1 in response to a 
UAG or UAA stop codon, and by RF2 in response to a UGA or UAA codon. 
There are three fundamental questions concerning the mechanism of translation 
termination: 1. How are the stop codons recognized? 2. What is the mechanism 
of peptidyl-tRNA hydrolysis? Is the reaction catalyzed directly by the release 
factors? 3. How is premature termination kept to levels on the order of 10-5 in 
the absence of proof-reading? We have determined crystal structures of 70S 
ribosome termination complexes bound with RF1 in response to UAA 
(Laurberg et al., 2008) or UAG (Korostelev et al., 2010) stop codons, and RF2 
in response to a UAA codon (Korostelev et al, 2008). Together with the 
structure of the 70S complex bound with RF2 in response to a UGA stop codon 
(Weixlbaumer et al., 2008), we can now describe the mechanism of translation 
termination at all three stop codons by release factors RF1 and RF2. Our 
mutational studies are consistent with the mechanisms of structural 
rearrangements in the release factor upon recognition of a stop codon and 
catalysis of peptidyl-tRNA hydrolysis by release factors that we have proposed 
using the crystal structures of 70S termination complexes (Laurberg et al., 
Korostelev et al., 2008). In summary, the answers to the long-standing questions 
concerning the mechanism of translation termination are the following. 1. The 
bases of the stop codons are recognized directly by conserved elements of 
domain 2 of the release factors. 2. The universally conserved GGQ motif of 
domain 3 contacts the acceptor end of the P-site tRNA, positioning the 
backbone amide group of the conserved Gln to participate in catalysis of the 
peptidyl-tRNA hydrolysis reaction through product and/or transition-state 
stabilization by hydrogen bonding. 3. The rearrangement of the switch loop, 
which connects domains 3 and 4 of a release factor, is consistent with the 
conformation of the ribosomal decoding center resulting from recognition of a 
stop codon. This rearrangement is critical for correct positioning of the GGQ 
motif in the ribosomal peptidyl-transferase center and therefore may play a role 
in strict coordination of peptidyl-tRNA hydrolysis with stop codon recognition.  
 
1. Laurberg M. et al. Nature 454, 852-7 (2008)  
2. Korostelev A. et al. PNAS 105, 19684-9 (2008)  
3. Weixlbaumer A. et al. Science 322, 953-6 (2008)  
4. Korostelev A. et al. EMBO J. 29, 2577 - 85 (2010)  
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THE ESSENTIAL C-TERMINAL DOMAIN OF THE C/NIP1 SUBUNIT 
OF EIF3 PROMOTES BINDING OF EIF3 TO THE 40S RIBOSOMAL 
SUBUNIT. 
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Translation initiation factor 3 (eIF3) is a multisubunit protein complex 
implicated in stimulation of numerous initiation reactions. We have 
obtained several lines of genetic and biochemical evidence indicating that 
the C-terminal domain (CTD) of c/NIP1 that is not required for integrity of 
the entire complex promotes association of eIF3 with the 40S subunit. 
Overexpression of a truncated form of c/NIP1 lacking its essential CTD in 
the background of mutations in other eIF3 subunits that were previously 
shown to affect binding of eIF3 to the 40S ribosome produced synthetic 
exacerbation of their mutant phenotypes. Consistently, expression of a 
viable shorter truncation of the c/NIP1-CTD or a 10-alanine substitution of 
the neighboring region upstream resulted in temperature sensitive, slow 
growth and Gcn- phenotypes, and a dramatic decrease in translation 
initiation rates accompanied by ~70% reductions of 40S-binding by eIF3 
and its associated eIFs but not eIF2. Interestingly, we found that the 
extreme C-terminal 111 amino acid residues specifically interact with the 
first three blades of the WD40 propeller of the small ribosomal protein 
RPS33/ASC1/RACK1 forming a head lobe on the solvent side of the 40S 
subunit. Moreover, a short region upstream of the ASC1-binding site is 
capable of a non-specific RNA binding activity that is indispensable for 
viability of yeast cells. Strikingly, as the RNA-binding site of the c/NIP1-
CTD is formed by a well-defined PCI domain not previously known to 
possess an RNA-binding affinity, this is the first evidence that PCI domains 
may in general mediate not only protein-protein but also protein-RNA 
interaction. Taken together we propose that the CTD of c/NIP1 makes two 
independent contacts with the 40S, one via 18S rRNA and the other via its 
ASC1 protein, that both help to anchor eIF3 to the solvent side of the small 
subunit. 
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APOPTOSIS DURING OSMOTIC STRESS IS INDEPENDENT OF 
PROTEIN SYNTHESIS INHIBITION BUT DEPENDENT ON THE 
CYTOPLASMIC ACCUMULATION OF NUCLEAR PROTEINS 
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Mammalian cells of the kidney, brain and lymphatic tissues when exposed 
to hyperosmotic conditions induce osmoprotective mechanisms leading to 
cell volume recovery. Mild stress (400 mOsm) causes a transient decrease 
of mTOR activity, no change in eIF2alpha phosphorylation and no decrease 
in protein synthesis rates. In contrast, severe stress (600 mOsm) caused a 
dramatic induction of eIF2alpha phosphorylation and induction of 
apoptosis. Using MEFs deficient in one of the four eIF2alpha kinases 
(GCN2, PERK, PKR and HRI) we tested if osmotic stress acted via a single 
pathway. In addition, severe osmotic stress caused an induction of the 
eIF2alpha phosphatase, MEFs deficient for GADD34 showed lower 
recovery from severe osmotic stress compared to the wild type MEFs, 
supporting the idea that induction of GADD34 protected cells from 
apoptosis. This was also shown by the absence of apoptosis in MEFs 
deficient for eIF2alpha phosphorylation (A/A cells). Therefore, in 
agreement with other stress conditions (ER stress and nutrient starvation), 
eIF2alpha phosphorylation contributes to the induction of apoptosis during 
severe osmotic stress. In contrast to other stresses, protein synthesis rates 
decreased by 90% in both WT and A/A MEFs, suggesting that osmotic 
stress-induced eIF2alpha phosphorylation caused apoptosis in a manner 
independent of decreased rates of protein synthesis. Analysis of mRNAs on 
polysome profiles from cells exposed to severe osmotic stress, revealed that 
the induction of apoptosis was associated with the more efficient translation 
of pro-apoptotic mRNAs (i.e. Apaf-1) and less efficient translation of pro-
survival mRNAs (i.e. c-IAP2). The mechanism of this regulation involves 
the eIF2alpha phosphorylation dependent cytoplasmic localization of 
nuclear proteins that act as positive or negative transacting factors (ITAFs), 
regulating IRES-mediated translation of antiapoptotic mRNAs. 
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ENHANCED IRES-DEPENDENT TRANSLATION CONTRIBUTES TO 
AURORA A KINASE OVER-EXPRESSION IN IMMORTALIZED CELL 
LINES. 
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Aurora A protein is a serine/threonine kinase that influences multiple 
processes during the G2/M phase of the cell cycle. Aurora A protein 
expression is tightly regulated and altering the level may cause cancer or 
cell death. For example, induced Aurora A over-expression leads to 
tumorigenesis and elevated Aurora A protein levels are found in many 
different tumors. Alternatively, reduced expression inhibits cell division and 
initiates apoptosis. Consequently, agents targeting Aurora A kinase 
expression could be effective chemotherapeutic tools. 
The mechanism(s) contributing to Aurora A protein over-expression is not 
known, although gene duplication can occur. However, increased level of 
Aurora A mRNA is not consistently observed in cells over-expressing the 
protein. Therefore, post-transcriptional mechanisms including protein 
synthesis are likely involved. To identify the mechanism(s) responsible for 
increased Aurora A expression, we compared the normal human lung 
fibroblast cell line WI-38 and primary human breast epithelial cells 
(HMEC) to the immortalized human breast epithelial cell lines MCF10A, 
MCF12A, and MCF-7 as well as the cervical carcinoma cell line HeLa S3. 
The latter two cell lines are also tumorigenic. Aurora A protein expression 
was increased in the MCF10A, MCF12A and HeLa S3 cells compared to 
the MCF-7 cells and the two normal cell types. The increase in Aurora A 
protein expression in the former cell lines was not due to increased 
transcription (as deduced from Northern blot analysis), increased protein 
half-life (as derived from Western blots of cycloheximide treated cells) nor 
increased cap-dependent translation (as measured by translation of a 
transfected cap-dependent mRNA coding for Photinus luciferase; RNA was 
quantitated using QRT-PCR). Assays utilizing monocistronic and 
dicistronic RNA constructs revealed that the Aurora A 5’ leader contains an 
IRES. Interestingly, IRES activity was highest in the immortalized cell lines 
in which the Aurora A protein expression was also enhanced (MCF10A, 
MCF12A and HeLa S3). Additional assays indicated that IRES-dependent 
translation of the Aurora A mRNA occurs in all cells examined, but it 
appears to be the primary translational mechanism in the cell lines over-
expressing Aurora A. Taken together, these results demonstrate that 
increased IRES-dependent translation contributes to Aurora A over-
expression. Moreover, since enhanced IRES activity occurs in the 
immortalized but non-tumorigenic cell lines, we propose that dysregulation 
of the Aurora A IRES is an early event during cancer progression. 
 
 
. 
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EIF4E1B 
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Eukaryotic initiation factor 4E, named eIF4E1b, is a close homologue of the 
canonical class I eIF4E cap-binding protein (eIF4E1a; 71% identity). As a 
component of the CPEB complex along with the eIF4E–binding protein 4E-
T (eIF4E-Transporter), the Xp54 RNA helicase and other RNA-binding 
proteins, eIF4E1b is proposed to mediate silencing of translation during 
Xenopus oogenesis. In its primary structure occur all residues required to 
bind the mRNA 5’cap structure 
(W56/W102/W166/E103/R112/R157/K162) but eIF4E1b in oocyte lysates 
only interacts weakly with m7GTP compared to eIF4E1a. Interestingly, 
several additional cap-proximal residues which may impact on cap-binding 
are found to systematically differ between vertebrate eIF4E1a and 1b 
proteins (1). Furthermore, other differences in the primary structure of 
eIF4E1b in relation to Xenopus eIF4E1a may determine the stability of its 
apo-form.  
We have used emission spectroscopy and site-directed mutagenesis to 
investigate the influence of the systematic substitutions in eIF4E proteins on 
the binding of Xenopus eIF4E1b to the cap structure. As a solvent 
component, glycerol has emerged to be a good tertiary structure stabilizing 
agent which strengthens the protein internal hydrophobic interactions and 
enables long-term fluorescent measurements. While no single characteristic 
feature was found to be responsible for the weakened eIF4E1b – cap 
analogue interactions, these studies show that the cap-bound conformation 
of eIF4E1b is stable. Quantitative cap analogue-binding analyses of 
Xenopus eIF4E1a and 1b proteins and the mutant results from ongoing 
studies will be presented.  
 
 
1. Minshall, N., Reiter, M.-H., Weil, D., Standart, N., 2007 CPEB interacts 
with an ovary-specific eIF4E and 4E-T in early Xenopus oocytes. J. Biol. 
Chem. vol. 282 (52), 37389  
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Cycloheximide is a well-known antibiotic which inhibits the eukaryotic 
translocation step (Obrig et al., 1971). Here, we report a new target of 
cycloheximide in yeast: the ribosome recycling step by eEF3 and ATP 
(Kurata et al., 2010). This step has been shown not to involve eEF2/GTP or 
eEF2/ATP; hence represents a novel target for this antibiotic. Effective 
concentration of cycloheximide on the release of mRNA ranged from 0.1 
μM (26% inhibition) to 360 μM (86% inhibition). These data are 
comparable with effective inhibitory concentration by cycloheximide on the 
translocation step of yeast (1 μM (20%)) (Dresios et al., 2003). 
Cycloheximide also inhibited splitting of the ribosome by eEF3 and ATP. 
On the other hand, vanadate, a transition state inhibitor, did not inhibit the 
release of mRNA, while another transition state inhibitor AlF4- and GDP 
stabilize 80S-eEF2 complex (Sengupta et al., 2008). Furthermore, ADPNP, 
a non-hydrolyzable analog of ATP, did not inhibit the release of mRNA or 
splitting of 80S ribosomes of post-termination complex (PoTC) by 
eEF3/ATP. In contrast, it is known that 80S-eEF2-GDPNP complex has 
been isolated (Taylor et al., 2007). From the structural view point, common 
ribosome component probably involved in both translocation and recycling 
is L1. It is known that L1 functions in the release of E-site-bound tRNA. 
Indeed, cycloheximide binds to the E-site of the 60S subunit together with 
the E-site-bound deacylated tRNA, resulting in the fixing of E-site tRNA on 
the ribosome causing translocation inhibition (Schneider-Poetsch et al., 
2010). Whether or not a similar mechanism applies to the inhibition of 
eEF3/ATP-dependent tRNA release from the P-site of PoTC is being 
investigated. 
 
1. Obrig et al., J Biol Chem 246 174-181 (1971) 
2. Kurata et al., Proc Natl Acad Sci U S A Jun 1 (Epub ahead of print) 
(2010) 
3. Dresios et al., J Biol Chem 278 3314-3322 (2003) 
4. Sengupta et al., J Mol Biol 382 179-187 (2008) 
5. Taylor et al., EMBO J 26 2421-2431 (2007) 
6. Schneider-Poetsch et al., Nat Chem Biol 6 209-217 (2010) 
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KINASE GCN2 OF BUDDING YEAST. 
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The regulation of the activity of protein kinases is a central aspect of 
intracellular signal transduction. One striking example is the regulation of 
the multidomain protein kinase GCN2, found in all eukaryotic kingdoms. In 
response to amino acid starvation, GCN2 phosphorylates the alpha subunit 
of eukaryotic initiation factor 2 (eIF2), which leads to the inhibition of 
general translation that allows starved cells to conserve resources and also 
the translational induction of GCN4, a transcriptional activator of amino 
acid biosynthesis. Yeast GCN2 is present in a latent form in nonstarved 
cells and is activated by binding of uncharged tRNA to the histidyl-tRNA 
synthetase (HisRS)-related domain adjacent to its protein kinase (PK) 
domain. Recent findings suggest that tRNA modulates association of the PK 
domain with the HisRS and C-terminal domain (CTD), converting 
inhibitory to stimulatory interactions. In addition to the HisRS and CTD 
segments, GCN2 contains a regulatory domain N-terminal to the KD that is 
required in vivo and in vitro for kinase activity. This region exhibits 
multiple conserved subdomains present in all eukaryotic protein kinases, 
although critical residues important for ATP binding and catalysis are 
lacking. The function of this degenerate kinase domain, or pseudokinase 
(YK) domain, in regulating the authentic PK domain is largely unknown. 
The YK domain showed in vitro binding interactions with the PK and CTD 
domains, suggesting that it can directly modulate GCN2 kinase activity. 
Based on mutagenesis and structural predictions, we isolated mutations in 
the YK domain that impair GCN2 activity in vivo without reducing the 
GCN2 protein level. These mutations identify three key regions in the YK 
domain essential for GCN2 activity. As the mutations alter residues 
predicted to reside on the surface of the YK domain, and because the YK 
domain and PK domains can physically interact, we hypothesize that the 
affected residues mediate an interaction between the domains that 
stimulates GCN2 kinase activity. Interestingly, we also isolated mutations 
in the YK domain that constitutively activate GCN2, reducing the 
requirement for high levels of uncharged tRNA for kinase activation. We 
hypothesize that the YK domain is an allosteric activator of the adjacent 
kinase domain, whose stimulatory function is tightly coupled to amino acid 
starvation and binding of uncharged tRNA to the HisRS-related domain in 
GCN2. Our results provide the first functional insights into the role of the 
enigmatic pseudokinase domain in regulating GCN2 function. 
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Mammalian mitochondrial ribosome (mitoribosome) is responsible for the 
synthesis of thirteen essential proteins of the inner mitochondrial 
membrane. These proteins are involved in the process of ATP production. 
Genomic studies suggest that mitochondria have arisen through an 
endosymbiotic event between an α-protobacterium and its eukaryotic host. 
So, the structures of a eubacterial ribosome and the mitoribosome were 
expected to be similar, even though the rRNA to protein ratio in the 
mammalian mitoribosome is reversed (~1:2 versus ~2:1 for the eubacterial 
ribosome). However, the cryo-EM studies from our lab revealed major 
differences between the two types of ribosomes, and suggested that the 
detailed mechanism of mitochondrial translation would be substantially 
different from that in the eubacterial system. This hypothesis is further 
supported by marked differences in the various translational factors, 
including initiation factors, for the mitochondrial and eubacterial systems.  
The mammalian mitochondria has only two initiation factors, initiation 
factor 2 (IF2mt) and initiation factor 3 (IF3mt), as compared to three (IF1, 
IF2 and IF3) in eubacteria. As in eubacteria, IF3mt acts primarily as an anti-
association factor, which binds to the 28S small ribosomal subunit (SSU) 
and prevents premature association between the SSU and the 39S large 
ribosomal subunit (LSU). Comparison of the amino acid sequences of the 
mammalian IF3mt with that of the eubacterial IF3 shows that two factors 
share a central conserved region. In addition, IF3mt has unique N- and C-
terminal extensions. Recent biochemical studies have shown that these 
extensions are necessary for proper dissociation of IF3mt from the 28S SSU 
during formation of the 55S mitoribosome.  
We have obtained a cryo-EM map of the 28S SSU-IF3mt complex. A 
difference map computed between the maps of the complex and the control 
28S SSU shows a unique mass of density corresponding to IF3mt. The IF3mt 
density so obtained has a bi-lobed feature and is situated between the head 
and platform regions of the 28S SSU. Furthermore, the C-terminal domain 
of IF3mt appears to form novel interactions with mitoribosome specific 
proteins of the SSU. A detailed analysis of the interactions between IF3mt 
and the 28S SSU, and functional implications of those interactions will be 
presented. 
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Most mRNA messages are translated in a cap-dependent manner. However, 
under conditions of stress, cap-dependent translation is globally down 
regulated and cap-independent translation is favored. The mechanism of 
cap-independent translation requires an internal ribosome entry site (IRES) 
to recruit ribosomes. IRESs differ in their requirements for a subset of the 
ten canonical translation initiation factors and some IRESs also require 
cellular RNA binding proteins. The mechanism of IRES-mediated 
translation initiation is not well understood. To this end, we have used a 
model IRES, the cricket paralysis virus (CrPV) intergenic region IRES 
(IGR IRES) to understand how IRESs recruit ribosomes and initiate 
translation. The CrPV IGR IRES does not require any initiation factors to 
form translationally active 80S complexes in vitro, there are existing 
structural and phylogenetic data, and it functions robustly in all eukaryotic 
systems including yeast, allowing genetic as well as biochemical studies. In 
order to determine which sequences are important for IRES function, an 
extensive mutational analysis of the key regions of the CrPV IGR IRES 
predicted to interact with the 40S and 60S ribosomal subunits was 
undertaken, using a robust in vivo reporter. As expected, most mutations of 
conserved nucleotides in these key regions either severely decreased or 
abolished IRES activity. Interestingly, other mutations were identified that 
enhance IRES activity, and some mutations in highly conserved areas had 
no effect. These mutations are distributed throughout the IGR IRES and 
suggest multiple points of contact with the ribosome. In vitro binding 
studies using ribosomal subunits were also performed on selected mutants. 
Several mutant IRESs with decreased translational activity also had 
decreased binding affinity, while others with decreased activity had binding 
affinities similar to the wild type IRES, suggesting these mutants likely 
affect a downstream step of translation initiation, such as 60S subunit 
joining or pseudotranslocation. Interestingly, this study found that the IGR 
IRES binds 40S subunits irreversibly while an IRES with a mutation that 
abolishes translational activity without disrupting 40S binding binds 
reversibly- suggesting a conformational change in the 40S subunit may lock 
the IRES into place. Taken together, these results provide new insights into 
the mechanism of ribosome recruitment by the CrPV IGR IRES and may be 
useful in continuing studies of IRES-mediated translation. 
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Control of eukaryotic gene expression is comprised of a series of highly 
dynamic steps including pre-mRNA transcription, 5’ cap formation, 
splicing, polyadenylation, export, translation, and mRNA degradation. 
These steps are specifically integrated to augment the efficiency and fidelity 
of the entire process. One of the most important quality control mechanisms 
of gene expression is the quality control of expressed mRNA. Abnormal 
mRNAs containing premature termination codons (PTC) are typically 
degraded by nonsense-mediated decay (NMD). Some PTC containing 
mRNAs are not degraded by NMD, however translation from these 
abnormal mRNA is inhibited by another mechanism, nonsense-mediated 
translational repression (NMTR). To clarify this translational repression, we 
inhibited NMD and evaluated the production of PTC-containing β-globin 
mRNAs and cognate proteins in transfected cells. PTC-containing β-globin 
mRNAs were recovered after inhibition of NMD, but proteins generated 
from these mRNAs were not detected. Likewise, PTC-containing β-globin 
mRNAs were distributed into lighter polysome fractions compared to 
control mRNAs, suggesting translational repression of these mRNAs. This 
repression likely occurred subsequent to the initiation step, as CrPV IRES-
mediated translation of PTC-containing β-globin mRNAs, which does not 
require initiation factors to assemble ribosomes, was repressed. Our 
findings suggest that NMTR operates in PTC-containing abnormal mRNAs 
at the level of translation, and this mechanism occurs without any 
translation initiation factors. 
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Eukaryotic translation initiation requires that the factor 4E (eIF4E) bind to 
the cap structure located at the 5' end of messenger RNAs (mRNA). Several 
eIF4E binding partners have been identified. The factor 4G (eIF4G) 
mediates the recruitment of the small ribosomal subunit at the cap structure, 
and 4EBP represses translation by competing with eIF4G for binding to 
eIF4E. Two eIF4E homologs have been identified in Leishmania major 
(LIF4E-1, LIF4E-4), and putative homologs of eIF4G (LIF4G 3) and 4EBP 
(L4EBP) have also been found in this parasite. Because they have evolved 
to bind the unique trypanomastid cap-4 structure, LIF4Es are structurally 
diverged from their higher eukaryote counterparts. We use nuclear magnetic 
resonance (NMR) spectroscopy to characterize LIF4E-1. Our aim is to 
highlight structural differences with eIF4E that could account for the 
requirement of the cap-4 structure in trypanosomatids. We are also studying 
the interactions of LIF4E-1 with its potential binding partners, with the goal 
of developing specific inhibitors of these interactions as potential 
therapeutic agents for leishmaniasis. 
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High throughput selective 2’ hydroxyl acylation analyzed by primer 
extension (hSHAPE) is a method of interrogating the backbone flexibility 
of an RNA structure. A chemical such as 1-methyl 7-nitroisatoic anhydride 
(1M7) is used to preferentially interact with 2’-OH residues of rRNA to 
determine at which positions the backbone is flexible. Fluorescently labeled 
primers are used to perform primer extension and the products are separated 
by capillary electrophoresis. This data is analyzed in a quantitative fashion 
using SHAPEFinder. The resulting data allow us the ability to map the 
flexibility of nearly the entire sequences of all 4 rRNAs in intact ribosomes. 
The refinement of this technology enables nucleotide-specific mapping of 
changes in rRNA structure depending on the status of tRNA occupancy, the 
presence or absence of other trans-acting factors, due to mutations of 
intrinsic ribosome components or extrinsic factors affecting ribosome 
biogenesis, or in the presence of translational inhibitors. 
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eIF3e is a component of the multi-subunit eIF3 complex, which binds 
directly to the 40S ribosome to facilitate ribosome recruitment to mRNA. 
Changes in eIF3e expression have previously been implicated in breast 
cancer development and progression. Expression of a truncated version of 
the mouse eIF3e (Int6sh) leads to malignant transformation of normal 
mammary cells, whereas overexpression of the full-length eIF3e inhibits 
growth and promotes apoptosis. Importantly, reduced expression of eIF3e 
has been found in up to 37% of human breast cancers. Together, these 
findings suggest that eIF3e is a tumor suppressor; however, the exact 
mechanisms by which loss of eIF3e leads to breast cancer are not well 
characterized. Moreover, the findings of a recent study of eIF3e depletion in 
several human breast cancer cell lines suggest that eIF3e may in fact play an 
oncogenic role in breast cancer. To gain a better understanding of the role of 
eIF3e in breast cancer we have performed translational profiling of the 
normal human breast epithelial cell line MCF-10A in which eIF3e 
expression has been reduced by eIF3e shRNA. We find that loss of eIF3e in 
MCF-10A cells does not affect global translation, but rather affects the 
recruitment of specific mRNAs to polysomes. Although we find that loss of 
eIF3e expression in MCF-10A cells causes a reduction in the proliferation 
rate, we find a specific increase in the polysomal recruitment of mRNAs 
that encode proteins involved in the response to oxidative stress, the cellular 
response to hormone stimulus, negative regulation of apoptosis, and the 
inflammatory response. Each of these processes is important for breast 
cancer cell growth and progression. Our findings therefore suggest that loss 
of eIF3e expression in normal breast epithelial cells leads to translation 
changes that promote cancer development and progression. 
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During Drosophila oogenesis, establishment of the anterior-posterior (A-P) 
and dorsal-ventral (D-V) pattern of a developing egg chamber requires the 
activity of locally translated Gurken (Grk), a TGFα-like protein. Previous 
work from our laboratory has discovered an unexpected link between the 
DNA damage induced checkpoint and the translational control of Grk. 
However, the molecular mechanism of this link requires further 
characterization. 
In the oocytes of mutants that block homologous DNA repair, including 
spnB, which encodes a RecA like protein, double-strand breaks occurring 
during meiosis are not repaired effectively, which leads to the activation of 
a meiotic checkpoint. This checkpoint activity affects dorsal-ventral 
patterning of the egg chamber by repressing Grk translation, likely through 
a Drosophila checkpoint kinase 2 (Chk2)-dependent posttranslational 
modification of Vasa, an eIF4A-like DEAD-box RNA helicase that has 
been shown to play an essential role in regulating the translational initiation 
of Grk. Previous work in our laboratory identified several mutations that are 
able to suppress the abnormal egg chamber patterning phenotype of the 
spnB mutant. One of these, BH167, dominantly suppresses the repression of 
Grk translation caused by the DNA damage checkpoint. We observed that 
in the spnB mutant, the presence of the BH167 mutation removes the Chk2-
dependent posttranslational modification of Vasa, which indicates that 
BH167 might regulate Grk translation through Vasa. Interestingly, we 
found that BH167 is a mutation in the Drosophila gene encoding the 
eukaryotic translation initiation factor eIF1A. We are currently using 
biochemical and proteomic methods to study how the activated DNA 
damage checkpoint affects the function of Vasa and eIF1A during Grk 
translation. |This analysis should allow us to define the link between the 
DNA damage induced checkpoint and protein translational control. 
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DAP5/p97 (Death Associated Protein 5) is a member of the eIF4G family. 
Similar to eIF4G, DAP5 is able to interact with eIF3 and eIF4A via the 
MIF4G domain. A significant difference between the proteins is that 
DAP5/p97 lacks the eIF4E binding site required for the interaction with the 
cap structure. This characteristic of the protein led us to the hypothesis that 
DAP5 mediates the cap-independent mode of translation initiation. Indeed 
we have shown that DAP5/p97 promotes IRES (Internal Ribosome Entry 
Site) translation of the pro-survival proteins Bcl-2 and CDK1 and that this 
activity is important for the maintenance of cell survival during mitosis. We 
resolved the crystal structure of the C-terminal domain of DAP5, 
highlighting among other things the structural properties of the domain 
which interacts with Mnk1 and eIF2β. Notably, while eIF4G contains a 
similar domain that interacts with Mnk1, it does not interact with eIF2β. 
Therefore, we have created a specific mutant of DAP5 (E862K), mimicking 
the corresponding site in eIF4G, and found that it greatly reduced DAP5 
binding to eIF2β. Next, we have established an in vitro translation system in 
which DAP5 mutants are examined for their effect on the translation of 
Firefly Luciferase RNAs driven by the Bcl-2 IRES as compared to cap-
dependent translation of the same reporter gene. Our results suggest that the 
interaction of DAP5 with eIF2β is important for its selective function in 
promoting IRES mediated translation. Thus, by utilizing this system we 
hope to understand to greater depths the mechanism of DAP5 function in 
cap independent translation and to delineate the similarities and differences 
between DAP5 and eIF4G mode of action. 
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The DEAD-box RNA helicase Rok1 plays a role in rRNA processing and in 
control of cell cycle progression in Saccharomyces cerevisiae. The 5’ UTR 
of ROK1 gene contains two upstream open reading frames (uORFs) that 
inhibit ROK1 mRNA translation. And Rok1 protein levels oscillate during 
the cell cycle, declining at G1/S phase and increasing at G2 phase. By using 
the yeast three-hybrid assay, Psk2, one of the yeast PAS kinase, was 
identified as ROK1 5’ UTR-interacting protein. The Psk2 is involved in 
translational regulation by phosphorylating translation factors, Caf20, 
eIF1A, component of 43S preinitiation complex (PIC), and Sro9. Deletion 
mutation of PSK2 resulted in constant level of Rok1 protein throughout the 
cell cycle, suggesting that the ROK1 mRNA translation is repressed by 
Psk2. Tub4, gamma-tubulin, was also identified as ROK1 5’ UTR-
interacting protein. Tub4 and Psk2 play an opposite role in ROK1 mRNA 
translation. Temperature sensitive mutation of TUB4 resulted in decreased 
level of Rok1, suggesting that the Tub4 is required to ROK1 mRNA 
translation. Taken together, these results suggest that Psk2 is effective for 
uORF-mediated repression of ROK1 mRNA translation and that Tub4 is 
required for uORF-mediated ROK1 mRNA translation. Also, we will 
present the effect of phosphorylation of eIF1A by Psk2 in regulation of 
ROK1 mRNA translation. 
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Micro RNAs (miRNAs) are cellular small non-coding RNAs (22 bases 
long) that regulate gene expression. They form with proteins the RISC 
(RNA Induced Silencing Complex) complex that is directed to specific 
target sites that are located (in most, but not all, case) to the 3' untranslated 
region of mRNAs and this lead to the inhibition of its translation (in case of 
imperfect nucleotide complementarity) and/or deadenylation. Despite a 
considerable amount of work on miRNAs over the last few years, the 
mechanism by which translation is inhibited remains to be determined. 
Some workers have postulated that translational blockage occurs at the 
elongation step whereas other claims that it could be at the initiation step. 
The recent characterization of in vitro systems based on cell extracts that 
mimick the miRNA response seems to favour the initiation step hypothesis.  
In order to gain insight into this process, we did a serie of constructions that 
all contain the renilla luciferase coding sequence followed by the same 3' 
untranslated region in which natural let-7 or artificial miR-451 target sites 
have been added. Then, a wide range of 5' untranslated region have been 
appended to these reporter constructs and their translation was monitored in 
HeLa cells containing endogenous let-7 miRNA or in rabbit retyculocyte 
lysate, containing endogenous miR-451.  
Our results show that the mechanism of translation initiation driven by the 
5’UTR can influence the rate of inhibition triggered by miRNA and confirm 
effect of miRNAs on this step of gene expression. 
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Programmed -1 ribosomal frameshifting (FS) is a translational recoding 
strategy used predominantly by RNA viruses in the eukaryotic host. Here, 
the reading frame of the translating ribosome is altered by cis-acting 
elements in the mRNA, which force the ribosome to shift one nucleotide 
back in the 5’ direction. This results in the expression of a novel protein 
from the overlapping reading frame. -1 FS is normally promoted by two cis-
acting mRNA elements, a slippery sequence and downstream stimulatory 
RNA structure (an RNA pseudoknot or hairpin-loop) separated by a short 
spacer region of 4-9 nucleotides (nt). Recent work from other laboratories 
has shown that the function of the stimulatory RNA can be replaced by a 
trans-acting stimulus in the form of an antisense oligonucleotide (AON) 
when this binds to a region immediately downstream of the slippery 
sequence (optimal spacing of 0-3 nt downstream of the slippery sequence). 
 
We have carried out biochemical and structural studies in order to 
characterise the AON-stimulated frameshift. We first confirmed the 
stimulation of -1 FS with 2-O-methyl AONs in an in vitro translation 
system (rabbit reticulocyte lysate [RRL]) and in cell culture. The extent of -
1 FS stimulation was found to be slippery sequence dependent and at the 
HIV slippery sequence (U6A), we observed both -1 and +1 (or -2) 
frameshift products. Further analysis of this frameshift event has revealed a 
spacer length dependency for the production of the +1/-2 FS product. This 
observation is not limited to AON-stimulated frameshifting, with similar 
results obtained for stem-loop and pseudoknot-stimulated frameshift sites 
on the U6A sequence. Preliminary work indicates that the mechanism of +1 
FS product synthesis is unusual. 
 
We are exploiting the capacity of these AONs to pause ribosomes to 
develop a cell-free assay to examine the unwinding of duplex RNAs during 
translational frameshifting. Our aim is to visualise the AON-ribosome 
unwinding event via toeprinting (primer extension). This method exploits 
our tRNA-dependent RRL system, which by addition of synthetic or 
purified tRNAs, allows us to step the ribosome codon-by-codon as it 
unwinds the annealed AON. These studies may be informative as to the 
active site of the 80S helicase, and may clarify the different spacing 
requirements of RNA pseudoknot- and AON-mediated frameshifting 
events. 
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The ansamycins are a diverse and often physiologically-active group of 
compounds that include geldanamycin and rifamycin, inhibitors of heat 
shock protein 90 and prokaryotic DNA-dependent RNA synthesis, 
respectively. Cytotrienin A is an ansamycin-type small molecule with 
potent anti-proliferative and pro-apoptotic properties. Herein, we report that 
this compound inhibits eukaryotic protein synthesis by interfering with 
eukaryotic elongation factor 1A function. In a reconstituted assay, we 
demonstrate that cytotrienin A increases aminoacyl-tRNA binding to the 
ribosome in the presence of a non-hydrolyzable GTP analog, GMPPNP. In 
addition, the compound inhibits eEF2-dependent translocation when 
aminoacyl-tRNA is loaded in an eEF1A-dependent manner. Cytotrienin A 
modulates neither ternary complex formation nor GTPase activity of eEF1A 
in vitro. We also find that cytotrienin A prevents HUVEC tube formation 
and diminishes microvessel formation in the chorioallantoic membrane 
assay. These results provide a molecular understanding into cytotrienin A’s 
previously reported properties as an anti-cancer apoptosis-inducing drug. 
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Eukaryotic mRNAs posses a 5’cap structure and most feature a 3’poly(A) 
tail. In protein synthesis the 5’cap and the 3’poly(A) tail interact 
synergistically to stimulate the initiation of mRNA translation. Unlike its 
cellular counterparts the small (S) mRNA of Andes Hantavirus (ANDV), a 
member of the Bunyaviridae, possesses a 5’cap but lacks a 3’poly(A) tail. 
Here we show that the 3’untranslated region (UTR) of the ANDV S mRNA 
functionally replaces a poly(A) tail and synergistically stimulates cap-
dependent translation initiation from viral mRNAs. Stimulation of 
translation by the 3’UTR of the ANDV S mRNA was found to be 
independent of viral proteins and of host poly(A)-binding protein. 
 
Proyecto Núcleo Milenio P-07-088-F, FONDECYT No 1100756, PHS 
grant 2U01AI045452-11. JV-O was supported by a MECESUP-USACH 
doctoral fellowship. EPR was supported by grants from Fondation pour la 
Recherche Medicale (FRM) and the French Ministry (MENRT). 
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Using a fully reconstituted S. cerevisiae translation initiation system, we are 
dissecting the molecular mechanics of mRNA recruitment to the 43S pre-
initiation complex (PIC). Efficient recruitment of capped mRNAs requires 
eIF3 and the eIF4 factors, which stabilize binding of the message and 
dramatically increase the rate of recruitment. Uncapped mRNAs can be 
recruited through an alternative pathway that does not require the eIF4 
factors. This pathway yields a complex that is unable to effectively locate 
the start codon. The cap strongly inhibits this alternative mRNA recruitment 
pathway, imposing a requirement for the eIF4 factors for rapid and stable 
binding of mRNA to the PIC. Our data suggest that the 5´-cap serves as 
both a positive and negative element in mRNA recruitment, promoting 
initiation in the presence of the full set of mRNA handling factors while 
preventing binding to the ribosome via an alternative, aberrant pathway 
requiring only eIF3. Thus the cap ensures that only fully functional pre-
initiation complexes containing all the required factors are assembled on an 
mRNA. 
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Variation in the cytoplasmic fate of individual mRNAs can play an 
important role in the regulation of gene expression. Cellular perturbations 
such as glucose deprivation cause a rapid inhibition of translation and a key 
question relates to the fate of mRNAs and translation factors under such 
conditions. As such, translation initiation factors and mRNAs accumulate in 
cytoplasmic granules following glucose starvation. These mRNPs can 
disassemble from polysomes and relocalise into P bodies which contain 
mRNA decay factors, and thus are likely to be destined for degradation. On 
the other hand, mRNPs can localise to EGP bodies, which lack decay 
components and are likely to represent sites of mRNA storage during times 
of cellular stress. These distinct functions for P and EGP bodies highlight 
the possibility that subsets of mRNAs might be specifically rationalised 
towards one or the other of these granules depending on the functional 
value that the transcripts hold following a particular stress.  
In this study four mRNAs have been selected that are neither 
transcriptionally or translationally up or down regulated following glucose 
starvation, as judged by microarray analysis. These mRNAs have been 
genomically tagged with MS2 RNA binding sites allowing their 
visualisation using MS2-fluorescent protein fusions. Initial observations 
suggest that bias exists for particular mRNAs as to whether they localise to 
P-bodies or EGP-bodies following glucose starvation. Moreover, across this 
relatively small set of mRNAs this correlates with the functionality of these 
mRNAs under glucose starvation conditions.  
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Eukaryotic mRNAs bear at their 5'ends a cap structure- m7GpppN. It is 
involved in mRNA synthesis, translation, mRNA turnover, regulation by 
miRNA. During translation initiation the cap is specifcally recognized by 
the eIF4E protein. It was shown that targeting eIF4E overexpressed in many 
types of tumor cells may inhibit their growth and induce apoptosis. 
Synthetic mRNA cap analogs are invaluable tools for studying 
aforementioned processes. Furthermore, analogs that are potent inhibitors of 
protein synthesis in vitro could be helpful in designing anti-tumor drugs 
and, when introduced at 5'end of mRNA, they could increase translational 
efficiency and stability of such mRNAs.  
Here we present novel cap analogs that combine two structural features:(i) 
the 5',5'-bridge is elongated to a tetraphosphate (4-P) to increase their 
affinity to eIF4E, and (ii) a single phosphorothioate or 
methylenebisphosphonate modification of the tetraphosphate bridge is 
introduced to decrease their susceptibility to decapping enzymes (Dcp1/2 
and DcpS). A series of Anti-Reverse Cap Analogs (ARCAs) have been also 
synthesized to facilitate their incorporation in vitro into mRNA exclusively 
in the correct orientation.  
The affinity for eIF4E of the methylenebisphosphonate 4-P analogs was 
shown to be around 5-9 fold higher than their triphosphate counterparts and 
unmodified m7GpppG. m7GpCH2pppG and m7GppCH2ppG analogs (and 
their ARCAs) were found to be resistant to hydrolysis by DcpS. All cap 
analogs of this serie were efficient inhibitors of cap-dependent translation in 
vitro in RRL and were much more stable in this system than their 
unmodified counterparts (except m7GpppCH2pG). ARCA-type analogs 
were incorporated into mRNA during in vitro transcription and obtained 
transcripts were efficiently and cap-dependently translated in RRL.  
All the synthesized phosphorothioate tetraphosphate ARCAs (4P-S-
ARCAs) showed at least 10 times higher affinity for eIF4E than m7GpppG. 
Both diastereoisomers of m27,2'-OGpSpppG (D1 and D2) were resistant to 
DcpS. All 4P-S-ARCAs were also used in in vitro transcription and capped 
mRNA transcripts were obtained. Strikingly, 4P-S-ARCA-capped mRNAs 
were translated 2.5–4.5 times more efficiently in RRL than m7GpppG-
capped mRNAs what makes them very promising candidates for RNA-
based therapeutic applications such as gene therapy and anticancer vaccines.  
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Mutations of genes involved in ribosome biogenesis have been increasingly 
linked to developmental malformations, inherited bone marrow failure 
syndromes, cancer and aging. Despite the ubiquitous expression of 
ribosomal proteins, any disruption in their expression can result in cell or 
tissue specific defects. Surprisingly, phenotypic analysis of mice with 
mutations in various ribosomal protein genes demonstrates that some are 
not essential for global development or maintenance of tissues. Rpl22 is a 
component of the 60S ribosomal subunit whose function is not well 
understood. Although it is ubiquitously expressed, the only currently known 
effects of disruption of the Rpl22 gene are subtle defects in lymphocyte 
development. Our hypothesis is that this surprisingly mild phenotype is due 
to compensation by a recently identified ribosomal protein, Rpl22L1 
(Rpl22-like 1) that has a protein sequence 69% identical to Rpl22. 
Previously Rpl22L1 was thought to be an unprocessed pseudogene but we 
and others have found that Rpl22L1 mRNA is translated. Rpl22L1 was 
recently identified as a minor component of ribosomes in wild-type liver 
and mammary gland tissues. Western blot analysis of various mouse tissues 
showed differential expression of Rpl22 and Rpl22L1. By performing 
quantitative RT-PCR and Western blot analysis, we detected an increase in 
Rpl22L1 mRNA and protein levels in multiple Rpl22-null tissues. 
Quantitative RT-PCR analysis of mRNA isolated from T-cell progenitors 
showed that Rpl22L1 expression does not appear to be substantially 
increased in Rpl22-null lymphocytes, suggesting that Rpl22L1 is not 
compensating in this cell population resulting in the phenotype observed in 
the Rpl22-null mice. Western blot analysis performed on gradient fractions 
collected from polysome analysis of Rpl22-null mouse liver also indicated 
that Rpl22L1 is present in actively translating ribosomes. Current studies 
are focused on better understanding ribosome function and elucidating the 
role of ribosomal proteins in the process of aging and the pathology of 
disease. 
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It is widely accepted that eukaryotic poly(A) binding protein (Pab) interacts 
with both poly(A) tails and the 5' cap structure of mRNA to promote 
translation initiation, leading to circularization of the mRNA. Wells et al. 
(1998) demonstrated the in vitro formation of mRNA circles, using purified 
recombinant yeast proteins eIF4E, eIF4G, and Pab1 with capped, 
polyadenylated double-stranded RNA. Also, circular and spiral polysomes 
have been visualized in situ by electron microscopy (EM) in thin sections of 
rER membranes of highly-specialized secretory cells, i.e., somatotropes and 
mammotropes in rat anterior pituitary (Christensen et al., 1987). However, 
in vivo circularized polysomes have not been seen in less specialized cells 
or in lysates from these cells. Using EM, we have now visualized circular 
and linear polysomes containg 5–8 or more ribosomes in negatively stained 
lysates of both yeast cells and mouse liver. Moreover, these polysomal 
structures persist through sedimentation centrifugation in high-salt sucrose 
gradients. Single particle EM imaging of the gradient fractions shows that 
the number of ribosomes in linear, bunched, or circular polysomes 
corresponds to the location of polysomal A254 peaks in the gradient profile. 
Fractions at or near the bottom of the gradients also contain both large and 
smaller polysomes attached to apparent membrane fragments, released by 
solubilization of the membranes in the lysates with deoxycholate and Triton 
X-100. Efforts to determine if Pab1 is required for polysome circularization 
are underway. 
 
Wells, S.G., P.E. Hillner, R.D. Vale and A.B. Sachs (1988). Circularization 
of mRNA by eukaryotic translation initiation factors. Molec. Cell 2:135-
140. 
 
Christensen, A.K., L.E. Kahn and C.M. Bourne (1987). Circular polysomes 
predominate on the rough endoplasmic reticulum of somatotropes and 
mammotropes in the rat anterior pituitary. Amer. J. Anat. 178:1-10. 
 
Supported by grants from the Howard Hughes Medical Institute, 
Washington Research Foundation, and the Murdock Charitable Fund (to 
TG) and the National Institute on Aging and the American Federation for 
Aging Research ( to BKK). 
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In mammals, insulin (ins) or ins-like growth factors (IGFs) have shown to 
regulate cell growth and ribosome biogenesis through the TOR signaling 
pathway. It has been demonstrated that ins is also able to stimulate growth 
in several plant species during germination process (GP). For maize, a 
similar pathway has been proposed to account for this phenomenon, 
activated by an endogenous IGF (ZmIGF), which highly stimulates growth 
and synthesis of rps (Dinkova, 2007). Considering that expression of rp 
genes constitutes a main platform for growth and development, the present 
research was undertaken to get a view of global expression regulation of 
these genes within GP, a relevant period for maize development. To ask 
about their expression regulation, microarray analyses were performed on 
total RNA from 0 and 24 h germinating MEAs, as well as on polysomal 
RNA from 24 h-MEAs. Further, for some experiments, the GP was 
accelerated by addition of ins. Results reveal that most rp mRNAs, required 
for new ribosome formation in this fast growing period, remain mostly 
steady through the GP, suggesting that transcriptional regulation of these 
genes is minimal at this developmental stage. Further, microarray analyses 
on total and polysomal mRNAs from ins-stimulated 24 h-MEAs, reveal that 
rp mRNAs are not transcriptionally up regulated by ins during GP. Rather, a 
translational control mechanism seems to account for the fast rp synthesis 
observed within this period, since 44 rp mRNAs increased their levels in 
polysomes from ins-stimulated MEAs. These data indicate that ins 
selectively induces rp mRNAs recruitment into polysomes. However, not all 
the rp mRNAs were translationally stimulated by this mechanism, since 35 
of them maintained steady levels, whereas 24 diminished their presence in 
polysomes. These results were validated by qRT-PCR determinations on 
some rp mRNAs. Their relative expression levels correlate with the patterns 
observed on microarrays. A bioinformatic analysis of 5’-UTR ends of the rp 
mRNAs was performed to find out whether 5´TOP-like sequences could be 
involved in this process. Indeed, a 5´TOP-like sequence was found only in 
the 5’-UTR set of rp mRNAs that were up regulated in polysomes. These 
data provide further support to the proposal, of a translational control 
mechanism present in maize, which might regulate specific rp mRNAs by 
selective mobilization into polysomes for translation. This work was 
supported by DGAPA (IN212910) and CONACyT (265055). Donayre A. is 
a postdoc. fellow of DGAPA-UNAM program. 
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Errors in translation can occur due to incorrect aminoacylation of a 
particular tRNA by its synthetase or selection of an incorrect tRNA by the 
ribosome. Aminoacylation has been shown to be a very accurate process. 
The decoding process contributes more towards the translational errors. 
There are three types of decoding errors: processivity errors, misreading 
errors and frameshift errors. Of these three errors, we are interested in 
estimating the misreading error frequency. Misreading is the 
misincorporation of an amino acid. Earlier studies on misreading errors 
have given a wide range error frequency of 10-1-10-4 per codon. These 
estimates represent a very specific and small number of positions where 
misreading could occur. They also required protein extraction and 
purification. We have developed a simple enzyme based reporter system to 
further characterize the misreading of codons in lacZ gene of E. coli. We 
study the missense errors for active site amino acids that are absolutely 
essential for the activity of the enzyme. We use a single positive reporter 
system assay to measure the frequency of all near cognate misreading errors 
by a single tRNA at mutant forms of a single codon in the lacZ gene. The 
approach is to measure the activity of mutants of β-galactosidase, which 
have inactivating mutations in their essential active site amino acid. This 
activity might be due to phenotypic reversion of mutants to wild type amino 
acid due to the misreading at mutant codon by the wild type near cognate 
tRNA. In that case, the ratio of activity of mutants to the wild type would 
give the missense error frequency of each near-cognate and noncognate 
codon for the specific amino acid. We are using this reporter system to 
measure the effect of the hypermodified nucleoside, queuosine, on 
translational accuracy. Queuosine is a highly conserved modification in 
position 34 of the tRNA. It is a hypermodified guanosine nucleoside present 
in the wobble position of Tyr, His, Asn and Asp tRNAs. These amino acids 
are among the essential active site amino acids in β-galactosidase. Absence 
of Q modification has been shown to cause amber mutation suppression, 
which suggests that Q modification might play an important role in 
decoding for certain tRNAs. Q modification might play two kinds of role in 
maintaining the translational accuracy. It might stabilize the correct base 
pairing between codon and anticodon or might destabilize incorrect base 
pairing. Either of these two hypotheses predicts a specific change in 
misreading with our reporter system. 
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Selection of AUG by the scanning 43S preinitiation complex (PIC) requires 
base-pairing with the anticodon of Met-tRNAiMet bound to eIF2-GTP in the 
ternary complex (TC). It is thought that entry of AUG in the P-site elicits 
dissociation of eIF1 from the 40S subunit, triggering release of Pi from 
eIF2-GDP·Pi and transition of the PIC from an open conformation to a 
closed state incompatible with scanning, to which Met-tRNAiMet is more 
tightly bound. While eIF1 accelerates TC binding to the open conformation, 
it must be released from the 40S to stabilize Met-tRNAiMet binding to the 
closed conformation of the PIC.  
We identified point mutations in eIF1 that derepress translation of GCN4 
(Gcd- phenotype) and also increase initiation from UUG codons (Sui- 
phenotype). One group of mutations appears to reduce the affinity of eIF1 
for the 40S subunit, decreasing TC loading to the open conformation to 
evoke Gcd-phenotypes, and enabling transition to the closed conformation 
inappropriately at UUG codons to produce Sui-phenotypes. Consistent with 
this model, the Gcd- phenotypes of such “type I” mutations are suppressed 
by overexpression of TC, and their Sui-phenotypes are suppressed by 
overexpression of the mutant protein and by an eIF1A mutation (17-21) 
shown previously to retard eIF1 dissociation from reconstituted PICs. 
Moreover, the type I eIF1 mutation 93-97 was shown previously to 
accelerate eIF1 dissociation from PICs in vitro. Consistently, type I 
mutations include substitutions of Lys residues with negatively charged Glu 
residues on the exposed face of helix-1, predicted to contact 18S rRNA.  
The Sui-phenotypes of a second class of eIF1 mutations, including 
previously described G107R, are not suppressed by overexpression nor by 
the eIF1A mutation 17-21. Such “type II” mutations appear to retard eIF1 
release from the 40S specifically at AUG codons. Retention of eIF1 at AUG 
impairs the 2nd step of Met-tRNAiMet binding, conferring a Gcd- phenotype 
that cannot be suppressed by TC overexpression, and a Sui- phenotype that 
involves decreased recognition of AUG versus increased UUG initiation.  
We have also identified mutations in eIF1 that suppress the increased 
UUG:AUG ratios conferred by Sui-mutations in eIF1, eIF2β and eIF5. 
Several such Ssu- mutations affect hydrophobic residues in helix-1 that are 
largely buried beneath the surface. We propose that proper packing of helix-
1 within eIF1 is crucial for its regulated dissociation from the 40S on start 
codon recognition.  
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m7G cap structure plays an important role in many aspects of translational 
control. In yeast, the intact cap is not essential neither for transport of mRNA 
from nucleus to cytoplasm nor regulation of mRNA stability, but is required for 
efficient translation initiation.  
We studied yeast strains bearing conditional mutant alleles of Ceg1p guanylyl 
transferase and Abd1p cap methylating enzyme. We analyzed more deeply 
viability of ceg1ts and abd1ts yeast strains after cultivation in non-permissive 
37°C for various periods of time and found considerable differences among 
used ts alleles of Ceg1 or Abd1 genes but unexpectedly we were unable to 
confirm our hypothesis that ceg1 strain should die more quickly due to 
triggering mRNA decay. Interestingly, all strains with defects in the cap 
formation were more sensitive to the elevated temperature than strain carrying 
thermosensitive CDC33 allele. Polysomal profiling of abd1 and ceg1 strains in 
various period of time revealed profound decline of polysomes corresponding to 
already published inhibition of translation initiation. Moreover, we observed in 
polysome profile of ceg1 strain two unconventional peaks which could 
represent accumulated MFCs and 48S PICs in cells, respectively. 
The stability of mRNA is severely affected in ceg1 strain. On the contrary, it 
was published that ts mutations in methyl tranferase Abd1p don’t exhibit this 
kind of rapid mRNA degradation, although the proteosynthesis is also severely 
affected. Two lines of evidence let us suggest that mRNA stability is affected 
almost comparable in abd1 and ceg1 strains after 12h cultivation at 37°C. We 
analyzed mRNA levels of Tif4631, Dbp2, Act1 and Rpl26B genes and found 
that only the last two transcripts are more stable in abd1 strain. 
We also utilized the S. cerevisiae ceg1 and abd1 strains as a tool in our attempts 
to determine new yeast mRNAs capable to enter the cap-independent translation 
initiation pathway. Determination of mRNA content in polysomes isolated from 
these strains after cultivation in non-permissive temperature revealed 21 
candidate genes. 
Bioinformatical analysis of experimentally verified 5´-UTRs did not discover 
any common sequence properties. We also analyzed 5´-UTRs of two selected 
mRNAs encoding Bas1p and Ptr3p using dicistronic assay and found out that 
both sequences induced expression of downstream reporter gene. Using 
promoter-less control vectors and qRT-PCR approach we determined that 
cryptic transcription attributed to this induction but we did not exclude the 
possibility that these two transcripts contain an IRES.  
Literature: Schwer et al. (1998), NAR 26: 2050-57, Schwer et al. (2000), 
Genetics 155: 1561-76. 
Supported by Ministry of Education, Youth and Sports of the Czech Republic, 
Grant No. LC06066. 
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Eukaryotic translation elongation factor 2 (eEF2) facilitates the movement 
of the peptidyl tRNA-mRNA complex from the A site of the ribosome to 
the P site during protein synthesis. ADP-ribosylation (ADPR) of eEF2 by 
bacterial toxins on a unique diphthamide residue inhibits its translocation 
activity. Mechanistically, it is unclear how ADPR inhibits eEF2 function. 
We have developed a novel S. cerevisiae system to directly address this 
question. This system employs eEF2 mutations which display dominant 
resistance to diphtheria toxin (DT) expression. These eEF2 mutants lack the 
diphthamide modification and are not a target of DT; however, their 
expression allows growth in the presence of wild type ADPR-eEF2. This is 
an excellent system to study the in vivo effects of ADPR-eEF2. For 
example, yeast expressing both mutant and wild type eEF2 display an 
increase in parmomycin sensitivity specifically upon DT induction 
demonstrating a link between ADPR-eEF2 and translation defects in vivo. 
These effects are due to the presence of the ADPR-eEF2, as determined by 
MS analysis. In addition, we conducted a genetic screen of random yeast 
35S rDNA mutations to identify those which confer resistance to DT 
expression as these mutations may provide insight into how ADPR-eEF2 
functionally interacts with the ribosome. 
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Nuclear factors 90 and 110 (NF90/110), which differ at their C termini, are 
products of the cellular ILF3 gene. They have two double-stranded RNA 
binding motifs (dsRBMs), an RGG domain capable of nucleic acid binding, 
and a DZF (dsRBM- and zinc finger associated) motif. NF90/110 form 
heterodimeric core complexes with NF45, the product of ILF2, and 
associate with a variety of cellular and viral RNAs thereby regulating their 
metabolism. NF90/110 participate in diverse biological processes including 
viral infection and cellular antiviral defense. We examined their function in 
HIV-1 pathogenesis.  
 
Over-expression of NF90, or its depletion by siRNA, established a positive 
function for NF90 in HeLa cells infected with pseudotyped HIV-1. Tat was 
the only HIV gene necessary for the inhibition of viral gene expression 
conferred by NF90 depletion. Inhibition occurred at the viral RNA level and 
was observed with a P-TEFb tethering system, indicating that NF90 
regulates transcription via this cellular transcription elongation factor. P-
TEFb, essential for Tat-mediated HIV transcription, is composed of CDK9 
and cyclin T1. NF90 depletion reduced the level of cyclin T1 protein 2-3 
fold, with a consequent marked decrease of its CDK9 partner, but with no 
effect on the level of either mRNA species. NF90 depletion specifically 
reduced the synthesis of cyclin T1 protein and the polysomal loading of 
cyclin T1 mRNA. The positive effect of NF90 on cyclin T1 translation is 
sensed by sequences in the long (~5kb) 3’-UTR of cyclin T1 mRNA. 
Despite the presence of miRNA sites, experiments suggest that the 
inhibition is likely due to direct binding of NF90 to cyclin T1 mRNA.  
 
Both cyclin T1 and NF90 proteins were induced by PMA in a latently 
infected monocytic cell line. NF90 depletion repressed virus production in 
this cell line, suggesting a role in HIV latency. While P-TEFb kinase 
activity is regulated by interactions of 7SK and HEXIM1/2 with cyclin T1, 
little is known about cellular modulators of cyclin T1 expression. Our study 
shows that NF90 is a cellular regulator of cyclin T1 translation, with broad 
implications for infected as well as uninfected cells. It also raises the 
possibility that NF90 regulates initiation of translation of a set of mRNAs 
via a novel mechanism.  
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In neurons, a variety of synaptic signalling regulates the translation of 
localized RNAs. Modulation of local protein synthesis at the nerve terminal 
plays a pivotal role in the production of long-term, activity-dependent 
changes in synaptic structure and function. The underlying molecular 
mechanisms regulating spatially restricted gene expression and mRNA 
localization are now beginning to emerge. One common mechanism of 5' 
translational control involves rapamycin-sensitive translation through the 
target of rapamycin complex (TORC1). Long-term facilitation (LTF) of 
sensory-motor neuron synapses in Aplysia is produced by five spaced 
applications of serotonin (5-HT) and requires a rapamycin-sensitive 
increase in the local synthesis of the sensory neuron neuropeptide sensorin. 
LTF has been shown to be dependent on S6 kinase downstream of TORC1, 
but no specific transcript has so far been identified (Weatherhill et al. 
(2010) J Biol Chem, 285, 12255-67). Recently, we have generated an assay 
to measure local translation of sensorin in the presynaptic terminal of the 
sensory neuron after LTF induction (Wang et al. (2009) Science, 324, 1536-
40). In this study, we examine whether sensorin synthesis is a downstream 
target of S6 kinase, using live-cell microscopy of photoconvertible 
fluorescent protein translational reporters at cultured Aplysia sensory-motor 
neuron synapses during LTF. 
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In S. cerevisiae, a whole-genome duplication approximately 100 My ago 
led to paralogous duplicate genes for many ribosomal proteins (RP). Many 
of these paralog pairs show similar expression levels under standard growth 
conditions, and have high protein and RNA sequence homology. 
Nevertheless, deletion of one paralog often shows a very different 
phenotype for growth rate, lifespan, and stress resistance than deletion of 
the other. We previously reported replicative lifespan and growth data for 
122 RP deletion strains available in the yeast deletion collection [1]. These 
strains are often slow growing, and we have found that many contain 
growth rate suppressors. We have now reconstructed suppressor-free 
versions for all viable yeast RP deletion strains, and all viable double 
paralog deletions. We rechecked growth rate in all suppressor-free strains 
and replicative lifespan in some (ongoing), several of which differ 
significantly from previously published data. 
Another phenotype shown to be affected by ribosomal protein deletions is 
response to tunicamycin [2]. Tunicamycin induces the unfolded protein 
response (UPR) by blocking N-linked glycosylation. Since increased levels 
of translation have been shown to increase ER stress, we hypothesized that 
reduced protein synthesis in RP deletion strains would promote tunicamycin 
resistance. Analysis of the newly made RP gene deletion strains indicates 
that slower growth in rich media correlates with increased tunicamycin 
resistance, which we hypothesize may be due to decreased overall 
translation. We have also shown that this resistance is not entirely 
dependent on HAC1, a component of the UPR. 
Although evidence shows that some phenotypic differences between 
paralogous RP deletions are likely due to differences in expression levels, 
Komili et al.[3] have suggested that there are further differences in 
functional specificity between ribosomal paralogs, in part by phenotypic 
clustering of existing data. Using our reconstructed deletion collection, we 
measured growth rate in the presence of a variety of other compounds, 
including 2,4 dinitrophenol, paraquat, hydrogen peroxide, 5-fluorouracil, 
cadmium chloride, and caffeine. Growth rate correlations across conditions 
as well as across deletions reveal some interesting patterns of sensitivity and 
resistance, and this analysis is ongoing. 
 
1. Steffen, K.K., et al., Cell, 2008. 133(2): p. 292-302. 
2. Zhao, Y., J.H. Sohn, and J.R. Warner, Mol Cell Biol, 2003. 23(2): p. 699-707. 
3. Komili, S., et al., Cell, 2007. 131(3): p. 557-71. 
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Myogenic differentiation reflects a highly complex and regulated series of 
changes in gene expression, driving myoblast cells to become myotubes. 
RBM4a (RNA binding motif protein 4a) has been shown to accelerate 
myogenic differentiation when over expressed in C2C12 cells (myogenic 
model cell line) but this was not seen when a Serine 309/Alanine mutant 
was used. This has led me to investigate whether RBM4 at physiological 
levels has a role in myogenic differentiation and whether RBM4b (a 
homologous protein sharing 87% amino acid identity) is also involved in 
this process.  
 
 
I have observed that during myogenic differentiation the protein level of 
RBM4a decreases whilst RBM4b protein level increases. The mRNA 
expression level for each isoform was also determined using qRT-PCR 
showing that the changes in protein expression are controlled at the 
transcriptional and post transcriptional stages. Also observed is that RBM4 
forms a complex with eIF4G and eIF4A at later stages of myogenic 
differentiation and that this complex is resistant to RNAse treatment. These 
data indicate that RBM4 could be involved in translational regulation 
during the process of myogenic differentiation. 
 
Funded by a studentship from the BBRSC 
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Despite encoding many replication components, viruses remain obligate 
intracellular parasites with an absolute dependence on host protein synthetic 
functions. By commandeering limiting cellular translation initiation factors, 
or by destroying those dispensable for viral mRNA translation, viruses often 
suppress host protein synthesis. In contrast, human cytomegalovirus 
(HCMV) does not inhibit host protein synthesis, necessitating that viral and 
cellular mRNAs compete for available initiation factors. Together with cap-
recognition complex subunits eIF4E and eIF4G, PABP levels rise 
substantially in HCMV-infected cells. Here, we establish that although the 
increase in overall steady-state levels of select translation initiation factors 
required viral gene expression, the abundance of eIF4E and eIF4G mRNAs 
was considerably elevated in infected cells, whereas PABP mRNA levels 
and protein stability remained essentially unchanged. Instead, new PABP 
synthesis was translationally controlled and dependent upon expression of 
the mTORC1 activator encoded by the virus UL38 ORF. Remarkably, 
preventing the rise in PABP abundance by RNAi impaired viral protein 
production, eIF4F assembly and viral replication. This represents the first 
example of a virus increasing host translation initiation factor concentration 
to foster its own replication and defines a new strategy whereby 
translational control of PABP abundance regulates eIF4F assembly. 
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Herpes Simplex Virus type 1 (HSV-1) is a large double-stranded DNA virus 
that infects the majority of the human population worldwide. By entering a 
non-productive state, termed latency, in sensory neurons that innervate the 
site of primary infection the virus evades the host immune system and 
colonizes infected individuals for life. In response to environmental cues 
such as stress, latent HSV-1 reactivates and lytically replicates in innervated 
epithelia, typically resulting in recurrent cold sores but also causing corneal 
blindness and encephalitis. 
 
While HSV-1 reactivation remains poorly understood, lytic infection has 
been shown to stimulate mTOR activity and increase eIF4F levels in the 
host cell. Here, we examined the potential of targeting eIF4F to inhibit 
either reactivation or lytic replication of HSV-1 using 4EGi-1, a small 
molecule inhibitor of the eIF4E:eIF4G interaction. Titrating 4EGi-1 on 
primary human cells to establish the most effective concentration it was 
found that ongoing translation could be significantly suppressed at 
concentrations below those required to notably disrupt eIF4F levels and 
without cytotoxic effects over extended periods. However, at these lower 
concentrations 4EGi-1 completely blocked both spontaneous and controlled 
HSV-1 reactivation in a tissue culture model and dramatically reduced the 
synthesis and accumulation of HSV-1 proteins during lytic infection with 
high doses of virus. Indeed, cells infected in the presence of 4EGi-1 
morphologically resembled uninfected cells and the production of infectious 
virus in cultures was reduced approximately 106-fold. In contrast, the 
mTORC1/2 inhibitor, Torin1 significantly reduced eIF4F complex levels 
but had relatively modest effects on both host and viral protein synthesis as 
well as viral antigen accumulation when compared to 4EGi-1, suggesting a 
subtle but important role for eIF4F in regulating global protein synthesis 
and providing further evidence for eIF4F-independent antiviral properties of 
4EGi-1. The antiviral properties of 4EGi-1 were not limited to HSV-1 as 
this inhibitor was also found to suppress infection by Vaccinia Virus, a 
member of the poxvirus family of DNA viruses. Our preliminary results 
have identified potential modifications to other components of the cellular 
translation initiation machinery that may contribute to the effects of 4EGi-1 
on translation and virus replication in primary human cells, which we are 
currently exploring. Overall, our findings suggest that 4EGi-1 represents a 
potent, non-cytotoxic inhibitor of both herpesvirus and poxvirus infection. 
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How is information flow coordinated through the ribosome to ensure the 
directionality of protein synthesis? Although the bulk of the ribosome is 
comprised of rRNA and many of its critical functions are mediated through 
RNA-RNA interactions, distinct structural domains of ribosomal proteins 
also participate in switching the ribosome between different 
conformational/functional states. Prior studies had demonstrated that two 
extended domains of ribosomal protein L3, the N-terminal extension and 
the W-finger, participate in an allosteric switch between the pre- and post-
translocational states. Missing was an explanation for how the movements 
of these domains are communicated among the ribosome’s functional 
centers. The current study focuses on a third domain of L3, called the basic 
thumb, that protrudes roughly perpendicular from the W-finger and is 
nestled in the center of a cagelike structure formed by elements from three 
separate domains of the large subunit rRNA. Mutagenesis of basically 
charged amino acids of the basic thumb to alanines followed by genetic, 
biochemical and structural analyses suggests that it acts as a molecular 
clamp to play a critical role in allosterically communicating the ribosome’s 
tRNA occupancy status to the elongation factor binding region and the 
peptidyltransferase center, thus facilitating coordination of their functions 
through the elongation cycle. The observation that these mutants also 
affected translational fidelity, virus propagation and cell growth 
demonstrates how small structural changes at the atomic scale can 
propagate outward to broadly impact the biology of cell. 
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TRANSLATIONAL CONTROL DURING EARLY DEVELOPMENT 
AND APOPTOSIS IN SEA URCHIN EMBRYOS 
 
Vlad Costache, Patrick Cormier, Julia Morales  
 
CNRS - UPMC, UMR 750, Roscoff, 29680, France 
 
Work in our laboratory has shown regulation of protein synthesis at the 
level of the initiation step of translation in sea urchin eggs and early 
cleavage stage embryos, and during apoptosis. The sea urchin early embryo 
has unique features of post-transcriptional gene expression regulation, 
naturally synchronous cell cycles, inducible and physiological apoptosis 
process. The genome has been obtained recently and most of the factors 
implicated in translational control are encoded by non-duplicated genes. 
The sea urchin embryo is therefore a good model for elucidating the 
network of actors involved in translational control in both physiological and 
pathological conditions. Translation initiation factor eIF2 is a key regulator 
in protein synthesis in eukaryotic cells, responsible for getting the initiating 
methionyl-tRNA to the ribosome at the initiation step of translation. In sea 
urchin unfertilized eggs, the alpha subunit of eIF2 is phosphorylated. 
Fertilization triggers eIF2alpha dephosphorylation, and is concomitant with 
an increase in protein synthesis. Using wild-type and mutants proteins 
microinjected into the sea urchin eggs, we showed that dephosphorylation 
of eIF2alpha is necessary for cell division following fertilization. During 
apoptosis induced by DNA-damaging agents, eIF2alpha is rapidly 
phosphorylated following exposure to apoptotic inducers, in a GCN2-
dependent manner. Our results suggest that modifications of translation 
factor and regulation of eIF2 play an important role in protein synthesis 
modulation that occurs during early development and apoptosis.  
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DROSOPHILA MIR-2 CAN TARGET THE COMPLETE MRNA FOR 
INHIBITION OF TRANSLATION INITIATION 
 
Francesca Moretti, Rolf Thermann, Matthias W Hentze  
 
EMBL, Directors' Research, Heidelberg, 69117, Germany 
 
MicroRNAs commonly mediate translational regulation by binding to the 3’ 
untranslated region (3’UTR) of target mRNAs. Conversely, few effective 
microRNA binding sites have been identified in 5’UTRs or open reading 
frames (ORFs), and their mechanisms of action remain unclear.  
We have systematically investigated how the position of microRNA binding 
sites in mRNA reporter constructs influences microRNA-mediated 
translational regulation. To this end, we generated reporter constructs 
containing six Drosophila miR-2 binding sites alternatively in the 5’ or 3’ 
UTRs or the ORF. The analysis of these reporters shows that specific miR-
2-mediated translational responses can be elicited irrespectively of the 
position of the microRNA binding sites, both in an in vitro system 
consisting of Drosophila cell-free embryo extracts and in vivo in Drosophila 
Schneider cells. We observe that miR-2 triggers deadenylation, without 
concurrent mRNA destabilization, and inhibits translation initiation, in a 
cap-dependent manner, also from the 5’UTR and the ORF. These 
observations uncover striking similarities to the previously described 
mechanism of action of 3’UTR microRNA binding sites. However, single 
or dual miR-2 binding sites in the 5’UTR or the ORF function much less 
well than 3’UTR counterparts. This discovery reveals a biological rationale 
for the commonly observed 3’UTR location of microRNA regulatory sites. 
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IDENTIFYING TARGETS OF CYTOPLASMIC CAPPING 
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The first step in pre-mRNA processing is the addition of a m7GpppX cap, 
and proteins binding to the cap coordinate subsequent steps in processing, 
export, surveillance, translation and decay. Capping was thought to be 
restricted to the nucleus and decapping was thought to irreversibly commit 
mRNA to decay. However, we identified a population of capping enzyme in 
the cytoplasm in a ~140 kDa complex that contains a kinase capable of 
generating a diphosphate capping substrate from 5’-monophosphate RNA. 
Because loss of capping enzyme results in apoptosis we developed a 
catalytically-inactive form of capping enzyme (DN-cCE) that is modified to 
restrict its distribution to the cytoplasm. Overexpression of DN-cCE 
reduced the ability of cells to recover from arsenite stress, suggesting it may 
function as a dominant negative protein. The current study looked for 
differences in the population of uncapped mRNAs as a function of DN-cCE 
expression. The expectation was that expression of DN-cCE would reduce 
cytoplasmic capping, increasing the pool of uncapped mRNAs. These 
would be evident by changes in their susceptibility to a 5’-3’ exonuclease. 
Triplicate cultures of tet-inducible U2OS cells carrying DN-cCE were 
treated ± doxycycline for 24 hr and cytoplasmic RNA was processed to 
remove contaminating ribosomal RNA prior to addition of the exonuclease. 
The recovered RNA was analyzed on Affymetrix human exon 1.0 ST 
arrays, focusing on changes in probe sets corresponding to the 5’-most 
exons. We will present results of this analysis and validation of changes in 
cap status resulting from interference with cytoplasmic capping by DN-
cCE. 
 
Supported by PHS grant GM084177 
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COUPLING TRANSLATIONAL CONTROL TO LIFE SPAN - C/EBPβ-
UORF DEFICIENCY MIMICS CALORIC RESTRICTION INDUCED 
METABOLIC REPROGRAMMING IN MICE. 
 
Laura Zidek, Sabrina Eichwald, Christine Müller, Cornelis F Calkhoven  
 
Fritz Lipmann Institute, Translational control, Jena, 07745, Germany 
 
Translation of the C/EBPβ-mRNA into the C/EBPβ-LIP protein isoform is 
achieved through re-initiation from a downstream AUG-codon following 
initial translation of an upstream open reading frame (uORF). The nutrient 
and energy sensing mTOR-S6K/mTOR-eIF4 signaling pathway stimulates 
expression of C/EBPβ-LIP (Calkhoven et al., 2000, Genes Dev 14, 1920), 
while inhibition of mTOR by rapamycin reduces C/EBPβ-LIP levels. We 
have generated knock-in mice that are deficient for the uORF and thus fail 
to translationally up-regulate the C/EBPβ-LIP protein isoform 
(C/EBPβΔuORF mice; Wethmar et al., 2010 Genes Dev 24, 15). Therefore the 
C/EBPβΔuORF mutation as such mimics low mTOR activity at the level of 
C/EBPβ translation. We now show that these C/EBPβ-LIP-compromised 
mice have improved metabolic parameters compared to wt mice: they are 
lean, and have a higher insulin sensitivity and glucose tolerance. Overall 
their metabolic parameters are very similar to phenotypes observed in 
genetic manipulations or feeding conditions that extend life span in mice, 
including that of the S6K knockout or the adipocyte-specific raptor 
knockout (abrogates mTOR signaling), and in particular of mice under 
caloric restriction. Typical healthy serum values are found including high 
adiponectin levels, lower insulin and glucose levels, and notably reduced 
IGF-1 levels. Furthermore, core body temperature of C/EBPβΔuORF mice is 
lowered by appr. 1˚C, which on its own extends life span in another mouse 
model. Thus our data strongly suggest that translational adjustment of 
C/EBPβ isoform expression is a crucial genetic switch for metabolic 
reprogramming regulated by mTOR in vivo and probably contributes to life 
span determination. 
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MUTATIONAL ANALYSIS OF THE INTERACTION BETWEEN THE 
N-TERMINAL DOMAIN OF EIF3A/TIF32 AND THE 5’ ENHANCER 
OF UORF1 FROM THE GCN4 MRNA LEADER THAT IS CRITICALLY 
REQUIRED FOR EFFICIENT REINITIATION 
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Reinitiation is a gene-specific translational control mechanism that utilizes 
short uORFs to down- or up-regulate translation of many regulatory 
proteins. Perhaps the best studied example of the reinitiation mechanism is 
the intricate regulation of expression of the yeast transcription factor GCN4, 
the mRNA leader of which contains four short uORFs. Importantly, the 
very first uORF1 qualitatively differs from the other three as it is flanked by 
the specific 5’ and 3’ enhancing elements that are critically required for 
efficient resumption of scanning of post-termination 40S ribosomes at the 
uORF1 stop codon for reinitiation downstream. We recently demonstrated 
that the 5’ enhancer sequences functionally interact with the N-terminal 
domain (NTD) of the a subunit of the translation initiation factor 3 
(a/TIF32), presumably as they emerge from the mRNA exit pore, and that 
this interaction is vital for retention of post-termination 40S subunits on the 
mRNA. Here we present detailed mapping analysis of this interaction with 
help of computer modeling combined with the enzymatic RNA structure 
probing. We revealed four discernible nucleotide stretches (dubbed 
Stimulatory Elements (SE)) in the 5’ sequences of uORF1 that together 
account for its highly stimulatory activity. Genetic analysis strongly 
suggests that whereas the most proximal unstructured SE i acts 
synergistically with the structurally conserved SE iv by interacting with 
a/TIF32-NTD, the other two SEs promote reinitiation independently of 
a/TIF32. Similarly, two separate clusters within the a/TIF32-NTD were 
identified, the mutations of which impair GCN4 regulation in a manner 
previously observed with the deletion of the entire a/TIF32-NTD. The fact 
that individual mutations of these clusters show differential effects on eIF3 
binding affinity towards 40S ribosomes allows us to separate the a/TIF32-
NTD activities in a) stimulation of 40S-binding and b) promoting efficient 
reinitiation. 
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IDENTIFICATION OF A GENETIC SUPPRESSOR OF GTPBP2 
DEFICIENCY 
 
Gabor Nagy, Ryuta Ishimura, Susan L Ackerman  
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Local translation in neurons is thought to underlie axon and dendritic 
development and synaptic plasticity. We have recently identified a recessive 
ENU-mutagenized mouse strain with disruption of the Gtpbp2 gene, which 
encodes a protein with sequence and domain homology to the eukaryotic 
elongation factor 1A (eEF1A). GTPBP2 is a component of dendritic RNA 
granules and indeed, dendritic spine development is disrupted in mutant 
mice. In addition, progressive degeneration of hippocampal pyramidal 
neurons and dentate gyrus, retinal ganglion cells, and cerebellar granule 
cells is observed in mutant mice beginning at 3- weeks of age. Mutant mice 
die by 8-weeks of age.  
The Gtpbp2 mutation was induced on the inbred C57BL6/J (B6/J) strain. 
However, when the B6/J mutant strain was crossed to various other well-
known inbred strains (e.g. A/J, BALB/cByJ, CBA/J, DBA/2J, NOD/Lt2J) 
suppression of the neurodegenerative phenotype and dramatic extension of 
lifespan was observed. Further studies demonstrated that these strains 
contained a dominant modifier locus that significantly delays neuron death. 
This suppressor locus was narrowed to an approximately 7 Mb candidate 
region on distal Chromosome 1 by recombination mapping. Importantly, 
this chromosomal region is highly enriched in quantitative trait loci (QTLs) 
that influence various behaviors, and is implicated in the control of RNA 
metabolism and protein synthesis. Final identification and characterization 
of this modifier will elucidate the function(s) of Gtpbp2, and may further 
our understanding of the molecular basis of translational components during 
synaptic development. 
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CHARACTERISATION OF THE STOP CODON READTHROUGH 
SIGNAL OF COLORADO TICK FEVER VIRUS. 
 
Sawsan Napthine, Ian Brierley  
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Stop codon readthrough is a process in which a stop codon is periodically 
misread as a sense codon, allowing the production a C-terminally extended 
polypeptide at a defined frequency. Readthrough is typically promoted by 
local context effects and/or by downstream RNA secondary structure. A 
structure-dependent readthrough signal derived from Colorado tick fever 
virus (CTFV) segment 9, was the subject of this study. CTFV is the type-
species of the genus Coltivirus within the family Reoviridae and is a tick-
borne, double-stranded, segmented RNA virus. Segment 9 encodes the viral 
protein VP9 and by readthrough, VP9’. Here we analysed the CTFV 
readthrough signal and identified the key motifs required for readthrough. 
 
Initially, sequence information corresponding to nucleotides from 11 nt 
upstream of, and ~300 nt downstream of, the suppressed UGA codon was 
shown to promote readthrough in rabbit reticulocyte lysate (RRL) using a 
readthrough reporter construct. Subsequently, deletion analysis revealed 
that only 87nts immediately downstream of the suppressed UGA stop signal 
was required for efficient readthrough. Computer-aided RNA folding 
programmes coupled with chemical and enzymatic RNA structure probing 
indicated the presence of a stable hairpin positioned eight bases downstream 
of the UGA codon. This RNA secondary structure has an organisation 
similar to that of the ribosomal frameshift-promoting secondary structure of 
the retrovirus Rous sarcoma virus, although does not appear to be 
pseudoknotted. The importance of the local context surrounding the stop 
codon in readthrough was also demonstrated. Using site-specific 
mutagenesis, we identified several essential nucleotides both 5' and 3' of the 
UGA codon. These experiments provide insight into the structural and 
functional diversity of viral and cellular readthrough signals. 
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IS THE VIRAL PROTEIN TAX A POST-TRANSCRIPTIONAL 
REGULATOR? 
 
Julia Neusiedler1, Vincent Mocquet2, Pierre Jalinot3  
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Correct expression of genetic information is essential for life, and several 
quality control systems have evolved to ensure accurate protein synthesis. 
One of these processes, termed nonsense-mediated mRNA decay (NMD), 
represents a translation-dependent posttranscriptional mRNA quality 
control process that degrades mRNAs containing premature termination 
codons (PTCs) and is also known to regulate non-mutated genes such as 
Gadd45α. In our laboratory we observed that a protein named INT6 
interacts with the core NMD factors UPF1 and UPF2. INT6 removal clearly 
results in the stabilization of PTC- containing mRNAs. Interestingly, our 
team detected as well an interaction between INT6 and the transcriptional 
activator of HTLV-1, Tax.  
To address the question of a putative impact Tax may have on NMD we 
have started deciphering the interaction network between the viral protein, 
INT6 and the UPFs by immunoprecipitation experiments. We were able to 
demonstrate that Tax prevents the correct interaction between INT6 and the 
UPF1/2 complex, suggesting that Tax titrates INT6 and delocalises it out of 
reach from the UPFs. Furthermore we observed an interaction with the 
phosphorylated form of UPF1 (which is active during NMD). Moreover, in 
Tax transfected cells immunofluorescence experiments revealed INT6 
delocalization as well as important changes in the shape and number of 
cytoplasmic structures named P-bodies. Taken together these data suggest 
that Tax might modulate the efficiency of the decay pathway. Thus we 
analysed the half life of mRNA in Jurkat cells expressing or not Tax. We 
observed a significant stabilization of canonical NMD targets.  
This work will contribute to a better understanding of both the basics of 
NMD and some effects of HTLV-1 infection on cell transformation.Tax, 
which trans-activates the expression of viral and cellular genes by binding 
to various enhancer-binding proteins needed for transcription could have an 
impact on the NMD and interfere at the post-transcriptional level of gene 
regulation 
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ROLE OF ENDOGENOUS DICER DEPENDENT PROCESSES IN THE 
DEVELOPMENT OF MOUSE RETINA AND TELENCEPHALON 
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Dicer is a type III endoribonuclease necessary for the maturation of micro 
RNAs. RNA interference is a biological process by which small RNA 
molecules can induce Post Transcriptional Gene Silencing (PTGS) by 
inhibiting translation of specific messenger RNAs or targeting them to 
degradation in the RNA Induced Silencing Complex RISC.  
 
The aim of this study was to investigate the role of Dicer dependent 
processes in cell division, death and differentiation during early 
development of mouse retina and telencephalon.  
 
Using the cre-LoxP recombination system, we mutated Dicer in mouse 
embryonic telencephalon and retina and investigated the expression of 
markers of the proliferative and differentiating pools. We found that the 
progenitor population was reduced in the dorsal telencephalon homozygous 
for Dicer mutation with no change in the proportions of neurons generated 
by embryonic day E12.5. We also noted that a lower proportion of early 
born neurons were located close to the pia. No difference was found in the 
overall dorso-ventral patterning of the telencephalon. Widespread tissue 
apoptosis was noticeable at E10.25 and profound at E12.5, but did not seem 
to show any differences along the depth of the telencephalic wall.  
 
Taken together, our results suggest that Dicer dependent processes are 
required for proliferation and survival of early neural progenitors in the 
mouse embryonic retina and telencephalon, as well as differentiation of 
early born neurons. 
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The vascular endothelial growth factor A (VEGF) is one of the most 
important regulators of both physiological and pathological angiogenesis. 
Expression of VEGF is tightly regulated at the transcriptional level, but 
little is known about its post-transcriptional control. The VEGF mRNA 
5’UTR contains two internal ribosome entry sites (IRES) A and B, which 
are able to promote efficient translation in a 5’cap-independent manner.  
We focus on the identification and functional analysis of cellular factors 
that are required for VEGF IRES-driven initiation of translation as well as 
the function of the VEGF mRNA 3’UTR in this process.  
For this purpose we established an in vitro translation assay based on MCF7 
breast cancer cell extract that demonstrates VEGF IRES and 3’UTR-
dependent translation of reporter mRNAs. Employing tobramycin aptamer 
affinity purification to isolate RNA binding proteins and RNA-protein 
interaction studies we identified cellular factors, which specifically bind to 
the VEGF mRNA IRES elements and/or the 3’UTR. Results of in vitro and 
in vivo assays, which were applied to characterize the functional relevance 
of individual factors for VEGF IRES-mediated translation will be 
discussed.  
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Erythroid precursor cells loose the capacity for mRNA synthesis due to 
exclusion of the nucleus during maturation. Therefore, stability and 
translation of mRNAs that code for specific proteins, which function in late 
stages of maturation when reticulocytes become erythrocytes are controlled 
tightly. Reticulocyte 15-lipoxygenase (r15-LOX) initiates the breakdown of 
mitochondria in mature reticulocytes. Through the temporal restriction of 
mRNA translation, the synthesis of r15-LOX is prevented in premature 
cells. The enzyme is synthesized only in mature reticulocytes, although r15-
LOX mRNA is already present in erythroid precursor cells. Translation of 
r15-LOX mRNA is inhibited by hnRNP K and hnRNP E1, which bind to 
the differentiation control element (DICE) in its 3’ un-translated region 
(3’UTR)1. The hnRNP K/E1-DICE complex interferes with the joining of 
the 60S ribosomal subunit to the 40S subunit at the AUG2. We took 
advantage of the inducible human erythroid K562 cell system that fully 
recapitulates this process to identify so far unknown factors, which are 
critical for DICE-dependent translational regulation. Applying RNA 
chromatography with the DICE as bait combined with hnRNP K 
immunoprecipitation we specifically purified the DEAD-box RNA helicase 
6 (DDX6) that interacts with hnRNP K and hnRNP E1 in a DICE-
dependent manner. Employing RNA interference (RNAi) and Fluorescence 
in situ hybridization (FISH), we show that DDX6 co-localizes with 
endogenous human (h)r15-LOX mRNA to P-body-like RNP granules, from 
which 60S ribosomal subunits are excluded. Our data suggest that in 
premature erythroid cells translational silencing of hr15-LOX mRNA is 
maintained by DDX6 mediated storage in these RNP granules.  
 
1 Ostareck, D.H., Ostareck-Lederer, A. et al. (1997). Cell 89, 597-606  
2 Ostareck, D.H., Ostareck-Lederer, A. et al. (2001). Cell 104, 281-290  
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“Ribosomal scanning” is the generally accepted hypothesis for explaining 
how eukaryotic 40S ribosomal subunits locate initiation codons that are far 
removed from the ribosome recruiting site (cap structure). However, 
recently described phenomena that cannot be explained by a ribosomal 
scanning mechanism challenge this prevailing view. Here, we show that 
cap-dependent translation occurs by “RNA looping” without involving 
scanning through the intervening mRNA segment between the cap structure 
and the initiation codon. The RNA looping hypothesis provides logical 
explanation for augmentation of translation by some, if not all, enhancing 
elements located upstream and/or downstream of a protein-coding region. 
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DFMRP AND CAPRIN, TRANSLATIONAL REGULATORS OF 
SYNAPTIC PLASTICITY, CONTROL THE CELL CYCLE AT THE 
DROSOPHILA MID-BLASTULA TRANSITION 
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The molecular mechanisms driving the conserved metazoan developmental 
shift referred to as the mid-blastula transition (MBT) remain mysterious. 
Much has been learned about how degradation of maternal mRNA and 
initiation of zygotic transcription contribute to the MBT, however the 
translational regulatory mechanisms that modulate rates of protein synthesis 
during this transition are largely unexplored. During the MBT cleavage 
divisions give way to longer asynchronous cell cycles with the acquisition 
of a gap phase. In Drosophila, rapid synchronous nuclear divisions must 
pause at the MBT to allow formation of a cellular blastoderm through a 
special form of cytokinesis termed cellularization. We previously found that 
the transcript-specific translational regulator Drosophila Fragile X mental 
retardation protein, (dFMRP), is required for the major morphological event 
of the MBT, cellularization (Monzo et al., 2006). The role of FMRP has 
been most extensively studied in the nervous system because the loss of 
FMRP activity in neurons causes the misexpression of specific mRNAs 
required for synaptic plasticity, resulting in mental retardation and autism in 
humans. However we find that in the early embryo dFMRP associates 
specifically with Caprin, another transcript-specific translational regulator 
implicated in synaptic plasticity, and eIF4G, a key regulator of translational 
initiation. dFMRP and Caprin associate with both Cyclin B and frühstart 
mRNAs, but function to activate translation of frühstart while repressing 
translation of Cyclin B to appropriately modulate the cell cycle at the MBT. 
The identification of Caprin as a partner for dFMRP in this novel context, 
the MBT, suggests that these proteins may respond together to diverse 
developmental signals. *These authors contributed equally to the work. 
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PHOSPHORYLATION OF EIF2B IN YEAST. 
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The guanine nucleotide exchange factor (GEF) eIF2B functions in 
translation initiation to re-activate eIF2 for subsequent initiation events. 
Phosphorylation of eIF2α to inhibit eIF2B function and regulate translation 
during various cell stress responses is critical in all studied eukaryotic cells. 
During our studies into eIF2B function and regulation in yeast 
Saccharomyces cerevisiae, we found that 2 subunits of eIF2B are 
phosphoproteins. Using mass spectrometry we identified eight 
phosphorylated-residues in the yeast eIF2Bγ and ε subunits. We have 
investigated their role in regulating eIF2B activity. Phospho-residues were 
mutated to non-phosphorylatable Ala or phospho-mimetic Asp/Glu, singly 
or in combinations, and introduced into yeast as the sole source of each 
protein. All mutants assessed are viable under standard growth conditions, 
although each exhibits varied growth sensitivities under conditions where 
translation is impaired. Alanine replacement at one phospho-residue in 
eIF2Bε (S435) causes growth arrest under all stress conditions tested. 
Microscopic examination revealed a cell cycle specific arrest. Through the 
use of custom made phospho-specific antibodies, we have monitored how 
phosphorylation of eIF2B subunits fluctuates through the cell cycle in 
synchronized cells and in the presence of cell cycle arresting compounds. 
S435 is phosphorylated when cells are synchronized using nocodazole 
(G2/M), but not α-factor (G1/S) phosphorylation of other eIF2B residues 
show a reverse correlation. Thus changes in phosphorylation of yeast eIF2B 
subunits through the cell cycle contribute to control of translation and cell 
growth. 
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IRES MEDIATED REGULATION OF LAMININ B1 TRANSLATION 
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The majority of transcripts that contain internal ribosome binding sites 
(IRES) and their corresponding proteins are involved in tumor progression. 
A crucial aspect of tumor progression referred to as epithelial to 
mesenchymal transition (EMT) allows tumor cells to acquire metastatic 
properties. Expression profiling of polysome-associated mRNA revealed 
Laminin B1 (LamB1) to be translationally upregulated upon EMT of 
malignant hepatocytes. The activation of LamB1 translation in metastatic 
hepatocytes was found to be IRES mediated by employing two different 
bicistronic reporter systems. Stringent assays for cryptic promoter and 
splice sites were performed with both reporter systems revealing no 
aberrantly expressed LamB1 transcripts. Interestingly, RNA-
immunoprecipitation identified La/SSB as transacting factor that binds to 
LamB1 mRNA in vivo. Furthermore, translation control of LamB1 during 
cancer progression depends on Ras subeffector signaling in cooperation 
with tumor-promoting functions of TGF-beta. Time course analysis showed 
reduced MAPK and PI3K signaling due to cellular stress directly after 
initiation of EMT, while those pathways were stimulated after long term 
treatment with TGF-beta. Noteworthy, IRES-mediated translation of 
LamB1 was activated during the initiation phase of EMT as cap-dependent 
translation was repressed. In accordance, LamB1 translation increased upon 
induction of cellular stress by heat shock treatment or interference with cap-
dependent translation by exogenous 2A protease expression. In summary 
these data provide evidence that the LamB1 5’UTR contains an IRES that 
mediates translational upregulation during TGF-ß dependent EMT and 
cancer progression. 
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Nearly all protein synthesis occurring in organisms from bacteria to humans 
initiates at an AUG start codon. Interestingly, the nucleotides flanking the 
AUG start codon are not random. In mammals, there is a strong preference 
for A or G at position -3 and G at position +4 relative to the A(+1) of the 
AUG codon. Our analysis of the yeast S. cerevisiae genome revealed a clear 
bias for A at positions -4 to -1 preceding the AUG codon, and a bias against 
C at position +4. Studies of mammalian translation established a start codon 
consensus sequence, (A/G)-C-C-AUG-G, and mutating this optimal 
sequence significantly impaired translation. Whereas previous studies 
suggested that flanking nucleotides play a minor role in AUG codon 
selection in yeast, our results using a sensitive reporter assay based on leaky 
scanning of an upstream AUG codon in the GCN4 mRNA reveal prominent 
roles for the flanking nucleotides. Of the single mutations tested, 
substituting U at position -3 for the consensus A had the most severe impact 
on translation. In addition, we found that replacing the optimal context A-
A-A-AUG-G with the least preferred context increased the frequency of 
leaky scanning of the AUG codon over 100-fold. In contrast to studies in 
mammalian cells indicating a positive impact of inserting C at position -2 
and -1 to improve recognition of an AUG codon in poor context, these 
mutations had no impact or led to increased leaky scanning in yeast. 
Consistent with these results from the GCN4 reporter system, replacing the 
natural good context of the CYC7 start codon with the non-preferred 
context decreased CYC7 reporter expression by ~70%. Taken together these 
results reveal that AUG context can have a significant impact on start codon 
selection in yeast, and our ongoing analyses are aimed at identifying factors 
that contribute to the flanking nucleotide dependence of AUG start site 
selection. 
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The endogenous mechanisms for resolving inflammation are poorly 
understood. We previously demonstrated that in monocytes and 
macrophages the IFN-g induced synthesis of a cluster of mRNAs encoding 
different chemokines, chemokine receptors and other inflammatory proteins 
are under translational control1. This control mechanism relied on IFN-
Gamma-Activated Inhibitor of Translation (GAIT) complex and its binding 
to the GAIT element located in the 3’ untranslated (UTR) region of the 
target mRNAs. Subsequent studies from our laboratory using a cell-based 
model identified the absolute requirement of ribosomal protein L13a in the 
translational silencing of this cluster of target mRNAs encoding 
inflammatory proteins. We hypothesized that L13a-dependent translational 
silencing is an endogenous defense mechanism in monocytes/macrophages 
against runaway inflammatory response and that genetic disruption of this 
pathway could compromise the resolution phase of inflammation. To 
directly test this hypothesis we have recently generated macrophage specific 
L13a-knockout (KO) mice using the Cre-Lox system. Upon endotoxin 
challenge the KO mice displayed prolonged symptoms of severe 
inflammation particularly at the recovery phase e.g. significantly reduced 
motor activity, high breathing rates, ocular exudates and piloerection. In 
addition we found significant increase of Gr1, CD11b and F4/80- positive 
cells in the peritoneum, showing the infiltration of neutrophils and 
macrophages. Our preliminary studies also show increased polysomal 
abundance of GAIT-target mRNAs in the macrophages harvested from the 
KO mice, thus showing the abrogation of translational silencing. We plan to 
present a comprehensive study showing other markers of inflammation 
using organ histopathology, and measuring the serum level of inflammatory 
cytokines, blood urea nitrogen (BUN) and aspartate aminotransferase 
(AST). Taken together, our results using the first animal model of L13a-
knockout document the essential role of L13a dependent translational 
silencing in the resolution of inflammation. 
 
1. Vyas, K. et al, Genome-wide polysome profiling reveals an 
inflammation-responsive posttranscriptional operon in gamma interferon-
activated monocytes. Mol Cell Biol, 2009, 29:458-47 
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Gene expression is an essential cellular process that must be carefully 
controlled to ensure an organism’s survival. Whereas transcriptional 
regulation has been studied intensively, factors contributing to translation of 
mRNA transcript into protein have proven more difficult to understand. In 
this work, we present a model that improves on measures of protein 
synthesis and describe a way to calculate efficiency of translation based on 
various endogenous properties of a transcript. 
 
The recent work of Ingolia et al. [1] utilizes deep sequencing of ribosome-
protected fragments (footprints) to extract the density of translating 
ribosomes per codon along genes in Saccharomyces cerevisiae. Although 
the average footprint count per gene roughly represents translation rate, the 
counts are inflated/deflated at slow/fast positions in a transcript. Assuming a 
constant ribosome flow per transcript, we present a sophisticated 
computational model that accounts for these differential translocation rates 
and elucidates governing factors of ribosomal pausing. Our model provides 
higher-quality estimates for protein synthesis rates, compared to previous 
experimental measures of protein abundance. We also show that the codon 
at each position plays a significant role in ribosomal pausing, as expected, 
but the local mRNA secondary structure does not. 
 
Using just our improved translational efficiency measures and the mRNA 
levels of budding yeast with a different ploidy, we can predict protein 
abundance in this new environment more accurately than simply using 
mRNA abundance. We find that high translational efficiency is correlated to 
the following: low folding energy of the window around the start codon 
(loose fold), presence of the Kozac site initiation motif, low folding energy 
of the 5' UTR, high usage of preferential codons along the gene, and 
presence/absence of RNA binding proteins known to help/inhibit 
translation. Using linear regression on these features, we can accurately 
predict the translational efficiency of a test set of genes not seen in model 
training, indicating we have captured a large degree of the regulatory 
landscape affecting translation. 
 
[1] N.T. Ingolia et al., (2009) Science 324:218-223 
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Termination-dependent reinitiation is a translational mechanism used to co-
ordinate the levels of viral protein expression, and has been characterised in 
a number of caliciviruses, influenza B, several of the pneumoviruses and in 
the dsRNA virus of chestnut blight fungus, Cryphonectria hypovirus-1. 
These examples differ from most cases of reinitiation in that the ribosome 
gains the ability to reinitiate following translation of a long, coding ORF, 
without any apparent transactivator. One example of termination-
reinitiation occurs in coupled expression of the M1 and BM2 open-reading 
frames (ORFs) from the dicistronic segment 7 influenza B mRNA. The 
AUG start codon of the BM2 ORF overlaps with the stop codon of the M1 
ORF in the pentanucleotide UAAUG, and BM2 synthesis is dependent on 
translation and termination of the upstream ORF.  
 
BM2 expression requires 45nt of RNA immediately upstream of the 
UAAUG pentanucleotide. This region, known as the termination upstream 
ribososome binding site (TURBS) is required for reinitiation on the BM2 
AUG and is split into sequence-specific and sequence-independent 
elements. Importantly, the sequence-dependent elements fit to an RNA 
secondary structure, whilst the sequence independent elements fit within a 
spacer region on the proposed structure. The TURBS region encodes a 
sequence complementary to 18S rRNA which likely plays a role in tethering 
the 40S subunit to the mRNA post-termination. Movement of the stop and 
start codons indicates that termination too far downstream of the 18S 
complementary sequence inhibits termination-reinitiation, likely due to 
reduced 40S tethering, yet the placement of the reinitiation site is more 
flexible. We have characterised the mRNA:rRNA interaction further in 
yeast, and using antisense oligonucleotides in vitro, which lend further 
support to an interaction that promotes ribosome tethering to the RNA 
following termination, allowing a proportion of ribosomes to reinitiate on 
the BM2 AUG. In addition, eIF3 stimulates reinitiation frequency, and we 
are further investigating the role of this factor in the reinitiation process. 
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The murine atrial cardiomyocyte-derived HL-1 cell line maintains a 
differentiated cardiac phenotype and spontaneously contracts in culture. 
Because of these features is frequently used as a model system to 
understand cardiac biology. We performed SOLiD™ sequencing on small 
RNA obtained over a 4-day growth time-course as HL-1 cells transition 
from a progenitor- to a beating heart-like state. Using a quality-score 
weighting approach to deal with sequencing errors we mapped 43-million 
reads to miRBase v15 (average length 22nt). We found a 45% global 
increase in miR levels across the time-course, with few miRs exhibiting 
differential expression. Many miRs with known roles in cardiac biology are 
highly expressed in HL-1 cells (eg miR-1, miR-133). Interestingly, we 
detect expression of many miR variants. 6.8% of miR reads represented 5’ 
iso-miRs (starting position offset to miRBase entry); in some cases the 
isomiR was the most abundant species (e.g. ‘cardiac’ miR-133a). 6% miR 
reads mapped to the ‘*’ strand of the miR duplex; for some miRs this 
represented the major species (e.g. the ‘cardiac’ miR-208a). A further 5-
million reads mapped uniquely to other sites in the genome. Sites of notable 
expression (>100 reads) included those overlapping with annotated features 
such as snords, tRNAs, repeat sequences, and intronic/UTR regions. Our 
data reveal surprising complexities in the expression of known miRs, 
document the existence of novel miRs and other small RNAs, and provide a 
compendium of cardiomyocyte small RNAs that can inform future research 
into cardiac biology and disease. 
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Modified nucleosides play important roles in RNA function and have been 
identified in multiple types of RNA including tRNAs, rRNAs, mRNAs, and 
small regulatory RNAs. Among these modifications, 5-methylcytidine 
(m5C) has been detected in rRNAs, tRNAs, and early reports suggested its 
presence also in mRNAs. Known and well studied as an epigenetic mark in 
DNA, the prevalence and function of m5C in RNA is either incompletely 
explored (tRNA, rRNA) or virtually unknown (mRNA, other noncoding 
RNA). Detection of m5C within DNA is readily carried out using bisulfite 
sequencing. We have been able to adapt this procedure for transcriptome-
wide m5C analysis, using a combination of bisulfite conversion of cellular 
RNA samples followed by SOLiD™ next-generation sequencing. Analysis 
of an mRNA-enriched HeLa cell RNA preparation yielded ~108 high 
quality 50mer reads, which were mapped to a custom reference 
transcriptome consisting of the human NCBI RefSeq database with some 
additions. Mapped reads were then mined for evidence of cytosine non-
conversion at particular positions, resulting in the detection of most 
previously known m5C sites in tRNA and rRNA. We furthermore identified 
a wealth of novel candidate residues in different RNA species, including 
mRNAs and other noncoding RNAs, which we are currently cataloguing, 
verifying and testing for function. Although entirely speculative at this 
point, an exciting prospect is that we may uncover patterns of m5C in 
(m)RNAs that serve as a molecular imprint of the mRNA’s history and/or to 
mark them for differential post-transcriptional fates. 
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Environmental conditions that disrupt Endoplasmic Reticulum (ER) 
homeostasis cause the accumulation of unfolded proteins in the ER lumen, a 
condition known as ER stress. ER stress triggers the unfolded protein 
response (UPR), a largely cytoprotective signaling cascade that re-
establishes ER homeostasis by inducing an early and transient block in 
protein synthesis and by increasing the folding and degradative capacity of 
the cell. The early and transient attenuation of mRNA translation under the 
UPR occurs as a result of phosphorylation of the eukaryotic initiation factor 
eIF2 on its alpha subunit by the activated ER transmembrane protein kinase 
PERK. While translation of most proteins is blocked under these conditions, 
the expression of transcription factor ATF4 is increased due to the presence 
of short open reading frames in its 5’ UTR. A target of ATF4 is GADD34, 
which acts with PP1 to de-phosphorylate eIF2alpha and restore global 
translation. 
 
While the mechanism for early and transient translational attenuation during 
ER stress has been described, translation control under prolonged ER stress 
is not well understood. Our data demonstrates that with prolonged ER stress 
treatment, protein translation is not fully restored to pre-stressed levels. 
Even after 24 hours of ER stress treatment and after eIF2alpha is de-
phosphorylated, we show that total protein synthesis only reaches 
approximately 80% of the level before stress. This incomplete recovery of 
translation is in spite of increases in the translation of ER chaperones and 
components of the ER degradation machinery and appears to affect a 
specific subset of proteins. Our experimental evidence demonstrates that 
prolonged endoplasmic reticulum stress reduces phosphorylation of 4EBP1 
and increases 4E-BP1’s ability to bind to the 7M-GTP cap, thus negatively 
regulating assembly of the eIF4F complex and cap-dependent translation. 
Furthermore, we show that the subset of mRNAs that do not recover from 
UPR-induced translational repression include those with complex 5’ 
untranslated regions, including cyclin D1. These mRNAs are particularly 
sensitive to loss of functional eIF4F, implicating 4E-BP1 
hypophosphorylation as a mechanism for the incomplete translational 
recovery during prolonged ER stress. 
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Some normally capped cellular mRNAs harbor internal ribosome entry 
sequences (IRES) that can mediate translation, especially during inhibition 
of cap-dependent translation. Previous work showed that the 3’ poly(A) tail 
enhances ribosome recruitment to cellular IRES-containing mRNAs, 
independently of the canonical poly(A)–binding protein, PABP (Thoma et 
al.,2004, Mol Cell.15:925-35; Thoma et al., 2008, RNA (8):1579-89). 
Depletion of PABP from the HeLa cell translation extracts impairs cap-
mediated translation of a polyadenylated mRNA template, but does not 
affect poly(A)-tail stimulated IRES-mediated translation. Using the c-myc 
mRNA IRES as model, we developed a functional complementation assay 
to identify the regulatory factor(s) responsible for the poly(A) tail 
stimulation of IRES activity. We passed a PABP-depleted extract over a 
poly(A)- (or a control poly(C)) -sepharose column, resulting in specific 
depletion of factor(s) for c-myc IRES-driven translation. A ribosomal salt 
wash was found to complement the missing factor(s), and we followed such 
activity over several purification steps. While further steps are still 
necessary for the identification of the factor(s) of interest, the results will 
enable us to gain insight on mechanistic details of translation control of 
cellular IRES and reveal the cellular IRES poly(A) tail promoting factor(s) 
(CIP). 
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Induction of BiP, a chaperone of the endoplasmic reticulum (ER), an ER 
stress marker, and master regulator of unfolded protein response (UPR) by 
agents such as lithium chloride, salubrinal, GSSG, DTT, tunicamycin, and 
brefeldin is found to interfere in the eIF2alpha phosphorylation- mediated 
cell death in the ovarian cells of Spodoptera frugiperda (Sf9) which are 
natural hosts of baculovirus. Cells experiencing ER stress and expressing 
BiP partly resist non ER stress-induced eIF2alpha phosphorylation 
mediated cell death. Complementing these observations, depletion of BiP 
stimulates the caspase activation of Sf9 cell extracts prepared from 
tunicamycin treated cells and supplemented with phosphomimetic form of 
eIF2alpha thereby suggesting that BiP intereferes into the eIF2alpha 
phosphorylation mediated caspase activation. Inhibitors of ERK 
phosphorylation associated with inhibition of BiP expression also stimulate 
caspase activation and cell death. Further analysis reveals that BiP interacts 
with active caspase (s), cytochrome C and more efficiently with 
unphosphorylated eIF2alpha than with phosphorylated eIF2alpha. These 
findings therefore suggest that BiP may be interfering in the interprotein 
interactions affecting eIF2alpha phosphorylation mediated caspase 
activation and cell death. (Financial support by DST, New-Delhi to KVAR 
and CSIR research fellowships to AI, and KR is acknowledged).  
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Trans-translation is an important ribosome rescue mechanism in bacteria. It 
is mediated by tmRNA (or SsrA RNA), a highly structured RNA molecule 
comprising mRNA and tRNA functions and four pseudknots, together with 
its cofactor small protein B (SmpB). The tmRNA•SmpB heterodimer 
recycles ribosomes, which are stalled on defective mRNAs lacking an in 
frame stop codon. During trans-translation the tRNA like domain of 
tmRNA (TLD) together with SmpB binds to the vacant and codon lacking 
A site and gets translocated through the ribosome. The mRNA like domain 
encodes for a degradation tag which is added to the C-terminus of the 
protein fragment and targets it for proteolysis [1,2,3]. Beside the very early 
steps of trans-translation [4,5] detailed structural information about the 
tmRNA passage through the ribosome is lacking. 
Here we present a cryo-EM structure of the fusidic acid (FA) stalled 
70S•tRNA•tmRNA•SmpB•EF-G•GDP•FA complex at sub-nanometer 
resolution. The complex contains two tRNA / tRNA like entities, the tRNA 
like domain together with SmpB and a deacylated tRNA in intermediate 
positions during translocation. It represents the first structural view of the 
tmRNA•SmpB heterodimer in the process of translocation. Our data reveal 
how the TLD•SmpB module is moving through the ribosome and how the 
mRNA like domain is loaded into the mRNA entry channel. This structure 
provides unique insights into the structural organization of the ribosome and 
the mutual arrangements of large ligands, such as EF-G and tmRNA, during 
the first translocation during trans-translation. 
 
References: 
[1] Keiler K.C., Waller P.R. and Sauer R.T. (1996), Science 271,990-993 
[2] Hanawa-Suetsugu K., Takagi M., Inokuchi H., Himeno H. and Muto A. 
(2002), Nucleic Acids Res 30,1620-1629 
[3] Gottesman S., Roche E., Zhou Y. and Sauer R.T. (1998), Genes Dev 
12,1338-1347 
[4] Valle M., Gillet R., Kaur S., Henne A., Ramakrishnan V. and Frank J. 
(2003), Science 300,127-130 
[5] Kaur S., Gillet R., Li W., Gursky R. and Frank J. (2006), PNAS 
103,16484-16489. 
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TRANSLATIONAL UPREGULATION OF PROTEIN KINASE C 
ACTIVATES NUCLEAR FACTOR -ΚB AND AUTOPHAGY 
 
Hadas Raveh-Amit, Alex Braiman, Etta Livneh  
 
Ben-Gurion Universuty, Microbiology and Immunology, Beer-Sheva, 
84105, Israel 
 
Different stresses activate a family of eukaryotic initiation factor 2 (eIF2) 
kinases that phosphorylate eIF2, leading to an adjusted gene expression 
profile in the cell. eIF2 phosphorylation reduces global translation, but also 
induces translation of specific mRNAs that are needed for the cells to cope 
with the stress. We have recently reported that the translation of a Protein 
Kinase C (PKC) isoform, PKCeta, is upregulated in response to amino acid 
deprivation by two upstream Open Reading Frame (uORFs) in its 5' 
Untranslated Region [Raveh-Amit et al., Mol Cell Biol. 2009 
Nov;29(22):6140-8]. This upregulation is dependent on the eIF2 kinase 
General Control Non-derepressible-2 (GCN2). Here we examined the 
functional role of the upregulation of PKCeta during amino acids 
deprivation. To do this we utilized PKCeta-expressing and shRNA 
knocked-down cells. Our results suggest that PKCeta is important for 
autophagy induction since amino acids deprivation induced- autophagy was 
abrogated in PKCeta- knocked cells. It was previously shown that eIF2 
phosphorylation activates nuclear factor κB (NF-κB) by lowering the 
translation of the short-lived regulatory protein IκB (inhibitor of NF-κB). 
Here we show that NF-κB is activated during amino acids deprivation and 
that this activation is partly dependent on PKCeta expression. Thus, eIF2 
phosphorylation upon stress leads to NF-κB activation by multiple 
mechanisms. Whether NF-κB is required for PKCeta induced- autophagy in 
response to amino acids deprivation is yet to be determined. Overall, we 
found that PKC translational upregulation in response to eIF2 
phosphorylation stimulates NF-κB activation during amino acids 
deprivation.  
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CHARACTERIZING THE ROLE OF THE UBIQUITIN-RELATED 
MODIFIER URM1P IN TRANSLATION BY THIOLATING THE 
WOBBLE POSITION OF SPECIFIC TRNAS  
 
Vanessa Rezgui1, Sebastian A Leidel1, Patrick G Pedrioli2, Matthias Peter1  
 
1ETH Zurich, Institute of Biochemistry, Zurich, 8093, Switzerland, 
2University of Dundee, SCILLS, Dundee, DD1 5EH, United Kingdom 
 
Translation fidelity depends on correct codon-recognition by transfer RNAs 
(tRNAs). To assure this specificity tRNA molecules are highly modified. In 
particular modifications of nucleotides located in or adjacent to the 
anticodon may directly influence protein translation. While Saccharomyces 
cerevisiae cells lacking single modification enzymes are viable under 
standard conditions, they are sensitive to various stress conditions and lethal 
when combined. Uridine34 of the anticodon of tKUUU (tK), tQUUG (tQ), and 
tEUUC (tE) carries such a modification, the 5-methoxy-carbonyl-methyl-2-
thio (mcm5s2) group. Recent work revealed that the conserved URM1-
pathway is responsible for the 2-thio modification, but the functional 
relevance of this modification in vivo is still poorly understood. 
Interestingly, urm1Δ cells are sensitive to the growth inhibitory drugs 
caffeine and rapamycin and to the oxidizing agent diamide, and these 
sensitivities can be rescued by overexpression of the unmodified tRNAs. 
However, while sensitivities to caffeine and rapamycin are rescued to a 
large extend by over-expression of tQ, diamide requires over-expression of 
tK. These data point to a role of tRNA thiolation in the regulation of a 
subset of proteins rather than in general translation. Indeed, polysome 
profiles of urm1Δ and wild-type cells are comparable, and urm1Δ cells are 
only weakly sensitive to the general translation inhibitors cyclohexamide 
and hygromycin B. In contrast they are very sensitive to paromomycin, an 
antibiotic known to increase misincorporation. In order to identify the 
proteins affected by lack of URM1 under different conditions, we are 
combining genetic suppression screens with quantitative proteomics. 
Moreover, we developed a modular fluorescent reporter system, which 
allows comparing the effect of specific codon sequences on protein 
expression in wild-type and urm1Δ cells. Preliminary results revealed that 
stretches of codons requiring the mcm5s2 tRNA modification specifically 
decrease translation efficiency. We will analyze different codon-traps to 
elucidate the general rules of the codon composition to complement and 
guide experimental approaches with an unbiased bioinformatic analysis. A 
better understanding of the effect of thiolation on protein synthesis will help 
to clarify how modification at the wobble position affects translation and 
how tRNA modification may regulate protein translation of a subset of 
proteins in response to different stress conditions. 
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Epstein–Barr virus (EBV) and Rhesus lymphocryptovirus (rLCV) are closely related 
herpesviruses that infect and trigger tumors and lymphoproliferative diseases in 
humans and rhesus monkeys, respectively. rLCV is an important model system for 
EBV pathogenesis. EBV and rLCV express microRNAs (miRNAs) from two 
genomic clusters. A remarkable 22 of 25 EBV pre-miRNAs are conserved in rLCV, 
yet little is known about the mRNAs targeted by EBV and rLCV miRNAs.  
 
We applied UV crosslinking immunoprecipitation and high-throughput sequencing 
(HITS-CLIP; Chi et al., 2009) to the Burkitt’s lymphoma cell line Jijoye to identify 
mRNA targets of both host and viral miRNAs expressed in unperturbed, EBV-
transformed B cells. Deep sequencing data of Argonaute-associated mRNAs yielded 
millions of unique reads that map to the human and EBV genome in hundreds of 3’ 
UTRs. Few viral genes appear to be targeted by miRNAs in these EBV-transformed 
cells; the vast majority (>99.6%) of sequence tags mapped to the human genome and 
the remainder to very select viral transcripts. Our data validate many previously 
identified EBV miRNA targets (Lo et al., 2007; Dolken, 2010) and yielded an 
extensive list of functionally-relevant potential EBV and human miRNA targets that 
are being validated by reporter assays.  
 
HITS-CLIP identification of mRNA-miRNA pairs relies on a bioinformatic 
connection between the sequence of biochemically purified mRNA tags and known 
miRNAs. Such predictions rely heavily on accurate annotation of miRNAs. We 
therefore applied deep sequencing technology to obtain a comprehensive inventory 
of rLCV miRNA expression in monkey B cells transformed with rLCV. Our data 
confirm the presence of all previously identified mature rLCV miRNAs and have 
resulted in the discovery of 21 new mature miRNAs arising from previously 
identified precursor (pre)-miRNAs, as well as two novel pre-miRNAs (rL1-34 and 
rL1-35) that together generate four new mature miRNAs. Thirty-five rLCV-encoded 
pre-miRNAs are processed into 68 mature miRNAs, the most of any virus 
examined. Most miRNAs exhibit marked sequence and length heterogeneity on both 
5' and 3' ends that could modulate function. Various length variants of rLCV mature 
miRNAs associate with Argonaute proteins in rLCV-infected B-cells. Validated 
mRNA targets of EBV compared to rLCV miRNAs will provide insights into viral 
function and the utility of rLCV as a model for EBV. 
 
Chi et al. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. 
Nature. 2009 Jul 23;460(7254):479-86. 
 
Dölken et al. Systematic analysis of viral and cellular microRNA targets in cells 
latently infected with human gamma-herpesviruses by RISC immunoprecipitation 
assay. Cell Host Microbe. 2010 Apr 22;7(4):324-34. 
 
Lo et al. Modulation of LMP1 protein expression by EBV-encoded microRNAs. 
Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16164-9.  
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BipA, also known as TypA, is a highly conserved prokaryotic GTPase that 
functions at a basal level to regulate numerous essential actions in bacteria. 
It is a member of the translational family of bacterial GTPases, which also 
includes EF-G, EF-Tu, IF2 and LepA. Although its exact cellular function 
remains elusive, BipA is involved in controlling stress and virulence events 
that secure bacterial survival and successful invasion of the host. Similar to 
other bacterial GTPases, the ribosome binding and GTPase activities of the 
protein are tightly coupled. An examination of the ribosome binding 
properties of the protein revealed that BipA has two ribosome binding 
modes. Under normal growth conditions, GTP-bound BipA associates with 
70S ribosomes while under conditions of stress, BipA:ppGpp associates 
with 30S ribosomes. However, the mechanism by which this occurs is still 
unknown.  
The crystal structure of the apo form of the protein revealed that the first 
four domains in BipA resemble those previously described for domains I, II, 
III and V in the EF-G/EF-2 family of translation factors, whereas the C-
terminal domain of BipA is unique. Biochemical studies demonstrate that 
the unique C-terminal domain is required for BipA to bind to either the 70S 
or 30S ribosomal species. Interestingly, deletion of this domain, as well 
successive truncation of domains III and V, resulted in a significant increase 
the intrinsic GTP hydrolysis rates of the protein and a loss of ribosome-
stimulated GTPase activity. The data cannot be explained by a simple relief 
of inhibitory contacts but instead suggest a reciprocal pathway of 
communication exists between the conformationally dynamic switch 
regions and the C-terminal domain of the BipA. Structural and biochemical 
data will be presented which describe how interdomain interactions 
contribute to the ribosome binding and also the biological activities of the 
protein. 
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Herpes simplex virus 1 (HSV-1) gene expression is a highly regulated 
process involving both transcriptional and post-transcriptional levels of 
regulation. Several viral transcription units encode sets of co-terminal 
transcripts as well as transcripts arising from alternative polyadenylation. 
The importance of such transcriptional complexity is unclear. We use the 
UL24 gene of HSV-1 as model gene to investigate post-transcriptional 
regulation of viral gene expression. UL24 is important for efficient viral 
replication, and also for reactivation from latency in mouse model of 
infection. UL24-deficient viruses also exhibit a syncytial plaque phenotype 
in cell culture, particularly at elevated temperature. There are three 
transcription start sites for UL24. During infection, alternative 
polyadenylation generates two sets of transcripts. Short transcripts, 
expressed with early kinetics, arise from use of the UL24 polyadenylation 
(polyA) signal, while long transcripts expressed with leaky-late kinetics, 
arise from use of the UL26 polyA signal. The objective of this project is to 
determine the importance of the different UL24 transcripts during infection. 
We hypothesize that the transcripts generated by differential 
polyadenylation have distinct functions. To test this hypothesis, we have 
generated recombinant viruses by homologous recombination in which the 
3’untranslated region (UTR) of UL24 has been mutated. To inhibit 
synthesis of the long UL24 transcripts, a stronger polyA signal, that of 
UL26, was inserted upstream of the endogenous weak UL24 polyA signal. 
Northern blot analyses confirmed that this mutation resulted in an increase 
in the amount of UL24 short transcripts as compared to levels with the wild 
type virus KOS, particularly at late times in infection. In contrast, we did 
not detect a difference in the general kinetics of expression of immediate-
early, early and late transcripts between wild type and mutant viruses. The 
change in the ratio of short versus long UL24 transcripts did not appear to 
affect expression of the other transcripts in the locus such as UL23, UL25 
and UL26. The UL24 polyA mutant exhibited a half log10 reduction in viral 
titer as compared to the wild type virus in a replication assay with multi step 
kinetics. The results of this project will contribute to a better understanding 
of the importance of different transcripts generated by alternative 
polyadenylation during herpes simplex virus infection 
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Background: There is accumulating evidence that microRNAs (miRNAs) 
are involved in drug metabolism and disposition. Since miRNAs can 
regulate the expression of drug metabolism or drug transporters, they might 
trigger some pharmacokinetic drug-drug interaction or provide new insights 
into multidrug resistance phenotype. The present study examined the effect 
of different xenobiotics agents (gemcitabine, daidzein, bilobalide, 
tanshinone IIA, paclitaxel, dexamethasone, imatinib, doxorubicin, 
mitoxantrone, and vinblastine) on the expression of 8 miRNAs (miR-27a, -
27b, -328, -324-3p, -1291, -451, -519c, and -148a) in MCF-7 and Caco-2 
cells after 48h-treatment. Material and Methods: MiRNAs expression was 
measured by SyBR GreenTM Real-time PCR assay in treated and control 
cells, and normalized to the level of small RNA U74. Results: In Caco-2 
cells, miR-27a/b, -328, -32-3p and -148 were highly expressed (Cq values 
below 25) at basal level, and miR-1291, -519c and -451 were moderately 
expressed (Cq values between 25 and 30). In MCF-7 cells, miR-27a, -27b, -
324 and -148a were -highly expressed, and miR-328 and 451 were 
moderately expressed, whereas miR-519c level was low (Cq values higher 
than 30). Vinblastine (1 µM) significantly decreased the expression of miR-
27b, -27a, -324-3p, -328, -451 and -148a in MCF-7 cells. Paclitaxel (5 µM) 
and tanshinone II A (1 µM) treatment increased miR-148a and miR-328 by 
2- and 3-fold, respectively. Bilobalide (100 µM) significantly increased the 
expression of miR-27b, -328, -451 and -519c by 2- to 3-foldin MCF-7 cells. 
In contrast, bilobalide decreased miR-451 and -148a expression, and 
paclitaxel decreased miR-27b and -324-3p expression in Caco-2 cells. 
Doxorubicin treatment led to a 3-fold increase in miR-1291 expression, and 
imatinib and mitoxantrone increased miR-27a and miR-1291 by 2-fold. 
Dexamethasone, a known inducer of CYP3A4, also led to a decrease of 
miR-27b in Caco-2 cells. Conclusion: These results reveal that xenobiotic 
agents exhibit differential effects on miRNA expression, and the effects 
may be cell dependent. 
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The binding of mammalian 4E-BPs to eIF4E is defined by their 
phosphorylation status, that itself is regulated by different environmental 
signals such as stress. In yeast, one 4E-BP ist the small acidic protein p20. 
We are studying the nature of possible posttranslational modifications that 
might regulate the interaction of p20 with yeast eIF4E. We have performed 
2D gel electrophoresis of yeast extracts and analysed p20 by immunoblot 
techniques. We observe at least five p20 spots that differ in their isoelectric 
point. Exposure to different stresses, as well as mutating putative 
phosphorylation sites lead to a shift of p20 spots to more basic forms. 
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The protein eIF5A is highly conserved from archaea to mammals and is 
structurally related to the eubacterial elongation factor P (EF-P). eIF5A is 
essential for cell viability and growth and it is the only protein known to 
contain the amino acid hypusine, a posttranslational modification of a 
specific lysine residue that requires the polyamine spermidine. Although 
eIF5A stimulates the synthesis of the first peptide bond and was initially 
identified as a translation initiation factor, recent studies strongly support a 
function for eIF5A in the elongation step of protein synthesis. However, the 
mode of action of eIF5A is still unknown. Here, we analyze the oligomeric 
state of yeast eIF5A in solution. First, we show using size-exclusion 
chromatography that this protein exists as a homodimer in solution, 
independently of the hypusine residue. Experiments using SAXS suggest 
that the shape of the homodimer is similar to that observed for the EF-P 
crystal structure, and \ it superimposes with the two eIF5A molecules found 
in the assymetric unit of the yeast eIF5A crystal structure. Finally, using 
pulldown assays we show that eIF5A is able to form oligomers in cell 
extracts, in a RNA-dependent manner, but independent of the ribosome. 
These data suggest that eIF5A exists as a homodimer in vivo as well as in 
vitro. 
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Double-stranded RNA, generated during viral infection, activates the 
protein kinase PKR, which phosphorylates the alpha subunit of eukaryotic 
translation initiation factor 2 (eIF2α). This leads to inhibition of translation 
and viral replication. Many viruses in turn evolved PKR inhibitors, 
including vaccinia virus K3L, which acts as an PKR pseudosubstrate. K3L 
is important for infection of mouse and hamster cells but not for human 
cells. We have previously shown that the kinase domain of PKR evolved 
much faster in vertebrates than those of the other eIF2α kinases HRI, PERK 
and GCN2. This faster evolution of PKR is due to positive selective 
pressure, likely exerted by K3L-like poxvirus pseudosubstrates.  
We compared the sensitivity of mouse, hamster, rabbit and human PKR to 
K3L inhibition. Rodent and rabbit PKR are much more sensitive to K3L 
inhibition than is human PKR, which correlates with the importance of K3L 
for vaccinia virus infection of rodent but not human cells. Since the natural 
host of vaccinia virus is unknown, we extended our analyses to myxoma 
virus, which naturally infects American forest and brush rabbits and causes 
highly lethal myxomatosis in European rabbits (E. rabbits). The K3L 
ortholog of myxoma virus, M156R, shows only 30% amino acid sequence 
identity to K3L. Whereas human and rodent PKR were completely resistant 
to M156R inhibition, E. rabbit PKR was sensitive. Cloning of brush rabbit 
PKR revealed 93% sequence identity to European rabbit PKR with amino 
acid differences clustering in the putative eIF2α/M156R-binding site. Brush 
rabbit PKR showed even higher sensitivity to M156R than E. rabbit PKR. 
Using a randomly mutated M156R library we identified residues in M156R 
that selectively increase inhibition of E. rabbit but not brush rabbit PKR. 
Thus the myxoma virus pseudosubstrate has been optimized to inhibit 
European rabbit PKR. 
Our data indicate that species-specific interactions of the innate immune 
system with viral modulators are important for virus infection and host 
range. Moreover our results provide a molecular explanation for the 
previously described host range function of vaccinia virus K3L and indicate 
a similar function for M156R for myxoma virus infection in rabbits. 
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The intergenic region (IGR) IRESs of the Dicistroviridae family of viruses 
are useful models to study IRES-driven translation, manipulation of the 
ribosome by structured RNA molecules, and eukaryotic ribosome function. 
The IGR IRESs do not require any initiation factors to recruit the ribosome 
and they begin decoding the open reading from a non-AUG start codon. 
Initiation from IGR IRESs is thought to occur by the following steps: 1) 
The IRES docks in the P site of the 80S ribosome, placing the non-AUG 
start in the A site, 2) eEF1a-tRNA delivers the cognate tRNA to the A-site, 
3) eEF2 translocates the ribosome without a peptide bond being made on 
the tRNA (pseudotranslocation). This translocation moves the IRES to the E 
site, the start codon to the P site, and the 2nd codon to the A site, allowing 
translation to then proceed as normal. Here, we explore the conformational 
dynamics that drive these mechanistic steps. Specifically, we hypothesize 
that the initial pseudotranslocation step is driven by the IRES’s ability to 
positionally mimic a P/E hybrid state tRNA. This mimicry prompts the A-
site tRNA and the ribosome to adopt important structural intermediates 
necessary for translocation. This hypothesis suggests that the IGR IRES 
initiates translation by co-opting the ribosome’s elongation cycle and the 
conformational states associated with elongation. To test this hypothesis, we 
are using single-molecule (sm) FRET to track the movements of the IRES, 
tRNA, and the L1 stalk of the ribosome during IGR IRES-driven initiation. 
We have succeeded in assembling and immobilizing fluorescently labeled 
IRES-80S ribosome complexes and have obtained preliminary smFRET 
data. These preliminary data suggest that the incoming A-site tRNA can 
fluctuate between two different positions relative to the IGR IRES upon 
entering the ribosome, supporting the idea that the IRES is specifically 
positioned to facilitate the formation of important translocation 
intermediates. 
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Translation is regulated in cells. The initiation step of translation is one of 
the most common targets of translation regulatory factors to modulate the 
level of gene expression in cell. Eukaryotic Initiation Factors (eIFs) in 
association with the regulatory sequence elements on mRNA such as 5’cap, 
3’poly(A) and IRES determine the expression of a specific mRNA. The 
synergistic effect of 3’-poly(A) and 5’-cap, mediated by the formation of 
the eIF4F complex, has been shown by Tarun et al. To initiate translation, 
5’-cap of mRNA associates with eIF4F complex which is composed of cap-
binding protein (eIF4E), scaffolding protein (eIF4G) and an ATP-dependent 
RNA helicase (eIF4A) while 3’-poly(A) binds to poly(A)-binding protein 
(PABP). Association of the eIF4F complex with PABP happens upon 
interaction of eIF4G with PABP. This association leads to the formation of 
the circular RNA/protein complex known as mRNA “closed loop”, which 
was first observed by wells et al. in 1998. Formation of the mRNA “closed 
loop” has been suggested to increase the rate of translation of the mRNA. 
Here, we have studied the interaction of eIF4G with PABP in the presence 
and absence of poly(A). The crystal structure of the ternary complex of 
eIF4G/PABP/poly(A) was determined at 2.0 Å resolution. The eIF4G 
fragment incorporated in the ternary complex adopts secondary structure 
which is composed of two β-strands, at its N-terminal and middle, and one 
α-helix at its C-terminal region. The crystal structure confirms our NMR 
results showing that eIF4G binds to RRM2 only and does not contact 
RRM1. It binds to the helical surface of RRM2 and does not interfere with 
poly(A)-binding to PABP. Our NMR and ITC studies also show that eIF4G 
binds to RRM2 independent of poly(A), however, the affinity of 
RRM2/eIF4G interaction increases in the presence of poly(A). Further 
experiments on RRM1-2/eIF4G interaction in the presence and absence of 
poly(A) using Electromobility Shift Assay, NMR and Isothermal Titration 
Calorimetry revealed that in the absence of poly(A), the interaction of 
eIF4G with RRM2 is affected by RRM1. RRM1 partially blocks the 
binding of eIF4G to RRM2 and decreases the affinity of its interaction with 
eIF4G. On the other hand, the presence of poly(A) stabilizes the 
conformation of RRM1-2 which facilitates eIF4G-binding. Here we have 
provided the evidence for positive cooperativity between eIF4G and 
poly(A) binding to PABP and proposed that cells use this mechanism to 
facilitate binding of eIF4G to PABP molecules that are already bound to 
3’poly(A) of mRNAs thereby direct eIF4G for incorporation into pre-
initiation/initiation complex to enhance translation. 
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Eukaryotic initiation factor 5 (eIF5) stimulates the hydrolysis of GTP bound 
to the eIF2•GTP•tRNAiMet ternary complex (TC) in the scanning 48S 
ribosomal preinitiation complex (PIC). Importantly, the Pi produced by GTP 
hydrolysis is released only when AUG enters the 40S P-site, being 
suppressed at non-AUG triplets by eIF1. The N-terminal domain of eIF5 
(eIF5-NTD) is required for its GTPase activation (GAP) function, whereas 
the eIF5 C-terminal domain interacts with other initiation factors and 
stimulates PIC assembly. The lethal mutation SUI5 in the eIF5-NTD 
(substitution G31R) increases GAP function in vitro at UUG codons and 
elevates the frequency of UUG initiation in vivo (Sui- phenotype), leading 
to the possibility that SUI5 enables non-AUG initiation simply by 
increasing GTP hydrolysis at near-cognate start sites. However, we found 
that SUI5 also impairs TC recruitment in vivo, conferring derepression of 
GCN4 translation (Gcd- phenotype), and we identified single amino acid 
substitutions in the eIF5-NTD that suppress the lethality, Sui- phenotype, 
and Gcd- phenotype of SUI5. Remarkably, these Ssu- (suppressor of Sui-) 
eIF5 substitutions also reduce the dominant Sui- and TC binding/Gcd- 
defects produced by mutations in eIF2β and eIF1A. Co-suppression of Sui- 
and Gcd- phenotypes was first described for Ssu- mutations in eIF1A, and 
provided strong evidence that the increased UUG initiation and defective 
TC binding in suppressible Sui-/Gcd- mutants are mechanistically linked. 
We proposed that such Sui-/Gcd- mutations destabilize the open, scanning-
conducive conformation to which TC initially binds, thus reducing the rate 
of TC loading (Gcd- phenotype) and also enabling inappropriate transition 
to the closed, scanning-arrested conformation at UUG codons (Sui- 
phenotype). By stabilizing the open, scanning conformation, Ssu- mutations 
restore the first step of TC binding and also suppress UUG initiation in Sui-
/Gcd- mutants. The co-suppression of Sui- and Gcd- phenotypes observed 
here for Ssu- mutations in eIF5 suggests that they likewise stabilize the open 
conformation of the PIC, thus implying that wild-type eIF5 acts to stabilize 
the closed conformation at AUG codons. This conclusion fits well with our 
previous results indicating that, in addition to its GAP function, eIF5 
promotes the closed conformation, dissociation of eIF1 from the PIC, and 
attendant Pi release on start codon recognition. 
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Ribosomal RNA (rRNA) is highly modified post-transcriptionally by 
methylation and pseudouridylation. Most of these modifications are found 
in functional regions of the rRNA such as the decoding center of the small 
subunit, the subunit interface and the peptidyltransferase center of large 
subunit. These modifications are thought to play a role in fine-tuning 
ribosome activity.  
We identified Bud23, a SAM-dependent methytransferase, as an important 
player in the biogenesis of 40S subunits in yeast. The protein methylates 
G1575 in the 18S rRNA, a modification conserved across all eukaryotes. 
The crystal structure of bacterial ribosome shows that 16S rRNA residue 
G1338 (corresponding to G1575 in yeast 18S rRNA), is positioned in the 
decoding center of the ribosome in close proximity to the P-site tRNA. 
Owing to this critical location, we speculated that methylation of G1575 
may be important for the correct geometry of the P-site in eukaryotes and 
hence, may play a role in translational fidelity, such as selection of the right 
reading frame or the efficiency of utilizing initiator tRNA during initiation. 
Here we show that deletion of Bud23p but not its methyltransferase activity 
confers a strong growth defect, frameshifting errors, increase in non-AUG 
initiation and hypersensitivity to drugs that affect the decoding center of the 
ribosome.  
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Translational elongation in eukaryotes is facilitated by two universally 
conserved G-proteins: eukaryotic Elongation Factor 1 (eEF1A), required for 
loading the cognate aminoacyl-tRNA at the A-site of the ribosome and 
eukaryotic Elongation Factor 2 (eEF2), essential for the translocation of the 
ribosome along the mRNA. In addition to theses two factors, fungal 
translation is uniquely dependent on an ATPase called eEF3. As an 
essential protein with no known mammalian homologue, eEF3 is an ideal 
target for developing anti-fungal drugs with high specificity and low host 
toxicity. Towards this end, we are working on understanding the functional 
role of eEF3 and its interacting partners in the cell. Stm1p, a non-essential 
protein involved in translation under nutrient stress, has been implicated in 
the binding of eEF3 to ribosomes. The ability of eEF3 from Cryptococcus 
neoformans, a distant fungal relative of Saccharomyces cerevisiae, to 
complement the loss of WT eEF3 in the latter, requires the presence of 
Stm1p. This genetic interaction reinforces the functional relationship 
between the two proteins. Based on the presence of each protein in different 
yeast, there is evolutionary significance to this finding. Mutations in the 
chromodomain insertion of eEF3, a region thought to be involved in rRNA 
binding, show a semi-dominant slow growth phenotype. This is indicative 
of altered binding of eEF3 to the ribosomes. We are currently investigating 
the effect of chromodomain mutants on the ribosome binding of eEF3 and 
the role of Stm1p. 
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The central feature of standard eukaryotic translation initiation is small 
ribosome subunit loading at the 5’ cap followed by its 5’ to 3’ scanning for 
a start codon. The preferred start is an AUG codon in an optimal context. 
Elaborate cellular machinery exists to ensure the fidelity of start codon 
selection. Eukaryotic initiation factor 1 (eIF1) plays a central role in this 
process. Here we show that the translation of eIF1 homologs in eukaryotes 
from diverse taxa involves initiation from an AUG codon in a poor context. 
Using human eIF1 as a model, we show that this poor context is necessary 
for an autoregulatory negative feedback loop in which a high level of eIF1 
inhibits its own translation, establishing that variability in the stringency of 
start codon selection is used for gene regulation in eukaryotes. We show 
that the stringency of start codon selection (preferential utilisation of 
optimal start sites) is increased to a surprising degree by overexpressing 
eIF1. The capacity for the cellular level of eIF1 to impact initiation through 
the variable stringency of initiation codon selection likely has significant 
consequences for the proteome in eukaryotes.  
 
*These authors contributed equally to this work 
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Pancreatic β cells are specialized for the regulated production of insulin to 
control blood glucose levels. These cells contain a large pool of cytoplasmic 
insulin mRNA (10–15% total mRNA), which is translationally quiescent at 
hypoglycemic (<3 mM glucose) concentrations. Recruitment of this mRNA 
to polysomes and the activation of translation initiation occur in response to 
higher glucose levels, leading to about 50-fold increase in insulin 
biosynthesis within an hour. The level of insulin mRNA does not alter 
significantly during this period of glucose stimulation and transcription 
inhibitors do not affect this early increase in insulin biosynthesis, indicating 
the predominance of the posttranscriptional events in enhancing the insulin 
biosynthesis. 
Glucose induced translation of insulin in pancreatic beta cells is mediated 
by the 5’UTR of insulin mRNA. We have previously reported the minimal 
sequence/structure in the 5’UTR of rat insulin gene1 for this regulation. We 
had shown that specific factors in the pancreatic islets bind to the 5’UTR of 
the insulin mRNA upon glucose stimulation. We identified a minimal 29-
nucleotide element in the 5’UTR that is sufficient to form the complex, and 
confer glucose mediated translation activation. Using RNA affinity pull 
down method, we isolated and identified the 5’UTR binding protein as 
protein disulfide isomerase (PDI). Through super shift RNA EMSAs and 
immuno-depletion of PDI we show its presence in the RNA binding 
complex. We confirmed the Ins-5’ UTR binding activity of PDI using yeast 
three hybrid assay. RNA immunoprecipitation, using anti PDI antibody in 
βTC-6 cell-line, show that the protein binds to the insulin mRNA in vivo 
and show increased association upon glucose stimulation. Translation 
activation function of PDI was demonstrated by an in vitro translation assay 
in which PDI was knocked down by neutralizing antibody and in vivo when 
PDI was over expressed. We further show that the PDI association with 
insulin 5’UTR is facilitated by PABP. A role for PDI and PABP has been 
shown in light stimulated translation regulation. Thus we have identified the 
translation regulatory mechanism in response to the energy stimulus that is 
conserved in plants and animals. Further characterization of the PDI and 
PABP interaction and its role in translation regulation will be discussed. 
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Histone mRNAs, unlike all other eukaryotic mRNAs, end in a conserved 
stem-loop rather than a poly-A tail. The stem-loop is bound by stem-loop 
binding protein (SLBP), which is required for histone mRNA processing, 
export, translation, and degradation. SLIP1 (SLBP-interacting protein 1) 
binds to the region of SLBP required for translation and enhances 
translation of reporter mRNAs ending in a histone stem-loop. SLIP1 
interacts with eIF4G, and may function to bring the 5' and 3' ends of histone 
mRNAs together. SLIP1 is also present in the initial mRNA degradation 
complex that forms at the 3' end of histone mRNA. Using RNA 
interference, we demonstrated that SLIP1, unlike SLBP, is required for cell 
viability. Since this data suggests that SLIP1 performs vital unknown 
functions in addition to its role in histone mRNA translation, we performed 
a yeast-two-hybrid screen to identify binding partners of SLIP1. 
 
We identified the DEAD-box RNA helicase Dbp5 as a SLIP1-binding 
protein. Dbp5 is an mRNA nuclear export factor, which has recently been 
shown to also have a role in translation termination. Immunoprecipitation of 
endogenous SLIP1 co-precipitates endogenous Dbp5, confirming that this 
interaction occurs in vivo. Pull-down assays with purified proteins show 
that the interaction is direct. We have solved the crystal structure of the 
complex between SLIP1 and the interacting region of Dbp5. We find that 
binding of SLIP1 does not interfere with the RNA-binding properties of 
Dbp5. The SLIP1-Dbp5 interaction is mediated by evolutionary conserved 
residues, mutation of which impairs binding in vitro. We have mutated 
amino acids in SLIP1 that abolish binding to SLBP but still allow binding to 
Dbp5. SLIP1 is a dimer, suggesting that it may bind multiple proteins acting 
to bridge the 3’ end of histone mRNA to different factors. We have also 
created a mutant SLIP1 that is a monomer. We are investigating the 
functional effect of the SLIP1 and Dbp5 mutants on histone mRNA export 
and translation. Mammalian cells stably transfected with an RNAi-resistant 
form of either wildtype or mutant SLIP1 will be treated with siRNAs to 
knock-down endogenous SLIP1, and analyzed by in situ hybridization for 
effects on histone mRNA export. To test whether mutations in SLIP1 
impact histone mRNA translation, either wildtype or mutant SLIP1 mRNAs 
will be injected into Xenopus laevis oocytes, and the effect on translation of 
luciferase reporters ending in a histone stem-loop determined.  
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The heterotetrameric GAIT (Gamma-interferon Activated Inhibitor of 
Translation) complex inhibits translation of multiple inflammatory transcripts in 
human myeloid cells, thereby preventing excessive accumulation of potentially 
harmful proteins. During the inhibition phase we have observed a low-level 
“trickle” of translation of GAIT target mRNAs independent of mRNA amount. 
In circumstances where inflammatory proteins also have protective functions, 
e.g., vascular endothelial growth factor-A (VEGF-A), complete knock-down 
can have adverse consequences such as tissue injury and tumor growth. Thus, 
incomplete inhibition of gene expression by the GAIT system might be 
beneficial. We have discovered a novel molecular mechanism that compels low-
level translation of GAIT element-bearing target transcripts despite robust 
inhibition by the GAIT complex. Bifunctional, glutamyl-prolyl tRNA 
synthetase (EPRS) is the sole component of the GAIT complex that binds the 
structural GAIT element in the 3’UTR of target mRNAs. The EPRS domain 
responsible for target recognition is the upstream two of three helix-turn-helix 
WHEP domains in the linker connecting the two synthetase domains. We have 
found a truncated form of EPRS, we term "mini-EPRS", which contains the N-
terminus ERS domain followed by the upstream pair of WHEP domains 
required for GAIT element-binding, but insufficient for GAIT complex 
formation. The authenticity of mini-EPRS was established by Northern and 
Western blot analysis, cDNA cloning, and mass spectrometry. The amount of 
mini-EPRS mRNA and protein in myeloid cells is about 6% and 10% of full-
length EPRS, respectively. Mini-EPRS mRNA is generated by an 
unprecedented alternative polyadenylation within a protein-coding exon of 
EPRS pre-mRNA. Cleavage and polyadenylation after "UA" in a Tyr-encoding 
"UAU" codon (in a region containing both “upstream” and “downstream” 
polyadenylation elements) generates a "UAA" stop codon followed immediately 
by a polyA tail with no intervening 3’UTR. Mini-EPRS binds GAIT element 
RNA with high affinity and is a dominant-negative inhibitor of GAIT complex 
binding and activity. Overexpression of mini-EPRS in monocytic cells reduces 
translational silencing of GAIT element-bearing inflammatory transcripts, 
including VEGF-A, ceruloplasmin, and zipper-interacting protein (ZIP) kinase. 
Alternative polyadenylation within the coding region, by generating 3’UTR-less 
mRNAs that are resistant to post-transcriptional regulation and encode C-
terminal truncated proteins, represents a novel expansion of the protein 
repertoire. Application of this mechanism to EPRS might have evolved to 
provide a small amount of mini-EPRS, a dominant-negative inhibitor of GAIT 
complex function, that assures a constant and continuous “translational trickle” 
of expression of VEGF-A and other GAIT targets. 
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Drosophila spermatogenesis features an extended 3.5-day meiotic G2 
prophase, which allows transcription of genes whose protein products are 
required for post-meiotic spermatid differentiation. Accurate timing of entry 
into the meiotic divisions at the end of prophase requires translational 
control of the core cell cycle regulators Cdc25/Twine and Cyclin B. 
Expression of the cycB RNA is detectable throughout spermatocytes (the 
male germ cell stage corresponding to meiotic G2), but CycB protein is 
robustly expressed only in mature spermatocytes poised to enter meiotic 
division.  
 
Rbp4, a testis-specific RNA-binding protein previously shown to be needed 
for male fertility, is required for repression of cycB translation in early 
spermatocytes. In rbp4 RNAi testes, the CycB protein was detected at high 
levels in immature spermatocytes. In addition, Rbp4-eYFP associated 
specifically with the cycB 3’UTR in biotin-RNA pulldown assays from 
testis extract. 
 
We investigated a candidate Rbp4-interacting protein, CG9975, which is 
likely testis-specific (FlyAtlas) and known to associate with Rbp4 by yeast 
two-hybrid (BioGRID). We found that Myc-Rbp4 co-immunoprecipitated 
with HA-CG9975 in S2 cells. Upon RNAi knockdown of CG9975, no 
CycB protein was detected in any spermatocytes (even late), and the cells 
arrested in late metaphase / early anaphase of meiosis I. Because of the 
striking appearance of the arrested cells, we have renamed CG9975 
wurstfest, or fest. We are currently investigating further the mechanisms by 
which Rbp4 and Fest act to regulate cycB translation. 
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The accumulation of unfolded proteins in the endoplasmic reticulum 
triggers a stress response program that protects the cells early in the 
unfolded protein response (UPR) and can lead to apoptosis during 
prolonged stress. Mammalian cells have signaling pathways that sense 
protein misfolding in the ER and initiate this response. Early in the stress 
response, activation of the ER-transmembrane protein PERK results in 
increased phosphorylation of eIF2α, causing global decrease of protein 
synthesis and increased synthesis of the transcription factor ATF4 which 
promotes expression of stress response genes. Later in the response, 
dephosphorylation of eIF2α allows translation of the transcribed stress 
response mRNAs. Activation of the IRE1 ER-transmembrane protein 
occurs early in the response and causes cytoplasmic splicing of an ER-
associated mRNA (unspliced XBP1 mRNA) leading to generation of the 
transcription factor spliced XBP1 that induces expression of genes involved 
in protein folding and degradation. The current view is that these two 
pathways are activated independently during the UPR. We show here that 
phosphorylation of eIF2α is required for maximal induction of the XBP1 
transcription factor levels via a mechanism that involves stabilization of the 
spliced XBP1 mRNA. Using cells deficient for eIF2α phosphorylation, we 
show that splicing of the XBP1 mRNA is independent of eIF2α 
phosphorylation, but enhanced stabilization of the spliced mRNA requires 
global inhibition of protein synthesis which induces disassembly of 
ribosomes. We propose a model where the immediate response to ER stress 
is the splicing of the unspliced XBP1 mRNA generating a translationally 
repressed mRNA at a time when global protein synthesis is inhibited. 
Stabilization of the spliced mRNA during translational repression allowed 
its accumulation and this was followed by its efficient translation during 
translational recovery. We propose that eIF2α-phosphorylation-mediated 
control of mRNA turnover amplifies the signals that promote the ER’s 
capacity to handle protein folding during stress. 
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The mechanisms that either repress or promote the translation of mRNAs 
and the spatio-temporal synthesis of a specific protein is often achieved 
through a variety of cytoplasmic post-transcriptional control mechanisms. 
We present data to suggest that a “combinatorial code” exists in which the 
combination of a limited number of RNA binding proteins can lead to a 
huge variety in the cytoplasmic fates and regulatory modes of subsets of 
mRNAs. We examined the role of one such RNA binding protein; 
polypyrimidine tract binding protein (PTB). In unstressed cells, data 
obtained from combined polysome profiling and ribonomic screens, 
strongly suggest that PTB plays a role in the post-transcriptional regulation 
of mRNAs that function in cytoskeletal organisation and cell migration, and 
decreasing expression of PTB caused changes in cell morphology, altered 
cytoskeletal networks and an inhibition of cell migration. In contrast, in 
apopotic cells where there is a reduction in global translation rates, PTB is 
required for the IRES-mediated translation of a specific group of mRNAs 
(MTG8A, SET7, cyclin T1, cy1B1) whose protein products are required to 
drive apoptosis. Our data suggests that this is mediated by the remodelling 
of PTB containing complexes during apoptosis allowing for the selective 
translation of certain mRNAs. By a proteomic screen we have identified the 
components of this complex and have examined how they contribute to 
IRES-mediated translation during apoptosis. These data show that PTB 
function is controlled by these co-recruited proteins which influence its 
cellular mode of action. 
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In eukaryotes adjusting protein synthesis via phosphorylating translation 
initiation factor eIF2α is one major mechanism to adapt to and overcome 
stress. The eIF2α kinase Gcn2 is essential for overcoming amino acid 
starvation in all eukaryotes. We have shown that for sensing starvation, the 
Gcn2 RWD domain must directly bind to its effector protein Gcn1, and both 
must bind to the ribosome, suggesting that Gcn1-Gcn2 interaction may 
occur while both proteins are residing on the ribosome. The mammalian 
protein IMPACT, highly expressed in neurons, and its yeast ortholog Yih1, 
consist of an Ancient Domain and an RWD domain with Gcn1 binding 
activity. We have shown that Yih1/IMPACT downregulates Gcn2 by 
competing with Gcn2 for Gcn1 binding. This raised the intriguing 
possibility that Yih1 may bind to Gcn1 on the ribosome to inhibit Gcn2 
activation. To test this, we conducted ribosome co-sedimentation assays 
under near physiological conditions where we preserve native in vivo 
interactions via formaldehyde crosslinking. We found that overexpressed 
GST-tagged Yih1, or Flag-tagged Yih1, co-sedimented with polyribosomes, 
but GST alone did not. Omitting formaldehyde crosslinking in our 
polysome co-sedimentation assays reduced polysomes to monosomes and 
concomitantly led to reduced amounts of GST-Yih1 sedimenting in the 
heavy fractions where normally polysomes are found, in agreement with the 
idea that Yih1 indeed associates with ribosomes. Similar results were found 
when using a gcn1Δ strain, supporting the idea that Yih1 contacts ribosomes 
independently of Gcn1.  
These findings raise the intriguing possibility that Yih1 resides on the 
ribosome together with Gcn1 and Gcn2. Yih1 being physically close to 
Gcn1 and Gcn2 would allow quick Yih1-mediated Gcn2 downregulation 
when and where necessary.  
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In all eukaryotes, phosphorylation of eIF2α is a major mechanism for 
adjusting protein synthesis in response to a variety of environmental or 
intracellular stresses. The eIF2α kinase Gcn2 is crucial for overcoming 
amino acid starvation. For sensing starvation, the Gcn2 RWD domain must 
directly bind to its effector protein Gcn1. The mammalian protein IMPACT, 
highly expressed in neurons, and its yeast ortholog Yih1, consist of an 
Ancient Domain and an RWD domain with Gcn1 binding activity. We have 
shown that Yih1/IMPACT competes with Gcn2 for Gcn1 binding thereby 
diminishing Gcn2 activity (Gcn- phenotype). Deletion of YIH1 does not lead 
to constitutively active Gcn2, suggesting that Yih1 inhibits Gcn2 only under 
certain physiological conditions or in specific cellular compartments. Our 
previous studies suggested that Yih1 resides in the cell in an inactive Yih1-
G-actin complex, and when released from actin inhibits Gcn2. Supporting 
this idea, we show that Yih1-actin interaction is independent of Gcn1, and 
that Yih1-Gcn1 interaction does not require actin. In an effort to further 
understand Yih1 function we undertook multiple sequence alignments of 
RWD domains from Yih1/IMPACT and Gcn2, and together with the 
published RWD structure of Gcn2 and our structural Yih1 modeling 
exercises, we identified putative surface exposed amino acid residues in two 
adjacent α-helices of the Yih1 RWD domain that may contact Gcn1. We 
found that substitution of exposed residues in one α-helix reverted the Gcn- 
phenotype associated with Yih1 overexpression, and this was associated 
with reduced Yih1-Gcn1 binding but not Yih1-actin binding, supporting the 
idea that these amino acids are in fact crucial for contacting Gcn1. 
Substitution of another set of amino acids in the other helix did not abolish 
the Gcn- phenotype associated with Yih1 overexpression, but did increase 
Gcn1-Yih1 and Yih1-actin interaction. Possible mechanisms will be 
discussed. 
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Chronic Lymphocytic Leukemia (CLL) is the main form of leukemia in the 
Western World. Various studies have been performed including 
identification of chromosomal aberrations, transcriptional analysis, telomere 
length analysis and microRNAs expression profiling to identify changes in 
the biology of CLL B-Cells. Unfortunately, the aggressive type of CLL is 
still in need of reliable prognosis markers and ultimately of an efficient 
therapy. Thus, we have decided to investigate the process of translation and 
its regulation in CLL and confront the aggressive to the indolent type in this 
context. Polysome profiling coupled to microarray analysis was performed 
on a panel of isolated B-Cells from CLL patients to assess the contribution 
of translational de-regulation to this disease. Our data show that some 
changes in regulation of translation can be detected when comparing 
indolent versus aggressive CLL. These changes, alongside the other 
hallmarks of CLL, could contribute to the differences in the outcome of the 
disease. Future work will consist in validating those changes in order to be 
used as reliable prognosis markers and investigating if these new targets 
could be the last pieces in the jigsaw of CLL biology and its successful 
therapy. 
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Translation of genetic information into proteins is a fundamental cellular 
process involving highly coordinated interactions between mRNA, 
ribosomes and hundreds of protein factors. Our current understanding of 
translation mechanisms comes from decades of research that utilized 
ensemble approaches. These “bulk” methods usually do not allow for direct 
observation of molecular events and rely instead on averaged signals to 
characterize biochemical processes. For extremely complex and dynamic 
systems like the translation machinery, where the remarkable efficiency and 
precision of protein synthesis is achieved through a precise coordination of 
transient molecular events, this limitation poses a serious challenge. Single 
molecule methods allow observation of individual molecular events and 
have emerged as a new powerful tool to study cellular processes on the 
molecular level in real time. Here, we combine two techniques, multi-
wavelength single molecule total internal reflection (SM-TIRF) microscopy 
and bio-orthogonal protein tagging, to study mechanisms and dynamics of 
the translation machinery in S. cerevisiae total cell extracts. We implement 
a novel SM-TIRF technique termed Colocalization Single Molecule 
Spectroscopy (CoSMoS)1 that permits detection of three or more 
fluorescent dyes simultaneously and thus enables us to detect the 
colocalization of multiple components in a macromolecular complex when 
each component is labeled using a different color fluorescent dye. Small 
protein tags for orthogonal labeling reactions (SNAP2 and DHFR3 tags) are 
fused to selected protein targets using standard genetic techniques. The 
introduced tags are then used for highly specific fluorescent labeling of 
these proteins in total cell extracts. In our single molecule experiments we 
monitor colocalization of the endogenous fluorescent protein factors with 
fluorescent, surface-immobilized mRNA. These colocalization signals 
reveal a kinetic framework of reaction pathways that involve coordinated 
factor binding and dissociation events. We demonstrate that this new 
approach opens new exciting possibilities for the study of macromolecular 
assembly and reaction pathways in translation.  
 
1Friedman LJ, Chung J, Gelles J. Biophys J. 2006 Aug 1;91(3):1023-31  
2New England Biolabs  
3N.T. Calloway, M. Choob, A. Sanz, M.P. Sheetz, L.W. Miller, V.W. Cornish. 
Chembiochem 2007 May 7;8(7):767-74  
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The 30S and 50S subunits of the bacterial 70S ribosome are held together by at 
least 12 intersubunit contacts. These contacts include RNA-RNA, RNA-protein, 
and protein-protein interactions.  
 
We have developed and implemented a microfluidic device that completely 
mixes two components to completion in 0.4 milliseconds (ms) and sprays the 
mixture in the form of microdroplets onto an EM grid that is being plunged into 
cryogen. The total reaction time before cryo-fixation can be as little as 9.4 
milliseconds. We have used this device to study association between the two E. 
coli ribosomal subunits. We have been able to trap association intermediates 
that form within 9.4 ms, and have determined three-dimensional cryo-EM 
reconstructions of these association intermediates.  
 
According to our structural analysis, about 25% of ribosomal subunits are 
already engaged in the formation of 70S ribosome particles within 9.4 ms. In 
general, but with some exceptions, RNA-RNA bridges tend form first, i.e., 
within 9.4 ms, whereas bridges involving protein contacts form later, as they are 
either absent or very weak in our cryo-EM maps. Among the first formed RNA-
RNA bridges are bridges B2a, B2b, B3, and B7a, whereas B1a, B2c, B4, B5, 
and B6 do not form within this time scale. Furthermore, classification of the 
70S-like images into three, more homogeneous groups reveals variability in 
three peripheral bridges B1a, B7b, and BX, such that the presence of two of 
these three bridges is inversely correlated with the presence of the third, 
suggesting a non-linear progression to subunit association. Of the five bridges 
formed along helix 44 of the 30S subunit, we find that the two bridges at the 
decoding end form first, followed by a bridge at the other end, and lastly the 
two bridges form situated along the middle of the helix. Our results suggest a 
model of association where the bridges at the center of the intersubunit face 
form first, while the two subunits teeter and flex against each other, and then 
finally adopt their conformation within a fully associated 70S ribosome.  
 
We have also collected cryo-EM data of subunit association after allowing 
subunit association for a longer reaction time by using a microfluidic device 
that allows 43 ms for reaction. Analysis of 9.4 ms dataset and the progress made 
with the 43 ms datasets will be presented.  
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Frameshift mutations at coding mononucleotide repeats (cMNR) are 
frequent in high-microsatellite instability (MSI-H) cancers. Frameshift 
mutations in cMNR result in the formation of a premature termination 
codon (PTC) in the transcribed mRNA, and these abnormal mRNAs are 
generally degraded by nonsense mediated mRNA decay (NMD). Thus 
blocking NMD in MSI-H cancer cell lines is able to be use to find out 
potent target genes which have PTC according to mutation in their cMNR 
region. By blocking NMD, we screened for differentially-expressed genes 
using DNA microarrays, and then used database analysis to select 28 
candidate genes containing cMNR with more than 9 nucleotide repeats. 
cMNR mutations have not been previously reported in MSI-H cancers for 
15 of the 28 genes. We analyzed the cMNR mutation of each of the 15 
genes in 10 MSI-H cell lines and 21 MSI-H cancers, and found frequent 
mutations of 12 genes in MSI-H cell lines and cancers, but not in 
microsatellite stability (MSS) cancers. Of these genes, to confirm whether 
their transcripts are affected by NMD, we conducted real time PCR and 
expression of transcripts shows increased pattern after NMD block using 
puromycin. Our combined approach of NMD block, database search, and 
mutation analysis has identified a large number of genes mutated in their 
cMNR in MSI-H cancers. The identified mutations are expected to 
contribute to MSI-H tumorigenesis by causing an absence of gene 
expression or low gene dosage effects. 
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Tobacco mosaic virus (TMV) particles initially enter plant cells in small 
numbers. The virions contain viral coding genomic RNA packed in a helix 
together with viral coat protein and no other proteins or RNA. Thus, subsequent 
development of TMV is totally dependent on the first round of genomic RNA 
translation by host ribosomes. The translation is initiated on the 5' untranslated 
region (UTR) of TMV RNA which is also called omega sequence.  
Earlier we have studied physical properties of the omega RNA in solution. We 
have found that omega RNA of TMV possesses a compact and stable structure 
under physiological conditions. The RNA displayed cooperative melting of its 
structure upon heating, high melting temperature, and sedimentation coefficient 
typical of compactly folded RNA of this molecular weight. In this work, 
chemical and enzymatic modifications of the omega RNA suggested that it: (1) 
Does not form prolonged nucleotide interactions of a Watson-Crick type; (2) 
Possesses a strong secondary structure of a non-Watson-Crick type at its 5' part 
involving highly ordered sequence with direct CAA repeats; (3) Forms short 
standalone regions of RNA A helixes in its 3' proximal part. Directed nucleotide 
replacements confirmed that formation of compact and stable structure of 
omega RNA depends on highly ordered sequence with direct CAA repeats. 
Substitution of only 3 adenines for 3 cytosines in-frame with CAA repeats lead 
to severe decompactization and destabilization of the entire structure. This fact 
is not in contradiction with recently suggested possible triple helical 
organization of the ordered (CAA)n polyribonucleotides. When conservative 
AU-rich sequences in the 3' proximal part of the omega RNA were replaced by 
GC-rich sequences, the structure of the omega RNA became less stable and less 
compact as well. This fact suggests that the structured 5' and conservative 3' 
parts of the omega RNA interact with each other and together contribute to 
formation of the stable tertiary structure; this being in a good agreement with 
overall high compactness of the molecule.  
We conclude that the regular region of CAA repeats within TMV omega RNA 
folds into a secondary structure of a non-Watson-Crick type with evidence in 
favor of the triple-helical arrangement. The complete compact and stable 
tertiary structure is organized by specific interactions between the 5' CAA rich 
part and the 3' AU rich part of the omega RNA. The structure formed by the 
omega RNA may be physiologically indispensible. It may provide a stable 
binding surface for the ribosomes that is permanently free of translationally 
negative interactions with other RNAs or proteins. 
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In order to survive, an organism must be able to respond to and endure 
stresses that occur in its environment. Specific stress responses in 
Saccharomyces cerevisiae inhibit translation initiation and lead to the 
formation of mRNA-containing bodies called Processing bodies (P bodies). 
These bodies contain mRNA decay enzymes and are therefore likely to 
degrade mRNA as part of a co-ordinated adjustment in mRNA levels 
following stress. Glucose starvation in S. cerevisiae results initially in P 
body formation and then later a different class of body that does not contain 
mRNA decay enzymes forms. These bodies have been termed EGP bodies 
or stress granules and contain translation initiation factors, RNA binding 
proteins and mRNAs. In order to delineate the widespread alterations in 
mRNA translation and abundance following stress, a microarray strategy 
was taken comparing the transcript level and the translatability in S. 
cerevisiae following glucose starvation. From within these data, specific 
classes of mRNA were selected for further investigation. These were picked 
from three categories. Firstly, those mRNAs that are up-regulated relative to 
the norm for translation, where the abundance of the mRNA remains 
constant. Secondly, mRNAs that are down-regulated for translation and the 
mRNA level is unaltered, and finally mRNAs where the transcript level is 
up-regulated, but their translation is equivalent to the norm. The 3’UTR 
encoding region of the selected genes was tagged with bacteriophage MS2 
sequences, which in the transcribed mRNA will direct interaction with the 
MS2 coat protein. Co-expression of this coat protein fused to a fluorophore 
shows the position of the mRNA within the cell. These experiments aim to 
show how mRNA localisation is effected following stress and whether a 
decrease in translation or transcription is linked with localisation to either P-
bodies or EGP bodies. 
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 eIF5 and eIF2B are the GTPase activating protein (GAP) and guanine-
nucleotide exchange factor (GEF) for eIF2, the GTP-dependent Met-tRNAiMet 
binding factor, respectively. In eukaryotic translation initiation, a conserved 
anti-parallel -helical repeat structures termed W2 domain, an atypical HEAT 
domain, is found in the C-terminal domains (CTD) of these factors and 
mammalian factor eIF4G, the major adaptor subunit of eIF4F. Aromatic and 
acidic (AA-) boxes are the signature of the W2 domains. Interestingly, members 
of MA3+W2 family found throughout the eukaryotes carry MA3-type HEAT 
domain and W2-type CTD, which were apparently derived from eIF4G. We 
previously identified a human member of MA3+W2 family termed eIF5-mimic 
protein 1 (5MP1 also known as BZW2 and HSPC028) as a binding partner of 
an Adeno-associated virus type 2 protein, and showed that 5MP1 expression 
derepresses general control response (Gcd- phenotype) in the yeast gcd6 
mutants deficient in guanine nucleotide exchange for eIF2, dependent on its 
AA-box 2. In this study, we advanced our characterization of human 5MP1 in 
translational regulation in mammalian cells. 5MP1 interacts with human eIF2 
and eIF3; the interaction with eIF2 depends on AA-box 2, as expected. Ectopic 
expression of 5MP1 in mammalian cells reduces the abundance of 
polyribosome, providing biological evidence that this is a translational 
repressor. The expression of 5MP1 but not that of its mutant altering AA-box 2 
derepresses translation of ATF4 in MEF homozygous for eIF2 S51A, altering 
its major phosphorylation site. This phenotype parallels with the Gcd- 
phenotype observed in yeast. In agreement with these, 5MP1 inhibits eIF2 
recruitment to the 40S subunit in rabbit reticulocyte lysate. We   also found that 
5MP1 inhibits GDP dissociation from eIF2 (GDI function as recently reported 
for yeast eIF5), thereby increasing eIF2/GTP/Met-tRNAiMet ternary complex 
(TC) level in vivo. This positive regulation by 5MP1 explains why its 
expression conferred Gcd- phenotype only in the presence of gcd6 mutations 
that reduce the TC level. These results establish that 5MP1 is a translational 
regulator that antagonizes eIF5 function in TC recruitment yet retaining its GDI 
function. We also discuss the evolution of HEAT-domain containing translation 
factors and regulators in eukaryotes. 
 257 
ACTIVITIES OF LIGATIN AND MCT-1/DENR IN EUKARYOTIC 
TRANSLATION INITIATION AND RIBOSOMAL RECYCLING  
 
Maxim Skabkin1, Olga Skabkina1, Vidya Dhote1, Anton Komar2, 
Christopher Hellen1, Tatyana Pestova1  
 
1SUNY Downstate Medical Center, Department of Cell Biology, Brooklyn, 
NY, 11203, 2Cleveland State University, Department of Biological, 
Geological and Environmental Sciences, Cleveland, OH, 44115 
 
Eukaryotic initiation begins with ribosomal recruitment of Met-tRNAMeti by 
eIF2. In cooperation with eIFs 3/1/1A, Met-tRNAMeti/eIF2/GTP binds to 
40S subunits yielding 43S complexes that attach to the 5’-terminal region of 
mRNAs and then scan to the initiation codon. Stress-activated 
phosphorylation of eIF2α reduces the level of the active eIF2-GTP, globally 
inhibiting translation. However, translation of several viral mRNAs, 
including Sindbis virus (SV) 26S mRNA and mRNAs containing HCV-like 
IRESs, is wholly or partially resistant to inhibition by eIF2 phosphorylation, 
despite requiring Met-tRNAMeti.  
We have now identified three related mammalian proteins as factors that 
individually (Ligatin) or in combination (the oncogene MCT-1 and DENR, 
which are homologous to N- and C-terminal regions of Ligatin, 
respectively) can promote efficient eIF2-independent recruitment of Met-
tRNAMeti to 40S/mRNA complexes resulting in formation of 48S complexes 
if the process of ribosomal attachment to mRNA places the initiation codon 
directly in the P-site, as on HCV-like IRESs (Pestova et al., 1998, G&D), 
and as we have found now, also on SV 26S mRNA. 48S complex formation 
on SV 26S mRNA requires only eIF3, DHX29 and either eIF2 or Ligatin 
(MCT-1/DENR). The 5’-terminal 140 nts of SV mRNA comprising the 5’-
UTR and the enhancer stem located in the adjacent coding region can 
associate with eIF3-bound 40S subunits, in what is likely the first stage of 
ribosomal recruitment. DHX29’s role in initiation on SV 26S mRNA might 
be to correctly position mRNA in the mRNA-binding cleft of the 40S 
subunit. As a result of this process, the initiation codon of SV 26S mRNA is 
placed directly into the P-site of the 40S subunits in 
40S/eIF3/DHX29/mRNA complexes. Binding of Met-tRNAMeti to such 
complexes can be promoted by eIF2 or by Ligatin with equal efficiency. 
Thus, on specific mRNAs, Ligatin and MCT-1/DENR have a potential to 
substitute for eIF2 in circumstances when its activity is down-regulated. In 
contrast to eIF2, Ligatin also promoted binding of deacylated initiator tRNA 
as well as elongator tRNAs to 40S/mRNA complexes if the P-site was 
occupied by a cognate codon. However, it did not mediate 48S complex 
formation on mRNAs translated by the 5’-end-dependent scanning 
mechanism, on a near-leaderless mRNA and on the EMCV IRES. In 
addition to their role in initiation, Ligatin and MCT-1/DENR can promote 
release of deacylated tRNA and mRNA from recycled 40S subunits after 
ABCE1-mediated dissociation of post-termination ribosomes.  
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Glioblastoma multiforme (GBM) is the most common and most aggressive 
type of primary brain tumour. It is currently treated by a mixture of ionising 
radiation and Temozolomide (TMZ) chemotherapy, however virtually all 
patients experience disease recurrence and 75% die within two years of 
diagnosis. Tumours which express elevated levels of the DNA repair 
protein methylguanine methyltransferase (MGMT) have a particularly poor 
prognosis, suggesting that the levels of MGMT and the inefficacy of 
treatment are linked.  
MGMT is a “suicide” repair protein that binds irreversibly to a DNA adduct 
(such as those caused by TMZ) and is destroyed by the proteasome once 
repair has taken place. Therefore the ability of the cell to repair DNA 
damage relies on the rate at which it can resynthesise MGMT. Previous 
research has shown that reducing MGMT levels via RNA silencing 
increases the effectiveness of treatment, however this causes toxicity in 
bone marrow stem cells and is therefore unable to be used as a possible 
treatment option.  
Our preliminary data suggests that inhibition of mTOR signalling reduces 
the steady state levels of MGMT without affecting mRNA levels, 
potentially making them more sensitive to TMZ treatment. We are therefore 
using inhibitors of the mTOR pathway to determine how these affect 
MGMT levels and determining whether a mixture of these inhibitors with 
DNA damaging agents could be used to increase the efficacy of TMZ 
treatment. 
 
Funded by BBSRC studentship 
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The herpes simplex virus type-1 immediate-early ICP27 protein is essential 
for the lytic viral cycle and has counterparts in all sequenced herpesviruses. 
ICP27 is required for the expression of a large number of viral genes, 
exerting its effects predominately at the post-transcriptional level where it 
has a well-established role in nuclear export of viral mRNA. Interestingly, 
we and others have previously demonstrated that ICP27 also has a role in 
stimulating the translation of specific viral mRNAs. The mechanisms by 
which mRNA-specific binding proteins activate translation are poorly 
understood prompting us to investigate the mechanism of ICP27-mediated 
translation. Importantly, we find that it differs significantly from that of 
previously studied activators. Using a tethered function approach we show 
that ICP27 stimulates 43S complex recruitment during the initiation phase 
of translation, acting downstream of cap binding. Investigation of the 
biochemical basis of this activity revealed a direct interaction with poly(A)-
binding protein (PABP). ICP27 point mutations, which block its ability to 
stimulate translation in reporter assays and its association with polysomes in 
infected cells, abrogate the interaction with PABP establishing that this 
interaction is required for ICP27 function. Further analysis revealed that 
ICP27-PABP activity depends on eIF4G, providing the first report of an 
mRNA-specific translational activator that acts independently of the cap by 
targeting the PABP-eIF4G interaction. 
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Previous work has revealed a network of translationally controlled genes 
during exit of mouse embryonic stem cells (mESC) from pluripotency1. We 
have initiated a similar genome-wide analysis of translation state during in 
vitro differentiation of human embryonic stem cells (hESC) into 
cardiomyocytes. In this protocol, hESCs are aggregated and induced with 
cytokines (Activin A and BMP-4) during days 1-4 of differentiation. A 
KDR+ cardiovascular progenitor (CVP) population is discernible on day 5 
of differentiation, well before the appearance of beating cardiomyocytes on 
day 11. Total transcript microarrays on samples from days 5-10 defined a 
cardiac-committed pre-beating population that appeared as early as day 6. 
The translationally controlled transcripts, as determined by Translation 
State Array Analysis (TSAA)2 during the window between days 5-7 include 
cardiac-specific genes as well as genes previously known to be controlled at 
the post-transcriptional level. We are using a high-throughput approach to 
identify mRNAs that are controlled at translational elongation during this 
lineage decision, as well as exploring the possible involvement of 
microRNAs in the process. Additionally, preliminary polysome profiles 
show that undifferentiated hESCs show greater translational activity than 
undifferentiated mESCs; we are currently examining the relationship 
between total translation rate and ESC developmental stage in these two 
species. 
 
1. Sampath P, et al: Cell Stem Cell. 2, 448-60. (2008):  
2. MacKay VL, et al: Mol Cell Proteomics. 3, 478-89. (2004): 
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Translational control is essential throughout early development of the fruit 
fly Drosophila melanogaster to ensure precise spatial and temporal 
regulation of gene expression. For example, translation of maternal nanos 
(nos) mRNA must be restricted to the posterior of the embryo to ensure 
proper patterning of the anterior-posterior body axis. During oogenesis, a 
subset of nos mRNA becomes localized to the posterior of the oocyte, 
where nos translation is activated. This localization is maintained into 
embryogenesis, as local production of Nos protein is required for abdominal 
development. The vast majority of nos mRNA remains unlocalized and 
translationally repressed, however. It is essential for this unlocalized mRNA 
to remain repressed in both the oocyte and early embryo, as the presence of 
Nos protein at the anterior of the embryo interferes with normal 
development of head and thorax structures.  
 
Although the mechanism by which nos mRNA is translationally repressed 
is not well understood, repression in the bulk cytoplasm is mediated by a 
translational control element (TCE) in the nos 3’ untranslated region. The 
TCE is a structural motif consisting of two major stem loops (II and III) that 
are bound by the repressor proteins Smaug (Smg) in the embryo and 
Glorund (Glo) in the ovary. We have shown that nos translation in the ovary 
occurs by two mechanisms, one that acts at the initiation phase and one that 
acts post-initiation, as repressed nos mRNA remains associated with 
polyribosomes in late stage oocytes. Our results suggest that both of these 
mechanisms are mediated by Glo and its interacting partners. Although the 
post-initiation block is maintained into embryogenesis, subsequent 
translational initiation in the embryo is then repressed at initiation by Smg 
and its interacting partners. 
 
While there is an abundance of data demonstrating that the TCE modulates 
nos translation throughout early development by its interactions with Glo 
and Smg, there is evidence that additional trans-acting factors are likely to 
be involved. These factors, through their binding to the 3’UTR, may 
contribute to the post-initiation phase of nos regulation. Through the use of 
the RNA Affinity in Tandem technique (RAT), we are purifying nos RNP 
complexes from ribosome-enriched embryonic lysates, which will allow us 
to identify as yet unknown components by mass spectrometry. Roles for 
these factors in translational control throughout oogenesis and 
embryogenesis will be investigated by taking advantage of the genetic 
resources available in Drosophila, together with molecular and biochemical 
methods.  
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In eukaryotic translation initiation, Met-tRNAi delivery is one of the 
important steps for translational control, in which eIF2 plays an essential 
role by directly binding Met-tRNAi in a GTP-dependent manner. In yeast 
and recently in plants, four eIFs (eIF1, eIF3, eIF5, and eIF2-GTP-Met-
tRNAi) have been found to form a Multi-Factor Complex (MFC) as a 
possible intermediate for Met-tRNAi delivery to ribosomes, although its 
biological significance is poorly understood. Since mammalian eIF3 is 
twice as large as the yeast complex (13 non-identical subunits compared to 
6 subunits in yeast) and is involved in many cancers, studying the MFC 
formation in mammalian cells is of special interest. 
We have purified human eIF2 and eIF3 from HeLa cell extracts, and eIF1, 
eIF1A and eIF5 as recombinant proteins. We first tested interactions among 
human eIFs by native-gel analysis, and found that eIF1, eIF2, eIF3, and 
eIF5 can form binary complexes in every possible combination. 
Unexpectedly, the human MFC formed with sufficient stability to enable its 
detection by native gel electrophoresis and by molecular sieve 
chromatography, even when formed in the absence of GTP/GDP and Met-
tRNAi. Furthermore, we found that the MFC discriminates more strongly 
than eIF2 against GDP for Met-tRNAi binding (i.e. Met-tRNAi affinity was 
greatly decreased from Kd=3.6 μM in TC to undetectable levels upon MFC 
formation in the presence of GDP, while it did not change significantly in 
the presence of GTP). This effect was mostly dependent on the presence 
eIF3 and eIF5. Since eIF5 has recently been shown to bind eIF2-GDP and 
inhibit GDP dissociation, our finding implies that MFC formation might be 
related to this regulatory pathway. We are now trying to see if there is any 
difference in Met-tRNAi delivery rates between MFC- and conventional 
TC-mediated pathways. 
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Decoding errors during translation elongation (amino acid 
misincorporation) and termination (stop codon read-through) can alter the 
specific activity of gene products, cause problems with correct protein 
folding, and negatively affect cell health. In consequence, cells have 
evolved many mechanisms to ensure accurate mRNA translation, and 
natural error rates are typically very low (between 10-2 and 10-6 depending 
on the type of error studied). However, mechanisms maintaining 
translational accuracy contribute to the energy cost of protein synthesis, and 
also reduce the speed of protein synthesis. In wild type cells, decoding 
accuracy is therefore maintained in a finely tuned balance with other 
cellular requirements.  
The core question of our work is how such balance is achieved and 
maintained. Our recent results show that mutations in many cellular 
processes can improve decoding accuracy in yeast cells. Pathways we have 
discovered so far in which mutations can lead to hyperaccurate decoding 
include vacuolar protein turnover, various signalling pathways, as well as 
cytoskeletal and mitochondrial processes. Decoding accuracy also varies 
significantly with environmental conditions. Importantly however, there is 
no general correlation between growth rate and accuracy. We are currently 
characterising mechanisms by which environmental conditions and/ or 
mutants in various cellular processes affect translational accuracy. 
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Translational control is critical for gene regulation during spermatogenesis. 
Genes that are under translational control during spermatogenesis include the 
two protamines (Prm1 and Prm2), which encode highly basic nucleoprotein 
required for nuclear condensation during spermatid differentiation. Prm1 and 
Prm2 mRNA is transcribed early in spermatogenesis and sequestered for up to 7 
days in cytoplasmic ribonucleoprotein (RNP) particles where it is translationally 
repressed. Translational activation of Prm1 and Prm2 coincides with spermatid 
differentiation. Translational inhibition of Prm1 mRNA is important for 
completion of spermatogenesis as premature translation of Prm1 causes 
dominant male sterility. Sequences in the 3’ untranslated region (3’ UTR) of 
Prm1 mRNA regulate its repression. However, the mechanism of translation 
repression is unknown. We have shown that a highly conserved 17 nt sequence, 
the translation control element (TCE) in the Prm1 3’ UTR is necessary for 
translational repression of a reporter gene, human growth hormone (GH). To 
test the positional dependence of the TCE, we generated several transgenic 
lines, differing in the positioning of the TCE in the 3’ and 5’ UTR of an hGH 
reporter mRNA. These studies revealed a strong positional dependence on the 
TCE.  
 
Previous studies have shown that the Y-box proteins MSY2 and MSY4 are 
associated with repressed mRNAs stored in RNP particles; these proteins also 
bind to a conserved 7 nucleotide sequence in the 5’ end of the Prm1 3’ UTR. 
We have shown that extending the temporal expression of MSY4 expression 
during late stages of spermatogenesis inhibits normal translational activation 
and causes dominant male sterility. We hypothesize that the MSY2 and MSY4 
proteins either stabilize the Prm1 and Prm2 mRNAs in RNP particles or 
directly inhibit translation. In order to investigate the role of MSY4 in 
regulating translation, we used gene targeting in embryonic stem cells to create 
a loss-of-function mutation in the gene encoding MSY4. Msy4 mutants are 
viable but both males and females are sterile. In order to assess if MSY2 and 
MSY4 have redundant functions, we attempted to generate Msy2 Msy4 double 
mutants. Interestingly, we found that the Msy4 -/+; Msy2 -/+ males were sterile 
and Msy4 -/+ ; Msy2 -/+ females were sub-fertile. Assessment of Prm1 mRNA 
stability and translation in the mutants is currently being performed.  
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Polysome profiling experiments, used to investigate the post-transcriptional 
regulation of gene expression, have been performed within our group to 
look at different types of cell stress. Other groups are also generating 
polysome profiling data, and there is a need to systematically compare the 
gene lists produced by these different experiments and different groups. The 
aim of an analysis would be to identify how, and which, specific subsets of 
mRNAs are translationally regulated in unison. In order to enable this type 
of meta analysis, and to make all these data available to the translational 
community, we are creating a resource to collate polysome profiling data. 
The relational database underpinning the resource has been designed, and 
implemented in MySQL, and the development of the semi-automated 
process of data input is almost complete. A user-friendly search interface is 
under development. Initially, data sets obtained within our group (from 
hypoxia, ER stress and UV exposure) will be incorporated into the resource 
and analysed to identify sequence motifs common to groups of coordinately 
regulated genes. Data from external groups will be incorporated and 
included in the analysis as they become available to us. 
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It is clear that translational control plays an especially important role in the 
regulation of gene expression in neurons, for example in the local 
translation of proteins involved in synaptic plasticity, and also given the 
large demands of neuronal metabolism. Neuronal tissue seems to be 
particularly sensitive to perturbations in the mechanisms controlling 
translation, and the small number of genetic diseases involving mutations in 
the translation machinery tend to have neurological phenotypes, and 
neurons appear to have use a characteristic complement of post-
transcriptional regulatory factors. It is well known that many of the proteins 
important in neurological disease are regulated at the level of translation, for 
example APP and Tau, the proteins characteristic in Alzheimer’s disease 
pathology, both contain IRESes and other post-transcriptional regulatory 
elements, and similar control mechanisms are seen in BACE1, an enzyme 
required for the pathogenic cleavage of APP. We have examined the 
expression of a number of mRNAs encoding proteins known to be 
important in neurological disease, and by targeting aspects of translation 
initiation, we are able to specifically modulate the expression of proteins 
predicted to be harmful, such as APP, Tau, BACE1, and the presenilins, 
whereas global translation is largely unaffected, and the expression of some 
proteins predicted to be neuroprotective such as SOD1 and thioredoxin, is 
increased. Cell viability is not compromised by these interventions. 
Polysome profiling indicates a redistribution of ribosomes on the affected 
mRNA suggesting a translational mechanism of gene regulation, and we 
have shown by western and northern blotting, and by immunoprecipitation, 
that protein levels change rapidly in the absence of corresponding 
differences in mRNA levels. By cloning the untranslated regions of these 
mRNAs into destabilised luciferase expression vectors, we have been able 
to confirm the importance of RNA regulatory elements in this mechanism, 
and propose that these represent a novel target for therapeutic intervention 
in dementias and other neurological diseases, and give us insight in the 
response of neuronal cells to oxidative damage and other stresses. 
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Saccharomyces cerevisiae genome harbors five families of long terminal 
repeat (LTR) retrotransposons. Retrotransposons are mobile DNA elements 
that replicate via an RNA intermediate. Ty1 retrotransposons consist of two 
open reading frames, TYA and TYB analogous to gag and pol proteins of 
retroviruses respectively. The pol protein is produced as a fusion to the 
upstream gag protein and this requires a +1 programmed frameshift event. 
Ty1 transposition in the yeast genome has to be kept to a minimum because 
transposition of these elements can mutate genes. A screen identified a set 
of proteins that restricted Ty1 transposition (Ty1 ‘restriction’ genes) and 
another that helped in Ty1 transposition (Ty1 ‘helper’ genes). Among the 
many Ty1 helper genes that were identified we were interested in the genes 
that encoded the large subunit, small subunit ribosomal proteins and other 
genes that were associated with either translation or ribosome biogenesis. 
The strains harboring deletion of the above said genes were assayed for Ty1 
programmed frameshift activity to determine if they affected transposition 
due to increased/decreased frameshift activity. Two deletion strains showed 
a significant increase in frameshift activity while nine of them showed 
decreased activity. All but one of the ribosomal protein genes are Ty1 
helper genes i.e. deletion of the ribosomal protein led to a decrease in Ty1 
transposition.  We also performed sucrose gradient centrifugation 
centrifugation to see a correlation between subunit abundance and ty1 
transposition. The results show that there is no correlation between the two. 
Currently we are investigating the GAG protein level, Ty1 mRNA levels 
and reverse transcriptase activity of the ribosomal deletion strains. 
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The initiation factor IF1, with about 70 amino acids the smallest initiation 
factor, is essential for viability in every cell. However, there is no 
compelling evidence, why this factor is essential for life. To address this 
question we constructed an Escherichia coli strain lacking the chromosomal 
IF1 and providing the essential IF1 gene on a plasmid after a promoter, the 
transcription activity of which could be regulated. Starving the cells for IF1 
affected predominantly the 50S assembly in a dramatic fashion. A closer 
inspection revealed that the polycistronic mRNAs coding for many 
ribosomal proteins are strongly affected by the reduction of IF1 amounts in 
the cell. A systematic comparison of in vivo expression of mono- and bi-
cistronic model-mRNAs identified a functional setting requiring the 
presence of IF1. 
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Translation initiation factor eIF4A is a canonical factor required for its 
RNA helicase activity during attachment of mRNA to the 43S initiation 
complex. It is a component of the heterotrimeric eIF4F complex with eIF4G 
and eIF4E. 
 
eIF4A undergoes asymmetric dimethylation of the “Arg finger” (Arg362) 
residue in helicase motif VI by Protein arginine methyltransferase 1 
(PRMT1). This modification affects RNA dependent ATPase and its 
association with eIF4G; consequently we believe that a physiological 
outcome of this covalent modification is an inhibition or downregulation of 
translation initiation.  
 
Methylated eIF4A was detected by immunofluorescence in intact LN229 
glioblastoma cells using antisera raised against motif VI peptide containing 
dimethyl-Arg362. Methyl-eIF4A was detected in the cytoplasm as a 
punctate, random constellation of small granules. Addition of physiological 
stressors: puromycin, CoCl2, or Na-arsenite caused a change in methyl-
eIF4A granule size and colocalization with stress granule marker TIA-1; 
however, under these conditions a significant proportion of the modified 
factor was not associated with stress granules.  
 
Preliminary immunostaining studies with antisera against DAP5/p97 and 
PDCD4 showed very little colocalization with methyl-eIF4A. Thus at this 
time questions remain whether methyl-eIF4A granules are independent 
entities or associate with other unidentified cytoplasmic proteins, e.g., other 
translation components. The methyl-eIF4A granules could serve as 
localized or regional caches of inactive factor available for new rounds of 
mRNA translation.  
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Many of the molecular steps leading to the selection of the AUG start codon 
in eukaryotic translation initiation have been elucidated using in vitro and in 
vivo systems, but the process is still not fully understood. Studies of tRNA 
selection during the elongation phase of prokaryotic translation have 
benefited from the use of small molecules. No such chemical tools exist to 
probe start codon recognition in eukaryotic translation initiation, however; 
we have developed an in vivo screen to identify compounds that alter the 
fidelity of translation initiation codon selection in S. cerevisiae. Compounds 
identified in this screen can be used in the reconstituted yeast translation 
initiation system to provide further insight into the mechanism of the 
selection of the start codon. Additionally, these small molecules would be 
possible leads for drug development for the treatment of a variety of 
diseases including genetic disorders, cancer and fungal infection. 
 
The screen utilizes a dual luciferase assay, where renilla and firefly 
luciferase are expressed from the same plasmid but as separate messages. 
Renilla luciferase mRNA, with an AUG start codon, acts as an internal 
control for expression of firefly luciferase mRNA, with the near cognate 
codon UUG. Screening of ~60,000 compounds identified 2 structurally 
related compounds that increase expression from UUG relative to AUG. 
Further in vivo and in vitro assays are being used to gain mechanistic 
information, and provide insight into the complex process of start codon 
selection in eukaryotes. 
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Eukaryotic cells have evolutionarily elaborated stress responses to deal with 
ever-changing environments. A myriad of signaling factors and pathways 
have been revealed to function in various responses including stress-
responsive gene expression and translational control. However, because 
physiological, low-dose of stress dose not induce apparent phenotypes such 
as cell death, it is still difficult to directly analyze the factors involved in 
low-dose stress response. 
To circumvent this difficulty, we have exploited the phenomenon called 
cross-tolerance. It is known that treatment of cells with low-dose of (or 
sublethal) stress leads to transient resistance to the following severe stress. 
We have identified cpc2+ as the responsible gene from a genetic screen for 
fission yeast mutants defective in cross-tolerance. Cpc2 is a highly 
conserved protein (homolog of mammalian RACK1) and is predicted to 
function as a scaffold to regulate signal transduction and to be involved in 
translational control. Translation initiation factor 2 α-subunit (eIF2α) is 
phosphorylated in response to cellular stress, which causes a reduction in 
the global translation rate and an increase in the selective translation of 
proteins that are required for cell survival under stress. We found that eIF2α 
phosphorylation upon stress treatment was decreased in cpc2Δ cells. 
Furthermore, cpc2 and gcn2, that encodes eIF2α kinase, exhibited genetic 
interaction, suggesting that Cpc2 modulates Gcn2 activation under stress 
condition. In addition, we found that cpc2 disruption caused defects in 
stress-activated MAP kinase-dependent gene expressions. These data 
indicate that Cpc2 is a key molecule in adapting to environmental changes 
by regulating both transcriptional and translational responses. 
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Cap-dependent translation of cellular mRNAs is compromised under 
conditions of cellular stress such as hypoxia, DNA damage, or serum 
deprivation, conditions that often result in the induction of apoptosis. In 
contrast, the translation of the cellular mRNAs containing Internal 
Ribosome Entry Site (IRES) within their 5’ untranslated region is less 
sensitive to the repression of global translation. Importantly, translation of 
several pro- and anti-apoptotic proteins is mediated by IRES during cellular 
stress and serves to fine tune the cellular stress response. One such protein 
is the X chromosome-linked inhibitor of apoptosis protein (XIAP), which 
interacts directly with distinct caspases to inhibit apoptosis. We and others 
have previously characterized the sequence and the structural attributes of 
the XIAP IRES and identified several trans-acting factors (ITAFs) that 
modulate XIAP IRES activity in vivo. However, the mechanism by which 
XIAP IRES, or in fact any cellular IRES recruits ribosome to support cap-
independent translation and in particular how this occurs during cellular 
stress remains unknown. This has prompted us to investigate the XIAP 
IRES function in an in vitro cell-free translation system using the in vitro 
transcribed XIAP IRES RNA. Using the toe printing assay, we have found 
that the in vitro transcribed uncapped XIAP IRES RNA is capable of 
forming translational competent initiation complex in vitro. A mutation in 
polypyrimidine tract (PPT) of XIAP IRES abolished the ability to form 
initiation complex which could be rescued, however, by addition of 5’ cap 
structure. XIAP IRES initiation complex could be formed even when eIF2α 
was phosphorylated. Immuno-inactivation of eIF2 or eIF5B resulted in the 
partial inhibition of XIAP IRES initiation complex formation. However, 
combined immuno-inactivation of both eIF2 and eIF5B resulted in complete 
inhibition of XIAP IRES initiation complex formation. This observation 
suggested alternative role of eIF2 and eIF5B in cellular IRES translation. 
Furthermore, we used RNA affinity chromatography combined with the 
sucrose density gradient centrifugation to isolate and further characterize 
translation initiation complexes formed on the XIAP IRES RNA. Our in 
vitro data provides support to the notion that XIAP IRES supports internal 
initiation of translation and establishes a model to investigate the precise 
molecular mechanism of IRES-mediated translation during stress. 
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Protein kinase PKR blocks viral replication by inhibiting cellular protein 
synthesis through phosphorylation of translation initiation factor eIF2alpha. 
In order to survive within the hosts, viruses synthesize inhibitors of PKR. 
E3L is one such protein synthesized by variola virus, the causative agent of 
small pox. E3L consists of a Z-DNA binding domain and a dsRNA binding 
domain (dsRBD), both of which are indispensable for PKR inhibition, and 
viruses lacking E3L are defective for replication. To gain further insight 
into the inhibition of PKR by E3L, we identified PKR mutations that 
conferred resistance to variola E3L, while retaining kinase activity. High-
level expression of PKR is toxic in yeast and this toxicity is suppressed by 
co-expression of variola E3L. The dsRBD of PKR was subjected to random 
mutagenesis and the mutant library was introduced into a yeast strain 
expressing E3L, and candidates showing a slow-growth phenotype were 
selected. Ten PKR mutants were identified in the screen including two 
mutants showing strong resistance to E3L. In contrast to wild type PKR, the 
PKR mutants did not show any decrease in eIF2alpha phosphorylation in 
the presence of E3L. The sensitivity of the PKR mutants towards K3L, a 
pseudosubstrate inhibitor of PKR, validated that the mutants were 
specifically resistant to E3L. The strong PKR mutants were also resistant to 
inhibition by a truncated version of PKR devoid of the kinase domain. To 
further examine the E3L-resistant phenotype of the PKR mutants, we 
utilized PKR knockdown HeLa cells and monitored the activity of PKR 
using a luciferase reporter assay. Expression of PKR reduces translation in 
the PKR knockdown HeLa cells while co-transfection with E3L restores 
protein synthesis as measured by an increase in luciferase activity. 
Confirming the data from yeast, the translation inhibition by the PKR 
mutant was not suppressed by co-transfection with E3L. Our data supports 
the hypothesis that E3L could inhibit PKR by heterodimerization mediated 
through the dsRBDs of PKR and the nucleic acid binding domains in E3L. 
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The D1 dopamine receptor is involved in mediating the psychomotor effects 
of cocaine. Various studies, using different drug administration regimens 
have demonstrated that cocaine treatment increases D1 receptor mRNA 
without a concomitant increase in protein in some brain regions. The 
mechanisms that mediate the post-transcriptional regulation of D1 receptor 
in cocaine-treated animals have not been determined. In this study, we used 
two different cocaine treatment regimens and measured the levels of D1 
receptor mRNA and protein in various brain regions of the Drd1a-EGFP 
mice model. Our results suggest that the D1 receptor exhibits post-
transcriptional regulation in the caudate region regardless of the cocaine 
treatment regimen used. Using the CAD catecholaminergic cell line, which 
expresses endogenous D1 receptors, we demonstrated that the 3’UTR of D1 
receptor mRNA is necessary and sufficient for post-transcriptional 
regulation. Having ruled out message and protein stability as mechanisms, 
we are currently testing a hypothesis that microRNAs (miRNAs) mediate 
the post-transcriptional regulation of D1 receptors. This hypothesis is 
supported by dicer knock-down studies in the CAD cells. The 3’UTR of D1 
receptor mRNA has putative binding sites for specific miRNAs that were 
identified in a genome-wide expression screen of miRNAs from the caudate 
region of cocaine-treated animals. A subset of these miRNAs is 
endogenously expressed in the CAD cell line which facilitates the use of 
these cells to evaluate their role in mediating the post-transcriptional 
regulation of D1 receptors. Funded by FM Kirby Foundation and NIH (R03 
DA026030). 
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The decay of eukaryotic mRNA is triggered mainly by deadenylation, 
which leads to decapping and degradation from the 5’ end of an mRNA. 
Several lines of evidences show that dissociation of ribosome is prerequisite 
for the decapping. First, translational initiation rate is inversely proportional 
to decapping rate. Second, mRNA decapping can occur efficiently in termed 
P-bodies, ribosome-free cellular foci. Third, mRNAs those are trapped in 
polysomes, as a result of treating the cells with cycloheximide, are resistant 
to decapping and are not found in P-bodies. Recently, it was reported that 
both deadenylated and decapped mRNA are distributed in polysomes, 
indicating that the decapping takes place while mRNAs are associated with 
actively translating ribosomes. It has been proposed that endogenous 
mRNAs are decapped on polysomes, and dissociation of ribosomes from 
mRNA is not a prerequisite for decay in yeast. 
The inhibition of decapping by poly(A) tails and poly(A) binding protein 
(Pab1) is conserved in eukaryotes. Pab1 has been proposed to block the 
recruitment of mRNA to the P-bodies where mRNA degradation takes place 
by stimulating translation initiation. In contrast, it was shown that deletion 
of the translation initiation factor eIF4G interacting domain in Pab1 has no 
effect on the ability of tethered Pab1 to block decapping in yeast. Although, 
this suggests that Pab1 may inhibit decapping via interactions that are 
independent of the translation initiation complex, it is still unclear whether 
Pab1 inhibits decapping without translation. To address translation-
independent function of Pab1 in the inhibition of decapping, we examined 
the contributions of Pab1 to the stability of non-translated mRNAs, an AUG 
codon-less (No-AUG) mRNA or mRNA containing a stable stem-loop 
structure at the 5’-UTR. The tethering of Pab1 stabilized non-translated 
mRNAs, and this stabilization required neither the eIF4G interacting 
domain of Pab1 nor Pab1 interacting domain of eIF4G. The tethering of 
Pab1 also stabilized non-translated mRNA without poly(A) tail in ski2Δ 
mutant. However, non-translated mRNA containing neither poly(A) tail nor 
cap structure was not stabilized by the tethered Pab1 in ski2Δ mutant. These 
results strongly suggest that tethering of Pab1 may inhibit the decapping 
reaction independent of translation. These results lead us to propose that 
Pab1 has an ability to inhibit decapping reaction in a translation-
independent manner in vivo. 
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Ty3 elements of S. cerevisiae contain two overlapping coding regions, 
TY3A and TY3B, which shows functional homologies to the retroviral gag 
and pol polypeptides, respectively. TY3B translated as TY3A-TY3B fusion 
protein upon +1 frameshift at the frameshift site of Ty3 mRNA. Our results 
indicated that the frameshift efficiency in Ty3 mRNA is modulated 
depending on various metabolic signals. Frameshift rate increases 3 to 4- 
fold in nutritionally deprived S. cerevisiae cells. We have shown that the 
nutrient depriviation signal exerts its effect on the frameshift through Snf1p 
and Stm1p. Cytoplasmic localization of Snf1p seems to be essential for the 
activation of Ty3 frameshift rate in nutrient deprived yeast cells. In 
addition, amino acid starvation and osmotic stress also activates the Ty3 
frameshift rate, indicating that the stress activated protein kinases also 
involve in the regulation of Ty3 frameshift rate in S. cerevisiae.  
Part of this research was supported by Uludag University research fond 
(Project no: 2009/42).  
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The full length mRNA of the laboratory adapted pNL4.3 clone of the 
immunodeficiency virus type 1 (HIV-1) harbors an internal ribosomal entry 
site (IRES) element within its 5’ UTR. In order to extend these findings we 
isolated the 5’UTR of natural variants of HIV-1 isolated from clinical 
samples and evaluated if they exhibited IRES activity. Interestingly, 
alignment of the pNL4.3 5’UTR with those recovered from all natural 
isolates showed important differences such as nucleotide substitution, 
deletions and insertion. The isolated HIV-1 5’UTR were then tested in the 
context of a bicistronic mRNA. Ex vivo assays showed that natural variants 
displayed cap-independent translation initiation. Strikingly, and despite of 
the number of mutations incorporated into the 5’UTR of the natural variants 
when compared to the reference clone pNL4.3, the IRES activities exhibited 
by the 5’UTR isolated from clinical samples were higher. In an attempt to 
explain these data, the secondary structure of the isolated 5’UTRs was 
analyzed using an RNA-probing approach. This study revealed important 
variations in the secondary structures within the 5’UTR of the natural 
variants when compared to the pNL4.3 5’UTR. Together these observations 
confirm the presence of an IRES element within the 5’UTR of the HIV-1 
full length mRNA. Additionally, finding suggest that in the case of the 
HIV-1 5’UTR multiple RNA structures are capable of driving cap-
independent translation initiation. 
Grant FONDECYT 1090318, Apoyo tesis doctoral Facultad de Medicina 
(PMD 10/09). MV is a CONICYT fellow. 
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The time scale of translation and the time scale of mRNA degradation are 
comparable under certain circumstances and in certain types of cells 
including prokaryotic cells. On the one hand, the time to translate an mRNA 
increases with its length. On the other hand, the time scale associated to 
non-specific degradation depends weakly on the length of the message. This 
implies that the translation of shorter and longer mRNAs is differently 
affected by the process of non-specific degradation [1]. We have thus 
developed a stochastic theory that quantifies the effect on the translation 
rate of two possible, different, non-specific degradation pathways. One 
pathway, which is commonly associated to prokaryotic cells, leads to the 
rapid degradation of the whole mRNA with no possibility for the ribosomes 
to conclude translation. The other pathway, commonly associated to 
eukaryotic cells, consists of decapping followed by the completion of 
translation of the loaded ribosomes. The translational ratio, defined as the 
number of proteins synthesized per unit of time per mRNA, is a measurable 
quantity given by the amount of proteins divided by the amount of 
corresponding mRNA. Our theory predicts that the translational ratio 
decreases, for increasing mRNA length, under both non-specific mRNA 
degradation pathways. Nonetheless, it shows that the decrease of the 
translational ratio associated to prokaryotes is much stronger than the 
decrease associated to eukaryotes [2]. We are also able to show that the 
prediction of the theory is compatible with available data about protein 
abundance per mRNA in E. coli. A general conclusion of the theory is that 
the pathway of degradation used in eukaryotic cells allows this kind of cells 
to support longer mRNAs than in prokaryotic cells. 
 
[1] A. Valleriani, Z. Ignatova, A. Nagar, R. Lipowsky, Turnover of 
messenger RNA: Polysome statistics beyond the steady state, Europhys. 
Lett. 89 (2010) 58003  
 
[2] A. Valleriani, G. Zhang, A. Nagar, Z. Ignatova, R. Lipowsky, Length 
dependent translation of messenger RNA by ribosomes, submitted for 
publication 
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Loss of function of the polyribosome-associated protein FMRP leads to 
Fragile X Syndrome, suggesting that the protein plays a key role in 
translational regulation in neurons, but there has been little consensus 
regarding mechanism. Here we develop a brain polyribosome-programmed 
translation assay to test the action of FMRP on transcripts to which it is 
directly bound, revealing that these mRNAs are associated with a 
population of stalled ribosomes. Ribosomal translocation on these 
transcripts is increased in brain polyribosomes derived from either the Fmr1 
null or I304N Fragile X disease mice, or when a decoy RNA specific for all 
FMRP paralogs acutely relieves FMRP-mediated translational repression, 
leading to increased protein expression. Thus FMRP represses translation of 
specific mRNAs during elongation. Loss of this repression, resulting in 
overexpression of the encoded synaptic proteins, likely underlies the Fragile 
X Syndrome. 
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The successful manipulation of embryonic stem cells for therapeutic 
applications requires a detailed understanding of the molecular pathways 
underlying gene expression on all levels. While current technologies have 
allowed the characterization of the transcriptome and the proteome in 
embryonic stem cells very little is known about the translational controls 
that operate within these cells and the role it plays in differentiation. We 
have taking a genomics approach to identify mRNAs that are differentially 
translated in both ES cells and cells undergoing early differentiation. 
Actively translated polysomal mRNAs were isolated from ES cells and ES 
derived Neural Precursor Cells (NPCs). These populations were compared 
to whole cell mRNA on genome wide expression arrays. We see a 
significant number of mRNAs that are selectively up and down regulated 
translationally following NPC differentiation. These results highlight the 
important role played by translational control in early differentiation. We 
will discuss the genome wide data and further analysis of selected 
translationally controlled candidate RNAs. 
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Regulation of the tau protein is critical for microtubule function and 
numerous cellular processes, particularly in neurons. Moreover, 
hyperphosphorylation of the tau protein, which results in the formation of 
neurofibrillary tangles is one of the hallmarks of Alzheimer ’s disease. 
Inhibiting tau protein expression is one approach for ameliorating this 
disease. To this end we have shown that the 5’ leader of the human tau 
mRNA contains an internal ribosomal entry site (IRES). We have begun to 
characterize elements integral for IRES activity. The mechanism by which 
eukaryotic IRESes recruit the translational machinery is not well 
understood, although both sequence and secondary structure appear to be 
involved. For viral IRESes, RNA structure is often required to recruit the 
ribosome and other translation initiation components. Initially, we 
performed deletion analysis and demonstrated that the majority of the 5’ 
leader was required for IRES activity. Indeed, using ApppG capped 
monocistronic luciferase reporter RNA as a read-out of IRES activity, any 
deletions resulted in almost a complete abolishment of translation. This 
result stands in contrast to reports from our lab and others where smaller 
segments within a 5’ leader can mediate IRES activity. This finding led us 
to hypothesize that the tau 5’ leader may exhibit a secondary structure 
required to initiate translation. In fact SHAPE analysis revealed that the tau 
5’ leader is highly structured. Moreover, we identified 4 regions that 
potentially exhibited long range interactions. Native gel analysis showed 
that individual mutations of the potential interacting regions led to a change 
in the RNA migratory pattern that was restored when compensatory 
mutations were made. Furthermore, these mutations led to a diminution of 
IRES activity that was partially restored with the compensatory mutations. 
Taken together, these results indicate that the tau IRES exhibits extensive 
secondary and tertiary structure that is necessary for IRES activity. 
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Initiation factor eIF5B (IF2) is a monomeric translation initiation factor that 
promotes binding of fMet-tRNA to the ribosome and is necessary for 
ribosomal subunit joining. Along with IF1/eIF1A it comprises initiation 
factors required for protein synthesis in all kingdoms of life. Recent data 
suggest that eIF5B in eukaryotes may play a role in translation of specific 
mRNAs. An EMS mutant of the model plant Arabidopsis thaliana, 
designated hot3-1, was identified which was unable to acquire tolerance to 
high temperature, but otherwise grew normally in the absence of stress (1). 
Mapped-based cloning of the mutant allele revealed a single point mutation 
in gene At1g76810 on chromosome 1, encoding eIF5B. At1g76810 (HOT3) 
encodes a 1294 amino acid, 142 kDa protein. Like human, yeast and other 
eukaryotic eIF5B proteins, HOT3 contains a predicted unstructured amino 
terminal region of ~700 amino acids and a C-terminal IF2/eIF5B domain of 
~600 amino acids. The hot3 mutation converts G969 to S, which 
corresponds to a universally conserved Gly residue in Domain II of 
IF2/IF5B proteins (2). Consistent with a defect in translation, hot3 mutant 
plants accumulate significantly reduced levels of major heat shock proteins 
after high temperature treatment, which may be the cause of reduced heat 
tolerance. A null allele, hot3-2, exhibits the same loss of heat tolerance and 
reduced HSP expression as the missense mutant hot3-1, suggesting that the 
heat sensitive phenotype of hot3-1 is not simply due to temperature 
sensitivity of a housekeeping protein, but rather a specific loss of function 
required for translation during or following heat stress. The hot3-2 null 
allele shows dramatically reduced growth rate, as does a null mutant of the 
eIF5B homologue, FUN12, in yeast. Interestingly, this reduced growth rate 
and loss of heat tolerance occurs despite the presence of three other 
transcribed eIF5B homologues in Arabidopsis, all on chromosome 1, 
probably the result of recent gene duplication (At1g78620, 130 kDa; 
At1g76720, 131 kDa; and At1g21160, 121 kDa). Whether these other 
eIF5B homologues fail to complement the defect of the hot3 mutations due 
to differences in expression and localization, or due to unique 
functions/interactions of HOT3 remains to be determined.  
 
(1) S-W. Hong and E. Vierling. PNAS 97:4392 (2000)  
(2) A.Roll-Mecak, C.Cao, T.E. Dever, S.K. Burley. Cell 103:781 (2000)  
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Dynamic interactions between the cap-binding complex, eIF3 and the 40S 
subunit help to recruit mRNA to the ribosome, promote helicase activity, and 
induce conformation rearrangements in the ribosome to initiate protein 
synthesis. Of these interactions, it is the direct interaction between eIF4G and 
eIF3 that functions to tether the cap-binding complex to eIF3. While this contact 
is crucial for mRNA recruitment, the molecular details of this interaction have 
not been fully characterized. The binding domain in eIF4G responsible for the 
direct interaction with eIF3 has been mapped to a broad 93 amino acid domain. 
However, a clearly defined consensus site within this domain has not been 
identified. In addition, the subunit(s) of eIF3 responsible for binding to eIF4G is 
currently unclear. 
 
To provide a more detailed examination of this interaction, we have established 
a fluorescence polarization assay using purified components to quantitatively 
measure the affinity of the eIF4G-eIF3 interaction. We are currently using this 
assay to test the effect of different mutations within the known eIF3-binding 
region of eIF4G. We will present data to show how this approach is enabling us 
to identify residues critical for this interaction and precisely define the eIF3 
consensus binding-site in eIF4G. 
 
The eIF3e subunit has been proposed to play a role in forming the eIF4G-
binding site in the eIF3 complex. To extend this work, we have sought to 
develop an assay that will allow us to analyze whether additional eIF3 subunits 
form a binding surface for eIF4G. To probe the spatial proximity of eIF3 
subunits to eIF4G we have taken a general approach to examine chemical 
crosslinks formed with eIF4G (1011-1105) bearing a site-specific diazirine 
crosslinker (sulfosuccinimidyl 4,4'-azipentanoate; Sulfo-SDA). This crosslinker 
creates a reactive carbene intermediate upon photoactivation, which has the 
advantage of rapidly forming non-specific covalent bonds. This approach also 
has the advantage that the eIF3 complex will not crosslink to itself, which 
occurs with approaches such as formaldehyde, glutaraldehyde, or UV 
crosslinking. Using this approach, three major crosslinked species are identified 
at roughly 130 kDa (a), 85 kDa (b) and 65 kDa (c). Accounting for the apparent 
molecular weight of eIF4G on SDS-PAGE (~15 kDa), these preliminary data 
indicate successful crosslinking to at least three eIF3 subunits, including either 
the core eIF3b and/or eIF3c subunits. We have begun to scale up these 
crosslinking reactions so that we can identify these crosslinked products using 
mass spectrometry. 
 
This work is supported by NIH grant R01 GM092927 and NIH training grant 
T32 GM-007377-29. 
 284 
ASSIGNING MOLECULAR ACTIVITIES TO INDIVIDUAL EIF3 
SUBUNITS  
 
Albrecht G von Arnim1, Bijoyita Roy1, Fujun Zhou2, Justin Vaughn1, 
Byung-Hoon Kim1  
 
1University of Tennessee, Biochemistry Cell and Molecular Biology, 
Knoxville, TN, 37996, 2University of Tennessee, Genome Science and 
Technology, Knoxville, TN, 37996 
 
The large eIF3 complex contributes to translation initiation by fostering 
ribosomal tRNA loading and joining between the 40S ribosome and the 
mRNA. Eukaryotic translation initiation factor 3 (eIF3) also functions in 
translation reinititiation on mRNAs harboring upstream open reading 
frames (uORFs). Carboxyl-terminal truncation alleles of the h subunit of 
Arabidopsis eIF3 (At1g10840) implicate this subunit in resumption of 
scanning. While short uORFs are fairly permissible for reinitiation, those 
encoding long peptides or inhibitory attenuator peptides require an intact 
eIF3h. A role in reinitiation has also been attributed to the large ribosomal 
protein RPL24B. Here we show, using a common set of uORF containing 
5’ leader constructs, that the rpl24b mutant suffers from a similar 
translational defect as the eif3h-1 mutant. Accordingly, eif3h-1 mutant 
plants undertranslate mRNAs for uORF-containing auxin response 
transcription factors (ARFs). Moreover, the eif3h-1 mutant displays 
phenotypes consistent with undertranslation of ARFs, as previously shown 
for the rpl24b mutant. To date, no other plant eif3 mutant has revealed a 
similar spectrum of molecular defects. We conclude that eIF3 cooperates 
with the large ribosomal subunit in bringing about translation reinitiation.  
Supported by DOE DE-FG02-96ER20223 and NSF DBI-0820047.  
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Linear plasmids were found in a number of yeast species belonging to nine genera, 
included Kluyveromyces, Debaryomyces, Saccharomyces, Saccharomycopsis, 
Wingea, Pichia etc. The genetic organization of yeast linear plasmids appears to be 
quite uniform with most thoroughly studied plasmids pGKL1 and pGKL2 from the 
yeast Kluyveromyces lactis. pGKL plasmids are peculiar in many respects since both 
plasmids are cytoplasmically localized, linear with distinct proteins covalently 
linked to terminal inverted repeats. Gene functional analysis has shown that pGKL1 
is instrumental in the expression of a killer toxin (called zymotoxin), whereas 
pGKL2 provides vital maintenance functions for both plasmids. Both plasmids are 
tightly packed with genetic information and carry fifteen open reading frames (ORF) 
in total. Genes encoded by pGKL plasmids are likely to be transcribed 
independently, as each is preceded by a sequence motif that was shown to be crucial 
for cytoplasmic promoters. The mRNAs transcribed from the pGKL plasmids are 
supposed to be capped and not to be polyadenylated, or contains only short poly(A) 
tail at the 3’ UTRs. Transcripts synthesized in the cytoplasm do not have access to 
the nuclear capping machinery, but a cap is essential for efficient initiation of 
eukaryotic translation.  
 
Here we present molecular and functional analyses of plasmid specific mRNAs 
UTRs, 5’ and 3’ respectively. First, we present a molecular analysis of a putative 
capping enzyme encoded by K2ORF3. We produced K2Orf3p as a HIS- or GST-
tagged fusion protein both in E. coli and baculovirus expression systems, purified all 
the overexpressed protein variants by affinity chromatography to almost 
homogeneity and successfully tested them for their guanylyltransferase activities. 
Surprisingly, we were not able to detect any N7-methyltransferase activities of any 
of the purified K2Orf3p protein. Second, we show that pGKL specific mRNAs do 
not bind to the cap-binding translation initiation factor 4E from S. cerevisiae in vitro 
while cellular mRNAs do. This result is further supported by our finding that killer 
toxin, naturally encoded by pGKL plasmids, is translated by cap-independent 
pathway, while control killer toxin gene artificially expressed under the control of 
the strong Pol II driven promoter is translated by cap-dependent pathway. And last 
but not least, we analyzed 3’ UTRs of the plasmid specific mRNAs to reveal its 
exact structure. 
 
Taking together, our results imply that plasmid specific mRNAs are either not 
capped or contain some kind of non-conventional cap structure. Our experiments 
concerning analyses of structures naturally occurring in vivo at 5’ terminus of the 
pGKL mRNA transcripts will be provided. 
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Eukaryotic translation is regulated by features of the 5’UTR and by the 
concentrations and state of initiation factors. mRNAs with short 5’UTR are 
translated efficiently, do not rely heavily on a functional initiation 
machinery and are thus called strong mRNAs. Weak mRNAs have long 
5’UTRs, are translated poorly and rely on a strong initiation complex. Weak 
mRNAs code predominantly for oncoproteins, growth factors and anti-
apoptotic proteins, which are thus down regulated by the nature of their 
5’UTR. Among the initiation factors, the concentration of the cap-binding 
protein eIF4E seems to be rate limiting. The eIF4E protein recruites the 
small ribosomal subunit to the 5’ end of the mRNA via the links to eIG4F 
and eIF3. Elevated concentrations of eIF4E have been found in several 
forms of cancer. 
We hypothesized that weakening the interaction of eIF4E with eIF4G 
would selectively reduce the translation of oncogenes and messages for 
growth-promoting proteins. Using high-throughput screening we discovered 
small molecules that inhibit the eIF4E/eIF4G interaction. The inhibitors 
were termed 4EGIs. Binding of the initial hit compounds and analogs to 
different states of human eIF4E was studied with NMR and X-ray 
crystallography. The compounds and analogs were tested in in-vitro and in-
vivo assays. The molecules exhibit activity against melanoma, breast, lung 
and prostate cancer cell lines, which are all cell lines tested. The lead 
compounds inhibit eIF4E/eIF4G iteractions in xenograft tumors in mice and 
reduce tumor growth. 4EGI-1 inhibits tumor expression of oncogenic 
proteins such as cyclin E, cyclin D1, c-myc and Bcl-2. Intra-peritoneal 
treatment with 4EGI-1 did not exhibit any toxic effects in mice. 
esented. 
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The peptidyl transferase reaction catalyzes a central process for the 
biological world: the generation of proteins. It also bears noting that the 
peptidyl transferase center is the favorite binding site for numerous 
antibiotics. Studying the mechanism of this process can be used to create 
new therapeutic resources for combating bacterial infections. This is 
especially important nowadays due to the increasing incidence of drug-
resistant bacteria. 
In our approach, in vitro protein synthesis system based on bacterial 
ribosome is utilized on the glass surface for single molecule detection. The 
ribosome protein L27 labeled with fluorescence groups interacts with 
fluorescently-labeled tRNAs via FRET (Fluorescence resonance energy 
transfer) process. The phenylalanine tRNA labeled at the Dihydro-U 
(16/17) position FRETs with the L27 with efficiencies of 0.44 and 0.65 
from the A- and P-site respectively. We have developed a novel 
classification method to interpret the dispersive single molecule FRET data 
and found that the ribosomes existed in subpopulations with distinctive 
dynamics. We have observed the transitions among the ribosome 
subpopulations at varied conditions including: (a) in the presence of EF-G; 
(b) spontaneously; (c) in different buffers; or (d) with antibiotics bound. 
Therefore, these subpopulations are biologically active ribosomes. 
We directly detect 3 FRET states, 0.2, 0.44 and 0.65 in the pre-translocation 
complex, assigned to the P/E - A/A hybrid state, the P/P -A/A classical state 
and the P/E - A/P hybrid state, respectively. Both of the hybrid states exist 
predominantly in the fluctuating ribosomes, not in the non-fluctuating 
ribosomes. This can be best explained by ribosome population bifurcation, 
where certain energy barriers separate multiple types of ribosomes, so 
ribosomes either remain stable in the classical state or fluctuate among the 
hybrid states and the classical state. The classical state in the stable 
ribosome population is not directly interchangeable with the classical state 
in the fluctuating populations. Consequently, the regulation of the hybrid 
state fluctuation is achieved by varying the partitions of the ribosome 
subpopulations, rather than the thermodynamic parameter of the hybrid 
states directly. Therefore, we propose that the ribosome hybrid state 
fluctuation occurs with sub-level dynamics and is hierarchically regulated.  
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The majority of translational regulation occurs at the initiation of 
translation, allowing a rapid and dynamic cellular response to a variety of 
stresses. The translation initiation complex includes the closed-loop mRNP 
complex of mRNA, eIF4E, eIF4G, and PAB1 conjoined with the 40S and 
60S ribosomal subunits and other initiation factors. In this study, we have 
used analytical ultracentrifugation with fluorescent detection system (AUC-
FDS) to identify the sizes of yeast translation initiation complexes rapidly 
(two-hour analyses), precisely, and without the time-consuming and tedious 
secondary analysis (Westerns and Northerns) that are normally required for 
detecting multimeric protein/mRNA complexes. Following a one step 
affinity purification with Flag-PAB1 using strains carrying translation 
factors and specific mRNA tagged with GFP, we identified a 78S complex 
that contains all of the major components of the translation initiation 
complex: mRNA, eIF4E, eIF4G1/eIF4G2, PAB1, 40S and 60 ribosomes, 
and several other proteins. Glucose depletion from the growth medium that 
causes immediate translation stoppage resulted in a decrease of the 78S 
translation initiation complex to 15% of its normal level. Readdition of 
glucose resulted, within 10 min, in a concomitant return to normal levels of 
78S abundance. In contrast, amino acid deprivation that operates through 
control of eIF2α function, unlike that of glucose depletion, caused only a 
50% decrease in the 78S complex. As glucose depletion is known to result 
in stress granule formation and amino acid deprivation does not, the 
disappearance of the 78S complex with withdrawal of glucose indicates that 
the stress of glucose deprivation acts to principally control 78S complex 
availability. AUC-FDS, in addition, identified at least two other novel 
translation initiation complexes and multiple new components within the 
78S complex. 
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Nascent peptides have been identified that regulate gene expression from 
within the ribosomal tunnel by selectively arresting translation. The 
arginine attenuator peptide (AAP) is encoded by a uORF in the 5'-leader 
regions of fungal mRNAs specifying the glutamine amidotransferase 
subunit of arginine (Arg)-specific carbamoyl phosphate synthetase. The 
AAP causes the ribosome to stall at the uORF termination codon in 
response to a relatively high concentration of Arg. The stalled ribosomes act 
as a blockade to the ribosome scanning process required for downstream 
initiation. In vivo, the stall also triggers nonsense mediated mRNA decay. 
The AAP can also stall ribosomes engaged in elongation. The major goal of 
these studies is to understand the mechanistic bases for how the AAP and 
Arg arrest translation. Fungal and wheat germ extracts were used to 
determine the translational step(s) affected by the AAP and the cis-acting 
sequences within the AAP required for its function. In vitro systems 
enabled direct assessment of the AAP’s effect on peptidyl transferase 
activity, examination of AAP-control of reporter enzyme synthesis, and 
determination of the positions of ribosomes that translate the AAP by 
toeprinting. We found that L-Arg and AAP function together to block 
peptidyl transferase activity. We assayed progressive C-terminal truncations 
of AAP to evaluate the requirements for regulatory activity and the 
correlation between AAP’s effects on peptidyl transferase activity and 
associated regulatory effects. We also examined the extent to which short 
synthetic peptides containing Arg could substitute for L-Arg in conferring 
regulation. The tripeptides RGD and RGG functioned similarly to L-Arg to 
block peptidyl transferase activity, but the tripeptide GRG did not. 
Furthermore D-Arg did not function similarly to L-Arg, nor did it diminish 
the function of L-Arg.  
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In response to nutrient starvation, GCN2 phosphorylates eIF2 to repress global 
protein synthesis, along with preferential translation of select mRNAs. Reduced 
translation conserves energy and allows cells time to reprogram gene expression 
to alleviate injury, while preferential translation of mRNAs, such as that 
encoding the transcriptional activator ATF4, direct stress-related genes that 
confer the Integrated Stress Response. Our previous work demonstrates that 
GCN2 is required for adaptation to dietary amino acid starvation, leading us to 
reason that GCN2 is essential in animals with genetic lesions that disrupt amino 
acid homeostasis. The branched-chain alpha-keto acid dehydrogenase enzyme 
complex catalyzes the irreversible catabolism of the branched-chain amino 
acids (BCAA). Phosphorylation of the complex by its kinase, BDK, inhibits 
BCAA oxidation. Mice lacking BDK demonstrate neurological abnormalities in 
association with decreased BCAA levels and increased phosphorylation of eIF2 
in whole brain lysates. To understand the role of GCN2 in the development of 
the BDK-/- phenotype, GCN2-BDK double null mice (GB) were produced 
alongside wild-type and heterozygous littermates. At day 1 postpartum, GB 
pups are indistinguishable from littermates in size, weight and blood glucose. 
However, GB pups stop gaining weight around day 7, becoming progressively 
wasted and neurologically unresponsive until expiring by day 14, even when 
given daily injections of glucose and BCAA. To better understand the 
biochemical basis for the neurological dysfunction, brains were harvested on 
days 3, 8 and 11 postpartum. At day 11, phosphorylation of eIF2 and activation 
of the Integrated Stress Response was present in the brains of BDK-/- but not 
GB mice. Myelin basic protein, normally induced by day 8 in wild-type mice, 
was enhanced in the brains of GCN2-/- mice. Yet, developmental induction of 
MBP failed in GB mice, resulting in hypomyelination in several regions of the 
brain. Expression of Olig2 mRNA, a marker of premyelinating 
oligodendrocyes, was reduced 2-fold, and TUNEL positive cells colocalized 
with regions of hypomyelination in GB brains, suggesting early death of 
immature oligodendrocytes. Gene expression of SOD2 in GB brains was also 
reduced to 66% of controls, suggesting that GB brains have a compromised 
ability to protect against oxidative stress that may arise due to glutamate 
excitotoxicity as a consequence of leucine deficiency. This study indicates that 
GCN2 is critically important for oligodendrocyte development and the onset of 
myelination under conditions of amino acid stress during early postnatal life. 
 291 
MIR-16 CONTRIBUTES TO TRANSLATIONAL REGULATION IN 
THE XENOPUS OOCYTE 
 
Anna Wilczynska1, Anna Git2, Joanna Argasinska1, Nancy M Standart1  
 
1Univeristy of Cambridge, Biochemistry, Cambridge, CB2 1QW, United 
Kingdom, 2Cancer Research Institute, Cambridge, CB2 0RE, United 
Kingdom 
 
Translational control mediated by specific RNA-binding proteins is critical 
in early development. Here we examine the possible co-operative role of the 
microRNA pathway and CPEB-mediated regulation in gene expression 
control in Xenopus oocytes. CPEB is a well characterised core component 
of a repressor complex in the meiotically arrested oocyte that controls the 
timed re-entry of its target mRNAs into the translating pool of mRNAs 
upon oocyte maturation.  
Cyclin E1 protein is expressed late in Xenopus oocyte maturation and 
remains at high levels in the egg and early embryo until the mid-blastula 
transition. The 3’UTR of cyclin E1 mRNA contains conserved sequence 
elements that can contribute to its translational regulation, most notably 
CPEs (CPEB binding sites) and putative miR-15/16 binding sites.  
Interestingly, our previous work showed mature miR-15/16 to be present in 
Xenopus oocytes, raising the possibility that they may function as additional 
regulators of translation in these cells.  
We present evidence that translational repression of cyclin E1 mRNA is 
mediated 3’UTR CPE elements in immature oocytes, and that the message 
is de-repressed following progesterone-stimulated oocyte maturation. 
Furthermore, we show that miR-16 may also contribute to translational 
regulation of cyclin E1 mRNA oocytes and during meiotic maturation. 
Strikingly, it appears that the function of the miRNA target sites appears to 
require the presence of the CPE elements, suggesting that there is a strict 
cooperation between CPEB-mediated translational control and miRNA-
mediated effects. 
Finally, injection of miR-16a AS LNA oligos, but not control LNA oligos, 
accelerates meiotic maturation, which is delayed by injection of miR-16a 
mimic duplexes. Ongoing work is aimed at elucidating the mechanism 
underlying this effect. 
Our observations support the idea that miRNAs regulate the translation of 
cell regulatory mRNAs in the resumption and completion of meiosis in 
oocytes and that they cooperate with other translational control mechanisms 
mediated by elements in the 3’UTR of transcripts. 
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The Myc family of proteins are sequence-specific transcription factors that 
regulate target genes integral to processes of cell proliferation, 
differentiation and cell death. Expression of these proteins is tightly 
regulated, with deregulation associated with tumorigenesis. 
The 5' untranslated regions of the myc genes contain an internal ribosome 
entry segment (IRES) that under the regulation of IRES trans-acting factors 
(ITAFs), facilitate internal ribosome entry. This mechanism of translation 
initiation continues to operate when cap-dependent translation is 
compromised, for example to promote gene expression during apoptosis or 
genotoxic stress. 
 
We have recently identified a subset of ITAFs that interact with Myc family 
IRESs including PSF, p54, YB1 and GRSF1. To identify whether additional 
subsets of mRNAs require these proteins for translation initiation we have 
performed translational profiling of cells in which the ITAFs expression has 
been decreased by siRNA transfection. Information from these studies will 
allow us to determine whether these ITAFs orchestrate a wider response to 
stress and apoptosis than is currently apparent, and whether targeting of 
ITAFs may be an avenue of therapeutic intervention in cancers. 
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The Ca2+/calmodulin-dependent protein kinase eukaryotic elongation factor-
2 kinase (EF2K) exerts translational control at the elongation step by 
phosphorylating and inhibiting eukaryotic elongation factor-2 (eEF-2). This 
inhibition leads to a remodeling of the translational repertoire of the cell, 
globally decreasing protein synthesis while stimulating the translation of a 
subset of messages, and has been implicated in several cellular processes 
including long-term synaptic plasticity. Recent evidence has suggested that 
such long-term forms of plasticity require a balance of protein synthesis and 
degradation, yet it remains unclear how these processes are dynamically 
regulated by activity, or how they may directly balance or synergize with 
each other. Our previous studies indicate that stimulation can regulate not 
only EF2K activity, but also protein abundance, as application of NGF, 
IGF-1, or forskolin in PC12 cells reduces EF2K levels. We hypothesized 
that this reduction may be due to phosphorylation-dependent targeting of 
EF2K to the proteasome via recognition by an SCF-family ubiquitin E3 
ligase. We have previously shown that the forskolin-mediated reduction of 
EF2K levels in PC12 cells is attenuated by application of the proteasome 
inhibitor MG132, that forskolin stimulation directly regulates EF2K 
turnover, and that a similar mechanism is engaged by stimulation in 
cultured neurons. Ongoing experiments utilizing mass spectroscopy and 
examination of EF2K mutants in cultured cells seek to identify which 
phosphorylation site(s) and kinase(s) target EF2K for degradation. 
Experiments using dominant-negative Cullin1 have demonstrated that 
EF2K stability is regulated by an SCF-family E3 ubiquitin ligase, and 
ongoing experiments seek to characterize the role of specific E3 ligases in 
EF2K poly-ubiquitinaition and turnover. We propose that the degradation of 
EF2K by activity-dependent phosphorylation would alter the complement 
of translating messages, which may in turn support ongoing plasticity 
processes. This may provide a mechanistic link between activity-dependent 
protein synthesis and protein degradation. Finally, ongoing experiments 
employing a Stable Isotope Labeling with Amino Acids in Cell Culture 
(SILAC) proteomic approach seek to identify the subset of proteins whose 
synthesis is stimulated by inhibition of elongation to clarify the functional 
consequences of EF2K activation or degradation. 
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The mammalian target of rapamycin (mTOR) is an atypical serine/threonine 
protein kinase that is highly conserved in mammalian cells. Through 
associating with other regulatory proteins to form protein complexes, 
mTOR modulates several important cellular functions via the regulation of 
multiple downstream targets. To date, there are two mTOR complexes 
defined in mammalian cells: mTOR complex 1 (mTORC1), composed of 
mTOR, Raptor, and mLST8 and the mTOR complex 2 (mTORC2), which 
similarly contains mTOR and mLST8 but with different regulatory 
components, rictor, SIN1, and PRR5. Among the cellular functions of 
mTOR, the regulation of translation initiation is more well-characterized. 
mTORC1 can activate p70 ribosomal S6 kinase (S6K) which regulates 
eIF4B and RPS6 to unwind the second structure of mRNA and promote the 
recruitment of 40S to mRNA. mTORC1 can also inhibit eukaryotic 
initiation factor 4E binding protein 1 (4E-BP1) to facilitate the formation of 
translation initiation complexes. These two events can both stimulate the 
ribosome biogenesis and protein synthesis. mTORC2, on the other hand, 
was reported to be involved in cytoskeleton reorganization as well as the 
phosphorylation and activation of several protein kinases. Whether 
mTORC2 also functions in translation process is still not understood. Our 
previous studies showed that mTORC2 controls the phosphorylation of turn 
motif (TM), which is critical for proper folding and protein stability, of the 
protein kinase Akt. Unlike phosphorylations at other sites, Akt TM is 
phosphorylated constitutively and ubiquitously, which suggests this event 
may occur on nascent polypeptides. To examine this hypothesis, we 
purified polysomes from HeLa cell lysates through sucrose gradient 
centrifugation and checked TM phosphorylation levels of nascent Akt 
polypeptides associating with translating ribosomes. Our results reveal that 
phospho-Akt TM signals colocalized with polysomes in high-density 
fractions, whereas phospho-Akt HM signals, which was reported to occur 
on cell membranes, only distributed in low-density fractions. Furthermore, 
mTORC2 components (mTOR, rictor, and SIN1) were also detected in 
high-density polysome fractions. These results suggest that mTORC2 could 
function during translation. 
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Decapping is one of the mRNA turnover processes. Digestion of mRNA 
transcripts requires activity of specific pyrophosphatases capable of 
degrading the cap structure of the 5’ mRNA end. One of them, the 
Decapping Scavenger (DcpS) enzyme, functions as a scavenger at the last 
step of the 3’-5’ mRNA decay pathway, which catalyzes the cap hydrolysis 
when the cap is attached to a very short oligonucleotide m7GpppN(pN)n (n 
< 3). Thereby, it is very important for preventing the inhibition of other cap 
binding proteins.  
DcpS enzyme belongs to nucleotide binding family of proteins that contain 
a histidine triad (HIT) motif. The central histidine of the His-X-His-X-His-
X stretch, where X denotes hydrophobic amino acid residue, is responsible 
for nucleophilic attack on the γ phosphate group within the m7GpppN. The 
reaction products are: m7Gp and ppN.  
To elucidate characteristic of substrate properties and hydrolysis 
mechanism of DcpS enzyme we used several synthetic cap analogs 
containing a methylene substituent in the triphosphate chain. Four m7G-
capped dinucleotide triphosphates in which one of the bridging oxygen was 
replaced by a methylene group were subjected to hydrolysis catalyzed by 
nematode DcpS from C. elegans. Two of these compounds (m7GpCH2ppG, 
m7GppCH2pG) are derivatives of a natural cap structure, while the other 
two (m27,3’-OGpCH2ppG, m27,3’-OGppCH2pG) are ARCAs (anti-reverse cap 
analogs) which bear additional methylation at 3’-OH ribose position. As 
reference compounds m7GpppG and m27,3’-OGpppG were used. The 
hydrolysis progress and the reaction products of examined cap analogs were 
analyzed by means of HPLC. For the hydrolysable analogs the relative 
maximum velocity was compared. The rates of hydrolysis were determined 
on the basis of initial velocity method. Moreover, a tetraphosphate analog 
with methylene group between β and γ phosphorous atoms 
(m7GpCH2pppG) was tested, which let us to determine enzyme specificity 
versus the length of cap’s phosphate chain. As we have previously 
established that C. elegans DcpS readily cleaves cap analogs with benzyl 
substituent instead of methyl group at N7 position of 7-methylguanosine it 
was very interesting to estimate the substrate properties of bn7GpCH2ppG. 
This kinetic research would complement with binding affinity experiments 
of non-hydrolysable cap analogs. The all-embracing knowledge of mRNA 
cap-DcpS interactions is indispensable to find selective inhibitors of 
processes in which nucleotide binding proteins are involved. Our studies of 
chemically synthesized DcpS-proof cap analogs promise to further 
understanding of the cap-specific regulation of the gene expression.  
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Hsp90 is a conserved molecular chaperone for specific client proteins 
critical for signal transduction, including several oncogenic proteins. 
Inhibition of Hsp90 activity suppresses tumor progression, probably 
through the dysfunction of its client proteins, therefore Hsp90 is regarded as 
a useful target for anticancer therapy and its inhibitors are under clinical 
evaluation. Hsp90 inhibition also sensitizes cancer cells to DNA damage, 
however, the underlying mechanisms are not fully understood. Here, we 
show that Hsp90 inhibition causes a reduction of all phosphatidylinositol 3-
kinase-related protein kinase (PIKK) family proteins, ATM, ATR, DNA-
PKcs, mTOR, SMG-1, and TRRAP,which are central regulators of stress 
responses including DNA damage, and suppresses PIKK-mediated 
signaling. These results indicate that Hsp90 is a general PIKK regulator. We 
further investigated the relationship between Hsp90 and known PIKK 
regulators, the RUVBL1/2 complex and Tel2, both of which interact with 
all PIKKs and control their abundance and functions. We found that Hsp90 
interacted with both the RUVBL1/2 complex and Tel2. The RUVBL1/2 
complex and Tel2 also interacted with two conserved Hsp90 cofactors, 
NOP17 and RPAP3. These results suggest that Hsp90 can form multiple 
complexes with the RUVBL1/2 complex and/or Tel2 and function in the 
regulation of PIKKs. Our results provide additional mechanisms explaining 
anticancer effect of Hsp90 inhibition including the sensitization to DNA 
damage, and support the effectiveness of Hsp90 inhibition for anticancer 
therapy. 
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PABP-interacting protein 2 (Paip2) is one of the key translational factors 
modulating PABP function in mRNA biogenesis, mRNA stabilization and 
translation. Two isoforms of Paip2, Paip2A and Paip2B, are highly 
expressed in the pancreas. Immunohistochemical analysis of the pancreas 
demonstrated that Paip2A is mainly expressed in the islet of Langerhans, 
implying its role in β-cells. To elucidate their roles in the pancreas, Paip2 
null mouse models were used.  
Insulin secretion is composed of two phases. The first phase is characterized 
by an increase of plasma insulin immediately after glucose administration 
and is due to secretion of preformed insulin from the storage granules. The 
secondary rise of insulin derives from newly synthesized insulin. Proinsulin 
biosynthesis stimulated by glucose is mainly regulated under translational 
control (1). The increase of proinsulin biosynthesis by translation starts 
rapidly within 20 minutes of glucose administration, while proinsulin 
mRNA is modestly increased after a longer time (>6 hr). The mechanism of 
proinsulin mRNA translation initiation induced by glucose has remained 
unclear. Interestingly, the secondary phase of insulin secretion was impaired 
in Paip2A knockout (KO) and Paip2B KO mice by age- and diet-induced 
obesity, implying their roles in translation initiation of proinsulin mRNA.  
Pancreas-specific post-translational modification of Paip2A and Paip2B was 
also observed. The modified Paip2A and Paip2B migrated ~2 kDa slower 
than unmodified proteins (25 kDa vs. 23 kDa). This modification was not 
caused by the phosphorylation since it was not prevented by λ-phosphate 
treatment. We address the relationship between the pancreas-specific 
modification of Paip2 isoforms and the insulin synthesis by translation.  
 
1. Itoh N, Okamoto H. Translational control of proinsulin synthesis by 
glucose. Nature. Jan 3 1980;283(5742):100-102.  
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Mammalian mitochondrial ribosomes (mitoribosomes) are responsible for 
the synthesis of thirteen inner membrane proteins which are involved in 
oxidative phosphorylation (or ATP generation). Significant differences exist 
between mitoribosomes and eubacterial ribosomes. The RNA to protein 
ratio in the mammalian mitoribosome is 1:2, which is reverse of that in 
eubacterial ribosomes. In addition, there are only two initiation factors in 
the mitoribosomes (IF2mt and IF3mt) as compared to three factors in 
eubacteria (IF1, IF2, IF3). In eubacteria, IF1 binds in the aminoacyl-tRNA 
site (A-site) region on the small ribosomal subunit (SSU), apparently to 
facilitate binding of the initiator tRNA to the peptidyl-tRNA site (P-site) by 
blocking the A site. Interestingly, no equivalent of IF1 has been identified 
in mitochondria. However, IF2mt possesses an insertion domain of 37 amino 
acids (aa), which is essential for the binding of the IF2mt to SSU but is 
absent in its eubacterial counterpart. IF2mt was shown to be capable of 
replacing eubacterial IF2 in a strain with IF1 and IF2 gene knockouts. 
However, deletion of the 37 aa insertion from IF2mt necessitates the 
presence of IF1 in E. coli, suggesting that the 37 aa insertion in IF2mt 
functionally mimics eubacterial IF1. 
We have determined the cryo-EM maps of the initiation complexes of both 
the mammalian 55S mitoribosome and the eubacterial 70S ribosome with 
IF2mt and the initiator tRNA. Both these maps show distinct mass of 
densities for the entire IF2mt, including the 37 aa insertion domain and the 
initiator tRNA. We have built a composite homology model of IF2mt based 
on the crystal structure of the archaeal IF2 (aIF5B) from Methanobacterium 
thermoautotrophicum and the NMR structures of the C1 and C2 terminal 
end domains of Bacillus stearothermophilus IF2. Flexible fittings IF2mt into 
the cryo-EM maps reveal that the 37 aa insertion domain in IF2mt occupies a 
position on the SSU that significantly overlaps with that of the binding 
position of eubacterial IF1. A detailed analysis of these results, which 
suggest functional and structural substitution of IF1 by the 37 aa insertion 
domain of IF2mt, will be presented. 
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FUNCTIONAL ANALYSIS OF MRNA MODULATING FACTORS IN 
STE12 MRNA TRANSLATION AND P-BODY FORMATION DURING 
MATING 
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The mating-specific transcription factor Ste12 is transcriptionally induced 
by the mating pheromone through the MAP kinase pathway in the budding 
yeast Saccharomyces cerevisiae. The Ste12 protein level was shown to be 
decreased by mutations in the DHH1 gene, which encode a decapping 
activator, and to be increased by over-expression of CAF20, which encode 
an eIF4E-binding protein (4E-BP). Dhh1 participates in P-bodies formation, 
where other mRNA decay factors such as Dcp1-Dcp2, Lsm1-7 complex, 
Pat1, and Kem1 also function. Recent experiments observed that P-bodies 
are increased upon α-mating pheromone treatment and Ste12 expression 
might be closely associated with the P-bodies formation. In the present 
work, we generated a series of mutations in each functional domain of 
Dhh1. Deletion mutations were also constructed in Lsm1 and Pat1. Effects 
of each mutation on the Ste12 protein level and P-body formation were 
analyzed. Furthermore, mutational analysis of eIF4E-binding motif of 
CAF20 was carried out. 
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TRANSLATIONAL REGULATORY ELEMENTS IN 5’UTR 
SEQUENCES OF AXONAL MRNAS CONFER THE SPECIFICITY OF 
TRANSLATION IN A CA2+-DEPENDENT MANNER 
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Localized translation of mRNAs plays a role in axonal pathfinding, injury 
signaling and regeneration. The capacity for axonal protein synthesis has 
further been shown to correlate with the capacity for axonal regeneration. 
Localization of mRNAs is most often controlled by elements found within 
the 3’UTR of the transcripts that are bound by RNA targeting/transport 
machinery as we recently showed for RanBP1 mRNA. Similar to RanBP1 
mRNA, transport of GAP-43 mRNA into the axons of cultured rodent 
sensory neurons is regulated through its 3’UTR. Since the 3’UTRs of 
axonal mRNAs encoding injury response (RanBP1) and growth-associated 
(GAP-43) proteins both drive axonal localization but the protein products of 
these mRNAs have strikingly different functions in axons, we examined 
these mRNAs for translational control elements. Reporter constructs 
carrying just their 3’UTRs showed no clear difference in translational 
efficiency. Thus, we asked if the 5’UTRs of RanBP1 or GAP-43 mRNAs 
contribute to temporal control of their translation in axons. For this, we used 
diffusion-limited fluorescent reporter proteins carrying the axonal 
localization elements of GAP-43 or RanBP1 plus their corresponding 
5’UTRs. By using myristoylated GFP and mCherry reporters, we were able 
to simultaneously visualize reporter mRNA translation for both transcripts 
in a single axon. Under normal growth conditions, both GAP-43 and 
RanBP1 5’UTR reporters showed recovery from photobleaching in distal 
axons, similar to results for the reporters fused to only the 3’UTRs of these 
transcripts. However, their translation could be distinguished upon 
alteration of intracellular Ca2+ concentration ([Ca2+]i). When [Ca2+]i was 
chelated by pretreatment with BAPTA-AM, only the construct with 5’UTR 
of GAP-43 mRNA showed translation-dependent recovery from 
photobleaching. [Ca2+]i-dependent regulation of localized RanBP1 5’UTR-
containing reporter mRNA translation was dependent upon intracellular 
Ca2+ stores, but independent of extracellular Ca2+. These data indicate that 
[Ca2+]i modulates the specificity of translation through the 5’UTRs of 
RanBP1 and GAP-43. [These studies were supported by funds from NIH 
(R01-NS041596, R01-NS30255), the Craig H. Nielsen Foundation]. 
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TRANSLATIONAL REPROGRAMMING FOLLOWING DNA 
DAMAGE ALLOWS SELECTIVE RECRUITMENT TO THE 
POLYSOMES OF MRNAS ENCODING PROTEINS REQUIRED IN THE 
DNA DAMAGE RESPONSE  
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We have shown that post-transcriptional regulation of gene expression 
forms an essential part of the DNA damage response (DDR). Following 
exposure of HeLa cells and/or FaDu cells to diverse DNA damaging agents 
including UVB and ionising irradiation (IR), ethyl methanesulfonate (EMS) 
and chemotherapeutic agents such as cisplatin, we observe a reduction in 
global protein synthesis, mediated specifically by one of two major 
mechanisms of translation inhibition. Following bulky adduct formation 
caused by UVB and EMS exposure, phosphorylation of eIF2α is activated 
by either GCN2 or PERK respectively. In contrast, 4EBP is modulated 
following IR. We have identified mRNAs subject to differential 
translational regulation following these DNA damaging agents using 
polysome profiling. Importantly, our microarray data shows an upregulation 
of mRNAs encoding genes involved in cellular stress responses, which are 
specific to each damaging agent. Examination of the 5’UTRs of these 
mRNAs shows a prevalence of upstream open reading frames (uORFs), in 
particular within mRNAs encoding DNA repair enzymes suggesting 
translational regulation is of upmost importance for regulating the DDR. 
These uORFs alone are sufficient to allow the selective up-regulation of 
translation of DNA repair enzymes following exposure to a range of 
chemotherapeutic agents. Importantly, we have shown that a polymorphism 
within the uORF of an mRNA encoding a particular DNA repair enzyme, 
leads to chemoresistance in a number of types of human tumour and these 
data are therefore deciding the appropriate course of treatment for a wide 
variety of cancers. 
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Discrimination of tRNA on the ribosome occurs in two consecutive steps: 
initial selection and proofreading. We propose the first proofreading 
mechanism based on comparison of crystal structures of the 70S ribosome 
with an empty A site or the A site occupied by cognate or near-cognate 
tRNA. We observe that ribosomal proteins S13, S19, L16, L25, L27 and 
L31 are actively involved in proofreading of tRNA. We suggest that 
proofreading begins with monitoring of the entire anticodon loop of tRNA 
by nucleotides from 16S rRNA (helices 18 and 44) of the small subunit and 
23S rRNA (helix 69) of the large subunit with involvement of magnesium 
ions. Subsequently the elbow region is scanned by rRNA (helices 38 and 
89) and proteins from the large subunit determining whether to 
accommodate the acceptor end of tRNA in the peptidyl transferase center or 
not. 
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The 70S ribosome maintains the mRNA reading frame during protein 
biosynthesis by simultaneously fixing tRNAs in their binding sites and 
grasping on to the mRNA chain. However, many details are still missing to 
fully explain and understand how the ribosome is able to reliably traverse 
the mRNA. Here we report the complete path of messenger RNA on the 
ribosome determined by X-ray analysis at 3.1A resolution.  
We show that transition from initiation to the elongation state provokes a 
conformational change in the 30S subunit that lead to a narrowing of the 
downstream mRNA tunnel causing it to grip the template more firmly. This 
triggers formation of a whole network of interactions between the mRNA 
downstream of the A-codon and the elongating ribosome, which stabilizes 
the decoding centre and possibly aligns the mRNA prior to its movement 
into the A-codon.  
Our study elucidates the mechanism by which hypermodified nucleoside 2-
methylthio-N6 isopentenyl adenosine (ms2i6A37) in tRNAPheGAA, which 
is essential in control of gene expression, stabilizes mRNA-tRNA 
interactions in all three tRNA binding sites. We demonstrate how contacts 
formed between ribosomal elements surrounding the mRNA E/P kink and 
this tRNA modification result in anchoring of P-tRNA. These data allow 
rationalization of how modification deficiencies of ms2i6A37 in tRNAs 
cause shifts of the translational reading frame.  
Our high resolution X-ray data also allowed us to construct an exact and 
complete model of protein L31. This Zn-binding protein forms a novel 
inter-subunit bridge between the functionally important central 
protuberance of the large subunit and the head domain of the small subunit.  
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THE ROLE OF GW182, PABP AND THE POLY(A) TAIL IN MIR2-
MEDIATED TRANSLATIONAL REGULATION. 
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The molecular mechanism(s) of how miRNAs mediate their mRNA 
repressive or destabilizing effects represents a most interesting question. 
We established a cell-free system from Drosophila embryos to study 
GW182/Ago1-dependent, miR2-mediated translational repression in vitro 
(Thermann and Hentze, 2007; Till et al., 2007). Using specifically selected 
cap structure analogs, this system also allows to investigate the role of the 
poly(A) tail without profound effects on general mRNA translatability 
(Zdanowicz et al., 2009). Our results show that the poly(A) tail is not 
required for repression by miR2, but its presence quantitatively contributes 
to the process. Furthermore, miR2-induced mRNA deadenylation is not 
sufficient for significant translational repression. We will also report on 
ongoing work with PABP-depleted extracts and using tethered GW182 to 
mimic miR regulation in vitro. 
 
 
Thermann, R. and Hentze, M.W. (2007) Drosophila miR2 induces pseudo-
polysomes and inhibits translation initiation. Nature. 447: 875-878. 
 
Till, S., Lejeune, E., Thermann, R., Bortfeld, M., Hothorn, M., Enderle, D., 
et al (2007) A conserved motif in Argonaute-interacting proteins mediates 
functional interactions through the Argonaute PIWI domain. Nat Struct Mol 
Biol. 14: 897-903. 
 
Zdanowicz, A., Thermann, R., Kowalska, J., Jemielity, J., Duncan, K., 
Preiss, T., et al (2009) Drosophila miR2 primarily targets the m7GpppN cap 
structure for translational repression. Mol Cell. 35: 881-888. 
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MRNA DECAY PATHWAY 
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Nonsense-mediated mRNA decay (NMD) is a surveillance pathway that 
rids cells of mRNAs that contain premature translation termination codons. 
It is active in all eukaryotes examined and the core factors are highly 
conserved. NMD pathways in higher eukaryotes can employ factors that are 
not present in the yeast Saccharomyces cerevisiae, such as components of 
the exon junction complex (EJC), which has a role in mRNA splicing. The 
genome of the model filamentous fungus Neurospora crassa contains core 
NMD components as well as EJC components, and, unlike S. cerevisiae, 
many of its mRNAs are spliced. We have established that knockouts of N. 
crassa genes for the NMD components UPF1 and UPF2 lead to the 
increased stability of specific mRNAs that are NMD substrates. We are 
using 454 whole transcriptome sequencing to perform studies of transcripts 
in N. crassa strains that are wild-type or deficient in NMD to evaluate at the 
genome-wide level the changes that occur when this surveillance pathway is 
eliminated. Here we present the results of our comparative analysis of the 
whole transcriptome data from wild type and knockout Neurospora strains 
and provide further evidence for the extent and complexity of NMD in 
regulating transcript metabolism. For example, in the mutant strain, 
approximately 15% of mRNAs for predicted proteins are at least two-fold 
up-regulated, and there are a large number of novel exons in the 
transcriptome. 
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UORFS WITH NON-AUG START CODONS ARE TRANSLATED IN 
VIVO BUT DISPENSABLE FOR TRANSLATIONAL CONTROL OF 
GCN4 MRNA 
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Recent genome-wide analysis of ribosome binding sites in the mRNAs of 
the yeast Saccharomyces cerevisisae revealed the presence of ribosomes 
translating upstream open reading frames (uORFs) that initiate with near-
cognate start codons rather than with AUG, in the leaders of many mRNAs. 
Two such non-AUG-initiated uORFs (nAuORFs) were identified in GCN4 
mRNA upstream of the four AUG-initiated uORFs (uORFs 1 to 4) that 
regulate GCN4 translation by amino acid levels. The second of these two 
elements (nAuORF2) begins with AUA and is situated at the 3’ end of the 
first element, nAuORF1 (initiated by UUG), and the two nAuORFs are in 
the same reading frame. It was reported that the 80S ribosome-occupancy of 
these nAuORFs increased under conditions of amino starvation, suggesting 
their possible involvement in GCN4 translational control. We have verified 
that nAuORF2 is translated in vivo by demonstrating β-galactosidase 
production from lacZ coding sequences fused in-frame to nAuORF2, in a 
manner abolished by replacing its AUA start codon with the non-cognate 
triplet AAA. Translation of nAuORF1 could not be verified by this 
approach. Importantly, replacing the near-cognate start codons of either or 
both nAuORFs with non-cognate triplets in otherwise wild-type GCN4, or 
in GCN4-lacZ alleles, had little or no effect on translational control by the 
canonical AUG-initiated uORFs. Thus, despite evidence that the nAuORFs 
are translated in vivo, they are dispensible for translational control of GCN4 
during single-amino acid deprivation. Additionally, we find no evidence 
that initiation from the AUA start codon of nAuORF2 is substantially 
elevated, or dependent on the eIF2α kinase Gcn2, in amino acid-deprived 
cells. 
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WITH FLUORESCENT DETECTION SYSTEM. 
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The primary components of the translation initiation complex have been 
identified by a variety of techniques. However, it is likely that all 
components of the translation initiation complex are still not fully 
discovered. Identifying new components should lead to a better 
understanding of the translation process and how it is regulated. Using mass 
spectrometric studies, we have identified 41 non-ribosomal proteins and 
non-translation initiation factors as possible components of the translation 
initiation complex. To determine which of these proteins are in the 
translation complex, we applied analytical ultracentrifugation with 
fluorescent detection system (AUC-FDS) to detect this complex. Following 
a one step affinity purification with Flag-PAB1 using strains carrying 
translation factors and specific mRNA tagged with GFP, we identified the 
80S translation complex (actually 74S in our system) that contains all of the 
major components expected of the translation initiation complex: mRNA, 
eIF4E, eIF4G1/eIF4G2, PAB1, 40S and 60S ribosomal components. Using 
GFP fused to about half of the 41 putative novel proteins of the components 
of the 74S translation initiation complex, we were able to identify at least 
two new proteins, SLF1 and SBP1 as being part of this complex. SBP1 had 
previously been shown to be a component of stress granules formed 
following glucose depletion and SLF1 to be associated with translational 
process. Components of the eIF3 and eIF2α complex were also found to be 
part of the 74S complex, although formaldehyde cross-linking was required 
to stabilize their association with this complex. These results confirm the 
utility  
of AUC-FDS for charactering the constitution of multi-subunit complexes 
and establish that unique factors of 74S translation initiation complex 
remain to be discovered. 
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Multidrug resistance protein 2 (MRP2, ABCC2) is an important transporter 
mediating the efflux of organic anions in small intestine, liver and kidney. 
The regulatory effects of the 5’UTR of MRP2 on expression of luciferase or 
GFP were investigated in HepG2 cells transfected with SV40 promoter-
5’UTR-Luciferase/GFP fusion constructs or using in vitro rabbit 
reticulocyte lysate translation assays (RRL) of the 5’UTRs-Luciferase 
mRNA. Transfection of HepG2 cells with constructs containing MRP2 
5’UTR fragments -247 (-247 to -1), -204 (-204 to -1), -99 (-99 to -1), -85 (-
85 to -1), -65 (-65 to -1), -35 (-35 to -1) or CF (control fragment), showed 
that luciferase activities of CF, -247 and -204 constructs were significantly 
lower than that of shorter MRP2 5’UTR fragments; there was no difference 
in luciferase mRNA expression among all constructs. The translation 
efficiencies determined in RRL were consistent with transfected HepG2 
cells. Incorporation of two copies of the -35 fragment of MRP2 5’UTR 
enhanced translation of the downstream ORF, either luciferase or GFP, two-
fold compared to one copy, while there was no difference in the mRNA 
expression in transfected HepG2 cells, demonstrating that the -35 RNA 
motif of MRP2 5’UTR stimulated down-stream ORF translation. The -35 nt 
fragment was inserted between two cistrons in a bicistronic construct to 
investigate whether it functions as an internal ribosome entry site (IRES). 
Analysis of mRNA expression and protein translation of both cistrons in 
transfected HepG2 cells showed that the 35 nt motif enhanced translation of 
the 3’ cistron and functioned as an IRES. An in vitro translation assay of the 
bi-cistronic mRNA transcript confirmed the IRES activity of the -35 RNA 
motif. We identified a protein, IGF2BP1 (Insulin-like growth factor 2 
mRNA-binding protein 1) that binds to the -35 RNA motif. Functional 
analyses of IGF2BP1 demonstrated that IGF2BP1 binding to the -35 RNA 
motif regulated MRP2 IRES mediated translation. Furthermore, we found 
that translation of MRP2 and c-Myc IRESs are more sensitive to NaCl 
compared to 5’-cap-dependent translation. This work identifies a new 
mechanism for the regulation of MRP2 expression.  
 
*This work was supported by USPHS Grant GM55343/HD58299 (to MV), 
NIH grant RO1GM084547 (to S.R.T) and Bankhead-Coley Cancer 
Research Program 08-BN10 (to Y.Z)  
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THE 7-REPEAT ARRAY IN YEAST EIF4B (TIF3) IS ESSENTIAL, BUT 
THE RRM IS DISPENSABLE, FOR CRITICAL FUNCTIONS OF TIF3 
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Binding of eIF4F to the mRNA cap structure is a key step in activating 
mRNA for attachment of the 43S preinitiation complex to the 5’ end of the 
mRNA. This function presumably involves the ability of eIF4A, a DEAD 
box RNA helicase, to produce a single-stranded region in the mRNA near 
the cap, in a manner stimulated by eIF4B, and the interaction of eIF4G with 
components of the 43S complex. eIF4A and eIF4B might also stimulate 
ribosomal scanning and AUG start codon recognition, particularly for 
mRNAs with structured leaders. It is unclear what steps of initiation are 
most critically dependent on eIF4B in vivo. The eIF4B homolog in budding 
yeast (Tif3) is non-essential but strongly stimulates protein synthesis and 
cell growth. From N- to C-terminus, Tif3 contains an N-terminal domain 
(NTD), RNA recognition motif (RRM), an array of seven ~26-residue 
repeats, and a C-terminal domain (CTD). We have characterized a panel of 
TIF3 alleles lacking its four domains in different combinations for the 
ability to complement the slow-growth phenotype of tif3∆ cells. The 7-
repeat array is essential for Tif3 function in vivo in the presence of all other 
domains, and is the only domain that provides measurable Tif3 function on 
its own. The NTD is also required for full complementation but, 
surprisingly, the RRM is completely dispensable in the presence of all other 
domains. Different combinations of two repeats from the 7-repeat array 
provide full complementation when all other domains are present, but more 
repeats are required when the NTD or RRM are missing, indicating a degree 
of functional overlap among these three domains. A conserved motif has 
been identified in the 7-repeat array, ExDxD(W/F)xxxR, and we found that 
substituting only the D, W/F, and R residues is sufficient to abolish repeat 
function in vivo. These findings are in general agreement with in vitro 
measurements showing that, in the presence of the NTD and RRM, only 2 
repeats are necessary and sufficient for Tif3 binding to the 40S subunit and 
for its function in recruiting mRNA to the 43S PIC. By contrast, the ssRNA 
binding function of the RRM is dispensible for both activities. Thus, the 
RRM and its ssRNA-binding activity are dispensable, whereas the ~26-
residue repeats are essential, for critical functions of Tif3 both in vitro and 
in vivo. 
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Post-transcriptional modifications of tRNAs, especially at the 34 wobble 
position, are important for expanding the coding potential of a pool of 
tRNA species that is outnumbered by the 61 amino acid codons in the 
genetic code. Decoding by 3 tRNAs (tRNAGln(UUG), tRNAGlu(UUC), 
tRNALys(UUU)) is enhanced by addition of 5-methoxycarbonylmethyl (mcm5) 
and 2-thio (s2) groups to uridine at the wobble position. A number of yeast 
mutants in Ncs6, Ncs2 and Uba4 are defective in the s2 modification, while 
a mutant of Elp3, part of the Elongator complex (Elp1-6), lacks the mcm5 
modification. These mutants have numerous phenotypes including 
temperature sensitivity, chromatin remodeling and transcriptional activation 
defects, and exocytosis defects. Interestingly, these phenotypes can be 
suppressed by overexpression of unmodified tRNAGln(UUG) and 
tRNALys(UUU), strongly suggesting that these phenotypes are the result of 
codon-specific translation defects. The gene-specific translational defects 
associated with tRNA modification mutants are currently unknown. We 
have performed ribosome-footprinting to analyze ribosome occupancy at 
the gene and codon level in these yeast mutants. This analysis will increase 
our understanding of the effects of tRNA modifications on translational 
elongation, and may begin to fill in the mechanistic gap between loss of a 
tRNA wobble modification and the pleiotropic phenotypes of the tRNA 
modification-deficient mutants. 
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The quantitative characterization of intra-population variability of basic 
parameters of cell metabolism has broad implications in cell biology. 
Although protein synthesis is a fundamental cellular function, methods have 
been lacking to directly measure protein synthesis within single cells at high 
spatial resolution. Here we address this gap through the development and 
application of a novel technique, termed Protein Synthesis Monitoring 
(PSM). PSM utilizes quantitative confocal microscopy and transfected bulk 
uncharged tRNA, labeled with fluorescent donor and acceptor groups in the 
D-loop, to generate and monitor fluorescent resonance energy transfer 
(FRET) signals. PSM enables the identification of intracellular sites of 
active protein synthesis, in individual mammalian cells at sub-micron 
resolution. PSM allowed us to distinguish between the mechanisms of 
action of different antibiotics, to quantitatively compare protein synthesis in 
mouse-derived mesenchymal stem cells and terminally differentiated brain 
astrocytes, and to reveal the spatial compartmentalization of protein 
synthesis in Epizootic Hemorrhagic Disease virus infected cells. 
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SecA is an essential component of the bacterial protein translocation 
machinery (Sec translocon) that resides in the inner membrane (IM). 
Expression of SecA is tightly regulated at the translational level by an 
upstream gene that encodes a presecretory protein (SecM). Under secretion-
deficient conditions, the recognition of a 17 amino acid C-terminal motif in 
E. coli SecM inside the ribosome tunnel causes ribosomes to stall 
translation prematurely. Translation arrest unfolds the hairpin structure of 
the secM-secA mRNA and leads to a concomitant increase of SecA 
translation. Under secretion-proficient conditions, the stalling is released 
when SecM is mechanically “pulled” by an interaction with the Sec 
translocon and the level of SecA remains low. Here we show that the SecM 
signal peptide, which contains an unusual N-terminal extension, plays a 
critical role in the release process. Substitution of the native signal peptide 
with a signal peptide that mediates slow post-translational targeting 
prolonged translation arrest and trapped SecM-ribosome complexes in the 
cytoplasm. In contrast, substitution with a signal peptide that mediates rapid 
co-translational targeting allowed membrane targeting but abolished arrest. 
These data suggested that the SecM signal peptide dictates an intermediate 
kinetics of targeting that ensures that “pulling” by the Sec translocon occurs 
immediately after the arrest motif has been synthesized. Consistent with the 
idea that the SecM signal peptide acts as a unique targeting “timer”, we 
found that heterologous proteins fused to the SecM signal peptide were 
targeted to the IM faster than proteins that contain a post-translational signal 
peptide but slower than proteins that contain a typical co-translational signal 
peptide. Furthermore, we found that translation arrest could be perturbed 
simply by altering the length of the SecM polypeptide to accelerate or delay 
the synthesis of the arrest motif. Previous results have suggested that 
translation arrest requires a compaction of the SecM C terminus inside the 
ribosome tunnel and that the release of arrest requires a dissipation of 
secondary structure through the pulling action of the Sec translocon. Our 
data, however, show that the compaction of the nascent chain and the 
exertion of physical force by the Sec translocon must be precisely 
coordinated events. 
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L-Trp (Trp) can selectively interact with the ribosome translating tnaC 
mRNA inhibiting translation termination. It has been suggested that the 
action of Trp on the ribosome function depends on the interactions between 
the nascent TnaC-tRNA with components of the ribosomal peptide exit 
tunnel. The precise locations of these functional interactions have yet to be 
revealed. This study was focused on understanding the mechanism involved 
in the ribosome inhibition induced by Trp: 1) exploring the role of different 
residues of the nascent TnaC peptide and 2) determining the structural 
changes in the ribosome induced by TnaC-tRNA in presence of Trp. We 
analyzed the structure and function of isolated stalled ribosomes that 
contain several mutant TnaC peptides and mutant 23S rRNAs using 
standard biochemical methodologies; peptidyl-tRNA cleavage induced with 
puromycin, crosslinking and methylation protection assays. Our results 
using puromycin assays showed that changes of the residue Trp12, Asp16, 
and P24 of TnaC affected the inhibition of the ribosome function by Trp. A 
similar effect was observed with the insertion of an adenine nucleotide in 
the position 751 (+A751ins) or with changes of the U2609 of the 23S rRNA 
and the K90 residue of the L22 ribosomal protein; these molecules are 
located in a constriction region of the peptide exit tunnel. Furthermore, 
crosslinking analysis established that the Trp12 residue of TnaC is located 
close to the 751 nucleotide of the 23S rRNA, indicating that Trp12 residue 
possibly interacts with the molecules around this constriction region of the 
exit tunnel. Interestingly, Trp12 mutational changes in TnaC as well as the 
+A751ins change in 23S rRNA increased the accessibility of the U2609 
nucleotide of the 23S rRNA to alkylating agents, which is usually low in the 
presence of a wild type TnaC peptide. Our results indicate that the Trp12 
interaction with the peptide exit tunnel either determines the way that TnaC 
peptide folds into the exit tunnel or induces changes in the ribosome 
structure. In any event, these structural rearrangements affect the spatial 
distribution of the U2609 nucleotide, inhibiting the ribosome function upon 
Trp binding. 
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After termination step of protein synthesis in prokaryotic cells, ribosome 
recycling factor (RRF) in conjunction with Elongation-factor G (EF-G) 
disassembles the post-termination complex (PoTC) into mRNA, tRNA and 
ribosomal subunits, to recycle machinery of protein synthesis for a fresh 
round of translation. The ribosomal binding site of RRF has been explored 
previously by single-particle cryo-EM and X-ray crystallographic studies, 
essentially revealing the same primary binding position, which we refer to 
as position 1 of RRF. One of the previous cryo-EM studies, a novel RRF 
binding position was identified. This RRF binding position, termed as 
position 2, represents a binding state of RRF on the large ribosomal subunit 
after splitting of the two ribosomal subunits and suggests a possible 
mechanism of the RRF action. However, the coordinated action of RRF 
with EF-G for the recycling step of the translation remained unresolved.  
In the present study, we have captured, for the first time, the simultaneously 
bound RRF and EF-G to a post termination complex. This complex was 
derived from a hybrid combination of components, formed by incubating 
the Escherichia coli 70S ribosome with Thermus thermophilus RRF 
(ttRRF), E. coli EF-G, GTP and fusidic acid. After the EF-G-dependent 
GTP hydrolysis, ttRRF moved from position 1 toward position 2, to newly 
discovered intermediate position. In this position, domain 2 of RRF 
interacts with domain 4 of EF-G, and domain II of RRF makes a direct 
contact with helix 69, revealing a functional state that may be necessary to 
destabilize inter-subunit bridge B2a, in order to promote dissociation of the 
two ribosomal subunits. In addition, we observed a strong density for the 
P/E state tRNA, suggesting that the tRNA release from the post termination 
complex does not take place at this stage. These results allow us to propose 
an advanced model of the RRF action during the recycling process.  
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Most of the mitochondria proteins are encoded in the nucleus and need to be 
imported to the mitochondria. Although it was suggested more than 30 
years ago that the import occurs co-translationally, the factors that 
coordinate this process have never been elucidated. To explore this, we 
utilized S. cerevisiae strains with altered expression of various candidate 
factors, and determined the impact on mRNAs association with the 
mitochondria. We found that the major proteins’ receptor of the 
mitochondria outer membrane (Tom20) has a critical role in association, 
which is exerted through the translated mitochondrial targeting sequence. 
Genome-wide analysis revealed that its role is implied for most mRNAs. 
We also found that protein chaperones, including ribosome-associated 
Hsp70-family members, are important for mRNA targeting. In their 
absence, many mRNAs, in particular those that encode hydrophobic 
proteins, do not approach the mitochondria. Conversely, their 
overexpreesion improved the mitochondria-association of mRNAs that are 
otherwise poorly associated with the mitochondria. 
Based on these results we propose that translation of mRNAs encoding 
mitochondria proteins initiates at the cytoplasm and once the mitochondria 
targeting signal emerges from the ribosome exit tunnel it becomes 
associated with protein chaperones. These chaperons maintain the peptide 
in an unfolded state and assist in targeting of the mRNA-Ribosome-Nascent 
peptide complex to the mitochondria. Protein receptors on the mitochondria 
outer membrane capture this complex and direct the co-translational 
insertion of proteins into the mitochondria. This mode of targeting is similar 
to the well-studied process for targeting to the ER and thus suggests 
functional conservation in intra-cellular protein targeting. 
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Accurate translation of the genetic information is a defining feature of the 
ribosome and the translation factors. Here we focus on quality control 
during translation in two different organisms, E. coli and S. cerevisiae. 
While much is known about the events that lead to ribosomal discrimination 
against the incorporation of the wrong amino acid (the process known as 
tRNA selection), less is known about the ribosomal response following a 
miscoding event. Using a well-defined in vitro bacterial translation system, 
we identified an unanticipated quality control system on the ribosome that 
monitors fidelity retrospectively. The in vitro and in vivo approaches that 
we have used to define this quality control system will be described. We 
have also begun to define the biochemical parameters of quality control 
systems in an in vitro reconstituted yeast translation system. In these 
studies, we have shown that two factors implicated in no-go decay, Dom34 
and Hbs1, promote subunit dissociation and peptidyl-tRNA drop-off on the 
ribosome to initiate the recycling events that eventually lead to mRNA 
decay. 
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The rate of translational elongation, which corresponds to the speed at 
which a nascent protein is synthesized, is modulated to control co-
translational events, including protein folding and the translocation of 
secreted proteins. This rate can be affected by codon usage in the mRNA 
template, features of the nascent peptide, and interactions with extra-
ribosomal factors. However, it has been difficult to monitor the synthesis of 
specific proteins in vivo. We have adapted our ribosome profiling 
technique, which provides a static measurement of ribosome density, to 
study the dynamics of elongation in living cells. We blocked translational 
initiation and then followed a timecourse of ribosome depletion across each 
transcript through run-off elongation. The rate of expansion of the 
ribosome-free region at the beginning of genes demonstrated variation in 
the rate of translation in different regions of different mRNA templates. In 
addition to measuring the speed of protein synthesis in vivo, these data 
inform measurements of translational gene expression more generally. 
Differences in the rate of elongation will distort the relationship between 
ribosome density, as measured by polysome or ribosome footprint profiling, 
and protein synthesis. Our data support an overall similarity in the average 
rate of elongation for different genes and identify specific exceptions. 
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We have described a transcript-selective translational regulatory pathway in 
which an mRNA ribonucleoprotein (mRNP) complex, containing 
heterogeneous nuclear ribonucleoprotein E1 (hnRNP E1) controls TGFβ-
mediated epithelial-mesenchymal transitions (EMT); (Chaudhury et al., Nat. 
Cell Biol. 12 (3): 286-293, 2010). hnRNP E1 binds to a 33-nucleotide (33-nt) 
structural element in the 3-UTR of mRNA transcripts required for EMT, such as 
disabled-2 (Dab2) and interleukin like EMT inducer (ILEI), and silences their 
translation. The 33-nt RNA element, which we have designated ‘BAT’ for 
TGFbeta activated translational element, is sufficient to mediate translational 
inhibition in vitro and in vivo. TGFβ treatment of epithelial cells activates a 
kinase cascade terminating in the phosphorylation of hnRNP E1, by isoform-
specific stimulation of Akt2, inducing its release from the BAT element, 
resulting in reversal of translational silencing and increased expression of EMT-
transcripts. Herein, we identify eukaryotic elongation factor 1A1 (eEF1A1) as 
the other component of this mRNP complex. We demonstrate mechanistically 
that hnRNP E1 and eEF1A1 interact and bind to the BAT element, preventing 
the release of eEF1A1 from the ribosomal A site, post delivery of the cognate 
amino acid, and thereby stalling translational elongation. This finding is the first 
demonstration of transcript-specific translation regulation that targets the 
elongation stage of protein biosynthesis rather than the more commonly 
targeted initiation step. Significantly, we proceed to demonstrate that 
modulation of hnRNP E1 expression, and thus translational silencing in vivo, 
alters not only EMT but induces allograft tumor formation with accompanying 
metastasis in mouse tumor models. Thus, we believe that this translational 
regulatory mechanism may represent a critical checkpoint coordinating 
expression of EMT transcripts during development and also in tumorigenesis 
and metastatic progression and has enormous potential for the development of 
novel anti-cancer therapeutics. *Authors contributed equally. 
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Evidence is mounting that regulating protein synthesis extends beyond 
quantitative control of translation of bulk or individual mRNAs. The 
localization of polysomes, which is clearly non-random, probably plays a 
key role in many cellular processes, including migration, polarization & 
synapse formation through the local synthesis of proteins that participate in 
these processes. Existing methods to visualize cellular translation sites 
(isotopic labels, fluorescent puromycin) suffer from poor sensitivity, 
compatibility with imaging other fluors, and linearity. We developed the 
RiboPuromyclation method (RPM) to visualize and quantify actively 
translating ribosomes in cells by standard immunofluorescence. RPM is 
based on the selective puromycylation of nascent chains stably bound to 
translating ribosomes and detection of the puromycylated nascent chains 
using a puromycin-specific monoclonal antibody. We provide extensive 
biochemical evidence supporting this conclusion, including the initial 
description of an ELISA to analyze binding of chemicals/proteins to native 
ribosomes/polysomes. We use this method to study the dynamics of the 
multi-tRNA aminoacyl synthetase complex (MSC) which contains nine 
tRNA aminoacyl synthetases (aaRSs) with three accessory proteins. The 
close association of translating ribosomes and MSC was clear following 
infection of cells with either a poxvirus or an alphavirus, where the MSC 
localized to focal zones of intense translation of viral gene products. These 
findings demonstrate that translation is a highly organized process that 
entails the formation of translation compartments consisting of translating 
ribosomes and aaRSs. Combining RPM with a Proximity Ligation Assay, 
we provide the first “visual” evidence supporting the channeling theory of 
translation first proposed by Murray Deutscher and colleagues three 
decades ago. We further established the utility of RPM showing that 
immune synapse formation between an antigen presenting cells and a T cell 
induces the formation of local translation sites at the synapse and the distal 
pole complex. This discovery could lead to a better understanding of 
immune system activation and highlights the power of this method for 
generating novel insights in cellular function.  
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Rare genetic diseases are thought to affect approximately 25 million people 
in the United States, and roughly 2.5 million of these individuals have 
diseases caused by Premature Termination Codons (PTCs). The 
pharmacological suppression of PTCs has shown promise in the treatment 
of patients with some genetic diseases caused by these mutations. However, 
the process of Nonsense-Mediated mRNA Decay (NMD), which reduces 
the abundance of transcripts carrying PTCs, has the potential to 
significantly reduce the effectiveness of this approach. In this study, we 
hypothesized that simultaneous inhibition of NMD and suppression of a 
disease-causing PTC will provide a synergistic increase in the amount of 
protein (and function) restored. To test this hypothesis, we constructed a 
knock-in Idua-W392X mouse that serves as a model for the lysosomal 
storage disease Mucopolysaccharidosis Type I-Hurler (MPS I-H, or Hurler 
Syndrome). The primary biochemical defect in MPS I-H is the 
accumulation of glycosaminoglycans (GAGs) in lysosomes. Thus, the 
reversal of GAG accumulation in this mouse model serves as an indicator of 
therapeutic correction of the primary biochemical defect associated with 
this disease due to suppression of the Idua-W392X mutation. We found that 
neither aminoglycosides nor PTC124 completely reversed GAG 
accumulation in either cultured MEFs or the Idua-W392X mouse. 
Interestingly, Real-Time PCR demonstrated that the Idua-W392X mRNA is 
subject to NMD in Mouse Embryo Fibroblasts (MEFs) and in various 
tissues from the Idua-W392X mouse. This suggested that NMD limits 
restoration of full-length protein from the PTC-containing mRNA. To test 
this possibility, we examined the ability of NMD inhibitors to enhance the 
level of PTC suppression observed. We found that the use of NMD 
inhibitory agents such as caffeine or NMDI-1 together with PTC 
suppression agents provided a larger decrease in GAG accumulation than 
PTC suppression alone. These results suggest that approaches to restore the 
abundance of a PTC-containing mRNA by NMD inhibition in conjunction 
with PTC suppression enhance the level of restored protein, leading to a 
greater overall therapeutic affect. The successful development of this 
combined therapeutic approach has the potential to improve the quality of 
life of many individuals with a wide range of genetic diseases. 
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The process of gene expression results in proteomes that are more complex 
than the corresponding transcriptomes or genomes. Translation contributes 
to this complexity as individual mRNAs can encode multiple peptides. 
Previously, work in eukaryotes has shown that ribosomes can initiate 
translation from the first AUG codon, a downstream codon, or multiple 
sites, depending on the mRNA and experimental paradigm. However, the 
variables that determine how ribosomes select initiation codons remain 
incompletely understood. Here we investigate initiation codon-accessibility 
as a possible variable using synthetic mRNAs with two in-frame AUG 
codons−both in excellent context. Translation of such an mRNA in COS-7 
cells was determined to be 5' cap-dependent, and to express the two 
encoded proteins. Initiation codon accessibility was decreased by using two 
different masking elements: an antisense locked nucleic acid 
oligonucleotide and an exon-junction complex. The deposition of the exon-
junction complex was directed by introducing an intron an appropriate 
distance downstream. When either element was used to mask AUG1, the 
ratio of the proteins synthesized changed, favoring the smaller protein. In 
addition, we observed that increased leader length by itself also changed the 
ratio of the proteins and favored initiation at AUG1. These observations 
demonstrate that initiation codon selection is affected by the accessibility of 
AUG codons, and is not necessarily determined by their order of occurrence 
(5'→3'). This study further suggests consideration of new mechanisms of 
translational regulation in eukaryotes involving modulation of AUG codon-
accessibility. 
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The oncogenic microRNA-155 (miR-155) is up-regulated in a number of 
lymphoid neoplasms and tumors of the breast, lung and pancreas. In all 
cases described, miR-155 reduces the expression of proteins from the 
targeted mRNAs. Our experiments now reveal that miR-155 stimulates 
translation of endogenous C/EBPβ mRNA into the N-terminally truncated 
C/EBPβ-LIP protein from a downstream AUG-codon. Using microRNA 
seed region mutation and rescue experiments we show that association of 
miR-155 with both a classical miR-155 binding site in the 3’UTR and an 
unconventional binding site in the 5’UTR is required for up-regulation of 
LIP. Our experiments reveal seed-sequence like base-pairing between miR-
155 and a conserved stem-loop structure covering the uORF-AUG initiation 
codon. In addition, our data suggest that concurrent interactions between 
miR-155::5’UTRβ and miR-155::3’UTRβ improves translation of the cis-
regulatory uORF. This produces more post-termination ribosomes that are 
competent for re-initiation at the downstream LIP-AUG. All regulatory 
aspects were reproducibly confirmed using both luciferase reporter systems 
and native C/EBPβ cDNA-based constructs. Furthermore, we could show 
that translational up-regulation of the C/EBPβ-LIP isoform, which itself has 
proliferation-promoting activities, is critically involved in miR-155 
dependent cell proliferation of cancer cells. Taken together, we present a 
novel mechanism for microRNA-mediated stimulation of translation, which 
further expands our understanding of the functional mode of microRNAs in 
gene regulation. Moreover, we can now explain the oncogenic activity of 
miR-155 through translational up-regulation of a proliferation-promoting 
factor (C/EBPβ-LIP) in addition to its known functions in post-
transcriptional repression of tumor suppressors. 
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In female Drosophila flies translational repression of msl-2 mRNA is 
important for survival and requires interaction of the protein Sex lethal 
(SXL) with specific binding sites in both the 5’ and 3’ UTR. In a dual 
inhibitory mechanism SXL employs two distinct modes of regulation that 
act via the individual UTRs (Beckmann et al., 2005). Here we report on the 
mechanism of the 5’UTR translational block that prevents scanning 43S 
pre-initiation complexes from reaching the MSL-2 coding sequence.  
We show that strong repression via this mechanism requires an evolutionary 
conserved inhibitory upstream open reading frame (uORF) that is 
specifically controlled by SXL bound to a regulatory element in the 
vicinity. SXL regulates the uORF in two complementary ways: it augments 
its inhibitory potential and also promotes recognition of the upstream 
translation initiation codon. RNA mutational analysis revealed that 
translation regulation via the uORF is independent of the encoded peptide 
and does not require a translation termination codon. This clearly separates 
msl-2 translational repression from previously reported uORF regulatory 
mechanisms that operate via re-initiation or peptide-mediated ribosomal 
stalling during uORF translation. Furthermore, we show that the uORF in 
combination with the SXL binding site is sufficient to confer translational 
repression to non-related reporters. Based on this knowledge of the 
minimally functional element we could identify a number of additional 
target mRNAs that are potentially regulated by SXL in a similar manner. 
Validation experiments confirmed SXL-dependent translational control on 
the first chosen candidate RNA, LRR47.  
Our findings highlight an important novel layer of translational control 
through protein-regulated uORFs – a potentially wide-spread regulatory 
mechanism in eukaryotic organisms with a large number of possible target 
mRNAs. 
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inhibitory mechanism restricts msl-2 mRNA translation for dosage 
compensation in Drosophila. Cell, 122, 529-540. 
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The mechanism of how internal ribosome entry sites (IRESs) directly 
recruit ribosomes internally to an mRNA is not understood. Therefore, we 
have taken the approach of using yeast genetics and a model IRES, the 
cricket paralysis virus (CrPV) intergenic region (IGR) IRES to identify 
important interactions between the IRES and the ribosome. The IGR IRES 
functions robustly in yeast and its initiation is the simplest of all IRESs; it is 
able to bind directly to 40S ribosomal subunits and recruit 60S subunits to 
form 80S complexes in the absence of any other factors. The ribosome 
consists of proteins and rRNAs, which are modified by methylations or 
pseudouridylations (Ψs) that are guided by snoRNAs.  
 
We have found that a ribosomal protein, RPS25, is required for IRES-
mediated translation. Importantly, cap-dependent translation is not affected 
by depletion of RPS25. The significance of our findings is not limited to the 
CrPV IGR IRES. We have also found that the HCV IRES, as well as some 
cellular IRESs, also rely on RPS25 for IRES activity. Therefore, 
functionally and structurally distinct IRES require RPS25. However, there 
are also IRESs, such as the picornaviral IRESs, which do not require RPS25 
and are only slightly inhibited when RPS25 is depleted. This suggests that 
there are at least two mechanisms of IRES-mediated initiation: RPS25-
dependent and RPS25 enhanced.  
 
Human cells from X-DC (X-linked dyskeratosis congenital) patients, which 
contain defects in rRNA Ψ, have a decrease in IRES-mediated translation 
with no defect in cap-dependent translation. We have recapitulated this 
phenotype in yeast by mutating CBF5, the yeast homologue of DKC1. 
Furthermore, by taking advantage of the fact that in yeast all snoRNAs are 
mapped to their Ψ site(s) on the rRNA, we have systematically screened Ψ 
sites to determine which rRNA modifications were required for IRES-
mediated translation. The vast majority of Ψs had no affect, however a few 
Ψ modifications, when deleted recapitulated defects observed for CBF5 
mutants. Specifically, IRES-mediated translation was reduced with no 
observed decrease in cap-dependent translation. Surprisingly, we identified 
one Ψ modification that when deleted increased IRES-mediated translation.  
 
Taken together these results clearly demonstrate differences between how 
IRESs and cap-dependent messages interact with the ribosome and begin to 
reveal how an IRES recruits and interacts with the ribosome.  
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The hepatitis C virus (HCV) uses a highly structured internal ribosome 
entry site (IRES) RNA to translate its genome. The HCV IRES RNA 
consists of three major domains (II-IV) spanning ~340 nucleotides that 
specifically bind eukaryotic initiation factor (eIF) 3 and the 40S ribosomal 
subunit. These domains work together in a coordinated mechanism to drive 
80S ribosome formation and the start of protein synthesis. Domain II of the 
IRES RNA, which wraps around the shoulder of the 40S ribosomal subunit 
and sticks into the decoding groove, is important for driving 80S formation. 
We have discovered that mutations made in the highly conserved apical 
loop of domain II (subdomain IIb), which lies closest to the 40S subunit’s 
E-site, retain the ability to form 80S complexes but are decreased in their 
ability to produce proteins. Hence, subdomain IIb is important for a step 
after 80S formation, but before successful progression to elongation. We 
used toeprinting and chemical probing analysis to test if IIb is important for 
proper orientation of the coding RNA in the decoding groove, possibly 
through alterations in ribosomal conformation; these studies reveal that 
even though the mutant IRESs form 80S ribosomes, the coding RNA may 
not be properly configured for downstream events. Interestingly, we have 
found that 80S ribosomes formed by these IIb mutants form peptide bonds 
as efficiently as those formed on wild-type IRESs, suggesting that the 
mutant IRESs are inhibited at the translocation step that occurs after peptide 
bond formation. This is the first report of the ability of the HCV IRES to 
alter events after 80S formation. This novel function for IIb may be due to 
its ability to affect ribosome function in a manner analogous to an E-site 
tRNA. 
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Fibroblast growth factor 1 (FGF1), a growth factor involved in muscle 
development and regeneration, is induced during myoblast differentiation. 
We have previously shown that FGF1 induction is both transcriptional and 
translational, involving specific and simultaneous activation of FGF1 
promoter A and IRES A at day 2 of differentiation (D2), whereas cap-
dependent translation is down-regulated (1). Strikingly, our data indicate 
that IRES-driven translation is clearly activated by a cis-acting element 
present in the promoter, revealing a novel mechanism of coupling of 
transcription and translation.  
In an attempt to decipher the molecular mechanism of such coupling, 
surface plasmonic resonance (biacore 3000) coupled to mass spectrometry 
(SPRSM) was used to identify proteins bound to FGF1 promoter and IRES 
A. Biotinylated RNA and DNA corresponding to FGF1 IRES and promoter 
A, respectively, were immobilized on the Biacore sensorchip and exposed 
to cell extracts of C2C12 myoblast at D2. Bound proteins were recovered 
and identified by mass spectrometry. This allowed us to identify hnRNPM 
as well as p54(nrb/nono) bound to the IRES RNA. Interestingly p54, a 
protein involved in transcription, was also bound to the FGF1 promoter A. 
Immunoprecipitation experiments allowed us to demonstrate that both 
proteins are present in the same protein complex and that this complex is 
translocated from nucleus to cytoplasm at D2 of myoblast differentiation. 
In order to analyse a potential IRES trans-acting factor (ITAF) function of 
the hnRNPM/p54 complex, knockdown of the proteins was achieved using 
siRNAs, and IRES activity was measured using classical bicistronic vector 
transfection. Results show that knockdown of either hnRNPM or p54 
generates a blockade of IRES activity, an effect observed in differentiating, 
but not in proliferating cells. No effect is observed on EMCV IRES activity. 
The present study reveals, for the first time, i) the ITAF function of the 
hnRNPM/p54 complex and ii) the binding of a similar protein complex to 
the promoter and the IRES of a same gene. This strongly supports the 
hypothesis that hnRNPM/p54 complex is first recruited by the promoter and 
then transfered to the IRES on the nascent mRNA in a co-transcriptional 
event, providing a molecular mechanism of transcription-translation 
coupling in FGF1 induction during myoblast differentiation. 
 
1) Conte et al, NAR 2009 
 
 327 
A CYTOPLASMIC CO-COMPLEX MEDIATES SPECIFIC ASH1-MRNA 
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For asymmetric mRNA localization, transcripts are recognized by dedicated 
RNA-binding proteins and incorporated into motor-containing messenger 
ribonucleoprotein particles (mRNPs). To date, the molecular assembly of such 
mRNPs is not well understood and most details on cargo specificity remain 
unresolved. The only mRNA-transport complex for which all core factors have 
been identified is the ASH1 mRNA-localization machinery in yeast. During 
mitosis, ASH1 mRNA and more than 30 other transcripts are actively 
transported from the mother cell to the daughter cell. After mRNP anchoring 
and cytokinesis, ASH1 mRNA is translated exclusively in the daughter cell. 
Specific recruitment of mRNAs into transport particles is thought to be 
mediated by its core RNA-binding protein She2p, which escorts the mRNA 
from the nucleus through the nucleolus into the cytoplasm. After nuclear export, 
the She2p-ASH1 mRNA complex binds to a co-complex consisting of the 
myosin-adapter She3p and the type V myosin motor Myo4p. In addition to 
She2p, three other RNA-binding proteins have been described to associate with 
localizing mRNAs.  
We performed reconstitution studies with recombinant proteins and RNA to 
follow the path of ASH1 mRNP assembly from the nucleus to the cytoplasm. 
We assessed binding affinities, specificities, and synergisms in complex 
assembly and confirmed key findings by in vitro and in vivo mutational studies. 
In contrast to the prevailing model, we found that no single RNA-binding 
protein of the ASH1 mRNP shows high specificity for localizing mRNAs. 
Instead a specific protein-protein interaction was observed, mediating the 
previously described nucleolar recruitment of the ASH1 mRNP. More 
importantly, we found that the cytoplasmic myosin adapter She3p is a 
previously uncharacterized RNA-binding protein with moderate specificity for 
localizing RNAs. The highly specific ASH1-mRNA binding required for 
selective transcript localization in vivo is achieved only by the co-complex of 
the rather unspecific RNA-binding protein She2p and the cytoplasmic myosin 
adapter She3p. Because this complex only forms in the cytoplasm, specific 
cargo recognition for ASH1 mRNA transport may also occur only during the 
late stage of cytoplasmic assembly of the mature myosin-transport complex. 
These data challenge the common view that localizing mRNAs are incorporated 
already with high specificity into immature mRNPs in the nucleus. Since no 
comparable study is available from higher eukaryotes, this work provides novel 
mechanistic insights into the assembly of mRNA-localization complexes in 
general. 
 
* Authors contributed equally 
 328 
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The processes of translational regulation and mRNA localization are 
intimately linked, with translation typically occurring only once the mRNA 
has reached its destination within the cell. In Saccharomyces cerevisiae, the 
localized mRNA ASH1 requires numerous trans-acting factors for both 
localization and translational repression en route. However, each factor’s 
full target repertoire and global effect on translation remain obscure. 
 
We have performed diverse genome-wide assays to determine the extent to 
which factors required for ASH1 regulation also regulate other cellular 
transcripts. Genome-wide chromatin- and RNA-immunoprecipitations 
identify an interconnected network of transcripts bound by these factors. 
Computational analysis shows these mRNA targets to be functionally 
related to each other and to ASH1. Analysis of protein and mRNA levels of 
individual transcripts demonstrates factor-dependent translational repression 
of the novel targets. 
 
To determine the effects of these factors on translational efficiency genome-
wide, we have applied ribosome profiling in both wild-type cells and in 
cells lacking each factor. This technique allowed us to identify which 
transcripts undergo translational regulation mediated by these factors. 
Additionally, it provides mechanistic information by mapping ribosome 
binding to specific nucleotides within the targeted transcripts in the 
presence and absence of each regulatory factor. Comparing the transcripts 
with aberrant translation to those bound by each factor indicates the extent 
to which these translational effects are direct. 
 
Together, our analyses provide a whole-genome portrait of translational 
regulation in Saccharomyces cerevisiae by factors affecting mRNA 
localization. 
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EMBRYONIC MICRORNA FAMILIES 
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MicroRNAs (miRNAs) play an important role in gene regulation during 
early animal development. To understand how miRNA-mediated silencing 
impacts on embryonic mRNAs, we conducted a functional survey of 
abundant maternal and zygotic miRNA families in the C. elegans embryo. 
Here, we show that the miR-35-42 and the miR-51-56 miRNA families 
define maternal and zygotic miRNA-induced silencing complexes 
(miRISCs), respectively, which share a large number of components. Using 
a novel cell-free C. elegans embryonic extract, we demonstrate that miRISC 
directs the rapid deadenylation of reporter mRNAs with natural 3'UTRs. 
The deadenylated targets are translationally suppressed, but are stable. 
Sampling of the predicted miR-35-42 targets reveals that approximately half 
are deadenylated in a miRNA-dependent manner, but with each target 
displaying a distinct efficiency and pattern of deadenylation. Interestingly, 
we identify toh-1, and the BH3-encoding egl-1 mRNAs as targets of the 
miR-35-42 family. Both mRNAs are also targeted by the miR-58, and miR-
80-82 miRNAs, which share seed sequence with Drosophila Bantam 
miRNA. Finally, we demonstrate that functional cooperation between 
distinct miRISCs within 3'UTRs is required for deadenylation to occur. 
Thus we demonstrate extensive and direct impact of miRNA-mediated 
deadenylation on embryonic mRNAs, and describe miRISC cooperation as 
a key factor in this mechanism. 
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The control of mRNA function by miRNAs in animal cells requires the 
GW182 protein. GW182 is recruited to the miRNA repression complex via 
interaction with Argonaute protein, and functions downstream to repress 
protein synthesis. Interaction with Argonaute is mediated by GW/WG 
repeats, which are conserved in many Argonaute-binding proteins involved 
in RNA interference and miRNA silencing, from fission yeast to mammals. 
GW182 contains at least three effector domains that function to repress 
target mRNA. Here, we analyze the functions of the N-terminal GW182 
domain in repression and Argonaute1 binding, using tethering and 
immunoprecipitation assays in Drosophila cultured cells. We demonstrate 
that its function in repression requires intact GW/WG repeats, but does not 
involve interaction with the Argonaute1 protein, and is independent of the 
mRNA polyadenylation status. These results demonstrate a novel role for 
the GW/WG repeats as effector motifs in miRNA-mediated repression.  
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VISITOR INFORMATION 
 
EMERGENCY                CSHL                          BANBURY 
Fire (9) 742-3300 (9) 692-4747 
Ambulance (9) 742-3300 (9) 692-4747 
Poison (9) 542-2323 (9) 542-2323 
Police (9) 911 (9) 549-8800 
Safety-Security Extension 8870  
 
Emergency Room 
Huntington Hospital 
270 Park Avenue, Huntington 
631-351-2300 
(1037)  
Dentists 
Dr. William Berg 
Dr. Robert Zeman 
 
631-271-2310 
631-271-8090 
Doctor 
MediCenter 
234 W. Jericho Tpke., Huntington Station 
631-423-5400 
(1034) 
Drugs - 24 hours, 7 days 
Rite-Aid 
391 W. Main Street, Huntington 
631-549-9400 
(1039) 
Free Speed Dial 
Dial the four numbers (****) from any tan house phone to place a 
free call. 
GENERAL INFORMATION 
 
Books, Gifts, Snacks, Clothing, Newspapers 
 BOOKSTORE   367-8837 (hours posted on door) 
 Located in Grace Auditorium, lower level. 
 
Photocopiers, Journals, Periodicals, Books, Newspapers 
 Photocopying – Main Library 
 Hours:  8:00 a.m. – 9:00 p.m. Mon-Fri 
             10:00 a.m. – 6:00 p.m. Saturday 
Helpful tips - Obtain PIN from Meetings & Courses Office  
to enter Library after hours.  See Library staff for photocopier 
code. 
 
Computers, E-mail, Internet access 
 Grace Auditorium 
 Upper level: E-mail only 
 Lower level: Word processing and printing. 
 STMP server address: mail.optonline.net 
 To access your E-mail, you must know the name of your  
 home server.    
 
Dining, Bar 
 Blackford Hall 
  Breakfast  7:30–9:00, Lunch 11:30–1:30, Dinner  5:30–7:00 
  Bar  5:00 p.m. until late  
 Helpful tip - If there is a line at the upper dining area, try the  
 lower dining room 
 
 
 
Messages, Mail, Faxes 
 Message Board, Grace, lower level 
 
Swimming, Tennis, Jogging, Hiking 
June–Sept. Lifeguard on duty at the beach. 12:00 noon–6:00 p.m.  
Two tennis courts open daily. 
 
Russell Fitness Center 
 Dolan Hall, west wing, lower level 
 PIN#:  Press 64495  (then enter #) 
 
Concierge 
 On duty daily at Meetings & Courses Office. 
After hours – From tan house phones, dial x8870 for 
assistance 
  
Pay Phones, House Phones 
Grace, lower level; Cabin Complex; Blackford Hall; Dolan Hall, 
foyer  
 
CSHL’s Green Campus 
 
Cold Spring Harbor Laboratory is pledged to operate in an 
environmentally responsible fashion wherever possible.  In the past, 
we have removed underground oil tanks, remediated asbestos in 
historic buildings, and taken substantial measures to ensure the 
pristine quality of the waters of the harbor. Water used for irrigation 
comes from natural springs and wells on the property itself.  Lawns, 
trees, and planting beds are managed organically whenever possible.  
And trees are planted to replace those felled for construction 
projects.   
 
Two areas in which the Laboratory has focused recent efforts have 
been those of waste management and energy conservation.  The 
Laboratory currently recycles most waste.  Scrap metal, electronics, 
construction debris, batteries, fluorescent light bulbs, toner cartridges, 
and waste oil are all recycled.  For general waste, the Laboratory uses 
a “single stream waste management” system, removing recyclable 
materials and sending the remaining combustible trash to a 
cogeneration plant where it is burned to provide electricity, an 
approach considered among the most energy efficient, while providing 
a high yield of recyclable materials. 
 
Equal attention has been paid to energy conservation.  Most lighting 
fixtures have been replaced with high efficiency fluorescent fixtures, 
and thousands of incandescent bulbs throughout campus have been 
replaced with compact fluorescents.  The Laboratory has also 
embarked on a project that will replace all building management 
systems on campus, reducing heating and cooling costs by as much 
as twenty-five per cent. 
 
Cold Spring Harbor Laboratory continues to explore new ways in 
which we can reduce our environmental footprint, including 
encouraging our visitors and employees to use reusable containers, 
conserve energy, and suggest areas in which the Laboratory’s efforts 
can be improved. This book, for example, is printed on recycled 
paper. 
                       1-800 Access Numbers 
 
 AT&T  9-1-800-321-0288 
 MCI  9-1-800-674-7000 
 
Local Interest 
 Fish Hatchery   631-692-6768 
 Sagamore Hill   516-922-4447 
 Whaling Museum   631-367-3418 
 Heckscher Museum  631-351-3250 
 CSHL DNA Learning  x 5170 
   Center 
 
New York City 
 Helpful tip - 
 Take Syosset Taxi to Syosset Train Station 
 ($8.00 per person, 15 minute ride), then catch Long Island  
 Railroad to Penn Station (33rd Street & 7th Avenue).   
 Train ride about one hour. 
 
   TRANSPORTATION 
Limo, Taxi 
 Syosset Limousine  516-364-9681  (1031) 
 Super Shuttle  800-957-4533  (1033) 
  To head west of CSHL - Syosset train station 
  Syosset Taxi  516-921-2141  (1030) 
 To head east of CSHL - Huntington Village  
  Orange & White Taxi 631-271-3600  (1032) 
Executive Limo  631-696-8000  (1047) 
 
Trains 
 Long Island Rail Road   822-LIRR  
 Schedules available from the Meetings & Courses Office. 
 Amtrak   800-872-7245 
 MetroNorth   800-638-7646 
 New Jersey Transit  201-762-5100 
 
Ferries 
 Bridgeport / Port Jefferson 631-473-0286 (1036) 
 Orient Point/ New London 631-323-2525 (1038) 
 
Car Rentals 
 Avis   631-271-9300 
 Enterprise   631-424-8300 
 Hertz   631-427-6106 
  
Airlines 
 American   800-433-7300 
 America West  800-237-9292 
 British Airways  800-247-9297 
 Continental   800-525-0280 
 Delta   800-221-1212 
 Japan Airlines  800-525-3663 
 Jet Blue   800-538-2583 
 KLM   800-374-7747 
 Lufthansa   800-645-3880 
 Northwest   800-225-2525 
 United   800-241-6522 
 US Airways   800-428-4322 
